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i 
Abstract 
 
The aim of this thesis was to evaluate the centralisation of emergency medical 
services (EMS) in different local hospitals into a single specialised emergency care 
hospital in terms of costs and quality of care. It also aimed to investigate preferences 
and trade-offs that individuals’ were willing to make to receive treatment at the 
centralised specialised emergency hospital. 
The economic evaluation method builds upon a systematic review of economic 
evaluation methods and types of economic evaluation that have been used to assess 
the performance of centralised healthcare specialities. 
A discrete choice experiment (DCE) was used to investigate preferences for 
centralised EMS and the trade-offs individuals were willing to make to receive 
treatment at the centralised hospital. The DCE identified preferences for: shorter 
travel times to the hospital; shorter waiting times; fewer days in hospital; low risk of 
death; low risk of readmission; and outpatient follow-up care in local hospitals. 
However, people were willing to trade-off increased travel time and waiting time for 
higher quality of specialised emergency medical care in the centralised hospital.  
A Markov model was developed to evaluate the costs and effectiveness of 
centralisation of EMS compared with non-centralised care. Multiple sensitivity 
analyses were carried out to assess whether centralisation had an impact on cost, 
quality and cost-effectiveness over the short and longer term. The incremental cost 
per QALY at one year (deterministic estimate £1,004 per QALY) and 10 years 
(deterministic estimate £636 per QALY) were both well below the threshold used by 
the National Institute for Health and Care Health Excellence (£20,000-£30,000 per 
QALY). There were fewer deaths in the centralised EMS compared with non-
centralised services (deterministic estimate: 31.47 fewer deaths at 1 year, 31.57 
fewer deaths at 10 years). Discounting the costs and outcomes at different rates did 
not alter conclusions.  
The economic evaluation suggested that centralisation of EMS into fewer more 
specialised units could be cost-effective, although cost-effectiveness may vary in 
specific population sub-groups. Sub-group analyses suggest that centralised EMS 
would be more cost-effective for elderly patients, the most economically deprived 
patients and those presenting with diseases of the circulatory system. These findings 
ii 
support the recommendations to centralise urgent and EMS in England. However, a 
cost benefit analysis that incorporated the results of the DCE into the economic 
evaluation suggested that centralised EMS could have negative societal value when 
compared with services provided in local hospitals. 
The implications of these findings, potential limitations of the methods used in this 
thesis and recommendations for future research are discussed. 
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Chapter 1. Introduction 
 
1.1 Background 
The National Health Services (NHS) was launched in 1948 with a fundamental 
principle that high quality health care should be available to all on the basis of clinical 
need and regardless of their ability to pay. Since its inception, it has provided 
universal health care services free at the point of use in the United Kingdom (UK), 
apart from some prescription fees in England and optical and dental services 
(National Health Services, 2016). The NHS has faced a rapid and consistent rise in 
the expenditure since it was launched. In 1948, the expenditure in NHS England was 
£437 million (today’s value roughly equivalent to £15 billion) and by 2015/2016 it was 
around £116.4 billion (National Health Services, 2016). In 2017/2018 the spending 
was around £125 billion (Full Fact, 2018). The NHS faces increasing pressure 
because of the increasing demand for health care services. Increasing demand is 
mainly due to the increasing strain of the changing population profile, the rise of long-
term chronic conditions and multimorbidity, increasing public/patient expectations, 
increasing costs of providing care and constrained financial and human resources. 
Taken together these pressure threaten the sustainability and financial stability of the 
NHS (NHS England, 2013c). The reasons driving the increasing demand for 
healthcare services in the NHS are described in the following sub-sections. 
 
1.1.1 Changing population profile 
The UK population was about 50 million (Office for National Statistics, 2014b) in the 
year 1948 when the NHS was launched and it now increased to about 66 million in 
2017 (Office for National Statistics, 2018b) and projected to continue rising to 73.3 
million by the year 2037 (Office for National Statistics, 2014a). Furthermore, the 
increasing ageing population aggravates the pressure on the NHS. There were 
nearly 12 million people aged 65 years and over (18.2% of the UK population) in 
2017 (Office for National Statistics, 2018b). The ageing of the UK population is 
projected to continue over the next few decades, with the fastest population 
increases in the numbers of those aged 85 and over (Office for National Statistics, 
2012). The population of those over 85 was estimated at 1.4 million in 2012 and is 
projected to be 3.1 million in 2032, more than doubling over a 20 year time period 
2 
(Office for National Statistics, 2014a). This growth has been the result of improved 
nutrition, housing, social welfare and health care services have meant that people 
are living longer than before and it is a matter to celebrate. However, an ageing 
population has implications in terms of demand and use of health and social care 
services. An analysis shows that in the past 20 years hospital admissions have 
increased much more rapidly in comparison to the increase in population and the 
increase is much higher and notable in those over 85 years (Ham et al., 2012). Age 
is one of the important factors associated with the bed occupancy in hospital 
emergencies. Patients under the age of 65 use only about 0.2 hospital emergency 
bed days whereas those over 85 use more than 5 bed days in an average year 
(Imison et al., 2012). The average length of stay of an emergency admission also 
varies with age. Older people are more likely to be ill and account for the majority of 
the inpatient admissions (Cornwell et al., 2012) and tend to stay longer in hospitals. 
An analysis of 2009/2010 data shows that average length of stay was approximately 
3 days in patients under 65 years of age, but 9 days for those above aged 65 and 11 
days for those above age 85 (Imison et al., 2012). These figures need to be 
interpreted with caution as it is not clear whether they were adjusted for severity of 
illness in the elderly. It is possible that the observed length of stay is due to the 
severity of illness with the increasing age, rather than age alone. Older patients are 
more likely to be readmitted to the hospital within month of discharge from the 
hospital and among the elderly the fastest rise in readmissions was observed in 
people older than 75 years in the past 20 years (Cornwell et al., 2012). In 2009-2010, 
emergency readmissions to hospital within 28 days of discharge from hospital were 
5.1% higher for people over 75 when compared to those between 16-74 years of age 
(Lawrie and Battye, 2012). In the decade between 2000/2001 and 2009/2010, 
emergency readmissions within 28 days of discharge from hospital rose 3.9% for 
people over 75 years compared to 2.5% in those in 16-74 age group (Lawrie and 
Battye, 2012). However, as statistical tests were not conducted it is unclear if this is a 
real difference or just an artefact of the data (Lawrie and Battye, 2012). 
 
1.1.2 Long-term chronic conditions and multi-morbidity 
Multi-morbidity increases substantially with age (Barnett et al., 2012). In England, 14 
% of the population under 40 years of age report having a long-term condition 
whereas 58% of those aged 60 and over report having a long-term condition, with 
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25% of over 60 years having two or more long-term conditions which include heart 
disease, stroke, cancer, diabetes, arthritis, and or dementia (Department of Health, 
2012; Melzer et al., May 2012, selected graphs updated August 2013). People with 
long-term conditions are extensive users of health care services and the average 
health care costs incurred by those with long-term conditions are much higher than 
those without (Department of Health, 2012). Among those with long-term conditions, 
patients with more than one long-term conditions have more health care needs and 
cost more than those with single conditions (Department of Health, 2012). The 
population of patients with multiple long-term conditions was 1.9 million in 2008 and 
was predicted to rise to 2.9 million in 2018 (Department of Health, 2012). Dementia 
often complicates multimorbidity and it is estimated to incur more costs than the 
combined costs of heart disease, stroke and cancer (Oliver et al., 2014) and costs 
associated with dementia are far higher than costs of all other mental health 
conditions put together (McCrone et al., 2008). Dementia is increasingly common in 
old age. There were 815,827 people with dementia in the UK in 2013; a majority of 
them (773,502 people) were over 65 years of age (Prince et al., 2014). By 2025, the 
number of population with dementia in the UK is forecast to be 1,142,677; a 40% 
increase from 2013 (Prince et al., 2014). The estimated cost of dementia to the 
English NHS, local authorities and families in 2014 was £26.3 billion a year , which is 
set to rise with the increase in dementia in the ageing population (Prince et al., 2014). 
 
1.1.3 Increasing costs and public expectations 
Development of new and more sophisticated technologies and extensive treatment 
procedures that could ever have been expected when the NHS was first launched is 
another reason behind increasing costs of the health care service (NHS England, 
2013c). New technologies and treatment methods which cost more and are hopefully 
more effective, are replacing the older and (hopefully) less effective ones. Increasing 
health seeking behaviour and changing public expectation may also be influence in 
the increase in healthcare demand and costs. The NHS is struggling to match the 
supply of funding with the increasing health care demand (NHS Confederation, 
2013b), indeed since its inception, costs in healthcare have increased at a higher 
rate than the costs in the economy and spending in the NHS has outpaced the 
growth in gross domestic product (GDP) (Appleby, 2013). An analysis by NHS 
England predicts that continuing with the current model of health care will lead to a 
4 
funding gap of around thirty billion pounds between 2013/2014 and 2020/21 in 
England (NHS England, 2013c). 
 
1.1.4 Human resource constraint 
The increasingly constrained human resources is another issue pressurising the 
NHS. The European Working Time Directives has restricted the maximum hours that 
doctors and trainee doctors are allowed to work to 48 hours a week, unless the 
individual opts out (Independent working time regulations taskforce, 2014). While this 
time restriction has beneficial impact on patient safety by preventing doctors from 
working long hours, it has stretched the already limited number of human resources 
in the NHS (Institute for Public Policy Research, 2006). The reduction in hours that 
doctors’ work comes at a time when healthcare demand is continuously increasing 
and this has further exacerbated the human resource constraint in certain 
specialities. The presence of consultants in the specialised acute services is vital for 
the delivery of high quality care and efficient processes (Geelhoed and Geelhoed, 
2008; White et al., 2010; Fielding et al., 2013), however there is a growing concern 
about the number of consultants available (College of Emergency Medicine, 2010; 
Higginson et al., 2013). The number of doctors choosing to specialise in emergency 
medicine has been insufficient to meet the growing need as assessed by NHS 
England and this poses a serious threat in future supply of consultants in emergency 
medicine and the sustainability of emergency care (NHS England, 2013b). The 
current staffing levels in most of the emergency department in England are not 
considered adequate (Higginson et al., 2013) and as of 2010 estimates, the total 
number of whole time equivalent emergency medicine consultants available in 
England were 852, which was far less than the required 2222 for the Emergency 
Department attendance levels then (College of Emergency Medicine, 2010). This 
shows a clear shortage of consultants, which may compromise the ability to provide 
high quality care and maintain the safety of patients. Shortage of consultants in the 
emergency departments across UK has led to the increasingly heavy reliance on 
locum doctors (Hassan et al., 2013), which in turn has increased expenditure despite 
other pressures on the NHS to reduce the costs (HCL Workforce Solutions, 2013). It 
will be harder for small and rural hospitals to recruit and retain enough emergency 
consultants providing round the clock acute care services and expensive locum cover 
will result in severe financial implications (NHS Confederation, 2013a). 
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1.2 Centralisation of Specialised Health Services 
Over the past decade, the benefits of reconfiguration of certain specialised health 
services in the NHS have been a subject of debate (Meadows et al., 2011). There is 
increasing evidence that centralisation offers the opportunity to make more intensive 
use of the services, which may offer economies and provide one stimulus to quality 
by concentrating and enhancing expertise. Simpson and colleagues report the 
increased quality of outcomes in terms of improved services, increase specialist 
presence and speedy access to the hospital beds for the seriously ill and injured 
patients after the centralisation of accident and emergency departments of three 
different hospitals (Simpson et al., 2001). Lord Darzi’s report recommended 
reorganisation of stroke and major trauma services in London into specialised 
services centralised in fewer high volume units catering to large populations with 
high-tech facilities and comprehensive consultant presence (Darzi, 2007). Lord 
Darzi’s and The National Stroke Strategy (Department of Health, 2007) 
recommendations led to the publication of London specific stroke strategy 
(Healthcare for London, 2008), which made the most significant recommendation to 
consolidate of stroke services into fewer specialised units to provide high quality 
stroke care and better patient outcomes. A study which assessed and compared the 
costs and outcomes before and after consolidation of stroke services in London, 
concluded that consolidating acute stroke services into fewer specialised units 
improves clinical outcomes while also being cost-effective (Hunter et al., 2013). 
Another model based study showed that redirection of stroke patients away from 
localised acute services to regional services improved outcome with small additional 
costs (McMeekin et al., 2013). A recent study investigating the impact of centralising 
acute stroke services in English metropolitan areas concluded that centralisation can 
reduce mortality and length of hospital stay (Morris et al., 2014). There is also an 
increasing evidence of improved outcomes achieved by the centralisation and 
increased volume of specific specialised healthcare services such as cleft care 
(Fitzsimons et al., 2012), cancer care (van Gijn et al., 2010; Woo et al., 2012; 
Brusselaers et al., 2014; Ravi et al., 2014), cardiovascular care (Fosbol et al., 2013), 
vascular surgery (Holt et al., 2007; Young et al.) and major trauma care (Gabbe et 
al., 2012; Metcalfe et al., 2014), showing a link between the volume of activity and 
the clinical outcomes. Evidence also supports that integrating emergency care 
services within departments of the same hospital also results in reduced mortality 
and better quality of care (Boyle et al., 2012). 
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While the study on consolidation of stroke services in London (Hunter et al., 2013) 
was of good overall quality, it does not mention whether it considered the viability of 
local hospitals after removal of acute stroke services. There are increasing concerns 
that centralisation will threaten the viability of local hospitals because of the reduced 
volume of patients’ attendance when some specialised services are moved away. 
Studies (McMeekin et al., 2013; Morris et al., 2014) show improved outcomes 
however, it should be noted that spillovers (effects of an intervention on population 
other than those targeted), possibly because of increased patients to the specialised 
centralised hospital from the surrounding areas, who would otherwise have been 
treated in their own local hospitals, may have biased the results in favour of 
centralisation. 
 
While evidence demonstrates better outcomes and economic benefits (Hunter et al., 
2013; Eichler et al., 2014) of reorganisation of hospitals or specialities, there are also 
some concerns whether centralisation offers economies of scale and whether it is 
cost-effective (Ke et al., 2012). Another important concern is the impact of 
centralisation on access to healthcare services. Healthcare services may be less 
accessible and may reduce quality of health outcomes as journey time increases 
after centralisation (Kelly et al., 2016). Specialised emergency centres may not be 
closer to peoples home and the better quality and specialised health care services 
may come only at the cost of increased travel times to the point of care. Populations 
living in rural areas already have poor access to the healthcare compared to those 
living in urban areas and there are concerns that centralisation may only benefit the 
urban majority and will further widen the urban-rural inequality of healthcare access 
(Baird and Wright, 2006). Increases in journey distances between home and hospital 
where the patient is admitted may also be associated with increased mortality 
(Nicholl et al., 2007; Wei et al., 2008). It is suggested that an increase of 10km in 
straight-line distance is associated with around one percent absolute increase in 
mortality (Nicholl et al., 2007). However, this may not always be the case. A study 
found that longer distances arising out of hospital centralisation were not associated 
with increased inpatient mortality in a range of time-sensitive conditions (Hsia et al., 
2012). In the UK, a vast majority of population live within 20km of their nearest 
Accident and Emergency (A&E); closing or downgrading the A&E in some cases will 
double the distance from home to hospital for emergency admissions and this may 
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have a large impact on local population (Roberts et al., 2014). In practice, time to 
appropriate treatment of emergencies is more important than the geographical 
distance and the effect of increased distance may be offset by better road networks 
and improved ambulance services. It is not known whether centralisation delays the 
time to get appropriate care. Furthermore, ambulance paramedics services can 
increasingly provide appropriate treatment in some cases and the availability of 
specialised team in a centralised emergency services may improve access and 
reduce the in house delay in getting appropriate clinical treatment; this may 
compensate for the increased journey time to arrival (Spurgeon et al., 2010). 
 
Centralisation of services is thought to have implications in access to care and is a 
matter which cannot be ignored when redesigning services (Mungall, 2005; 
Stitzenberg et al., 2009); a trade-off exists between increased travel times and 
improved clinical outcome and patient safety. There are also fears of distance decay 
effect; where the utilisation of healthcare services decreases with the increase in 
travel distance to the healthcare facility (Turnbull et al., 2008; Raknes et al., 2013). 
Decreased health service utilisation may have an effect in the population health and 
wellbeing. 
 
Another concern with centralisation of specialised services is patient preferences. It 
has not been formally examined what choice society is likely to make in the trade-offs 
between perceived advantages and disadvantages of current services compared with 
centralised services (Barratt and Raine, 2012). Some early studies whose findings 
were based on conjoint analysis (Shackley et al., 2001) and standard gamble 
(Finlayson et al., 1999) techniques of preference elicitation, showed that majority of 
patients prefer local treatment to the centralised one despite the higher mortality and 
morbidity in the local services. Contrary to these finding, more recent studies which 
generated preferences using a modified standard gamble technique (Landau et al., 
2013) and using questionnaires covering a number of discrete service attributes (Holt 
et al., 2010), concluded that patients are willing to travel longer distances to receive 
better quality of care in a specialised unit. A possibility that preferences were 
incorrectly estimated in these studies cannot be ignored because their findings were 
based on preference elicitation techniques other than a discrete choice experiment 
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(DCE) (Ryan et al., 2008). DCEs offer strong and useful results (van Helvoort-
Postulart et al., 2009) with a better understanding of how people make choices 
(Louviere et al., 2010) and they are favoured over other preference elicitation 
techniques. It is also possible that the differences between results of these studies 
may be due to the differences in population profiles which consequently may differ in 
perception of scale of adverse events and their impact. In Great Britain people 
already travel 30% longer for other trips such as work, shopping and leisure than the 
average distance they need to travel to emergency hospitals from their homes 
(Roberts et al., 2014), then why people would not be willing to travel a bit longer 
distances to get quality health care? It may be suggested that people may value the 
proximity of local NHS services, but may prefer to travel longer distances depending 
on the seriousness of the condition when specialised expertise and better quality of 
care is needed. However, there is paucity of evidence. 
 
The possible social impact of centralisation of specialised health care cannot be 
ignored (Meadows et al., 2011). Getting specialised healthcare may become stressful 
and unpleasant to the patients and families because of the likelihood of reduced 
choice and increased travel time and costs. There may be strong social attachment 
to the local healthcare services and local people may protest against the closure, 
downgrading or moving away of local services to elsewhere. 
 
1.3 Emergency Medical Services 
The increase in demand and costs of health care services is set to continue with the 
increase in ageing population with increasingly complex and often multiple, long-term 
conditions. A radical and transformative change is essential for the NHS to survive 
without compromising on safety and quality of health care services. While efforts to 
reduce waste (i.e. eliminate activities that incur costs but with no reductions in 
quality) are important, the NHS must respond to the increasing demand and will need 
to consider tough choices, some of which may reduce the quality of care for some 
patients. While all areas of health care face unprecedented challenges and major 
changes in healthcare service provision, the challenges faced by acute hospitals are 
larger because they spend a major proportion of the healthcare budget. One area 
where commissioners and policy makers have to make tough choice is in Emergency 
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Medical Services (EMS). EMS are struggling to cope with the increasing demand and 
extra pressures on resources described above from the ageing population with high 
levels of dementia and changing patterns of disease (Fahy et al., 2011). 
 
While there exists some disease specific evidence that centralisation of specialised 
services yields better clinical outcomes with financial savings, there are arguments 
against centralisation in terms of poor patient access, increased travel time and 
costs, and patient preferences. In NHS England, emergency medical services are 
typically provided by district general hospitals (local hospitals) and there is pressure 
to consolidate these services in fewer more specialised emergency medical service 
units that cover larger populations. Consolidation of specialised medical care is one 
of the new care models envisaged by the NHS “Five year forward view” (NHS 
England, 2014). The review by Sir Bruce Keogh recommends reconfiguration of 
emergency care and the development of centralised and more specialised 
emergency units that benefits patients with more serious and life threatening 
conditions by providing more expertise and potentially better quality of care (NHS 
England, 2013a). Therefore, emergency medical service provided in district general 
hospitals within the English NHS are expected to continue to centralise into fewer, 
more specialised, emergency units. Centralisation of services is only one option 
however, and there are alternative ways that such services could be reconfigured, 
e.g. shifting the balance of care by enhancing the role of the ambulance service, 
shifting some of the health care services from local hospitals to the community much 
closer to patients home, increasing the role of telehealth and telemedicine, 
enhancements to the NHS 111 service (NHS England, 2014). In each different model 
of service provision there are groups of patients who could benefit and groups that 
could lose out. Little is known about implications of different service configurations or 
about societal preferences relating to equity of access and overall outcome about 
how emergency medical services could be reorganised. 
 
1.4 Objectives 
The discussion in earlier sections of this Chapter warrants the aim and objectives of 
this thesis. Whilst it would have been valuable to assess and compare the 
implications of various alternative configurations of emergency medical services, it 
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was not feasible to carry out all of these in terms of time and resource limitations of 
this thesis. Hence, the case of centralisation of emergency medical services is the 
only focus of this thesis. The aim of this thesis is to analyse the costs and quality 
implications of centralisation of emergency medical services. 
 
The thesis addresses the following questions: 
i. What is the methodological quality of existing economic evaluations 
considering centralisation of specialised healthcare services and are these 
sufficient to inform judgements on the cost-effectiveness of centralisation? 
ii. What are the preferences for emergency medical services and what trade-offs 
society would be willing to make if emergency medical services were 
centralised? 
iii. What are the short and long term implications in terms of cost and quality after 
centralisation of emergency medical services and which configuration 
approach (provided from local hospitals or provided from centralised 
specialised hospital) offers the best utilisation of available resources? 
iv. Which emergency medical service configuration provides the best value for 
money spent? 
 
1.5 Structure of rest of the thesis 
 
The remaining thesis is structured into Chapters as follows. 
Chapter 2 addresses the first question and presents the systematic review of 
economic evaluations on centralisation of specialised healthcare services and reports 
the methodological quality of existing studies. It also describes why it was important 
in this thesis to carry out a systematic review of existing economic evaluations 
considering centralisation of specialised healthcare services. 
 
Chapter 3 provides an overview of preference elicitation techniques that are used in 
healthcare and justifies the importance of eliciting preferences in healthcare. Along 
with this, it also highlights why a discrete choice experiment was the most 
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appropriate preference elicitation technique to use to address the issues focused on 
within this thesis. 
 
Chapter 4 addresses the second research question. It reports the development of the 
discrete choice experiment which explored the public preferences of emergency 
medical services and quantifies the strength preferences towards different 
emergency medical care service configurations (local versus distant location of 
emergency services). It examines how individuals weigh up and trade-off between 
attributes of emergency medical service. The results from this Chapter are also 
utilised to inform the economic evaluation model in Chapter 6. 
 
Chapter 5 provides a robust methodological background to the economic evaluation 
methods used in Chapter 6. It describes the methodological development of an 
economic evaluation model with the focus on decision analytic model framework. The 
Chapter demonstrates methods of assessing and presenting the uncertainties in 
cost-effectiveness estimates. 
 
Chapter 6 addresses the third and fourth research questions. It describes the 
economic evaluation of centralised specialised emergency medical service compared 
with those provided at local hospitals using data from a UK setting. It first describes 
the use of the decision analytic framework to conduct the economic evaluation of 
centralised provision of emergency medical care compared with the local provision 
and then presents the summary of the results. The Chapter also incorporates the 
results of the discrete choice experiments described in Chapter 4 into the economic 
evaluation. 
 
Chapter 7 provides an overview and discussion of the main findings (reported in 
Chapter 2, Chapter 4, and Chapter 6) of this thesis. It highlights the main 
contributions of the thesis and policy implications followed by the outline of major 
strengths and limitations. It also suggests areas for further research. Finally, Chapter 
7 provides an overall conclusion of the work focussed in this thesis.  
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The next Chapter presents the systematic review of economic evaluations on the 
centralisation of specialised healthcare services and reports the methodological 
quality of existing studies.   
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Chapter 2. Economic Evaluations on Centralisation of Specialised 
Healthcare Services 
 
2.1 Introduction 
Chapter 1 provided an overview of centralisation of specialised healthcare services 
and provided an outline for this thesis. The aim of the work described in this Chapter 
is to systematically review and critically appraise the methodological quality of 
economic evaluations considering centralisation of specialised healthcare services to 
ensure that the development of economic evaluation described in Chapter 6 is 
informed by strong methodology. A journal paper based on this Chapter has been 
published (Bhattarai et al., 2016). This Chapter addresses the first research question 
set out in Chapter 1. 
 
The Chapter is structured as follows: section 2.2 provides a brief overview of the 
importance of systematic review of economic evaluation methods used in 
centralisation of specialised healthcare services, section 2.3 describes commonly 
used economic evaluation methods, section 2.4 describes the methods used in the 
systematic review, section 2.5 presents the results of the systematic review, section 
2.6 discusses the findings before the concluding the Chapter in section 2.7. 
 
2.2 Importance of Systematic Review of Economic Evaluation Methods in 
Centralisation 
Centralisation of specialised healthcare services is typically characterised by 
reorganisation of healthcare services into fewer specialised units serving a higher 
volume of patients and aims to improve patient outcomes and efficiency. As outlined 
in Chapter 1, Lord Darzi’s 2007 report (Darzi, 2007) recommended the reorganisation 
of London stroke and major trauma services into specialised centralised higher 
volume units catering for large populations with high-tech facilities and senior medical 
continuity. A number of studies suggest that reconfiguring healthcare services into 
fewer consolidated units will lead to increase in high quality care and better patient 
outcomes (Simpson et al., 2001; Fitzsimons et al., 2012; Gabbe et al., 2012; Woo et 
al., 2012; Fosbol et al., 2013; Metcalfe et al., 2014; Morris et al., 2014; Ravi et al., 
2014). Cost savings arguably resulting from the economies of scale is also one of the 
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driving force behind centralisation of healthcare services (Posnett, 1999; Imison et 
al., 2014). However, redistribution of limited resources could have secondary or 
unpredictable effects such as increased costs of access for patient and their carer. 
Increased journey distance to hospital may reduce healthcare utilisation particularly 
in some groups of population such as the elderly, those with poor socio-economic 
status and those with poor access to transport (Posnett, 1999; Mungall, 2005; Lee et 
al., 2007; Turnbull et al., 2008). Increased journey distance may also lead to 
increased risk of mortality in patients with life threatening medical emergencies 
whereas in some cases the benefits of specialised care in centralised healthcare 
services may outweigh the detriments of increased travel times (Nicholl et al., 2007). 
Thus, it is important to understand the trade-off between the quality of care and cost 
of centralisation. Economic evaluation methods can be used to explore this trade-off 
and inform decisions as to whether the resources required or redistributed to 
centralise services are “worth” the health outcomes achieved. 
 
Economic evaluations are increasingly used in decision-making (Eddama and Coast, 
2008; Simoens, 2010; Gray and Wilkinson, 2016) but the methodological rigour 
varies and this can lead to erroneous conclusions being drawn. Therefore, when 
considering the economic evidence on centralisation of healthcare services it is 
important to systematically identify relevant economic evidence and to appraise the 
methodological quality. Such a review has not hitherto been published. It was also 
important that the development of economic evaluation, described in Chapter 6 of 
this thesis, is informed by studies using strong methodological quality. 
 
2.3 What are Common Economic Evaluation Methods? 
Economic evaluations compare the costs and consequences of two or more 
competing healthcare interventions to identify which makes best use of limited 
resources. On the basis of the consequences measured and valued, the full 
economic evaluations techniques are commonly classified as cost-effectiveness 
analysis (CEA), cost consequence analysis (CCA), cost-benefit analysis (CBA) and 
cost-utility analysis (CUA) and can be based on primary empirical studies such as 
trials, decision analytic modelling or a combination of the two approaches 
(Drummond et al., 2005). 
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In CEA, costs are related to single, common effect that may differ in magnitude 
between the alternatives compared, for example life years gained, premature births 
averted, discharge from hospital. CEA is often useful to decision-makers in situations 
where costs per disease/condition specific outcomes are important, for example cost 
per discharge from the hospital. However, different diseases/conditions are 
presented on different outcomes posing a problem in comparison between 
diseases/conditions. This makes CEA inappropriate for cases where decision-makers 
have to assess opportunity cost (i.e. benefits forgone) of selecting one program over 
another (Drummond et al., 2005). 
 
CUA is essentially a variant of CEA where the outcome is presented in terms of a 
generic measure of health gain, usually the Quality Adjusted Life Years (QALYs). 
CUA allows comparison between competing healthcare programmes on a single 
outcome measure such as cost per QALY. 
 
CBA allows the monetary valuation of health outcomes that can be interpreted 
alongside costs of the programme. The results of CBA are either stated as the ratio 
of costs to benefits or in terms of net benefit of one programme over another 
(Drummond et al., 2005). Where functioning markets exist, monetary valuation of the 
outcomes is undertaken using prices revealed in the market. But, where no such 
markets exist outcomes are monetised using techniques of willingness to pay (WTP) 
(Drummond et al., 2005). CBA is useful in resource allocation decisions across 
sectors of economy. 
 
In CCA, costs are presented alongside a number of outcomes. The costs and 
outcomes are not formally combined in a CCA but it allows decision-makers to make 
their opinion of the importance of those health outcomes and costs of a healthcare 
programme in their context. CCA is particularly useful when little is known about the 
programme/intervention under evaluation and it is difficult to identify an appropriate 
outcome measure to use CEA. 
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2.4 Methods 
 
2.4.1 Search strategy 
 A comprehensive and systematic literature search in the database of PubMed, NHS 
Economic Evaluation Database (NHS EED), Health Economic Evaluation Database 
(HEED), and Excerpta Medica database (EMBASE) was first undertaken in January 
2015 to identify studies on economic evaluation of centralisation of any health care 
services. The search was updated on 10th March 2016 to check for any new 
publications. However, HEED and NHS EED ceased their searches in December 
2014, so 31st December 2014 is the date of last search of HEED and NHS EED. In 
addition, the reference lists of the retrieved articles from the search were also 
manually searched for relevant publications. Google was also used to check for 
relevant articles. The search was performed using an extensive search strategy 
using keywords and free text for each of the databases, with no restrictions on date 
and year of publication. A detailed search strategy is shown in Table A1 in Appendix 
A. The Preferred Reporting Items for Systematic Review and Meta-Analyses 
(PRISMA) guidelines were closely followed to during this review (Moher et al., 2009). 
 
2.4.2 Selection criteria 
Inclusion/ exclusion criteria were used to select studies. Studies were included in the 
review according to the following criteria: 
1. Full economic evaluations comparing costs and consequences of at least two 
alternatives were included i.e. those using the following methodologies: CCA, 
CEA, CUA, or CBA, were included. Partial economic evaluations i.e. those not 
involving comparison between alternatives or not relating costs to benefits or 
those studies which only considered costs analysis / comparison / description 
were excluded. 
 
2. All relevant health economic evaluations were considered, including those 
alongside high quality randomised trials, modelling studies based on a meta-
analysis of data from high quality randomized trials or utilising secondary data 
from literature and those based upon observational studies or analysis of large 
administrative databases. 
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3. Literature reviews and studies focussing only on methodology were excluded. 
Reviews, letters, comments, conference abstracts and other general articles 
which limited the assessment of their methodological quality were also 
excluded. 
 
4. Only publications in the English language were included. 
 
5. An assessment of centralisation of any specialised healthcare service was 
included; assessment of institutional/hospital volume of activity as a proxy for 
centralisation was included but excluded those assessing centralisation on the 
basis of surgeon/physician volume which measure individual clinician impact 
rather than the service. It was assumed that the outcomes achieved by a 
surgeon/physician are mainly driven by the resources provided at the 
institutional level. 
 
6. Only publications from peer-reviewed journals were included; it is expected 
that studies published in peer-reviewed journals have already undergone 
some basic checks on their quality. 
 
2.4.3 Data extraction 
Data extraction from the full texts included in the review was focussed on key 
methodological features such as study objective, population, type of economic 
evaluation, overall design, economic perspective, time horizon, comparator and 
intervention, incremental costs and outcomes and handling of uncertainties. The 
author of this this thesis independently carried out the extensive search and 
extracted the information from the selected studies, reviewed the evidence and wrote 
the manuscript while the supervisory team contributed to the critical revision of the 
manuscript and provided critical comments. 
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2.4.4 Quality assessment 
Studies were assessed for their reporting quality using a template (Appendix A:Table 
A2) based on the Consolidated Health Economic Evaluation Reporting Standards 
(CHEERS) (Husereau et al., 2013) and Drummond’s (Drummond and Jefferson, 
1996) checklists. Scoring systems for quality ratings of included studies were not 
used, but important aspects of economic evaluations were summarized. 
 
2.5 Results 
 
2.5.1 Literature search 
The literature search of the databases initially generated 11,544 hits of potentially 
relevant articles. Screening of titles and abstracts resulted in 86 articles which 
appeared to meet the eligibility criteria. After a detailed review of full text of these 
articles, 27 articles were excluded. The reasons for exclusion of these full text were: 
not a full economic evaluation (12), only analysing surgeon volume (8), not analysing 
centralisation aspects (5), not an economic evaluation (1) and not a peer reviewed 
journal publication (1). References from identified papers were also cross checked 
and a further five full text articles were identified and included. A total of 64 full text 
articles met the inclusion criteria and were finally considered in this review (Figure 
2.1). A list of studies included in the review is available in Appendix A, Table A3. 
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Figure 2.1: PRISMA flow diagram of the study selection 
  
2.5.2 Key characteristics of economic evaluations 
An overview of the key characteristics of economic evaluations included in the review 
is presented in Table 2.1. 
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Table 2.1: Summary of key characteristics of studies included in the review 
Characteristics Number of 
studies 
Study Reference (Appendix A, Table A3) 
Study Country   
UK 2 10, 31 
Germany 1 6 
Netherlands 3 7, 11, 55 
Canada 1 13 
USA 47 1, 2, 3, 4, 5, 8, 9, 12, 14, 17, 18, 19, 20, 22, 23, 24, 25, 26, 27, 
28, 29, 30, 33, 34, 35, 36, 37, 38, 39, 40, 44, 45, 46, 48, 49, 
50, 52, 53, 54, 56, 57, 58, 59, 60, 62, 63, 64 
Taiwan 4 15, 32, 43, 51 
Japan 4 16, 21, 42, 47 
South Korea 2 41, 61 
Aspect of centralisation   
Hospital Volume 51 1, 2, 3, 4, 6, 8, 9, 12,15,16,17,18,19, 20, 21,22, 24, 25, 26 ,27, 
28, 29, 30, 32, 33, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 
46, 47, 48, 49, 50, 51, 52, 53, 57, 58, 59, 60, 62, 63, 64 
Hospital Location 2 11, 31 
Healthcare Specialisation 10 5, 7, 10, 13, 14, 23, 34, 54, 55, 61 
Multidisciplinary care 1 56 
Study Design   
Decision analytic modelling 11 4, 5, 6, 8,10,11, 12, 27, 54, 55, 60  
Cohort 34 1, 2, 3, 7, 8, 13, 14, 15, 17, 18, 19, 23, 24, 25, 26, 29, 32, 35, 
36, 39, 42, 43, 44, 47, 51, 52, 53, 56, 57, 58, 59, 62, 63, 64,  
Case-control 2 33, 45 
Cross-sectional 15 9, 16, 20, 21, 22, 28, 30, 37, 38, 40, 41, 46, 48, 49, 50,  
Before-And-After 3 10, 31, 61 
Case series 1 34 
Economic evaluation type   
Cost Utility Analysis (CUA) 10 4, 5, 6, 10, 11, 13, 14, 27, 54, 55 
Cost-effectiveness Analysis 
(CEA) 
4 7, 8, 12, 56 
Cost Consequence Analysis 
(CCA) 
50 1, 2, 3, 9, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 28, 29, 
30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 
46, 47, 48, 49, 50, 51, 52, 53, 57, 58, 59, 60, 61, 62, 63, 64 
Economic perspective   
Societal 4 7, 8, 12, 54 
Societal & health insurance 1 6 
Healthcare 4 10, 13, 58, 63 
Third party payer 3 27, 56, 60 
Not stated 52 1, 2, 3, 4, 5, 9, 11, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 
25, 26, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 
42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 55, 57, 59, 61, 
62, 64 
Targeted health services   
Emergency  14 4, 5, 6, 10, 13, 14, 17, 30, 31, 32, 33, 34, 46, 61 
Non-emergency 50 1, 2, 3, 7, 8, 9, 11, 12, 15, 16, 18, 19, 20, 21, 22, 23, 24, 25, 
26, 27, 28, 29, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 47, 
48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 62, 63, 64 
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It is recommended that studies provide a clear description of the location, setting and 
other relevant aspects of the healthcare system is reported in studies so that external 
validity, generalisability and transferability of study results  in a different setting can 
be assessed (Husereau et al., 2013). All included studies have clearly reported their 
location and setting. Whilst the majority of studies were undertaken in the United 
States (n=47), two studies were carried out in the UK, one in Canada, four in 
European countries, and the rest (n=10) in Asian countries. Most (n=51) used 
hospital volume (defined in terms of activity level) as a proxy for centralisation of 
healthcare services, however there was a wide variation in the definition of high and 
low volume hospitals across studies. The variation in definition of volume may further 
complicate the impact of the findings generated from these studies. Volume alone 
cannot be a proper measure of quality (Khuri and Henderson, 2005) and the 
improvement in quality is rather explained by underlying mechanisms of care such as 
staff expertise, resource availability and specific processes of care correlated with 
volume (Halm et al., 2002; Mesman et al., 2015). The theme of centralisation 
assessed was location of health service in two studies, specialisation of healthcare 
services in nine studies, and multidisciplinary care in one. 
 
It was observed that the majority of the studies followed non-randomised designs 
including retrospective cohort (n=34) with one (13) also using cross-sectional 
effectiveness data, cross-sectional (n=15) of which one (9) was repeated cross-
sectional, comparative case series (n=1), case control (n=2) of which one (33) was 
matched case control and before and after studies (n=3). Cross-sectional designs are 
particularly prone to selection and measurement bias. Uncontrolled before-and-after 
study designs are generally considered to have poor internal validity because they 
may fail to account for any prevailing temporal trend which might confound and bias 
the outcomes of the intervention (Goodacre, 2015; Portela et al., 2015). Only one 
study (10) which used a before-and-after study design attempted to account for 
potential confounder and bias by modelling intervention effects before and after 
centralisation using several independent, population based datasets and by 
conducting sensitivity analysis. However, this may be insufficient because it has been 
argued that controlled before-and-after studies should have at least two intervention 
sites and two control sites to control for site specific confounding effects on the 
observed differences between intervention and control groups (Effective Practice and 
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Organisation of Care (EPOC), 2015. Available at: http://epoc.cochrane.org/epoc-
specific-resources-review-authors). Altogether 11 studies used some form of 
modelling approach as their analysis method. 
 
Looking at the economic evaluation methods used in the studies, most of the studies 
used CCA (n=50) where costs and outcomes such as mortality, length of stay, 
complications, readmissions were assessed in a disaggregated form. CCA, a variant 
of CEA, presents a range of outcomes of an intervention in a disaggregated form that 
decision-makers are likely to use in a trade-off of their importance, however it can be 
challenging for decision-makers to weigh up different outcomes against each other 
and compare alternatives (Drummond et al., 2005). CEA is an appropriate economic 
evaluation method when the outcomes of alternatives can be expressed in common 
measures such as cost per life years saved, costs per cases averted or costs per 
readmissions avoided (Drummond et al., 2005). CEA was used in only in four 
studies. Seven studies (1, 2, 3, 26, 28, 45, 60) which were reported as CEA were in 
fact CCA. CUA is considered the best approach for decision-making in healthcare 
because it allows broader comparisons to be made across widely differing 
alternatives (Robinson, 1993; Drummond et al., 2005), nevertheless it is limited to 
measuring only health benefits. The results of this review showed that CUA method 
was used only in ten studies. CBA was not applied by any of the studies. 
 
Studies assessed a wide range of healthcare services or procedures such as stroke, 
cancers, trauma, accident and emergency services, congestive heart failure, 
coronary artery bypass grafting, pancreatitis, organ transplantations and other 
condition specific surgical procedures. A majority of studies (n=50) assessed elective 
care centralisation issues and the remaining (n=14) focussed around those 
appearing to be emergency health care need. 
 
2.5.3 Methodological quality of economic evaluations  
The results of the methodological quality assessment are presented in Table 2.2 and 
reflect inconsistency across the studies assessing centralisation of healthcare 
services. 
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Table 2.2: Quality assessment criteria for economic evaluations included in the 
review 
Dimension of 
quality 
Reported 
(Study reference in Appendix 
A, Table A3) 
Not Reported 
(Study reference 
in Appendix A, 
Table A3) 
Note 
A clear description 
of the study 
objective and 
comparators is 
provided 
1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 
11, 12, 13, 14, 15, 16, 17, 
18, 19, 20, 21, 22, 23, 24, 
25, 26, 27, 28, 29, 30, 31, 
32, 33, 34, 35, 36, 37, 38, 
39, 40, 41, 42, 43, 44, 45, 
46, 47, 48, 49, 50, 51, 53, 
54, 55, 56, 57, 58, 59, 60, 
61, 62, 63, 64 
52 52- Not clearly stated 
Characteristics of 
target population 
and subgroups are 
described and 
analysed  
1, 2, 3, 4, 6, 8, 9, 10, 11, 12, 
13, 15, 16, 17, 18, 19, 20, 
21, 23, 24, 25, 26, 27, 28, 
29, 30, 32, 33, 34, 35, 36, 
37, 38, 39, 40, 41, 42, 43, 
44, 45, 46, 47, 48, 49, 50, 
51, 52, 53, 54, 55, 56, 57, 
58, 59, 60, 61, 62, 63, 64 
 
5, 7, 14, 22, 31 55- reference for target 
pop given,22- only stated 
no difference between 
groups 
Setting and location 
of the study is 
stated 
1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 
11, 12, 13, 14, 15, 16, 17, 
18, 19, 20, 21, 22, 23, 24, 
25, 26, 27, 28, 29, 30, 31, 
32, 33, 34, 35, 36, 37, 38, 
39, 40, 41, 42, 43, 44, 45, 
46, 47, 48, 49, 50, 51, 52, 
53, 54, 55, 56, 57, 58, 59, 
60, 61, 62, 63, 64 
  
Study perspective is  
clearly stated 
6, 7, 8, 10, 12,13, 27, 54, 56, 
58, 60, 63 
1, 2, 3, 4, 5, 9, 
11, 14, 15, 16, 
17, 18, 19, 20, 
21, 22, 23, 24, 
25, 26, 28, 29, 
30, 31, 32, 33, 
34, 35, 36, 37,38, 
39, 40, 41, 42, 
43, 44, 45, 46, 
47, 48, 49, 50, 
51, 52, 53, 55, 
57, 59, 61, 62, 64 
7 has only health care 
payer costs; 12-not what 
is stated, 60- not what is 
stated 
Time horizon of 
costs and benefits is 
clear 
1, 2, 3, 4, 5, 6, 7, 9, 10, 11, 
12, 13, 14, 15, 16, 17, 19, 
20, 21, 22, 23, 26, 27, 28, 
30, 31, 33, 34, 35, 36, 37, 
38, 39, 40, 41, 42, 44, 45, 
46, 47, 49, 50, 51, 53, 54, 
55, 56, 57, 58, 60, 61, 
62, 63, 64 
8, 18, 24, 25,  29, 
32, 43, 48, 52, 59 
 
Discount rate is 
stated or an 
explanation is given 
if costs or benefits 
are not discounted 
(where applicable) 
4, 5, 6, 10, 12, 13, 14, 27, 
54, 
55 
3, 7, 15, 51, 
 
5, 54, 13 benefits only  
 Table Continued 
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Table 2.2 continued: Quality assessment criteria for economic evaluations 
included in the review 
Dimension of 
quality 
Reported 
(Study reference in Appendix 
A, Table A3) 
Not Reported 
(Study reference 
in Appendix A, 
Table A3) 
Note 
Source and 
methods used to 
collect effectiveness 
data described  
1, 2, 3, 4, 5, 6, 7, 9, 10, 11, 
12, 13, 14, 15, 16, 17, 18, 
19, 20, 21, 22, 23, 24, 25, 
26, 27, 28, 29, 30, 31, 32, 
33, 34, 35, 36, 37, 38, 39, 
40, 41, 42, 43, 44, 45, 46, 
47, 48, 49, 50, 51, 52, 53, 
54, 55, 56, 57, 58, 59, 60,  
61, 62, 63, 64 
8 8-not clear 
The primary 
outcome 
measure(s) for 
economic 
evaluation are 
clearly stated 
1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 
11, 12, 13, 14, 15, 16, 17, 
18, 19, 20, 21, 22, 23, 24, 
25, 26, 27, 28, 29, 30, 31, 
32, 33, 34, 35, 36, 37, 38, 
39, 40, 41, 42, 43, 44, 45, 
46, 47, 48, 49, 50, 51, 52, 
53, 54, 55, 56, 57, 58, 59, 
60, 61, 62, 63, 64 
  
Quantities of 
resources are 
reported separately 
from their unit costs 
6, 7, 10, 11, 12, 54, 55, 54, 
56,  
1, 2, 3, 4, 5, 8, 9, 
13, 14, 15, 16, 
17, 18, 19, 20, 
21, 22, 23, 24, 
25, 26, 27, 28, 
29, 30, 31, 32, 
33, 34, 35, 36, 
37, 38, 39, 40, 
41, 42, 43, 44, 
45, 46, 47, 48, 
49, 50, 51, 52, 
53, 57, 58, 59, 
60, 61, 62, 63, 64 
7 only unit costs reported 
separately, 55 ref to web 
table given 
Approaches used to 
estimate resource 
use and cost is 
clear 
1, 2, 3, 4, 5, 6, 7, 8, 10, 11, 
12, 13, 14, 15, 16, 17, 19, 
22, 23, 24, 25, 26, 27, 28, 
29, 30, 31, 32, 33, 34, 35, 
36, 37, 38, 39, 40, 41, 42, 
43, 44, 45, 46, 47, 48, 49, 
50, 51, 52, 53, 54, 55, 56, 
57, 58, 59, 60, 61, 62, 63, 
64 
9, 18, 20, 21   
Cost components 
clear 
6, 7, 10,11,12,14, 42, 54, 55, 
56 
1, 2, 3, 4, 5, 8, 9, 
13, 15, 16, 17, 
18, 19, 20, 21,22, 
23, 24, 25, 26, 
27, 28, 29, 30, 
31, 32, 33, 34, 
35, 36, 37, 38, 
39, 40, 41, 43, 
44, 45, 46, 47, 
48, 49, 50, 51, 
52, 53, 57, 58, 
59, 60, 61, 62, 
63, 64 
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Table 2.2 continued: Quality assessment criteria for economic evaluations 
included in the review 
Dimension of 
quality 
Reported  
(Study reference in Appendix 
A, Table A3) 
Not Reported 
(Study reference 
in Appendix A, 
Table A3) 
Note 
Currency/price year 
are explicitly stated 
2, 4, 5, 6, 9, 10, 12, 14, 19, 
20, 26, 27, 29, 32, 35, 37, 
40, 41, 43, 45, 47, 50, 51, 
53, 54, 55, 58, 61, 62, 63 
1, 3, 7, 8, 11, 13, 
15, 16, 17, 18, 
21, 22, 23, 24, 
25, 28, 30, 31, 
34, 33, 36, 38, 
39, 42, 44, 46, 
48, 49, 52, 56, 
57, 59, 60, 64 
 
Analytic methods 
supporting the 
evaluation including 
methods for dealing 
with skewed, 
missing, or 
censored data, 
extrapolation 
methods, methods 
for pooling data, 
approaches to 
validate or make 
adjustments to a 
model, methods for 
handling population 
heterogeneity and 
uncertainty 
described in detail  
1, 2, 3, 4, 5, 6, 7, 8, 9, 
10,11,12, 15, 16, 17, 18,19, 
20, 21, 22, 23, 24, 25, 26, 
27, 28, 29, 30, 31, 33, 34, 
35, 36, 37, 38 , 39, 40, 41, 
42, 43, 44, 45, 46, 47, 48, 
49, 50, 51, 52, 53, 54, 55, 
56, 57, 58, 59, 60, 61, 62, 
63, 64 
7, 13, 14  
Incremental costs 
and outcomes 
reported (If 
applicable 
incremental cost-
effectiveness ratios 
reported) 
2, 4, 5, 6, 7, 8, 9, 10, 11, 12, 
13, 14, 26, 41, 48, 54, 55, 56 
1, 3, 15, 16, 17, 
18, 19, 20, 21, 
22, 23, 24, 25, 
27, 28, 29, 30, 
31, 32, 33, 34, 
35, 36, 37, 38, 
39, 40, 41, 42, 
43, 44, 45, 46, 
47, 49, 50, 51, 
52, 53, 57, 58, 
59, 60, 61, 62, 
63, 64 
11-only in graphs 
Sensitivity analysis 
carried out 
1, 4, 5, 6, 7, 8, 10, 11, 12, 
13, 14, 27, 33, 42, 45, 54, 
55, 57, 60 
2, 3, 9, 15, 16, 
17, 18, 19, 20, 
21, 22, 23, 24, 
25, 26, 28, 29, 
30, 31, 32, 34, 
35, 36, 37, 38, 
39, 40, 41, 43, 
44, 46, 47, 48, 
49, 50, 51, 52, 
53, 56, 58, 59, 
61, 62, 63, 64 
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Table 2.2 continued: Quality assessment criteria for economic evaluations 
included in the review 
Dimension of 
quality 
Reported 
(Study reference in Appendix 
A, Table A3) 
Not Reported 
(Study reference 
in Appendix A, 
Table A3) 
Note 
Limitations clearly 
discussed 
1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 
11, 12, 13, 14, 15, 16, 17, 
18, 19, 20, 21, 23, 24, 25, 
26, 27, 28, 29, 30, 31, 32, 
33, 34, 35, 36, 38, 39, 40, 
41, 42, 43, 44, 45, 46, 47, 
48, 49, 50, 51, 52, 53, 54, 
55, 56, 57, 58, 59, 60, 61, 
62, 63 
22, 37 Not clearly reported in 22, 
37 
 
Generalisability of 
findings discussed 
1, 2, 6, 10, 15, 16, 17, 19, 
20, 21, 28, 30, 31, 32, 33, 
34, 35, 42, 53, 54, 60, 61 
3, 4, 5, 7, 8, 9, 11 
,12, 13, 14, 18, 
22, 23, 24, 25, 
26, 27, 29, 36, 
37, 38, 39, 40, 
43, 44, 45, 46, 
47, 48, 49, 50, 
51, 52, 55, 56, 
57, 58, 59, 62, 63 
 
 
2.5.4 Study objectives and comparators 
Cost-effectiveness may vary by population characteristics and it is recommended that 
these studied should be clearly reported (Husereau et al., 2013). It was observed that 
most of the studies clearly reported their objectives, comparators and description of 
the target population characteristics, but statement of objective in one study (52) and 
population characteristics reported by two studies (55, 22) were incomplete; one (55) 
referred to another study for the characteristics and the other (22) only stated that 
there was no difference between the two population groups analysed. Five studies 
(5, 7, 14, 22, 28) did not provide any description and analysis of target populations 
characteristics. 
 
2.5.5 Perspective of the study 
Perspective is the viewpoint from which the costs and outcomes are evaluated and 
should be clearly stated in an economic evaluations (Husereau et al., 2013). Only 12 
studies clearly reported the perspective of the analysis. Among these five (7, 54, 9, 
12, 60) reported the use of societal perspective and one (6) reported societal 
perspective along with statutory health insurance perspective, four (11, 13, 58, 63) 
reported using healthcare perspective and two (27, 56) reported third party payers 
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perspective. However, on a closer examination it was clear that three (7, 9, 12) and 
one (60) of those studies which reported using a societal perspective actually 
followed a healthcare and payers’ perspective respectively. 
 
2.5.6 Effectiveness data 
It was observed that the source and methods of effectiveness data were clearly 
reported in all studies, but one (9). The majority (n=52) of studies analysed the data 
derived from a single source database. One modelling study (10) utilised information 
from three different databases. Eight (4, 5, 6, 7, 11, 12, 54, 55) modelling and two 
(13, 56) observational studies used information from multiple sources including 
literature review and databases, but one (13) also carried out a cross-sectional 
survey to derive effectiveness data. A major limitation of eight (4, 5, 6, 7, 12, 54, 55, 
13) of these studies which reported using effectiveness estimates from literature 
review was the failure to report whether a systematic review was conducted; making 
it unclear whether the best available evidence was used. 
 
2.5.7 Outcomes assessed 
The commonly used outcome measures in studies were in-hospital mortality, length 
of stay in the hospital, readmissions, life years gained or deaths averted, 
complications, length of stay in the intensive care unit (ICU), long term survival and 
quality adjusted life years (QALYs). Only 11 studies assessed QALYs as one of their 
outcome measures. Three studies (21, 43, 61) assessed length of stay in the hospital 
as the only outcome measure (Appendix A, Table A3). 
 
2.5.8 Costing 
The costs resulting from healthcare centralisation can be broadly divided into direct 
and indirect costs. Direct costs are healthcare related costs that result from inpatient 
or outpatient healthcare services used to address the health problem, for example 
costs of surgery, drug treatment, lab tests, staff and equipment. Indirect costs are 
other types of costs which occur outside the healthcare sector, for example like value 
of time loss such as productivity/wages lost or leisure time lost, travel costs and costs 
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associated with other aspects like child care. Direct costs were included in all studies 
included in this review (Appendix A, Table A3). These were the hospital costs like 
costs of diagnosis, treatment and surgery associated with the illness, however 18 of 
the studies used hospital charges and did not report any conversions to actual 
incurred costs. Eight (1, 6, 10, 11, 12, 13, 14, 54) studies appeared to have 
considered indirect costs in their analysis (Appendix A, Table A2), however in one of 
these (11) economic evaluation was restricted to travel costs to hospitals borne by 
patients, two (1,13) were not clear in what indirect costs were included, one (54) 
included costs of lost productivity and one (6) included costs of hospital infrastructure 
and informal carer travel, but explicitly excluded the productivity costs citing an 
average patient age of 74 years. All studies mentioned how the resource use and 
costs were estimated and all seem to have used activity based costing method, but 
three (18, 20, 21) were not clear enough. Only ten (6, 7, 10, 11, 12, 14, 42, 54, 55, 
56) of the studies reported the detailed breakdown of components of the total costs 
assessed. Quantities of resource use and unit costs were reported in eight studies (6, 
7, 10, 11, 12, 54, 55, 56), however in two (7, 56) of these studies only unit costs are 
presented and resource use were not presented separately with one (56) only 
presenting fee codes. 
 
2.5.9 Adjustments for timing of costs and benefits 
It is recommended that the time horizon over which the costs and consequences of 
an intervention occur and any discount rate used should be stated (Husereau et al., 
2013). In this review it appeared that 40 studies had a time horizon of less than a one 
year. Discounting was not reported nor necessary in these studies with a time 
horizon shorter than one year. However, it is recommended that analysts should 
report this as 0% discount rates for clarity (Husereau et al., 2013). Fourteen studies 
(3, 4, 5, 6, 7, 11, 12, 13, 14, 15, 27, 51, 54, 55) had a time horizon longer than one 
year, but only seven (4, 6, 11, 12, 14, 27, 55) reported discounting both costs and 
effects. In three studies (5, 13, 54) the time horizon for costs and effects appeared to 
be different and effectiveness data only was discounted. Costs in two (13, 54) 
appeared to have incurred within a year and discounting was not necessary. In the 
other study (5) the costs were expected for 10 years, but discounting was still not 
reported. Justification on why costs were not discounted was not provided. It was 
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difficult to ascertain the time horizon in ten studies (9, 18, 24, 25, 29, 32, 43, 44, 52, 
59). 
 
Price changes over time and research settings. Reporting dates, currency and any 
conversions facilitate comparisons of results from studies carried out at different 
times and jurisdictions. It is recommended that price year, the currency used and any 
currency conversions are reported (Husereau et al., 2013). Currency or price dates 
and conversions were explicitly stated by only 30 studies. 
 
2.5.10 Statistical analysis 
All the analytic methods used in the studies must be reported to allow judgement of 
the appropriateness of the methods and the corresponding results in economic 
evaluations (Husereau et al., 2013). Single study based economic evaluations should 
report regression methods that are used in in their analysis (Husereau et al., 2013). 
The majority of studies (n=53) in this review were primarily single study based 
economic evaluations and among these only 45 studies explicitly reported the 
regression methods and other statistical tests used in their analysis. Reporting of 
statistical analysis in five studies (31, 39, 46, 52, 56) was very limited. Among these 
one (46) only stated using logistic regression analyses for demographic and clinical 
variables but nothing was reported on costs. Three studies (31, 52, 56) reported the 
test of statistical significance in the difference. One (39) of these studies reported the 
tests of significance but also indicated accounting for clustering effects in groups, one 
(52) only stated using non parametric analyses in testing continuous variables but 
failed to explain further, while another one (56) only stated that comparisons between 
groups were made by ANOVA and did not provide further details. Three studies (7, 
13, 14) did not report any statistical methods in analyses of data. Altogether, 24 
single empirical studies reported using statistical methods to account for skewed 
distribution of costs and resource utilisation data, and 14 of them also indicated 
accounting for potential clustering effects in the groups studied. 
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Model based economic evaluations should describe and report methods used in 
estimating parameters used in the model (Husereau et al., 2013). Among the 11 
model based economic evaluations in this review, seven studies (4, 6, 10, 11, 27, 54, 
55) clearly reported the model parameters estimation methods however in four (27, 
54, 55, 60) of these studies there was no indication that any possible heterogeneity 
effects in parameters was addressed. Three studies (5, 8, 12) reported parameter 
estimation methods poorly, and reported limited explanation on estimation of 
transition probabilities, however one (12) study indicated that heterogeneity was 
addressed. Ignoring heterogeneity effects in parameters may influence the results of 
an economic evaluation (Grutters et al., 2013). Only two (6, 12) reported half cycle 
corrections to account for transition events occurring half-way through the cycle. Not 
incorporating half cycle corrections in states may lead to over or under estimation of 
economic evaluation outcomes (Siebert et al., 2012). Several methods for analysing 
healthcare costs and handling patient heterogeneity are currently in practice (Elliott 
and Payne, 2004; Mihaylova et al., 2011; Grutters et al., 2013). Appropriateness of 
these methods is dependent on the data used by each study, but is beyond the 
scope of this review. 
 
2.5.11 Consideration of uncertainty 
Effects of uncertainties in parameters arising out of methodological assumptions, 
sampling variation or structure of analyses should be described in economic 
evaluations (Husereau et al., 2013). It was observed that analysis in 54 studies were 
mainly based on patient level data, however only 15 studies presented confidence 
intervals for both costs and effects results and one presented cost-effectiveness 
acceptability curves. Some form of sensitivity analysis was included by less than one 
third of studies (n=19). Among the eight studies (1, 7, 13, 14, 33, 42, 45, 57) which 
were mainly analysis of patient level data, only seven (1, 7, 13, 14, 33, 42, 57) 
performed sensitivity analysis: six used one way sensitivity analysis and one (13) 
used two way sensitivity analysis. 
 
Eleven studies (4, 5, 6, 8, 10, 11, 12, 27, 54, 55, 60) were model based analysis- six 
(4, 5, 8, 11, 27, 60) performed one way sensitivity analysis although reporting was 
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limited to thresholds graphs in one (27). In another five (6, 10, 12, 54, 55) one or two 
way sensitivity analysis was required along with probabilistic sensitivity analysis. 
 
2.5.12 Presentation of results 
The recommended practice in economic evaluation studies is to report mean values 
for the main categories of estimated costs and outcomes of interest as well as the 
mean differences between the comparator groups and - if applicable - incremental 
cost-effectiveness ratios (ICERs) (Husereau et al., 2013). Although, all of the studies 
in this review presented mean values for the estimated costs and major outcomes, it 
was observed that only 18 studies reported results in terms of incremental costs and 
outcomes or ICERs. One (11) of these only presented the results graphically and the 
economic evaluation results were not reported clearly in numerical terms. Study 
limitations were clearly discussed by all studies but two (32, 37). Generalisability of 
study findings was discussed only by 22 studies. 
 
2.6  Discussion 
The main purpose of this review was to critically appraise the methodological quality 
of published economic evaluations considering centralisation of specialised 
healthcare services. The review identified 64 studies undertaking some form of 
economic evaluation of the centralisation of healthcare services. Considerable 
variation was observed in the methodological approaches used. The studies 
reviewed generally did not adhere to current standards for reporting economic 
evaluations and whilst they might have been sufficient for the purpose they were 
originally conducted, they provide a very limited evidence base to guide decision-
makers in other settings. 
 
Most of the studies in this review used non-experimental designs. It may be 
impossible or impractical to undertake randomised trials to assess centralisation, 
therefore quasi-experimental designs such as controlled before-after studies, 
interrupted time series and repeated measures studies may generate more robust 
and convincing evidence compared with non-experimental designs (Goodacre, 
2015). Modelling is also useful when there is a need to understand the long-term 
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costs and effects of an intervention, however validity of the modelling results depend 
on the evidence and assumptions on which they are based upon (Drummond et al., 
2005). 
 
The health outcomes assessed in studies were generally appropriate to their 
objectives. However, QALY which is widely preferred as a summary measure of both 
quantity and quality of life outcomes in health economics (Kind et al., 2009), was 
assessed in only 11 studies. Length of stay is widely used both as quality and 
efficiency measures of healthcare services. It is significantly influenced by several 
other factors and it has been argued that length of stay alone should not be used as 
a quality measure to compare healthcare services unless appropriately adjusted 
(Brasel et al., 2007). Nevertheless, length of stay was the only health outcome 
measure assessed in three studies (21, 43, 61) in this review. Most of the studies 
had short-term follow-up and it is possible that their outcomes would have been 
different if they had considered longer time frame. 
 
It is important to clearly state the perspective of analysis in studies because cost-
effectiveness may vary with the perspective and an intervention which is cost-
effective from one view point and may not be from another. For example, from the 
National Health Service (healthcare) perspective which typically includes direct 
medical costs, centralisation of hospitals may appear cost-effective whilst from a 
societal perspective which includes broader costs to the society, such as lost 
productivity and leisure time costs due to additional travel time, costs to family 
members or caregivers, centralisation may not appear cost-effective. Nevertheless, a 
large majority (n=52) of studies fail to state their analysis perspective. Studies always 
did not consider all costs relevant to a particular perspective. One study (6) in this 
review followed a societal perspective but did not consider the lost productivity costs 
in the elderly citing their age, however leisure time forgone may however not be 
valueless to the elderly and not considering it may discriminate against healthcare 
interventions aimed towards the elderly population. Furthermore, it is also important 
that the source and methodology used in generating effectiveness are well reported 
because validity of the estimate of the measure of effectiveness used in the studies 
depends on the methodology used to generate those estimates. 
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A number of studies in this review have used hospital charges as costs. But, hospital 
charges are not considered a good approximation of costs because charges are 
essentially the list prices which are set to compensate costs such as free or 
discounted care to the poor, facility costs and other community service costs incurred 
by any healthcare organisation (Finkler, 1982). In this context, it is possible that the 
charges set by a centralised or a high volume hospital for a particular treatment is 
higher than that of a low volume local hospitals to compensate for the better facilities 
and services it provides to its patients. Alternatively, high volume central hospitals 
may charge less than small volume local hospitals by spreading out their costs of 
facilities and equipment over a very large volume of patients they cater to. Therefore, 
using charges in place of costs to determine if centralisation reduces healthcare 
costs could lead to unsubstantiated conclusions on healthcare centralisation. 
 
Transparency in the costing methodology and cost components is another important 
aspect in economic evaluations. Depending on the purpose and the context, there 
exists variation in estimates of commonly used costing approaches (Chapko et al., 
2009), therefore unclear reporting of estimation of resource use and costs may make 
it hard to judge applicability of estimates in a different healthcare setting. It is 
recommended that costing approaches and data sources are clearly described in 
economic evaluations (Husereau et al., 2013). Limited data may lead to biased 
conclusions but incomplete reporting may make it hard to judge applicability of study 
results for a different setting. Nevertheless, very few studies (n=10) in this review 
have presented the cost components clearly. 
 
Centralisation would also be expected to impact on the travel distance to hospitals, 
resulting in changes in cost to health services and patients as well as potentially 
health outcomes. The impact on financial and other costs of accessing healthcare 
caused by centralisation may have equity implications as increases in cost may be 
disproportionately felt by those less well-off, who coincidently may also be in the 
greatest need (Stitzenberg et al., 2009). Furthermore, costs generated by the 
increased distance to hospitals would become a significant component of the total 
costs of centralisation. Thus, it is important that wider aspects of healthcare 
centralisation are considered in the estimates of costs and health outcomes. 
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Notwithstanding the limitations as presented earlier, economic evaluations assessing 
QALYs as well as other relevant health outcomes and both direct and indirect costs 
would give a better picture of costs and benefits of healthcare centralisation 
(Appendix A, Table A2). Sensitivity analysis helps to understand the robustness of 
their findings by varying the assumptions in the values of major variables. 
 
Many health services are facing an increasing pressure to centralise healthcare 
services into fewer but more specialised units. The case for greater concentration of 
some of the specialised health services reflect a relationship between quality of care 
and patient volume, derived from the greater clinical expertise, more specialised 
facilities, and greater standards of care in the concentrated services (NHS England, 
2014). Whilst it may be attractive and fairly acceptable to transfer findings from one 
setting to another, healthcare costs and outcomes often have limited transferability 
across settings because of differences in health and economic systems (Hutubessy 
et al., 2003). In the light of the methodological limitations and differences, decision-
makers should take caution while making decisions on the basis of existing economic 
evaluation studies on centralisation of healthcare services. Decisions on centralising 
any health care speciality should be informed by findings from methodologically 
strong economic evaluation studies considering multifaceted aspects of 
centralisation. Studies adhering to standard guidelines on economic evaluations and 
with a clearly reported methodology in terms of cost components, outcomes, analysis 
perspective, time horizon, robustness of the findings, limitations, and generalisability 
aspects of the findings would assist decision making. 
 
2.6.1 Strengths and limitations 
A number of economic evaluations on centralisation of specialised healthcare 
services have been conducted, however studies assessing the methodological 
quality of these economic evaluations are lacking. An earlier review of economic 
evaluations considering centralisation was narrower and focussed only on specific 
health issues like cancer (Ke et al., 2012). To the best of my knowledge, this is the 
first systematic review to comprehensively attempt to assess the methodological 
quality of economic evaluations assessing centralisation of specialised healthcare 
services irrespective of their speciality. One of the strength of this review is the use of 
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a checklist adapted from recommended standard guidelines. Whilst we have adopted 
rigorous searches, we caution that we may have left out some key search terms and 
it is possible that we may have missed some relevant English language publications. 
Databases may be sensitive to different search terms and use of generally similar 
search terms across databases could have missed key papers. A more substantive 
limitation is the exclusion of unpublished evaluation, grey literature and non-English 
language studies. However, it is also likely that unpublished and grey literature may 
either be of lower methodological quality or be no different compared to the published 
studies (Higgins JPT and Green S, 2011). Since quality assessment was primarily 
conducted by only one researcher, the likelihood of bias in quality assessment 
cannot be ignored. Length of stay, also a surrogate for cost, was assessed as a 
quality outcome measure in this review, and because of this some of the studies 
were classified as CCA. Finally, though the checklist used to assess the 
methodological quality was adapted from standard guidelines it only examines the 
quality reported by studies. It was not possible to judge the quality of conduct from 
what was reported by studies, and was beyond the scope of this study. Although 
arguably complete reporting is a part of good conduct and the safe inference from 
incomplete reporting is to assume the quality of conduct was poor. 
 
Another important point to note is that, the last search for literature for this systematic 
review was carried out on 10th March 2016 and did not consider any relevant studies 
(Lahr et al., 2017; Hunter et al., 2018) published thereafter. It could be argued that 
the search could be re-run to update the review with any new publications. However, 
the main objective of the systematic review was to inform the development of 
economic evaluation conducted in Chapter 6. 
 
Critical appraisal of new publications in this situation may not be beneficial and 
feasible, nevertheless future studies may benefit from a review of studies published 
more recently. Therefore, the search strategy was re-run in December 2018 to check 
if any relevant studies were published after the conduct of the systematic review for 
this thesis in 2016, which informed the subsequent research reported in later 
Chapters. Only two additional studies (Lahr et al., 2017; Hunter et al., 2018) meeting 
the inclusion criteria of this systematic review were identified. One study (Lahr et al., 
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2017) utilised a discrete-event simulation model to assess the short-term (6 months) 
costs and effects of centralisation of thrombolysis and optimised care in 
decentralised stroke care systems in Netherlands. The cost-effectiveness analysis 
was conducted from the perspective of the policy maker (i.e. healthcare provider).  
While the other study (Hunter et al., 2018) utilised a Markov model to calculate 
difference in differences in costs and outcomes before and after the implementation 
of two major system change strategies in stroke care in London and Greater 
Manchester, UK. The cost-utility analysis was conducted from the NHS perspective 
(the healthcare provider). 
 
Whilst Lahr and colleagues assessed the costs and effects for a very short time 
horizon (6 months) and did not assess the results in terms of incremental costs per 
QALY gained, both the studies addressed most of the issues that were raised by the 
systematic review. Wider aspects of costs arising out of centralisation are considered 
by these two economic evaluations and in both travel time to the centralised service 
and length of stay in the hospitals were incorporated into the economic evaluation 
models. Hunter and colleagues went beyond the incremental cost per QALY gained 
from centralisation and also attempted to use the results as part of a Programme 
Budgeting and Marginal Analysis (PBMA) exercise to reflect a potential real-world 
scenario. 
 
In general, the new studies published after the conduct of the systematic review have 
adhered to the current standards for reporting economic evaluations and are 
methodologically stronger compared with most of the studies included in the 
systematic review reported in this Chapter. The methodology used in the UK study 
(Hunter et al., 2018) is similar to that used in the economic evaluation reported in 
Chapter 6, however none of the studies assessing centralisation have tried to 
incorporate peoples’ valuation (preferences) into economic models. 
 
2.7 Conclusion 
This Chapter demonstrated that economic evaluations on centralisation of 
specialised healthcare services have limited methodological quality and their results 
37 
should be interpreted with caution in other settings. The rationale behind 
centralisation of specialised healthcare services is the improvement on healthcare 
quality and its efficiency. However, evidence coming from methodologically poor 
studies may force decision-makers make uninformed decisions on centralisation. It is 
important to improve the methodology and reporting of economic evaluations so that 
decisions to centralise specialised healthcare services are informed by robust 
evidence of improvements in healthcare quality and efficiency arising out of 
centralisation. Future economic evaluations of specialised healthcare centralisation 
should adhere to standard guidelines on economic evaluations. Estimates of costs 
and health outcomes of specialised healthcare centralisation should consider wider 
aspects of centralisation. These findings informed the development of economic 
evaluation described in Chapter 6. Nonetheless, more recent economic evaluations 
have a stronger methodological quality and have considered a wider perspective for 
the costs associated with centralisation. They did not however attempt to consider a 
wider perspective for the benefits of centralisation from the viewpoint of individuals’ 
preferences. The next Chapter describes the preference elicitation techniques used 
in healthcare. 
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Chapter 3. Preference Elicitation in Health Care 
 
3.1 Introduction 
Chapter 2 demonstrated that economic evaluations on centralisation of specialised 
healthcare services published up to the end of 2016 have limited methodological 
quality and their results should be interpreted with caution in other settings. Chapter 
3 now provides an overview of preference elicitation techniques that are used in 
healthcare and justifies the importance of eliciting preferences in healthcare. Along 
with this, it also highlights why a discrete choice experiment (DCE) was the most 
appropriate preference elicitation technique to use to address the issues focused on 
within this PhD. The rest of the Chapter is structured as follows: section 3.2 presents 
the importance of patient and public preferences in healthcare, section 3.3 presents a 
short discussion on whose preferences matter, section 3.4 presents the classification 
of preference elicitation methods commonly used (or that could be used) in 
healthcare, section 3.5 presents the theoretical framework of DCE and section 3.6 
presents the overall summary of the Chapter. 
 
3.2 Importance of Patient and Public Preferences in Healthcare 
Patient and public involvement in all levels of healthcare decisions is expected to 
result in more responsive services leading to improved health outcomes (Florin and 
Dixon, 2004; Dirksen et al., 2013). Therefore, there have been a strong movement 
towards the involvement of patients and the public in healthcare policy decisions 
(Mockford et al., 2012; Ocloo and Matthews, 2016). In the NHS England, it is 
emphasized that patient preferences should be at the heart of healthcare decisions 
(Coulter and Collins, 2011). However, patient preferences are often overlooked and 
inaccurately measured by healthcare providers and decision-makers (Mulley et al., 
2012). Inaccurate measurement of patient preferences may risk wrong decisions 
being made in healthcare. Therefore, it is necessary that healthcare decisions are 
informed by preferences generated from robust methods underpinned by theory. 
 
3.3 Whose Preferences- Patient or Public? 
There is a considerable debate in health economics around whose preferences, 
patient or public, are more appropriate to inform decision making (Dolan, 1999; 
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Brazier et al., 2005; Gandjour, 2010; Stamuli, 2011; Mott and Najafzadeh, 2016). The 
argument for patient preference are based on the fact that patients have real 
experiences and are better positioned to value their own health condition under 
evaluation compared to the general public trying to imagine them (Brazier et al., 
2005). The general population is not fully informed and do not have accurate 
expectations of consequences of ill health, and therefore their uninformed 
preferences can result in sub-optimal public resource allocation (Karimi et al., 2017). 
Furthermore, it has been put forward that the use of patient preferences is founded in 
preference-utilitarian theory and welfare economics whereas the use of public 
preferences has no compelling theoretical basis (Gandjour, 2010). In contrast, others 
argue that public preferences would be more appropriate in a publicly funded 
healthcare system like the UK NHS where the fully informed general population 
should have a say in the allocation of resources (Stamuli, 2011). Moreover, the 
general public are more likely to have no vested interest and provide an unbiased 
judgement of values compared to patients (Brazier et al., 2005; Stamuli, 2011). 
Although there is still no firm consensus on whose preferences is more appropriate, 
the choice often depends on the decision making context (Stamuli, 2011). For 
example, it is hard to argue against the use of public preferences in system-level 
decision making in publicly funded healthcare system such as UK NHS (Mott and 
Najafzadeh, 2016). Moreover, obtaining public preferences from a general population 
well informed on patient experiences, adaptations and patient values have also been 
advocated previously (Brazier et al., 2005). 
 
3.4 Valuation Methods 
Preference elicitation methods in health care can be broadly categorised into stated 
preference elicitation methods and revealed preference methods. Figure 3.1 
illustrates the categorisation of preference elicitation methods used. The following 
sections describe these methods. 
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Figure 3.1: Simplified classification of preference elicitation methods  
 (Adapted from Ali and Ronaldson (2012)) 
 
3.4.1 Revealed preferences 
Economists have traditionally relied on consumer behaviour in actual market setting 
to make decisions, and these consumer behaviour observed in actual market setting 
are known as the revealed preferences (Ali and Ronaldson, 2012). For example, 
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analysis of data on choice of opticians over a time period may reveal how patients 
trade-off different attributes of opticians. The advantage of revealed preferences is 
that it is based on actual decisions which gives revealed preferences a high reliability 
and face validity (Mark and Swait, 2004). The commonly used revealed preference 
methods are set out below. 
 
3.4.1.1 Travel cost  
Travel cost method is often used to reveal the value of a good or service by taking 
into account of monetary expenses incurred, such as travel cost, access cost, time 
cost of travelling, by an individual visiting a service or facility. The travel cost method 
is used extensively in environmental economics to reveal the recreational value of 
activities in an environment site such as hiking in a park, fishing at a lake, hunting, 
and indicated by the trip cost incurred by an individual in reaching that site (Parsons, 
2017). Although, use of travel cost method is quite rare in health economics, 
estimates of willingness to pay for improved access to healthcare services have been 
derived using this method (Clarke, 2002). However, the travel cost method has been 
criticised for generating superficial estimates of travel costs as a proxy of value of a 
good or service and is limited by problems in accurate valuation of time (leisure time) 
spent travelling, exclusion of costs of equipment such as vehicles that may be 
involved, lack of consideration of other characteristics of amenities visited and other 
available choices forgone (Randall, 1994; Hanley and Barbier, 2009). 
 
3.4.1.2 Hedonic pricing 
Hedonic pricing is another revealed preferences technique which infers that the price 
of a marketed good is directly related to its other non-marketed attribute/s (Basu and 
Sullivan, 2017). Therefore, the value of a particular attribute or combination of 
attributes of a good is revealed by observing the changes in the price individuals are 
willing to pay with the change in attribute/s. Hedonic pricing method is often used in 
valuing environmental characteristics in property prices in housing markets (Taylor, 
2017). For example, the monetary trade-offs people are willing to make for a house 
on a tree lined street which is otherwise similar to other house/s reveals the value 
people place on trees. This technique has been used in health economics to assess 
the demand for various health insurance policies and the trade-offs consumers made 
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between premiums and insurance cover (Jensen and Morrisey, 1990; Robst, 2006). 
However, market failure in the publicly funded healthcare systems like the UK NHS 
where consumers do not face the marginal price of consuming healthcare would 
make the use of hedonic pricing approach difficult to operationalise (Basu and 
Sullivan, 2017). 
 
3.4.1.3 Averting behaviour 
Averting behaviour is a revealed preference method that infers the value of avoiding 
an adverse effect by observing how much people pay to defend against adverse 
effects (Dickie, 2017), for example buying bottled water or boiling water prior to 
drinking to avoid drinking contaminated water (Birol et al., 2006). However, 
individuals may take more than one form of defensive behaviour in response to an 
adverse event and therefore, averting behaviour method may fail to explicitly 
consider all the costs involved (Birol et al., 2006). 
 
A common problem of all the revealed preference techniques is that they are not 
applicable in new and developing field or policy due to the lack of an established 
market nor in health care where an actual market situation often does not exist 
(Lancsar and Louviere, 2008; Ali and Ronaldson, 2012). Nevertheless, even though 
a market might not exist resources still need to be allocated. Therefore, it would still 
be important to make judgements about how individual consumers would respond to 
proposed goods or services. Furthermore, revealed preference is criticised for its 
inability to estimate non-use values i.e. the values people derive from a good or 
service without actually consuming it (Lazo et al., 1997). For example, even if there is 
no observational data on people utilising a primary health care service near their 
home, these people may still derive value from its availability for others or simply 
because they know it is there for their own future use. Stated preference methods 
overcome some of these limitations of revealed preference methods, and hence 
widely used in the healthcare field (Ali and Ronaldson, 2012). 
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3.4.2 Stated preferences 
In a lot of cases economists observe preferences rather than elicit, but there are 
limited opportunities in healthcare to do so. In contrast to the revealed preferences, 
stated preferences involve asking respondents to make a choice between 
alternatives varying in their characteristics (often hypothetical) and allows 
assessment of trade-offs that respondents make. Therefore, stated preference 
methods are particularly useful when no actual market exist or when preferences 
across hypothetical alternatives need to be evaluated (Ali and Ronaldson, 2012). For 
example, the valuation of the preferences for a new drug not yet available in the 
market or the comparison of preferences of two currently available alternative drugs. 
Stated preference methods can be divided as either cardinal or ordinal methods, 
though the categorisation is not based on theory in itself. Cardinal stated preference 
methods generate quantitative preferences from the respondents and provide direct 
estimates of the degree to which one health state (or health programme) is preferred 
over another (Ratcliffe et al., 2009). Standard gamble (SG), time trade-off (TTO), 
visual analogue scale (VAS) are commonly used examples of cardinal methods. 
Contrary to the cardinal stated preference methods, ordinal stated preference 
methods do not directly establish the degree preference of one alternative over 
another (Ratcliffe et al., 2009). Discrete choice experiments (DCE) and ranking 
exercises are commonly used examples of ordinal methods (Ali and Ronaldson, 
2012). These methods of stated preferences are described as follows. 
 
3.4.2.1 Ranking 
Ranking is the simplest form of stated preference methods. It involves assessing the 
preferences by presenting individuals with a set of attributes or alternatives and 
asking them to order those attributes or alternatives, example from the best to the 
worst, based on their value (Ali and Ronaldson, 2012; Weernink et al., 2014). 
Ranking studies are relatively less complex to design and easy to administer and 
have a reduced cognitive burden posed to the respondents (Ali and Ronaldson, 
2012). However, ranking studies are criticised for lack of consideration of the 
principle of opportunity cost, lack of consideration of marginal context of decision 
making and failure to provide a measure of strength of preferences (Ryan et al., 
2001). 
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3.4.2.2 Standard gamble 
Standard gamble (SG) is the conventional method for measuring utilities and 
conforms to the axioms of expected utility theory (Torrance and Feeny, 1989). 
According to the expected utility theory, under conditions of uncertainty any 
individuals behaving rationally will make decisions that maximise their utility. 
Therefore, in health care programs or interventions (or health states) individuals 
should choose the one that increases their survival duration and quality of life. 
 
The SG method involves asking participants to consider the choice between two 
alternatives A and B, where A is the continuation of current health state (for a given 
time) with certainty, whereas B is to take a gamble offered with the possibility of 
perfect health (for a given time) with a probability P or immediate death with a 
probability 1-P (Torrance and Feeny, 1989). The application of SG is displayed in 
Figure 3.2. The value of P is varied until the participant is indifferent to the choice 
between alternative A and B, at which point P is the utility of alternative A (Torrance 
and Feeny, 1989; Morimoto and Fukui, 2002; Whitehead and Ali, 2010). Therefore, 
the lower the value of P, the less desirable is the health state A and the greater the 
risk of death the participant is prepared to accept for a perfect health (Torrance and 
Feeny, 1989; Whitehead and Ali, 2010). 
 
Figure 3.2: Standard gamble method of measuring utilities 
(adapted from (Torrance and Feeny, 1989) 
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However, respondents may find SG cognitively demanding in terms of interpreting 
the complex risk probabilities involved (Dolan and Iadarola, 2008). Furthermore, SG 
utility estimates are likely to suffer from upward biases arising from the effect of 
probability weighting (the tendency of people to process probabilities in a non-linear 
manner; that is they tend to overweight small probabilities and underweight large 
probabilities) and loss aversion (tendency to strongly prefer avoiding losses to 
acquiring gains; losses weigh more heavily in decisions compared to gains) (van 
Osch et al., 2004) (Bleichrodt, 2002). These concepts have been defined in details by 
van Osch et al, 2004. In addition, having to rate health states relative to death may 
make respondents risk averse which in turn will lead to higher utility estimates from 
SG. 
 
3.4.2.3 Time trade-off 
Time trade-off (TTO) is a similar technique to the SG method, however TTO was 
developed specifically for the use in health care and it is not based on the expected 
utility theory (Torrance, 1986; Bleichrodt and Johannesson, 1997). It involves asking 
participants to trade-off the longevity for quality of life (Torrance, 1986; Arnesen and 
Norheim, 2003). The participant is offered a choice between two alternatives: health 
state i for time t followed by death or perfect health for time x<t followed by 
immediate death. The time x is varied until the participant is indifferent between the 
two alternatives, at which point the preference for health state i is x/t (Torrance, 
1986). The application of TTO is displayed in Figure 3.3. 
 
Figure 3.3: The time trade-off method of measuring utilities 
(adapted from (Torrance, 1986)) 
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TTO is argued to be less cognitively demanding compared to the SG (Torrance, 
1986), however is criticised for problems in valuing health states considered worse 
than death (Robinson and Spencer, 2006; Devlin et al., 2011). Nevertheless, other 
modified TTO approaches have been suggested to overcome this limitation 
(Torrance, 1986; Devlin et al., 2011). 
 
3.4.2.4 Visual analogue scale 
Visual analogue scale (VAS), the most common form of rating scales, has long been 
used in measuring the preferences in health care (Torrance et al., 2001). It involves 
providing the participant with a linear rating scale often between 0 (worst imaginable 
health, usually death) and 100 (best imaginable health) and asking them to place 
preferences for different health states (Torrance et al., 2001; Whitehead and Ali, 
2010). An example of a VAS is shown in Figure 3.4. However, this method is 
criticised for the fact that it involves a rating task which does not involve any trade-
offs or choice tasks like SG or TTO (Brazier et al., 1999; Whitehead and Ali, 2010). In 
addition, a VAS also suffers from scaling bias, as the participant may be reluctant to 
place their preferences for a health state at the extreme ends of the scale (Weinstein 
et al., 2009; Whitehead and Ali, 2010). Therefore, VAS as a method of eliciting utility 
values is generally considered inferior to SG and TTO (Weinstein et al., 2009). 
Nevertheless, being a simple and quick preference tool, it has been argued that VAS 
could be best used jointly with other methods (Torrance et al., 2001; Whitehead and 
Ali, 2010). 
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Figure 3.4: Visual Analogue Scale (VAS) 
 (adapted from EuroQol group www.euroqol.org ) 
 
3.4.2.5 Contingent valuation and willingness to pay 
Contingent valuation (CV) is trade-off based method used to measure the monetary 
valuation of a health state or programme (O'Brien and Gafni, 1996; Klose, 1999; 
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Hanley et al., 2003). It involves presenting participants with hypothetical scenarios, 
event, goods in healthcare and asking them directly to express their willingness to 
pay (WTP) or willingness to accept (WTA) compensation for the particular scenario or 
event through questionnaires/structured interviews. These are helpful in estimating 
the marginal WTP for a service. Various question techniques such as open-ended 
CV, bidding game, payment card, and dichotomous choice are used to determine the 
WTP or WTA (Diener et al., 1998; Klose et al., 2016). The open-ended CV questions 
directly ask respondents to provide their maximum WTP value for a good or service. 
For example: “what is the maximum amount you would be willing to pay for the 
treatment at a specialised hospital?”. The bidding game involves asking respondents 
“Would you pay £X for a service?” (£X is the starting bid amount). If the respondent 
answers “Yes”, the starting bid is increased in specified increments until he/she says 
“No”, but if the respondent answers “No”, the starting bid is lowered until he/she says 
“Yes”. The payment card method involves asking respondents if they would be willing 
to pay £X (is one of the amounts from a list) for a service; respondents are shown 
one amount at a time usually written on a card. A dichotomous choice respondents 
reply to the question if they would be willing to pay the specified amount the WTP 
question in “Yes” or “No”. 
 
A higher WTP or WTA value for a given level of income indicates a greater benefit 
derived by the participant from the scenario or event (or from avoiding the scenario or 
event in the case of WTA) under consideration. The strength of the CV method lies in 
its ability to value welfare implications in the absence of market and being less 
complex and less burdensome to respondents compared with other stated 
preference methods such as discrete choice experiments, described below (Hanley 
et al., 2001; Olsen and Smith, 2001). However, the CV method is also criticised in a 
number of respects (Carson et al., 2001; Murphy et al., 2005; Lusk and Norwood, 
2009). First, respondents may find it difficult to place a price value when faced with 
unfamiliar goods or service, in particular those related to healthcare. Second, the CV 
method only provides the value of the goods or services as a whole and provides no 
information on the value of individual attributes that make up the goods or services. 
Third, the estimates from CV survey may suffer from challenges such as anchoring or 
framing effects (as there may be a tendency to rely heavily on the first piece of 
information offered. Depending on the techniques used, the WTP values generated 
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from CV studies may also suffer from biases such as starting point bias (tendency of 
the maximum WTP amount be influenced by the starting bid amount), ordering bias 
(tendency to be affected by the order of questions asked), warm-glow effect 
(tendency to express a socially desirable attitude rather than the true intention), yea-
saying bias (tendency to accept the bid in order to limit cognitive effort) and protest 
zero bids (tendency to state zero WTP when the respondents actually have a positive 
WTP value) (van Exel et al., 2006; Grammatikopoulou and Olsen, 2013). 
 
3.4.2.6 Conjoint analysis 
Conjoint analysis (CA) is one of the stated preference methods based on trade-off of 
attributes. The term “conjoint analysis” has been inconsistently used in the literature 
and often referred to as Discrete Choice Experiments (DCE) (Louviere et al., 2010). 
The major difference between a CA and DCE is the fact that CA developed out of 
purely mathematical theory of “Conjoint Measurement” (CM) concerned with the 
behaviour of number systems but DCE is based on long standing and well tested 
theory of choice behaviour (Louviere et al., 2010). Therefore, in line with the earlier 
recommendations from Louviere et.al. (2010), this thesis identifies CA and DCE as 
different methods. 
 
CA involves asking participants to rate or rank hypothetical alternatives that vary 
along several attributes (Ryan, 1999; Ratcliffe, 2000). In the ranking approach 
participants are asked to order alternatives according to their preferences for each 
alternative, whereas in the rating approach participants are asked not just to order 
alternatives on the basis of their preferences but also to indicate the strength of their 
preferences (Ratcliffe, 2000; Boyle et al., 2001). Adaptive conjoint analysis (ACA) is 
another form of CA method, which involves presenting the ranking or rating task to 
the respondents and then based on their ranking/rating responses, a set of attributes 
are selected and again presented asking them to indicate their preferences 
(Fraenkel, 2010; Adrian et al., 2016). Although, ACA improves the efficiency of CA by 
focussing on attributes most relevant to respondents, it is limited by the need to 
administer it using computers or mobile devices, the longer time taken to complete it 
and a possible increase in cognitive burden (Cunningham et al., 2010; Pieterse et al., 
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2010). Nevertheless, increasing number of smart phone users worldwide may still 
make ACA easier to administer. 
 
CA as a method of preference elicitation is criticised for diverging from the 
neoclassical utility theory based on choice, because ratings and rankings in CA do 
not straight away translate into a choice (Louviere et al., 2010). Furthermore, ranking 
and ratings are rarely carried out by individuals in the real world decision-making 
process (Ryan, 1999). Therefore, inferences drawn from a CA study may not 
represent the actual behaviour and could be misleading (Louviere et al., 2010). 
 
3.4.2.7 Discrete choice experiment 
Discrete choice experiment (DCE) is an ordinal preference elicitation method 
increasingly used in healthcare research (de Bekker-Grob et al., 2012; Clark et al., 
2014). In a DCE, healthcare service/intervention are usually described by their typical 
features, known as attributes (Reed Johnson et al., 2013). For example, 
effectiveness of the intervention, mode of administration of the treatment, length of 
stay in the hospital. Each attribute is assigned a range of possible values known as 
levels (Reed Johnson et al., 2013). For example, the attribute “mode of 
administration of treatment” could include levels as oral, intravenous, nasal, and the 
attribute “length of stay in the hospital” could have levels as 1 day, 3 days, 5 days 
and 7 days. A DCE involves presenting individuals with a series of hypothetical 
alternative choice sets, usually pair-wise, differing in their attributes and levels, and 
asking them to indicate their preferred alternative in each set (Ryan et al., 2008; 
Reed Johnson et al., 2013). Figure 3.5 shows an example of choice set used in a 
DCE. Based on Lancaster’s consumer theory (Lancaster, 1966), it is assumed that 
the respondents consider attribute levels of each alternative to choose the alternative 
with highest utility value for them. Lancaster’s theory is further described in section 
3.5.1 of this Chapter. A DCE also allows the quantification of the relative importance 
of attributes in terms of willingness to pay (WTP) for monetary (cost) attributes and 
marginal rates of substitution across non-monetary attributes (Ryan et al., 2008). 
Furthermore, when health states are used as attributes, DCE can be useful in 
generating preference weights and then utility values for each health state included 
as attributes (Stolk et al., 2010; Bansback et al., 2012; Brazier et al., 2012). DCE’s 
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are rooted in a long standing and well-tested neoclassical utility theory of choice- the 
random utility theory (RUT) (Louviere et al., 2010) and can adequately predict actual 
behaviour in the public health setting (Salampessy et al., 2015). RUT is further 
described in section 3.5.2. Therefore, compared to other traditional stated preference 
elicitation methods described in the earlier sections of this Chapter, DCE offer 
several advantages for economic evaluation and decision-making (Ali and 
Ronaldson, 2012; Salampessy et al., 2015). 
 
 
Figure 3.5: An example of choice set in a DCE 
 
3.4.2.8 Best-worst scaling 
Best-worst scaling (BWS) is an alternative to DCE and is considered more appealing 
than the DCE for its simplicity and ability to provide additional insights compared to 
traditional DCE (Flynn et al., 2007; Krucien et al., 2016). There are three types of 
BWS methods, namely object case (case 1), profile case (case 2) and multi-attribute 
case (case 3) (Flynn, 2010). Figure 3.6 shows examples of BWS methods. The 
object case involves asking respondents to choose best and worst attributes 
(Cheung et al., 2016). In contrast to the object case, the profile case involves asking 
respondents to choose best and worst attributes with their levels shown (Cheung et 
al., 2016). Therefore, in the object case and profile case BWS, the choices are made 
within alternatives not between alternatives. The multi-attribute case closely 
resembles the DCE but involves respondents making repeated choices of the best 
and worst set of profiles from the given set of alternatives (at least three), each 
described by a number of common attributes (Lancsar et al., 2013; Cheung et al., 
2016). 
 
Hospital characteristics Hospital A Hospital B
Travel time to the hospital 30 minutes 1 hour
Waiting time to be treated 1 hour 30 minutes
Length of stay in the hospital 5 days 2 days
Risk of death while in hospital 3 in 100 5 in 100
Out of pocket expenses £10 £20
Which hospital would you choose to go?
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Figure 3.6: Examples of best-worst scaling methods 
 
The best worst-discrete choice experiment approach (case 3) is recommended as a 
valuable tool to provide rich preference information in healthcare (Lancsar et al., 
2013). However, research suggests no significant differences between the 
preference weights generated using best worst-discrete choice experiment (case 3) 
and traditional DCE (Potoglou et al., 2011). Moreover, BWS format is reported to be 
less definitive compared to a traditional DCE in terms of consistency in the responses 
and respondent acceptability (Whitty et al., 2014). Furthermore, research comparing 
the DCE and multi-profile based BWS in eliciting preferences for the EQ-5D-5L, 
found the DCE more feasible and reliable than BWS (Xie et al., 2014). Another study, 
suggested that BWS provides lower quality data compared to a DCE and cautioned 
the use of BWS in measuring health preferences (Krucien et al., 2016). The 
limitations in DCE have been extensively researched compared to BWS, and a 
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comprehensive research is suggested before BWS is used as an alternative to DCE 
(Krucien et al., 2016). 
 
3.5 Theoretical Framework of Discrete Choice Experiments 
Both the DCE and BWS are underpinned by the same theoretical foundations. 
However, the limitations of the BWS discussed in section 3.4.2.8 of this Chapter 
would suggest that a DCE would be a less risky preference elicitation method 
compared to BWS (Clark et al., 2014). Furthermore, as discussed in section 3.4.2.7, 
a DCE offers several advantages over other stated preference elicitation methods 
such as ranking, rating, CA, CV; as well as the other methods described earlier in 
this Chapter. This is because attributes in a DCE are traded against each other, it 
incorporates the concept of opportunity costs and allows the presentation of 
preference values in the marginal context; both of which are desirable characteristics 
of a preference elicitation method (Shackley and Ryan, 1995; Ryan et al., 2008). In 
addition, a DCE is underpinned in the neoclassical utility theory of choice, is 
considered a reasonable basis for predicting actual choice behaviour in practice 
(Louviere et al., 2010). Therefore, given the advantages offered by a DCE, it was 
considered the most appropriate preference elicitation method to predict actual 
behaviour in health care and was thus used within Chapter 4 to assess preferences 
for emergency medical services. Other preference elicitation methods are not 
discussed further in this thesis. 
 
Given the focus on the DCE approach and given that the DCE is underpinned by a 
number of economic theories of consumer behaviour a brief exposition of the key 
theories is provided. The two theories that are important in the DCE are Lancaster’s 
theory and the random utility theory which are described in sections 3.5.1 and 3.5.2 
respectively. 
 
3.5.1 Lancaster’s theory 
DCEs in economics are underpinned in the Lancaster’s consumer theory (Lancaster, 
1966). The essence of Lancaster’s consumer theory is stated as follows: 
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1. The good, per se, does not give utility to the consumer; it 
possesses characteristics, and these characteristics give rise to 
utility. 
2. In general, a good will possess more than one characteristics, and 
many characteristics will be shared by more than one good. 
3. Goods in combination may possess characteristics different from 
those pertaining to goods separately. 
Lancaster’s theory considers a good as a bundle of attributes and consumer’s choice 
of a good is defined over the attribute bundles. Therefore, according to Lancaster’s 
theory, the utility of a healthcare alternative in a DCE is determined by its attributes 
and any changes in attributes can change the consumer preference from one 
alternative to another with the most beneficial combination of attributes. 
 
3.5.2 Random utility theory 
The DCE also has the theoretical foundations in random utility theory (RUT) which is 
used to explain uncertainty around predicting consumer and respondent choices. The 
RUT was originally developed by Thurstone (1927) in psychology, and was 
substantially developed into economics by McFadden (1974) who applied a 
conditional logit model consistent with RUT laying the foundation for the modern day 
DCE (McFadden, 1974). RUT introduces the idea that individuals choice behaviour is 
essentially probabilistic and at random (Thurstone, 1927). The basic axiom of RUT 
can be separated into two parts: 1) a systematic (explainable) component that can be 
observed by the researcher, and 2) a random (unexplainable) component which 
cannot be observed. The RUT framework assumes that individuals when faced with 
making a choice between alternatives will act rationally and will choose the 
alternative that maximises their utility. Therefore, the utility function is specified by the 
following equation: 
𝑈𝑖 = 𝑉𝑖 + 𝜀𝑖                                                                                                           (3.1) 
where, 
𝑈𝑖 is the latent utility of an individual for the alternative 𝑖  
𝑉𝑖 is the systematic component of utility 
𝜀𝑖 is the random and unobservable component of utility 
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In a DCE, 𝑉𝑖 is defined by the attributes and levels in the alternatives presented. The 
𝜀𝑖 is the random error term representing all the unobservable factors influencing the 
choice decisions made by the individual. This random error implies that a researcher 
cannot observe the individuals true utility function, therefore a probabilistic utility 
function is used to estimate the likelihood of an individual choosing a particular 
alternative from a set of alternatives to choose from. The probability that an individual 
will choose alternative 𝑖 over another alternative 𝑗 is given by the following equation: 
𝑃𝑖 = 𝑃𝑟𝑜𝑏(𝑈𝑖 > 𝑈𝑗) = 𝑃𝑟𝑜𝑏(𝑉𝑖 + 𝜀𝑖 >𝑉𝑗 + 𝜀𝑗) = 𝑃𝑟𝑜𝑏(𝑉𝑖 − 𝑉𝑗 >  𝜀𝑖 − 𝜀𝑗)                 (3.2) 
 
Equation 3.2 shows that higher the probability of choosing alternative 𝑖, the larger will 
be the difference in utility between alternative 𝑖 and alternative 𝑗. With the increase in 
quality of attributes in alternative 𝑖 relative to quality of attributes in alternative 𝑗 (i.e. 
the difference in estimated utility between alternatives increases) the probability of 
choosing alternative 𝑖 converges towards 1. In a DCE, each respondent makes 
discrete choices in each set of alternatives and the proportion of respondents 
choosing alternative 𝑖 is interpreted as the probability of choosing alternative 𝑖. 
 
3.6 Conclusion 
This Chapter discussed the importance of preferences in healthcare and identified 
commonly used preference elicitation techniques. Although there is a considerable 
debate on whose preferences should be used in health care, preferences from the 
representative general public would be most appropriate in a publicly funded health 
care system like the UK NHS. The preference elicitation techniques can be broadly 
categorised into revealed preferences methods and stated preference methods. In 
the absence of data on revealed preferences through participation in the market, 
stated preference methods prove useful in healthcare. Furthermore, the stated 
preferences methods can be also classified either as cardinal or ordinal methods. A 
DCE is an ordinal preference elicitation method that is well established and 
increasingly used in healthcare and offers several advantages compared to other 
preference elicitation techniques. A DCE is rooted in Lancaster’s consumer theory 
and RUT, and it incorporates the concept of opportunity costs. Furthermore, it allows 
the presentation of preference values in the marginal context, which are desirable 
characteristics of a preference elicitation method. Therefore, the DCE approach was 
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considered the most appropriate method in the context of this PhD thesis. Chapter 4, 
describes application and results of a DCE in eliciting preferences for an emergency 
medical care context. 
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Chapter 4. Eliciting Public Preferences for the Provision of 
Emergency Medical Care 
 
4.1 Introduction 
Chapter 3 provided an overview of preference elicitation techniques that are used in 
healthcare and highlighted the importance of DCE. The aim of this Chapter is to 
report the development of the DCE which explored the public preferences of 
emergency medical services and quantified the strength preferences towards 
different emergency medical care service configurations (local versus distant location 
of emergency services).The two main objectives of the DCE were: i) to examine how 
individuals’ weigh-up and trade-off between attributes of hospitals in an emergency, 
as well as the influence of their individual characteristics’ upon their choice ii) to 
utilise the utility coefficients of hospital attributes from this study to inform an 
economic evaluation model of centralisation of emergency medical services in 
Chapter 6. The Chapter addresses the second research question set out in Chapter 
1. The Chapter is structured into the following sections: section 4.2 presents the 
background to the importance of preferences in healthcare centralisation, section 4.3 
describes the methods and process of DCE design including the samples, attributes 
and levels, survey design and analytical methods used, section 4.4 presents the 
results of the DCE using different analytical methods and models, section 4.5 
presents the discussion of the results, implications of the findings, strengths and 
potential limitations of the experiment and finally the Chapter ends with section 4.6 
summarising the Chapter. 
 
4.2  Importance of Preferences in Healthcare Centralisation 
Public preferences regarding the location and nature of healthcare providers have 
become an important influence upon policy and many European countries have 
incorporated patient preferences into decisions about their healthcare systems 
(Beckert et al., 2012). Promoting patient choice is suggested to result in quality 
improvement and efficiency gains (Dixon et al., 2010b). While designing and 
evaluating healthcare programmes in the context of limited resources, it is important 
to understand how users of the healthcare might respond to healthcare reforms and 
what elements they are prepared to exchange for improvement in one aspect of care 
compared with other aspects. 
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Centralisation of emergency healthcare services is one of the areas where patients 
may face alternatives with different consequences for different populations. This is 
because the activity of local district hospitals is transferred to fewer more specialised 
emergency units providing specialised review and technology services to patients 
(NHS England, 2013a). The expected quality of care at the specialised emergency 
units however may come only at a price of increased travel times, some delay in 
initial assessment and challenges for repatriation and continuity of care. Patients may 
have strong preferences towards local healthcare services and depending upon the 
nature of their illness may value proximity of local services more than the higher 
quality care provided by centralised services further away. It is also likely that 
patients may trade-off increased travel time, inconvenience and possibly greater 
fragmentation of care for improved quality of outcomes and other proposed benefits 
of centralised healthcare services, such as the availability of specialised teams and 
investigations. 
 
Patient experience has been a core aspect in reformation of emergency medical 
services in the UK NHS (Fernandes, 2011; Department of Health, 2010) and it is 
important that patient preferences continue to inform centralisation decisions. 
Previous research projects in the UK have examined patient preferences towards 
different hospitals varying in their characteristics, however they did not consider 
emergency medical services (Ryan et al., 2000; Shackley et al., 2001; Burge et al., 
2005; Dixon et al., 2010a). Gerard and Lattimer (Gerard and Lattimer, 2005) have 
quantified patient preferences for emergency primary care during usual GP surgery 
hours, but this was limited to healthcare advice and not the comparison between 
hospital configurations. Incorporating patient preferences in healthcare policy 
decisions may improve the uptake and efficiency of emergency healthcare services. 
Thus, it is desirable that the key drivers of choice of hospitals in an emergency are 
explored and preferences are established and incorporated in the emergency 
healthcare reforms to enable decision-makers better understand patient preferences 
and to give patients a greater say in the way how emergency medical services are 
best organised. 
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4.3  Methods 
 
4.3.1 Discrete choice experiment 
As noted in section 3.4.2.7 of Chapter 3, DCEs are an increasingly popular method 
for eliciting preferences in healthcare (de Bekker-Grob et al., 2012; Clark et al., 
2014). DCEs provide rich data sources for economic evaluation and decision-making 
and offer several other advantages compared to other traditional stated preference 
elicitation methods (Ali and Ronaldson, 2012; Salampessy et al., 2015). Chapter 3 
provided an overview of preference elicitation techniques used in healthcare, 
discussed the appropriateness of DCE to address the issue focussed in this thesis 
and described its theoretical framework. In short, DCEs are rooted in a long standing 
and well-tested neo-classical utility theory of choice (Louviere et al., 2010) and 
evidence (Salampessy et al., 2015) has shown that preferences derived from DCEs 
can adequately predict actual behaviour in the public health setting. DCEs involve 
presenting individuals with a series of hypothetical choice sets which differ in 
characteristics and their magnitude or levels, and ask them to choose the alternative 
they prefer in each set. The choices that individuals make from DCE survey enable 
researchers to understand the value that individuals place on various levels of 
healthcare provision characteristics. Therefore, a DCE process was applied to elicit 
individual’s preferences regarding a choice between local and distant hospital during 
an episode of emergency medical need according to different descriptions of care 
provision and outcome. The key stages involved in the development of a DCE are 
described in the next sections. 
 
4.3.2 Defining attribute and levels 
The first step when conducting a DCE is to define the variables (attributes) and 
associated range of values (levels). Several studies (Ryan et al., 2000; Shackley et 
al., 2001; Burge et al., 2005; Gerard and Lattimer, 2005; Dixon et al., 2010a) 
reporting patients’ preferences and choices in healthcare were reviewed to identify 
important attributes in emergency medical services from the patient perspective. It 
was also essential that attributes also reflected the performance measures commonly 
used in emergency medical services (Sorup et al., 2013) and also the key hospital 
quality indicators in NHS England (Cameron et al., 2011; The College of Emergency 
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Medicine, 2011; Roberts et al., 2014). Therefore, it was essential that the attributes 
balanced the need to identify important attributes with the need to reflect key hospital 
quality indicators. The identified attributes were assigned levels that were potentially 
applicable under the existing NHS systems (Acute surveys co-ordination centre for 
the NHS patient survey programme, 2009). 
 
A number of qualitative research approaches such as focus group discussions, 
patient interviews and brain-storming could be conducted while developing attributes 
and levels in healthcare DCEs (Helter and Boehler, 2016). It has been highlighted by 
Coast and colleagues that if important attributes are excluded, then intuitively and 
self-evidently the resulting DCE is likely to be biased or useless for policy formation 
(Coast et al., 2012). A recent publication has also highlighted the importance of 
qualitative research to inform the development of a DCE (Vass et al., 2017). 
However, qualitative research exploring the attributes in the DCEs in this case was 
challenging in terms of time and resource constraints of this PhD. Getting the 
required sample for the qualitative work within a limited time was difficult. 
Furthermore, this DCE focussed on considering patient preferences of hospitals 
based on their key quality indicators. 
 
The number of attributes considered appropriate in a DCE is context specific, but 
previous studies have used between four and six, with a few using more than ten 
(Ryan and Gerard, 2003; Marshall et al., 2010; Clark et al., 2014). However, 
increasing the number of attributes and their levels increases the complexity and the 
cognitive burden to the respondents in completing the DCE survey (Ryan and 
Gerard, 2003) which may lead to unreliable responses. Respondents are also likely 
to ignore attributes with narrow levels because of little difference between the levels 
(Lancsar and Louviere, 2008). A long list of attributes and their levels were identified 
from the literature which was then discussed with the expert supervisory team who 
voted on the relative importance of attributes. This list was then shortened, balancing 
the need to consider important attributes in this DCE with the need to reflect key 
hospital quality indicators in NHS England as discussed above. Therefore, only six 
key attributes (three quality outcomes and three process outcomes) and with a 
maximum of four reasonably wide levels for each attribute were selected (Table 4.1). 
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The attributes selected were travel time to hospital, waiting time to be treated, length 
of stay in the hospital, risk of dying, risk of re-admission to the hospital and outpatient 
care after emergency treatment. These attributes reflected the key quality indicators 
used in emergency medical services in the UK (Cameron et al., 2011; The College of 
Emergency Medicine, 2011; Roberts et al., 2014). The selection of attributes 
balanced the need to keep the choice set simple with the need to reflect key quality 
indicators of emergency medical services in the preference data. In addition, the 
appropriateness of these attributes and their levels were discussed extensively with 
the thesis supervisory team. 
 
Table 4.1: Attributes and levels used in the DCE 
Attributes Levels 
Travel time to hospital Less than 30 min, 
1 hour, 
1 and half hours, 
2 hours or more 
Waiting time in the A&E department to be seen by 
a doctor or nurse who can provide treatment 
30 min, 
1 hour, 
2 and half hours, 
4 hours or more 
Length of stay at the hospital before going home 1 day or less, 
3 days, 
5 days,   
6 days or more 
Risk of dying from the illness  Low (Less than 1 in 100 patients), 
Mild (3 in 100 patients), 
Moderate (5 in 100 patients), 
High (More than 7 in 100 patients) 
Risk of being re-admitted to the hospital after going 
home 
Low  (Less than 1 in 100 patients), 
Mild (3 in 100 patients), 
Moderate (5 in 100 patients), 
High (More than 7 in 100 patients) 
Outpatient care after emergency treatment At your Local hospital, 
At a hospital which is about an extra 1 
hour travel time from your local 
hospital 
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4.3.3 Initial experimental design 
In the absence of underlying theory guiding DCE survey design or analysis the 
choice experiment design depends on the study circumstances (Amaya-Amaya et al., 
2008). However, the available guidance (Reed Johnson et al., 2013) for best practice 
were closely followed in designing the DCE described in this Chapter. The attributes 
and attribute levels in Table 4.1 were used to develop an initial experimental design 
of choice scenarios using Ngene software version 1.1.1 (ChoiceMetrics, 2012). A full 
factorial design which incorporates all possible combinations of attributes and levels 
(Lancsar and Louviere, 2008) would have resulted in 2128 (i.e. 45 x 21) possible 
scenarios. However, considering numbers of attributes, task complexity and the 
time/resource constraints in this project a full factorial design was considered too 
large and thus inappropriate. Therefore, a fractional factorial design was used to 
reduce the number of choice scenarios to a more manageable number but still 
enabled the exploration of all main effects (effects of each attribute) of interest 
(Lancsar and Louviere, 2008). There are various approaches to obtaining a fractional 
factorial design. An efficient design, which maximises the statistical efficiency of 
designs by minimizing the predicted standard errors of the parameter estimates 
(usually the D-error statistic) was used for the initial experimental design (Rose and 
Bliemer, 2009). The generation of an efficient design requires knowledge of prior 
coefficient values, which in most instances are not known prior to the model 
estimation (Rose et al., 2008). It could be expected that people prefer less travel 
time, less waiting time, fewer days in hospital, low risk of readmission, low risk of 
mortality and outpatient care in their local hospital; this could have shown the 
direction of attribute coefficients. However, prior coefficient values for all of the 
attributes considered in this case were not readily available. In addition, it was not 
certain whether similar direction of coefficients applied for the case focussed on in 
this Chapter. Therefore, the prior coefficient values were assumed to be zero for the 
initial efficient design which was piloted (explained in section 4.3.5). D-efficiency 
scores were used to ensure that an optimal set of choice scenarios are used in the 
DCEs survey. 
 
The initial efficient design generated 20 choice sets-a number which may place 
heavy cognitive burden on respondents. Therefore, to minimise the potential 
cognitive burden to the respondents, the choice sets were blocked into two, with 
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each block having 10 choice sets (Reed Johnson et al., 2013). Respondents were 
randomly assigned one of the blocks of choice sets. The respondents were asked to 
make a forced choice between the hospitals. Whether or not to include an “opt out” 
alternative in choice studies has been widely debated. Studies (Dhar and Simonson, 
2003; Brazell et al., 2006; Parker and Schrift, 2011; Veldwijk et al., 2014) have 
shown that presence of ‘opt out’ alternative in choice sets generates smaller attribute 
coefficients compared to the coefficients from a forced choice which could have 
implications in computation of marginal rates of substitution. It has also been argued 
that including an opt out alternative in choice studies leads to unnecessary loss of 
efficiency in choice designs if a higher number of respondents choose to opt  out 
(Brazell et al., 2006; Veldwijk et al., 2014). Dual response design, in which 
respondents are first forced to choose between the available alternatives and then 
immediately after choosing are again asked to choose between the available 
alternatives and the opt-out alternative, could have allowed a better estimation of the 
attribute coefficients (Brazell et al., 2006; Rose and Hess, 2009; Veldwijk et al., 
2014). However, dual response design would have increased response burden. 
Furthermore, considering the nature of decision problem faced by respondents in this 
case of healthcare emergency considered by this DCE, an opt-out alternative of “no 
treatment” in a healthcare emergency would have lacked realism. 
 
One choice scenario was repeated in each of the blocks (making 11 choice scenarios 
in each block) to assess the completeness in the participant responses. The 
completeness (test-rest reliability) axiom of consumer theory specifies that each 
individual has a well-defined preference between any two possible alternatives 
(Lancsar and Louviere, 2006) i.e. if participants prefer A to B  in a choice set at any 
point in a survey then they should again prefer A to B when the choice set is 
repeated at any subsequent point within the questionnaire (Ryan and San Miguel, 
2003).Violation of completeness axiom was considered irrational. Completeness 
axiom as a test of rationality was used in initial experimental design because it is 
simple and is more often used in preferences studies compared to other tests used in 
health economics such as Sen’s expansion and contraction and transitivity (Lancsar 
and Louviere, 2006). 
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The questions on socio-demographic and general health information are very useful 
in understanding the characteristics of the population studied. It is also common to 
use these information as covariates in different analysis models in discrete choice 
experiments. The socio-demographic questions in the survey included: gender, age-
group, partial-postcode location (the first part of the postcode, for example only NE2 
for NE2 4AX) and their GP surgery name. The postcode and GP surgery information 
was used to ensure that any respondent outside of Northumberland region (the study 
area) was not included. In addition, the survey also included questions on difficulty in 
completing the choice task and the number of emergency visits in the last 12 months. 
The data on choice task difficulties was expected to provide insights into the 
cognitive burden on respondents. The data on number of emergency visits in the last 
12 months was expected to inform whether the preferences varied with experience of 
emergency visits. Person identifiable information such as name, date of birth, full 
postal address and NHS number were not collected to comply with data governance 
protocols. 
 
Generic health information is expected to provide insights into the health related 
quality of life of the respondents. Therefore, the survey also included EQ-5D-5L and 
EQ-VAS generic health status questions from the EuroQol group (Herdman et al., 
2011; Devlin and Brooks, 2017). The EQ-5D-5L describes health on 5 dimensions: 
mobility, self-care, usual activities, pain/discomfort and anxiety/depression. Each 
dimensions include five levels ranging from no problems to extreme problems from 
which the respondents are asked to select the level closely matching to their health 
state. The descriptive data is commonly converted to utility weight in a scale where 0 
is equivalent to dead and 1 is considered full health, but negative values indicating a 
health state worse than dead is also possible. The utility values for each health state 
were derived from EQ-5D-5L tariffs for England (Devlin and Shah, 2018). The EQ-
VAS is a scale where respondents are asked to indicate their self-rated health 
ranging between 0 (worst imaginable health state) to 100 (best imaginable health 
state). 
 
The survey questionnaire had a study information section in the very beginning which 
included: the aim of the survey, what the participation in the survey would involve, the 
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estimated time to complete the survey, the description of each of the attributes 
included in the DCE, clear statement of voluntary participation in the survey and 
assurance of no person identifiable questions, an example of selection of hospitals in 
a choice scenario and contact details of the researcher in case of any questions on 
the survey. This information section was included to ensure that this survey was 
conducted ethically. 
 
4.3.4  Pre-testing the survey 
The paper format of the initial survey design was pretested among six members of 
the Institute of Health & Society (IHS), Newcastle University. Following the pre-test, 
the survey questionnaire was revised with some simplification to the wording of 
survey introduction and choice sets. The pre-test indicated that it would take 
participants about 12-18 minutes to complete the survey. 
 
4.3.5 Piloting the survey 
After the pre-test, the paper format of revised questionnaire was piloted on a sample 
of 29 purposively selected participants registered with the Healthwatch 
Northumberland’s network. Healthwatch England is a national consumer champion in 
healthcare and operates through networks in every local authority across England. 
The survey pilot was run between July 2015 and September 2015. The survey pilot 
was expected to provide prior coefficients for each attributes to be used in final 
design of the DCE choice sets (see section 4.3.6). It was also expected to assess 
whether the wording of the survey was appropriate to the potential respondents and 
whether they had any difficulties in understanding and completing the survey. Three 
respondents among the 29 included in the pilot did not fill out the survey correctly 
and were excluded from the pilot analysis. The majority (58%) of remaining 26 
participants reported no difficulty in completing the DCE choice sets and most of 
them answered all questions correctly. Although 42% reported DCE survey as 
difficult and two participants did not complete the self-reported health questions, all 
the 26 participants provided complete responses to the choice questions. The high 
level of correct and complete responses to survey questions was considered 
satisfactory. However, among the 26 participants analysed, 8 (30.76%) were not 
consistent in their choice and failed the completeness axiom/test-retest reliability in 
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their responses. The pilot study showed that respondents understood the choice task 
and easily manage the choice questions. 
 
It is well known that DCEs can be cognitively demanding. A high level of complete 
responses in this DCE was assumed to reflect that the text, attributes and levels 
used in the survey were appropriate and did not result in cognitive overload for 
respondents. However, to further ensure the clarity of the survey some of the text 
were reformatted and simplified. The respondents were reassured by reiteration that 
no questions will identify them. Some of the text was changed to bold and some 
underlined to highlight important information about the survey. The paragraph of text 
following the example choice set was changed to bulleted list form to increase clarity. 
The font size of the text was also enlarged and only one scenario per page was 
presented to respondents. An option “Prefer not to say” was added in the question 
asking about the participant’s gender. In the pilot it was realised that participants 
disliked the question on their education / qualifications. Therefore, this question was 
removed from the final survey questionnaire. The pilot also helped to identify the 
need for a paper format of the survey questionnaires with large font for the visually 
impaired participants. The characteristics of participants of the pilot test are 
presented in Table 4.2. 
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Table 4.2: Characteristics of participants of the pilot test 
Characteristics All 
Sample (n) 26 
Age groups  
60-64 4(15.3%) 
65-69 9(34.6%) 
70-74 4(15.3%) 
75-79 4(15.3%) 
80-84 3(11.5%) 
85+ 2(7.6%) 
Gender  
Male  13 (50%) 
Female 13 (50%) 
Self-reported health*  
Mean EQ-VAS score (SD) 62.91(23.21) 
Mean EQ-5D score(SD) 0.64 (0.29) 
Emergency experience  
Yes 6 (23.07%) 
No 20 (76.92%) 
*Analysis based on only 24 participants who completed self-reported health 
 
The pilot data was used to generate the prior coefficient parameters in Table 4.3 and 
the pilot results indicated the direction of the attribute preferences. The negative 
coefficients in each of the attribute indicate that respondents preferred less travel 
time to the hospital, less waiting time to receive the treatment, fewer number of days 
in hospital, low risk of death, low risk of readmission, and outpatient follow-up in their 
local hospitals; the higher the level of the attribute, the higher the level of attribute the 
individual is less likely to choose that attribute. 
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Table 4.3: Regression results from the pilot study 
Attributes Coefficients (SE) 
 (Main effects-MNL) 
Travel time -0.01 (0.003)*** 
Waiting time -0.007 (0.0013)*** 
Length of stay -0.10 (0.04)* 
Risk of death  -0.28 (0.05)*** 
Risk of readmission -0.16 (0.04)*** 
Outpatient follow-up  -0.62 (0.17)*** 
***p<0.001, *p<0.05; SE=Standard Error, 
 
4.3.6 Final discrete choice experiment design and survey questionnaire 
The final survey was also designed using Ngene software version 1.1.1 
(ChoiceMetrics, 2012). In the last 10 years coefficient values estimated from pilot 
surveys have been used to re-design and improve the level of statistical efficiency of 
the final survey design (Rose et al., 2008). But, the robustness of these priors used in 
this DCE design is questionable because they were based on a small and purposive 
pilot sample. If the priors were mis-specified then the statistical efficiency of the 
design would be reduced. However, experiments have demonstrated that statistically 
efficient designs are likely to outperform orthogonal designs, even if the priors used 
in the construction are incorrectly specified, even up to ±40% deviation (Rose and 
Bliemer, 2013). Therefore, coefficients generated from the pilot data (Table 4.3) were 
used as priors to re-design the final survey. 
 
Efficient design with twenty choice sets blocked into two with 10 choice sets in each 
block were designed. Blocking reduced the number of choice sets answered by 
respondents and was expected to minimise the potential cognitive burden on them 
(Reed Johnson et al., 2013). Respondents answered the block randomly assigned to 
them. New design in Ngene meant that the choice sets in the final design differed 
from those used in the pilot, however the questions on socio-demographic 
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information and general health remained the same as in the pilot. Both the blocks 
had the same socio-demographic and general health questions. 
 
DCE results are based on hypothetical scenarios which means that it is important 
that these results are externally valid i.e. similar results are observed in the real 
world. However, there is often little scope of tests of external validity of DCE results in 
the health sector because of lack of market in health care and unavailability of real 
data on individuals’ health (de Bekker-Grob et al., 2012; Clark et al., 2014). 
Therefore, tests of external validity were considered difficult in this study context and 
were not applied. It is difficult to establish whether the respondents’ stated 
preferences were consistent with their actual behaviour. Nevertheless, the study 
attempted to minimize any such differences in the stated and actual choice by 
offering best possible real world alternatives to choose from. 
 
Internal validity checks were carried out using the tests of theoretical validity and 
rationality. Theoretical validity was assessed by checking whether the parameters 
moved in expected direction by looking at the estimated signs of the parameter 
coefficients. For example, it was expected that shorter travel time to a hospital is 
preferred over longer travel time duration. The completeness axiom used as 
rationality tests in initial survey design and the pilot (see section 4.3.3) was dropped 
in the main study for tests of “transitivity” and “monotonicity”. The importance of these 
tests was realised only after the pilot was conducted. Transitivity was used as the 
test of the underlying axioms of consumer theory and is considered the more 
fundamental test of rationality in preference elicitation compared to completeness 
(Lancsar and Louviere, 2006). A completeness test in addition to transitivity and 
monotonicity tests would obviously have made investigation of rationality checks 
stronger but this could have come only at a price of increased cognitive burden and 
time for respondents caused by the increased number of choice sets in the 
questionnaire. Another commonly used rationality test is Sen’s expansion and 
contraction which implies that if a respondent prefers A in choice set with three 
choice options A, B and C, then again when presented with choice set 2 contracted 
to just two options A and B, the preferred choice should not be B (Lancsar and 
Louviere, 2006). Sen’s expansion and contraction test (which involves at least three 
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alternatives in original choice set contracted to two alternatives in another choice set 
or vice-versa) as a rationality test in the two alternative DCE described here in this 
Chapter would have been difficult and was considered inappropriate. 
 
Transitivity implies if A is preferred to B and B is preferred to C, then A should be 
preferred to C (Ozdemir et al., 2010).  In each of the blocks of questionnaire, choice 
set number 3 with alternatives as hospital A and hospital B (i.e. from the choice 
design) was taken as a base for the transitivity test. The transitivity test were spread 
out as evenly as possible across the choice task. Therefore, another choice set 
number 6 was manually added keeping hospital B attribute levels the same as in the 
choice set 3 but with a new alternative, hospital C with completely different attribute 
levels. Another additional choice set number 9 was manually added taking 
characteristics of hospital A from the choice set 3 and characteristics of hospital C 
from choice set 6. In short, the test was structured as follows: 
Choice set number 3: Hospital A=A, Hospital B=B 
Choice set number 6: Hospital A=B, Hospital B=C 
Choice set number 9: Hospital A=A, Hospital B=C 
However, in the questionnaire in each of the choice sets the alternatives were named 
as hospital A and hospital B. So, if the respondent made choices in a cyclic order 
(prefer A to B and prefer B to C and then prefer C to A; prefer B to A, C to B, and 
then prefer A to C) the choice was considered intransitive and thus irrational. 
 
Though not essential for rationality, monotonicity, is a desirable axiom of consumer 
theory and implies that more is preferred to less (Lancsar and Louviere, 2006). 
Therefore, another choice set number 12 where one hospital alternative was 
obviously dominant in terms of all attributes was manually added to the choice task 
as a test of violation of monotonicity axiom. It was assumed that individuals preferred 
the alternative with shorter travel time, shorter waiting time, low risk of mortality, low 
risk of readmission, shorter length of stay and outpatient follow-up at their local 
hospital. Any violation of monotonicity axiom in the respondent choices was 
considered irrational. 
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Hence, the final survey consisted of 13 choice sets in each block asking participants 
to indicate which of the two hypothetical emergency care emergency hospitals 
varying in terms of the attribute levels they would choose in case of emergency (see 
Appendix B for a sample block of questionnaire used in the survey). However, the 
responses to the choice sets number 6, 9 and 12 used as internal validity tests were 
not included in the final data analysis. The number of choice sets used were 
considered manageable considering the existing evidence (Clark et al., 2014). It has 
been suggested that respondents can manage multiple number of choice scenarios 
(up to 17 in the experiment) without any difficulty (Bech et al., 2011). There are 
instances where many more scenarios have been used for example 36 choice 
scenarios in a DCE involving people with glaucoma (Burr et al., 2012). However 
there will be a tendency for choice variance to increase with the increase in the 
number of choice sets (Bech et al., 2011). 
 
So, how was violation of validity tests in discrete choice experiments dealt with? Any 
respondents violating such tests may be deleted and excluded from the main 
analysis (Ryan and Bate, 2001; San Miguel et al., 2005; Hifinger et al., 2017) 
however an influential research article (Lancsar and Louviere, 2006) has argued that 
failure of the test would not necessarily mean the respondent was irrational and 
deletion of responses that fail the validity tests may result in removal of valid 
preferences which may lead to biased results. Moreover, random utility theory is 
expected to be robust to such violations in validity tests (Lancsar and Louviere, 
2006). Furthermore, qualitative research (San Miguel et al., 2005; Ryan et al., 2009) 
in this area also revealed that respondents failing the validity tests had rational 
reasons for doing so. Therefore, in this choice experiment the choice data was 
analysed with and without respondents failing the validity tests. 
 
4.3.7 Electronic questionnaire 
The paper format of the questionnaire was adapted into an web version of survey 
using a commercial platform Qualtrics (Qualtrics, 2015). The web version of the 
survey was purposively tested on five staff from Institute of Health & Society, 
Newcastle University. There were no reports of technical issues in completing the 
web version of the survey. Table 4.4 shows an example of the choice set. 
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Table 4.4: Illustrative example of choice set used in the DCE 
Suppose you have an emergency healthcare need which required calling an 
ambulance. Below are two hospitals, hospital A and hospital B, each with different 
characteristics. If you have a choice, which hospital would you choose from below? 
Characteristics Hospital A Hospital B 
Travel time to hospital 1 and half hours 1 hour 
Waiting time in the A&E department 
to be seen by a doctor or nurse who 
can provide treatment 
4 hours or more Less than 30 
minutes 
Length of stay at the hospital before 
going home 
3 days 5 days 
Risk of dying from the illness 
(..patients die) 
Moderate 
(5 in 100 patients) 
Mild 
(3 in 100 patients) 
Risk of being re-admitted to the 
hospital after going home 
Mild 
(3 in 100 patients)  
Moderate 
(5 in 100 patients) 
Outpatient care after emergency 
treatment 
At a hospital which 
about an extra 1 hour 
travel time from local 
hospital 
Local hospital 
Which hospital would you chose to go 
in emergency? (Please tick only one 
box at the right) 
☐ ☐ 
 
4.3.8 Survey sample and data collection 
The survey sample was taken from list of individuals over 18 years of age either 
registered with the healthwatch Northumberland (Healthwatch) network or with a 
record of emergency healthcare visit in the Northumbria Health Care NHS 
Foundation Trust (NHCT). The survey was administered to the potential participants 
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via healthwatch Northumberland and NHCT. The survey was administered between 
January 2016 and April 2016. 
 
Potential participants with email access were sent an electronic link to the survey 
using online commercial platform, Qualtrics (Qualtrics, 2015) whereas those without 
email access were sent a paper format of the survey in post. Participants previously 
identified with visual impairments and no email access were sent a paper format of 
the survey questions in large fonts in post. All the participants accessed via NHCT 
were sent a paper format of the questionnaire in post. An invitation to participate, 
containing key information explaining the survey, time required and how the 
responses will be used, were also sent along with the web link to the survey. The 
web link was provided in case some potential respondents receiving the survey 
questionnaires in post would prefer to complete the survey online. As explained 
earlier in section 4.3.6, the survey was blocked into two and the participants were 
randomly assigned to a block. 
 
4.3.9 Sample size 
Sample size estimation methods in healthcare DCE studies are currently developing 
(de Bekker-Grob et al., 2015). Traditional designs and existing sampling theories do 
not address the issue of minimum sample size requirements in terms of reliability of 
parameter estimates produced and  assumptions are often employed in computing 
sample estimates (Rose and Bliemer, 2013; de Bekker-Grob et al., 2015). A range of 
the range of 100 to 300 respondents used by most of the DCE studies in health care 
(de Bekker-Grob et al., 2015).The sample size in more recent studies vary, with 
fewer samples in disease specific population (Shalowitz et al., 2018), higher samples 
in studies in general population (Nexo et al., 2017) and within the range of 100-300 in 
others (De Brún et al., 2018). It appears these sample sizes are mainly determined 
by the rule of thumb or in line existing DCE studies or based on the context. 
 
The sample required for this study was estimated following the rule of thumb 
suggested by Johnson and Orme (Orme, 1998; de Bekker-Grob et al., 2015; Orme, 
2010) using the following equation: 
74 
𝑁 > 500𝐿/𝑇𝐴  
where 𝑁 is sample size required, 𝐿 is the largest number of levels for any of the 
choice attributes, 𝑇 is the number of choice sets, and 𝐴 is the number of alternatives 
assessed. The required minimum sample was estimated as 100 respondents. 
However, a much larger sample was targeted to allow for heterogeneity between 
respondents. 
 
It should be noted that rules of thumb are considered a sub-optimal approach. Even 
the sample estimate computed using an alternative sample size estimation method 
(de Bekker-Grob et al., 2015) suggested that this study would only need a minimum 
53 respondents to generate adequately powered coefficient estimates; at the same 
time it should be noted that the estimated minimum sample was increased to above 
1000 respondents when risk of death and risk of readmission were recoded into 
categorical levels. This method requires prior knowledge of the significance level, the 
statistical power level, the statistical model to be used in the DCE analysis, prior 
coefficients and the DCE design. Using these information, the sample size is 
computed by this method using the following equation: 
𝑁 > ((𝑍1−𝛽 + 𝑍1−𝛼 )√∑ /𝛿)𝛾𝑘   
Where, N is the sample size, 1 − 𝛽 is the power level, 𝛼 is the confidence level, ∑𝛾 is 
the variance-covariance matrix, 𝛿 are the effect sizes. The step by step guideline to 
estimate the sample size using this method in R programming language is provided 
by de Bekker-Grob et al (2015). 
 
Hence, a sample of 148 respondents included in the analysis in this DCE was 
considered adequate. 
 
4.3.10  Data analysis 
Discrete choice modelling within a random utility modelling framework was used to 
analyse the survey data collected. A wide range of logistic regression modelling 
approaches are available (de Bekker-Grob et al., 2012) and selection depends upon 
the characteristics of data collected (Amaya-Amaya et al., 2008). Multinomial Logit 
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(MNL) analyses, also sometimes known as conditional logit analyses, are 
increasingly popular in analysing choice data in health economics (Clark et al., 2014). 
A simple MNL analyses was performed and depending upon the characteristics of 
the data and restrictions of MNL model, estimates from other model specifications 
such as Mixed Multinomial Logit (MIXL) and Generalised Multinomial Logit (GMNL) 
were also considered. Although the initial plan was to perform the subgroup analysis, 
small sample size in the subgroups were considered insufficient to generate 
meaningful results. However, covariate interactions with the attributes were assessed 
to see how the results were influenced by the patient characteristics. Both the pilot 
and final survey data analysis was performed in R (R Core Team, 2016) and were 
replicated in STATA 13 (StataCorp, 2013). 
 
Model 1A and Model 1B utilised MNL regression on the choice data. Model 1A tested 
the main effects assuming homogenous choice across all respondents in the sample. 
Model 1B assessed the significance of attribute interactions with the respondent 
characteristics to understand how the respondent characteristics influenced the 
preference estimates. However, the MNL models are based on assumptions of 
independence of irrelevant alternatives (IIA), independence and identical distribution 
of error terms (IID) across observations and no heterogeneity across respondents. 
This may be restrictive and limited in describing human choice behaviour (de Bekker-
Grob et al., 2012). Therefore, the MIXL model (Hensher and Greene, 2003; Hess and 
Train, 2017), a popular extension of the MNL which, while keeping the IID and not 
making the IIA assumptions eliminates the limitations of MNL by allowing for choice 
heterogeneity across respondents was considered in Model 1C. 
 
It has been argued that generalised multinomial logit (G-MNL) model allows for the 
scale heterogeneity by accounting for some respondents who exhibit more random 
(i.e. relatively insensitive to attributes) and extreme (i.e. near lexicographic- always 
choosing a particular attribute regardless of others) choices, and thus offers a better 
fit; outperforming the MIXL model (Fiebig et al., 2010). Therefore, Model 1D was 
considered utilising the G-MNL model. All these models initially considered all the 
attribute levels as continuous but were again repeated (except Model 1B) after 
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recoding risk of readmission, risk of death and outpatient follow-up as categorical 
variables. 
 
Akaike information criterion (AIC) and Bayesian information criterion (BIC) were used 
as measures of the model fit. The lower the AIC and BIC measures the more 
preferred is the model (Hauber et al., 2016). 
 
4.3.11  Marginal rates of substitution 
The signs (negative or positive) of coefficients indicate the direction of a particular 
attribute in terms of utility, however attribute coefficients are not directly comparable 
against each other because of differences in the scale of measurement in each 
attribute (Vass et al., 2018). The magnitude of coefficients alone provide a little 
meaningful information. One of the commonly used approach is to compare the 
coefficient results is to estimate the marginal rates of substitution (MRS). Therefore, 
MRS were calculated, across all models, to compare respondent preferences on a 
common value scale and understand the trade-offs they were willing to make 
between two attributes. MRS values were estimated as the ratio between coefficients 
of two attributes i.e. dividing coefficient of one attribute by coefficient of another 
attribute. Since there was no cost attribute in this choice experiment, willingness to 
pay (WTP) was not generated. However, time was utilised as the “currency” to derive 
how much travel time or waiting time respondents were willing to give up to get more 
of other attributes. Ratios of other selected attributes were also estimated. 
 
4.3.12  Ethical considerations 
The DCE survey conducted via Healthwatch was ethically approved by the 
Newcastle University Faculty of Medical Sciences Ethics Committee (approval code 
00893/2015) (see Appendix B-B1). The survey via NHCT was administered via the 
trust patient experience team so there were no data protection issues relating to 
transfer of names and address. Furthermore, only anonymised data were provided 
for the analysis. All potential participants were provided brief information about the 
survey and reassured that personal identifiable information will not be collected. 
Since this survey was administered using postal and web based electronic methods, 
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specific written consent of the participants was not obtained. However by 
participating in the survey, respondents were made aware that they were providing 
consent for their views to be collected. Participants were also informed that 
participation in the survey was voluntary and they could stop completion of the 
survey at any time without providing any reason whatsoever. However once 
completed, it was not possible to remove their responses as no identifiable 
information were collected. Participants were provided with the contact details of the 
researcher to provide them an opportunity to raise any concerns regarding the 
survey. All data collected from the participants were anonymous. 
 
The survey data and other related materials were handled in accordance with the 
Newcastle University’s rules and regulations in place with strict adherence to The 
Data Protection Act 1998 and the Newcastle University Information Security 
Guidelines (http://www.ncl.ac.uk/data.protection/policy.htm). 
 
4.4 Results 
 
4.4.1 Descriptive statistics 
The survey was sent through post to a total of 681 potential respondents (181 via 
Healthwatch and 500 via NHCT). A total of 148 respondents completed the survey: 
62 completed the web version and 86 completed the postal version. The response 
rate in the survey sent through post was 12.62%. It was quite difficult to assess the 
response rates in the web version of the survey. However, the survey web-link was 
emailed to 342 individuals (these do not include individuals who were sent the survey 
through post) and to 301 organizations, 115 parish councils, as well as 67 county 
councillors requesting them to share the survey web link. The web link to the survey 
was opened by 101 potential respondents and the response rates in terms of those 
opening the survey in the web version of the survey was about 61%. 
 
Table 4.5 presents the summary of the key characteristics of the respondents. Most 
of the respondents were above 55 years of age, close to retirement. There were 
almost twice the number of female respondents compared with the number of males. 
About half of the respondents had some form of emergency experience in the 
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immediate 12 months before the survey. The general health measures (EQ-
VAS=75.5, EQ-5D-5L=0.77) suggested the health status of the respondents is rather 
low compared to UK general population average, however, it was generally similar to 
the average for those above 55 years of age in the UK general population (Janssen 
and Szende, 2014). A majority of respondents in this survey were aged more than 55 
years suggesting that general health measures could be reasonable reflection of 
members of the general population of a similar age. 
 
Table 4.5: Summary of respondent characteristics 
Characteristics All 
Sample (n) 148 
Age groups  
16-29 4 (2.70%) 
30-34 6 (4.05%) 
35-39 5 (3.37%) 
40-44 4 (2.70%) 
45-49 9 (6.08%) 
50-54 12 (8.10%) 
55-59 19 (12.84%) 
60-64 21 (14.19%) 
65-69 27 (18.24%) 
70-74 17 (11.48%) 
75-79 9 (6.08%) 
80-84 9 (6.08%) 
85+ 6 (4.05%) 
Gender  
Male  49 (33.10%) 
Female 98 (66.21%) 
Prefer not to reveal 1 (0.67%) 
Self-reported health  
Mean EQ-VAS score (SD) 75.50 (20.48) 
Mean EQ-5D-5L score(SD) 0.77 (0.22) 
Emergency experience  
Yes 78 (52. 70 %) 
No 70 (47.30%) 
 
Among the sample, 65 (44%) respondents self-reported some form of difficulty in 
completing the choice task (Table 4.6). However, only two respondents (one 
completed the postal version and the other completed the web version of the survey) 
failed the transitivity test among the two internal validity checks (transitivity and 
monotonicity) employed. 
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Table 4.6: Reported choice task difficulty and internal validity failure 
Characteristics Number of respondents (percentage) 
Choice task difficulty  
Very Difficult 3 (2.03) 
Difficult 9 (6.08) 
Somewhat Difficult 53 (35.81) 
Neutral 27 (18.24) 
Somewhat easy 27 (18.24) 
Easy 19 (12.84) 
Very Easy 10 (6.76) 
  
Internal validity failure 2 (1.4) 
 
4.4.2 Regression analysis of DCE data 
A very small number of respondents (two) failed the validity tests and the initial 
regression analysis indicated that the coefficient estimates remained similar 
regardless of whether those respondents failing the validity tests were included or 
excluded in the analysis. Therefore, all respondents were included in the final 
analysis. Table 4.7 presents the regression analysis considering all the attributes as 
continuous, whereas Table 4.8 presents the analysis where the attributes “risk of 
readmission”, “risk of death” and “outpatient follow-up” were dummy coded as 
categorical variables. The coefficient generated from each models considered in the 
analysis (see section 4.3.10) are presented in Tables 4.7 and 4.8. The negative and 
positive signs in the coefficients indicate preference of a lower level and higher level 
of an attribute respectively. 
 
In Table 4.7, Model 1A utilised MNL regression (see section 4.3.10) on the choice 
data to test the main effects and presents the utility coefficients for each attributes 
used in the choice experiment. The negative signs in the coefficients value in Model 
1A indicated that higher the level of these attributes in an alternative, the less likely 
the individual was to choose the alternative. The coefficients estimates were in line 
with the priori expectations that individuals would prefer less travel time to the 
hospital (-0.0086, p<0.001), less waiting time to receive the service (-0.0056, 
p<0.001), fewer number of days of length of stay in hospital (-0.0768, p<0.001), low 
risk of death (-0.3258, p<0.001), low risk of readmission (-0.1442, p<0.001), and 
outpatient follow-up care after the emergency treatment in their local hospital (-
0.9624, p<0.001). 
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Model 1B in Table 4.7 utilised the MNL regression but also assessed the significance 
of attribute interactions with respondent characteristics. None of the attribute 
interactions with respondent age and self-reported health measures were significant. 
This ruled out important differences therefore age and health status were 
unimportant in this case. Only the interactions (Travel Time* Gender, Waiting 
Time*Gender, Waiting Time* Survey Mode, Risk of Death* Gender, Risk of 
Death*Survey Mode, Risk of Readmission* Gender) were significant and were 
included in the final specification (Table 4.7). Results suggest that men have stronger 
preferences for less travel time (-0.0049, p<0.01), less waiting time (-0.0021, 
p<0.05), lower risk of death (-0.1047, p<0.01) and lower risk of readmission (-0.0775, 
p<0.01) compared to women. Respondents completing the web based survey 
showed stronger preferences for less waiting time (0.0027, p<0.001) and lower risk of 
death (0.0862, p<0.01) compared to those completing the survey in paper. Model 1B 
had lower AIC and offered a better model fit compared to Model 1A. However, it has 
to be noted the coefficients for travel time and risk of readmission were no longer 
significant. 
 
Model 1C in Table 4.7 utilises mixed logit (MIXL) model (see section 4.3.10) and 
takes heterogeneity into account. The significance of attributes remained the same 
as Model 1A, however, the lower AIC and BIC in Model 1C indicated that it provided 
a better model fit compared to Model 1A and Model 1B. Furthermore, the statistically 
significant standard deviations in Model 1C indicates the presence of heterogeneity 
among respondents, which suggests that the mixed logit models in this case are 
more appropriate than the multinomial logit models. Coefficient estimates in Model 
1D which utilises generalised multinomial logit (G-MNL) model (see section 4.3.10) 
also retained the signs and significance similar to Model 1A and Model 1C, but had 
reduced significance.
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Table 4.7: Regression results 
Attributes Model 1A  
(Main effects-MNL) 
Model 1B  
(Including respondent 
characteristics-MNL) 
Model 1C  
(Main effects-MIXL) 
Model 1D  
(Main effects-GMNL) 
 Coefficients (SE) Coefficients (SE) Coefficients (SE) SD (SE) Coefficients (SE) SD (SE) 
Travel Time -0.0086 (0.0009)*** -0.00068 (0.0032) -0.0125 (0.0020)*** 0.0165(0.0024)*** -0.0235 (0.0097)* 0.0254 (0.0091)** 
Waiting Time -0.0056 (0.0005)*** -0.00333(0.0015)* -0.0077 (0.0008)*** 0.0048(0.0009)*** -0.0146 (0.0059)* 0.0078 (0.0028)** 
Length of Stay -0.0768 (0.0152)*** -0.0784(0.0153)*** -0.1217 (0.0262)*** 0.1608(0.0395)*** -0.2501 (0.1149)* 0.2668 (0.1264)* 
Risk of Death -0.3258 (0.0202)*** -0.1953(0.0553)*** -0.4623 (0.0425)*** 0.2577(0.0434)*** -0.8409 (0.3184)** 0.3930 (0.1478)** 
Risk of Readmission -0.1442 (0.0159)*** -0.0192 (0.0518) -0.1803 (0.0262)*** 0.1384(0.0386)*** -0.3436 (0.1491)* 0.2210 (0.1171) 
Outpatient Follow-Up -0.9624 (0.0776)*** -0.9887(0.0792)*** -1.2442 (0.1424)*** 0.7290(0.1826)*** -2.2214 (0.8883)* 1.5190 (0.1478)* 
Interaction terms       
Travel Time*Gender - -0.0049 (0.0019)** - - - - 
Waiting Time*Gender - -0.0021 (0.0009)* - - - - 
Waiting Time*Survey Mode -  0.0027 (0.0008)*** - - - - 
Risk of Death*Gender - -0.1047 (0.0327)** - - - - 
Risk of Death*Survey Mode -  0.0862 (0.0291)** - - - - 
Risk of Readmission*Gender - -0.0775(0.0297)** - - - -- 
Sample size (Observations) 148(2960) 148(2960) 148(2960) - 148 (2960) - 
Log Likelihood -813 -800 -763 - -757 - 
AIC 1640 1623 1522 -- 1544 - 
BIC 1670 1687 1621 - 1624 - 
***p<0.001, **p<0.01, *p<0.05; SE=Standard Error, SD= Standard Deviation; AIC= Akaike information criterion; BIC = Bayesian information criterion
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Similar models to those presented in Table 4.7 are presented in Table 4.8, but they 
do not consider MNL with attribute interactions with respondent characteristics. 
Model 2A, 2B and 2C are MNL model, MIXL model and G-MNL model respectively. 
In Table 4.8, the attributes “risk of death”, “risk of readmission” and “outpatient follow-
up” which were coded as continuous attributes earlier were recoded into categorical 
levels. Among Models 2A, Model 2B and Model 2C, the AIC was lowest in Model 2C 
indicating that it offers the better model fit compared to others. The coefficients of 
“length of stay” in Model 2A and the level mild of “risk of death” attribute were not 
significant across all three models (Model 2A, Model 2B, and Model 2C). The non-
significant coefficients in the models indicate that it was not sure whether length of 
stay in the hospital and mild risks of death did really matter to the respondents. 
 
The coefficients increased with the increase in the levels of “risk of death” and 
“outpatient follow-up”, however coefficients of levels of “risk of readmission” 
demonstrated non-linearity (Figure 4.1 and Figure 4.2). The coefficient of the level 
mild of “Risk of Readmission” was not significant. 
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Table 4.8: Regression results after recoding selected variables as categorical 
Attributes Model 2A  
(Main effects-MNL) 
Model 2B 
(Main effects-MIXL) 
Model 2C 
(Main effects-GMNL) 
 Coefficients (SE) Coefficients (SE) SD (SE) Coefficients (SE) SD (SE) 
Travel Time -0.0065 (0.0009)*** -0.0094  (0.0020)*** 0.0160 (0.0026)*** -0.0105 (0.0022)*** 0.0165(0.0026)*** 
Waiting Time -0.0039 (0.0007)*** -0.0051 (0.0010)*** 0.0046 (0.0010)*** -0.006 (0.0013)*** 0.0049 (0.0010)*** 
Length of Stay -0.0277 (0.0168) -0.0608 (0.0265)* 0.1459 (0.0429)*** -0.0744 (0.0302)* 0.1541 (0.0419)*** 
Risk of Death  
(Base level: Low (1 in 100)) 
     
                    Mild (3 in 100) -0.6103 (0.319) -0.3169 (0.4903) 0.2563 (0.6952) -0.6024 (0.5483) 0.2919 (0.3664) 
                    Moderate (5 in 100) -1.8155 (0.288)*** -2.0607 (0.4388)*** 0.3318 (0.5390) -2.4479 (0.5104)*** 0.0473 (0.4896) 
                    High (7 in 100) -1.5249 (0.161)*** -2.1425 (0.2830)*** 1.3199 (0.2785)*** -2.4847 (0.3624)*** 1.3312 (0.2726)*** 
Risk of Readmission 
(Base level: Low (1 in 100)) 
     
                    Mild (3 in 100) 0.3326 (0.1296)* 0.3297 (0.1864)   0.3266 (0.6027) 0.4436 (0.2119)* 0.5174 (0.2913) 
                    Moderate (5 in 100)^ - - - - - 
                    High (7 in 100) -0.7728 (0.1219)*** -0.9753 (0.1986)*** 0.7813 (0.2846)** -1.1345 (0.2297)*** 0.8667 (0.2689)*** 
Outpatient Follow-Up 
(Base level: Local hospital) 
     
                    Distant hospital -0.8455 (0.1027)*** -1.0647 (0.1808)*** 0.9440 (0.1821)*** -1.2177 (0.2222)*** 1.0642 (0.1940)*** 
Sample size (Observations) 148(2960) 148(2960) - 148 (2960) - 
Log Likelihood -796 -751 - -747 - 
AIC 1612 1539 - 1533 - 
BIC 1680 1640 - 1647 - 
**p<0.001, **p<0.01, *p<0.05; SE=Standard Error, SD= Standard Deviation; AIC= Akaike information criterion; BIC = Bayesian information criterion, ^ could not be estimated because of collinearity 
issues  
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Figure 4.1: Coefficients of levels of Risk of Death across models 
 
 
Figure 4.2: Coefficients of levels of Risk of Readmission across models 
 
4.4.3 Marginal rates of substitution  
The coefficients generated from each model presented in Table 4.7 were used to 
calculate the marginal rates of substitution (MRS) and helped to understand the 
trade-offs the respondents would be willing to make among the attributes. MRS 
approach is described in section 4.3.11. 
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For example, the coefficients in Model 1A indicated that individuals would be willing 
to give up their preferred outpatient follow-up care at their local hospital only if the 
risk of death was reduced by at least 2.9 % (0.9624/0.325). Similarly, individuals 
would be willing to give up outpatient follow-up care only if the length of stay in the 
hospital was reduced by minimum of 12.5 days (0.924/0.0768) and risk of 
readmission was reduced by minimum 6.7% (0.0924/0.1442). Model 1B, Model 1C 
and Model 1D showed generally similar ratios, however Model 1B showed different 
but statistically non-significant ratio of outpatient follow-up care and risk of 
readmission in model. 
 
Furthermore, the ratios between selected attributes presented in Table 4.9 show how 
much respondents were willing to travel or willing to wait for an improvement in 
another attribute. For example, the ratio of coefficients of length of stay and travel 
time from Model 1A indicated that respondents are willing to travel nine minutes and 
willing to wait 14 minutes for one day reduction in length of stay in hospital. 
 
In Model 1B (Table 4.7), coefficients of travel time and risk of readmission were not 
significant, therefore in Table 4.9, the MWT derived across all attributes and MWW 
derived for attribute risk of readmission were not significant.  In terms of both MWT 
and MWW, across all models (with an exception to Model 1B which had  statistically 
non-significant coefficients) the respondents most valued outpatient follow-up 
attribute followed by risk of death, risk of readmission and length of stay. 
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Table 4.9: Marginal rates of substitution in terms of willingness to travel and willingness to wait 
Attributes Marginal rates of substitution Interpretation 
MWT (in minutes) MWW (in minutes) 
Model 1A Model 1B Model 1C Model 1D Model 1A Model 1B Model 1C Model 1D  
Length of 
stay 
8.93 115.29 9.74 10.64 13.71 23.54 15.81 17.13 
For 1 day reduction in length 
of stay in hospital 
Risk of Death 37.88 287.21 36.98 35.78 58.18 58.65 60.04 57.6 
For 1% reduction in risk of 
death in hospital 
Risk of 
Readmission 
16.76 28.24 14.42 14.62 25.75 5.77 23.42 23.53 
For 1% reduction in risk of 
readmission in hospital 
Outpatient 
Follow-Up 
111.90 1453.97 99.54 94.53 171.85 296.91 161.58 152.2 
For having outpatient follow- 
up care at their local hospital 
MWT- Marginal willingness to travel; MWW- Marginal willingness to wait; Model 1A- Main effects MNL, Model 1B- With interactions MNL, Model 1C- Main effects MIXL,  
Model 1D- Main effects GMNL 
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4.5 Discussion 
This DCE demonstrated the influence of hospital attributes on the choice of hospitals 
in an emergency. In line with priori expectations, the results confirmed that people 
prefer less travel time to hospital, less waiting time, fewer number of days in hospital, 
low risk of death, low risk of readmission and outpatient follow-up care in their local 
hospital. 
 
The generation of MRS allowed an understanding of trade-off the respondents were 
willing to make among attributes. The results highlighted that follow-up outpatient 
care at their local hospital is more important to the respondents than any other 
hospital attributes. It was unexpected that participants would value outpatient follow-
up care more than the risk of death. But, high valuation of outpatient follow-up in the 
local hospital may highlight the emotional attachment, sense of belongingness and 
enormous pride associated with the local hospital (Thomson et al., 2005). However, it 
is also likely that this study might have suffered from attribute non-attendance, where 
the participants always chose hospitals providing outpatient follow-up in a local 
hospital irrespective of other attributes. Issue of attribute non-attendance is described 
later in section 4.5.3.2. It is also likely that the levels of risk of death used might have 
been very low and were not perceived to be important by the respondents compared 
to the outpatient follow-up. Respondents were willing to trade-off increased travel 
time and waiting time for the lower risk of death, lower risk of readmission, less days 
in the hospital and follow-up outpatient care in their local hospital which was highly 
valued. In general, the MRS indicated that people can compromise other attributes 
for high quality of healthcare provided by hospitals. However, the results also 
indicated that the specialised hospital should not be too far away (more than two 
hours of travel time) to be valued. 
 
Gender of the individual influenced the strength of the preference, with results 
suggesting that men have stronger preferences for less travel time, less waiting time, 
lower risk of death and lower risk of readmission compared to women. The difference 
in preferences of men and women could possibly be related to the differences in 
thinking, problem solving, healthcare perception (Wessels et al., 2010).  However, 
the influence of other individual characteristics such as age, recent experience of 
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emergency care and current health state of the person on the choice of hospitals 
were not statistically significant. 
 
4.5.1 Comparison with other studies 
This section compares the findings of this DCE with other relevant existing studies. 
While differences exist between studies in terms of healthcare context, design, 
attributes and attribute levels used, the findings of this study are in line with other 
relevant DCE studies. Earlier studies attempting to quantify the strengths of individual 
preferences for emergency health care available during usual GP service hours have 
indicated that patients do prefer less waiting times to get a decision on treatment and 
prefer the services provided closer to their homes (Gerard et al., 2004; Gerard and 
Lattimer, 2005). A study on Australian public’s choice among alternatives of 
emergency care reported clear preferences for shorter wait times and strong 
emphasis on quality emergency health care (Harris et al., 2015). In another DCE 
study patients choice of hospitals for elective health services demonstrated individual 
preferences for less travel time to the hospital, less waiting time to receive the 
service, the follow-up care at their home hospital rather than the alternative hospital 
and high valuation of hospital reputation (Burge et al., 2005). Schwappach and 
Strasmann revealed that potential patients in Germany were willing to sacrifice longer 
travel distance and preferred location of care for a highly specialized surgical care 
provision with short waiting times (Schwappach and Strasmann, 2007). Ryan and 
colleagues also observed negative utilities for increased travel times to hospital and 
increased waiting time to receive care in their study assessing trade-offs between 
location and waiting times to elective surgery (Ryan et al., 2000). A more recent 
study assessing preferences for centralising specialised cancer services also 
concluded that patients, health professionals and the public all preferred shorter 
travel times, lower risks of deaths and complications, and access to specialised 
centres (Vallejo-Torres et al., 2018). 
 
The findings of this DCE study are also consistent with the findings of other studies 
assessing choice of healthcare using methods other than DCE. A study examining 
the choice of hospitals for elective hip replacements amongst patients in England, 
using the records of hospital episode statistics (HES), identified that people do take 
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hospital quality in particular low mortality and less waiting time, the Methicillin-
Resistant Staphylococcus Aureus (MRSA) infection rate and Care Quality 
Commission (CQC) ratings into account when choosing hospitals (Beckert et al., 
2012). Results of another study assessing patient preference for location of elective 
abdominal aortic aneurysm surgery indicated that patients would accept increased 
travel distances for care with reduced risks of perioperative mortality (Landau et al., 
2013). A recent study suggested that  choice of hospital is influenced by overall 
health gain not just by the more traditional measures of hospital quality such as risk 
of death and readmission (Gutacker et al., 2016). Using the data on elective hip 
replacement patients in the English NHS, Moscelli and colleagues demonstrated that 
patients value quality while choosing hospitals in particular those with low 
readmission rates, low mortality risks, less waiting times, closer to their homes 
(Moscelli et al., 2016). 
 
4.5.2 Implications of the study findings 
This study reveals preferences and the trade-offs individuals are willing to make 
across attributes while choosing hospitals for emergency healthcare and provides 
valuable insights to the decision-makers in relation to the centralisation of emergency 
health care services into fewer specialised units. The results of this study indicate 
people prefer less travel time and waiting times to treatment however, they are willing 
to travel longer or wait longer for receiving better quality emergency healthcare in 
terms of lower mortality risk, lower readmission risk and fewer days of stay in 
hospital. At the same time, the findings also indicated that individuals value outpatient 
follow-up care at their local hospital more than any other hospital attributes 
considered. For example, in the context of the hospitals compared in this PhD thesis, 
individuals are likely to choose to go to the specialised emergency hospital only if it 
offered lower mortality, lower risk of readmission and fewer days of stay in the 
hospital compared to their local hospitals even if it meant increased travel time to the 
hospital and increased waiting time to be seen. If the specialised emergency hospital 
offers the possibility of outpatient follow-up care at a local hospital, individuals would 
be willing to travel 1.5 to two hours for the treatment at a specialised hospital. But for 
the specialised hospital service to be utilised without the provision of outpatient 
follow-up care at a local hospital, it should provide a very high quality service where 
the risk of mortality is reduced by 2.9%, length of stay in the hospital is reduced by 
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12.5 days, and risk of readmission by 6.7% (see section 4.4.3). Furthermore, to 
ensure the service at specialised hospital is utilised, the geographical location of the 
hospital should not be more than two hours of travelling time (whether or not it 
provides high quality care or outpatient follow-up at a local hospital) for the 
catchment population. Therefore, the results of this DCE would mean that decisions 
to centralise emergency care into fewer specialised hospitals should not only be 
justified on clinical grounds and cost savings, but should also be informed by patient 
preferences. Patients are more likely to use the high quality service at a specialised 
hospital only if their preferences are valued. Consideration of individual preferences 
in emergency services centralisation decisions may mean increased value, increased 
satisfaction across a population and efficiency gains. 
 
If the results of this study hold, then these could have implications for practice. The 
review by Sir Bruce Keogh recommends reconfiguration of emergency care and the 
development of centralised and more specialised emergency units that benefits 
patients with more serious and life threatening condition by providing best expertise 
and potentially better quality of care (NHS England, 2013a). In addition, consolidation 
of specialised medical care is one of the new care models envisaged by the NHS 
“Five year forward view” (NHS England, 2014). However, centralised healthcare may 
not be closer to people’s homes and the specialised healthcare services may come 
only at the cost of increased travel times to the point of care. Centralisation of 
hospitals may mean increased travel time to most of the patients and a poor 
utilisation. There are concerns about distance decay, where the utilisation of 
healthcare services decreases with the increase in travel distance to the healthcare 
facilities (Turnbull et al., 2008; Raknes et al., 2013) (see section 1.2, Chapter 1). 
Contrary to this, the results of the DCE reported in this Chapter suggest that whilst 
people may place a high value on their local hospital, they may be willing to trade-off 
the increased journey time with the treatment at a specialised hospital providing 
better quality of care. The preferences are not influenced by age, health status or 
previous experience of emergency medical services which suggests that emergency 
medical services do not necessarily have to be tailored according to age-groups or 
health status, at least within the range of respondents. However, the results also 
suggest that the specialised hospital should not be too far away to be valued and 
should make provisions of outpatient follow-up care in the local hospital (both of 
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which are highly valued) whenever possible. Overall, the DCE results support the 
decisions to centralise emergency care in local hospitals into fewer specialised units 
in the NHS England. 
 
4.5.3 Strengths and limitations 
The results of this DCE should be interpreted in the light of several strengths and 
limitations, the major ones are presented in the following sections. 
 
4.5.3.1 Respondent sample, response rates and survey approach 
A wide cross section of the local general population taken from the Healthwatch 
Northumberland or NHCT were studied. This sample was considered most 
appropriate to represent the preferences of potential users of a newly built 
specialised emergency hospital; the focus of this PhD. However, it is likely that some 
specific population groups from the general population may be under represented, 
particularly those not registered with the Healthwatch or NHCT (e.g. very old, very 
young, those with special needs). The EQ-5D-5L and EQ-VAS scores of the 
respondents included in the survey were lower than those of the general population 
in England (see section 4.4.1) but consistent with those for the general population of 
a similar age. Therefore, it is likely that the healthiest groups may have been left out 
because of not being registered with Healthwatch or NHCT. The study would have 
benefitted from a larger sample of respondents. The National Institute for Health and 
Care Excellence (NICE) and the United States (US) Public Health Service’s panel on 
Cost-Effectiveness in Health and Medicine, each recommend that preferences on 
health outcomes should be estimated from a representative sample of general public 
(Russell et al., 1996; National Institute for Health and Care Excellence, 2013). 
However, there is a considerable debate around whose preferences (patient or 
general public) count when valuing health outcomes in health economics and no firm 
consensus exists (Dolan, 1999; Brazier et al., 2005; Stamuli, 2011). 
 
The survey response rates were low, for both electronic and paper formats and it is 
possible that non-response bias which occurs due to systematic differences between 
respondents and non-respondents might have impacted on the DCE results. 
92 
Financial incentives for completing the survey would have provided a higher 
response rate (Church, 1993; Shaw et al., 2001; Singer and Ye, 2013). However, 
when a financial incentive is offered, the extent to which individuals complete each 
survey with sincerity could be questionable, as there is a possibility that respondents 
might be participating in and completing the survey merely to qualify for the incentive. 
In this survey, no financial incentive was offered to respondents completing the 
survey, therefore it is assumed that the results were a representation of genuine 
preferences of respondents. 
 
The strength of this DCE also exhibited by the fact that it was pre-tested and piloted 
before finalisation. A high proportion of correct and complete responses in this DCE 
could mean that the respondents clearly understood the choice sets and the overall 
survey. However, a high proportion of respondents found the choice tasks difficult to 
complete which could mean that attributes were not appropriate to them and the 
choices were arbitrarily made. Furthermore, it was not possible to get the information 
of respondents attempting to complete the survey but who did not ultimately respond 
because the survey was too difficult for them to complete. It could be possible that 
the non-respondents differed in characteristics and had different choices compared 
to the respondents. Therefore, there remains a concern that this study may not have 
truly reflected the real preferences of targeted general population. 
 
Another strength of this survey lies in the fact that both survey approaches –web 
based and postal were used enabling the representation of a wider cross section of 
population. This might have also introduced a response bias because of the 
systematic differences between the respondents in each approach. Although, 
experimenting with the different approaches for survey administration was beyond 
the scope of this survey, the results indicated that the strength of preferences of less 
waiting time and low risk of death may be higher in those completing the web version 
of the survey (see section 4.4.2). 
 
4.5.3.2 Attribute selection, framing and attribute non-attendance 
The attributes identified in this survey were taken from the literature and did not 
involve any qualitative research to identify them which might mean that some other 
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attributes which were very important to respondents were left out. Therefore, it is 
likely that the study results might have suffered from the impact of important 
attributes not included in the choice experiment. However, as explained in section 
4.3.2, it could have been challenging to get the representative respondent sample for 
qualitative research into one place and conduct the qualitative research in the limited 
time frame and context of this PhD. Nevertheless, the importance of qualitative 
research in a DCE has been highlighted recently (Vass et al., 2017) and hence 
should be considered in future DCE studies. 
 
The way the attributes were framed might have influenced the choices the 
respondents made. The query that remains to be answered is would the choices 
remain the same, if the attributes were framed in the other way, for example do the 
preferences differ when one of the attributes “risk of dying” is framed as “chances of 
survival”? Whilst experimenting with the framing of DCE questions was not the 
objective of this thesis, several research findings show that attribute framing can 
influence respondents’ choice behaviour (Howard and Salkeld, 2009; Kragt and 
Bennett, 2012; Veldwijk et al., 2016). Furthermore, presentation of attribute levels in 
choice tasks only in text formats could have created difficulties for some respondents 
in understanding the choice sets. Graphics and icons are often superior to text in 
communicating health information (Tait et al., 2010b; Tait et al., 2010a; McCaffery et 
al., 2012). However, within a DCE context, independent of educational level and 
literacy of respondents, words depicting the attribute levels lead to more consistent 
answer patterns, more accurate attribute level interpretation, and more accurate 
attribute level estimates (Veldwijk et al., 2015). 
 
The conventional practice for a DCE assumes that respondents choose among 
alternatives by rationally trading off across all attributes in their choice set. However, 
emerging evidence suggests that some respondents trade-off only a subset of 
attributes and ignore one or more attributes while choosing among alternatives 
(Hensher et al., 2005; Carlsson et al., 2010; Colombo et al., 2013). This 
phenomenon, which is widely referred to as attribute non-attendance raises a 
concern on violation of continuity axiom and a departure from compensatory 
behaviour: a conventional framework underlying choice experiments (Campbell et al., 
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2008). Failing to account for the attribute non-attendance may lead to biased 
preference estimates (Hensher and Greene, 2010). It is possible that the coefficient 
estimates generated in this study could have been influenced by attribute non-
attendance, but do not have any evidence for this. A number of methods to identify 
attribute non-attendance have been proposed in the literature. One of the approach 
is to ask respondents directly if they ignored any of the attributes (if so which 
alternatives) while making choice between alternatives (Hole et al., 2013). Another 
approach is to use econometric models such as the latent class model to estimate 
the probability of attribute non-attendance (Hensher and Greene, 2010; Campbell et 
al., 2011; Hole et al., 2013). Another alternative approach to identify the attribute 
non-attendance is the use of eye tracking technology which records the focus of 
respondents while making a choice in a computer based survey (Spinks and 
Mortimer, 2016). However, there is no consensus on which approach to use to 
identify attribute non-attendance in a DCE. 
 
4.5.3.3 Marginal willingness to pay and cost-benefit analysis 
Time was used as the non-monetary metrics to generate marginal willingness to 
travel (MWT) and marginal willingness to wait (MWW). However, inclusion of a cost 
attribute in a DCE could have allowed the generation of marginal willingness to pay 
(MWP) for the potential cost-benefit analysis (Lancsar and Louviere, 2008). The use 
of a cost attribute was considered, however, it was excluded because framing of a 
cost attribute is difficult in this context where individuals are not used to out of pocket 
payments for healthcare at the point of use (Johnson et al., 2011). In a publicly 
funded healthcare system like the UK NHS, respondents may ignore the cost 
attribute as it is not borne by them directly (Ratcliffe, 2000). Inclusion of a cost 
attribute was expected to provoke strong reactions with respondents not trading off 
between all available attributes and only trading-off against the cost attribute by 
always choosing the cheapest alternative or not making a choice at all (Pedersen et 
al., 2011). Therefore, with the inclusion of a cost attribute, the inferences drawn 
possibly would not have reflected individual’s true preferences. Nonetheless, the 
MWT estimates were converted to MWP to conduct the cost-benefit analysis (see 
section 6.4.5 in Chapter 6). 
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4.6 Conclusion 
In summary, this Chapter described the development of the DCE, explored and 
quantified the strength of individual preferences towards different emergency medical 
care service configurations (local versus distant). The results indicated that people 
prefer less travel time to hospital, less waiting time, fewer number of days in hospital, 
low risk of death, low risk of readmission and outpatient follow-up care in their local 
hospital. However, people were willing to trade-off increased travel time and waiting 
time for the lower risk of death, lower risk of readmission, fewer number of days in 
the hospital and follow-up outpatient care in their local hospital which was highly 
valued. The findings revealed that individuals value outpatient follow-up care at their 
local hospital more than any other hospital attributes. Any decisions to centralise 
emergency medical services into specialised hospitals should not only be justified on 
clinical grounds and cost savings, but should also be informed by preferences of 
potential users of that service. However, considering the limitations in this study, 
these findings should be interpreted with caution. 
 
The results of this DCE will be incorporated into the economic evaluation model 
described in Chapter 6. The next Chapter will provide methodological background to 
the economic evaluation in Chapter 6. 
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Chapter 5. Decision Analytic Modelling in Economic Evaluations 
 
5.1 Background 
Chapter 4 reported the development of the DCE and quantified the preferences for 
characteristics of centralised provision of emergency medical services. The role of 
economic evaluations is to inform decision-making by comparing the expected costs 
and health outcomes of alternative treatment strategies or healthcare interventions 
against each other (Drummond et al., 2005). Chapter 2, suggested that the economic 
evaluations on centralisation of specialised healthcare services is dominated by 
studies with limited methodological quality and generally not adhering to the current 
standards for reporting economic evaluations. 
 
Therefore, the aim of this Chapter is to provide a methodological background to the 
economic evaluation methods used in Chapter 6 of this thesis. It describes the 
methodological development of an economic evaluation model with the focus on a 
decision analytic model framework. This Chapter is structured into the following 
sections: section 5.2 presents a brief description on types of economic evaluations 
commonly used and their importance in healthcare; section 5.3 provides a 
justification for the economic evaluation model selected in this thesis; section 5.4 
describes the key steps in building a decision analytic model framework; section 5.5 
describes the presentation of the economic evaluation results and section 5.6 
summarises the Chapter. 
 
5.2 Economic Evaluations in Healthcare 
Economic evaluations are increasingly undertaken to inform decisions on global 
health policy on wide range of topics including healthcare organisation and delivery 
(Gray and Wilkinson, 2016). For example, economic analysis is highly integrated into 
the technology appraisals of National Institute for Health and Care Excellence (NICE) 
in England (Williams I et al., 2008; National Institute for Health and Care Excellence, 
2013). Likewise, the Scottish Medicines Consortium (SMC) in Scotland require the 
assessment of new health care technologies to be well supported by economic 
evaluations (Scottish Medicines Consortium (SMC), 2017). Similarly, economic 
evaluations are integral component of regulatory and reimbursement decisions on 
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technologies and interventions in Australia, Canada and other countries (Hutton et 
al., 2006; Pharmaceutical Benefits Advisory Committee (PBAC), 2016; Canadian 
Agency for Drugs and Technologies in Health (CADTH), 2017). Hence, economic 
evaluations are now a key element of funding decisions in health care (Clement et 
al., 2013; Cerri et al., 2014; Dakin et al., 2015). Economic evaluations in healthcare 
can take one of the two approaches: i) conducted as part of a randomised controlled 
trial (RCT) and conducted using the cost and effectiveness data collected or ii) 
conducted using data from wide range of sources synthesized into decision analytic 
models (Sculpher et al., 2006). 
 
RCTs are a common vehicle of data collection for economic evaluations and are 
often utilised to help make informed decisions on healthcare interventions providing 
best value for money (Doshi et al., 2006; Petrou and Gray, 2011a). Trials present the 
opportunity to collect resource utilisation and outcomes data related to the health 
care under evaluation directly from the trial. Moreover, economic evaluations 
conducted alongside rigorously designed trials benefit from prospectively collected 
patient data with high internal validity. The addition of data collection for economic 
variables is likely to be less costly compared to data collection for stand-alone 
economic evaluations (O'Sullivan et al., 2005). However, it has been argued that 
economic evaluations conducted alongside single RCTs do not always form a 
sufficient basis for decision-making (Ramsey et al., 2015). For example, an economic 
evaluation based on single trial may fail to incorporate all relevant evidence from 
other trials, meta-analyses and observational studies and may not compare all 
available alternatives than the ones considered in the trial or may have inappropriate 
time horizons which may not capture differences in economic outcomes. All of these 
may restrict the generalisability of an economic evaluation to other decision-making 
context (Sculpher et al., 2006; Petrou and Gray, 2011b). In addition, the sample size 
of a trial are commonly based on primary clinical outcomes alone which could 
potentially result in inappropriately powered economic evaluations (Ramsey et al., 
2015). Considering the limitations of economic evaluations based on a single RCTs, 
decision analytic modelling are seen as an alternative framework for economic 
evaluation (Petrou and Gray, 2011b). 
 
Decision analytic modelling (DAM) is extensively used in healthcare economic 
evaluations to inform decisions regarding optimal allocation of limited resources 
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(Buxton et al., 1997; Claxton et al., 2002; Petrou and Gray, 2011b). DAM is 
particularly useful when the intervention under consideration is relatively new and 
RCTs are difficult to conduct or when the existing economic data is very limited 
(Buxton et al., 1997). A DAM provides a framework for explicit representation of 
decision problems under uncertainty by combining evidence from range of sources 
and facilitates the extrapolation of costs and outcomes over time and across patient 
groups and health care settings (Claxton et al., 2002). An economic evaluation 
utilising DAM enables a wide range of costs and effects from various sources to be 
synthesized within a model framework to generate cost-effectiveness outcomes of an 
intervention. But, it may not be always possible to include all the 
consequences/outcomes of an intervention within the modelling framework. 
Therefore, DAM may not always reflect reality and modellers need to be careful in 
deciding the pathways, consequences and outcomes considered in the model 
framework (Briggs et al., 2006). Decision analytic models are often criticised for being 
heavily relied upon assumptions (Sheldon, 1996) and several concerns have been 
raised about modelling (Buxton et al., 1997). The first concern is around 
inappropriate use of clinical data, mainly related to the inadequate attention to the 
quality of data used in the model. Use of poor quality data in models may mean 
incorrect estimation of economic benefit. Second is the biases in the observational 
data used in the model, such as failure to account for the competing risks of outcome 
under consideration. It can be sometimes very difficult to know the biases present. 
The third concern is around difficulties in extrapolating the results beyond the end of 
the trial, for example the differences in extrapolated results and the results of 
subsequent trials with longer follow-up time. The fourth concern is around 
transparencies and validity of model. Models may not be fully transparent and it may 
be sometimes difficult to understand the underlying conceptual basis and there might 
be difficulties in verifying the model in the absence of similar models. However, 
despite these limitations, DAM still remains a useful tool to help decision-making 
under conditions of uncertainties in costs and outcomes. The basic concepts of DAM 
in healthcare has been extensively covered in the literature (Drummond et al., 2005; 
Briggs et al., 2006). 
 
5.3 Selection of Economic Evaluation Model 
The two broad approaches to economic evaluations described in the previous section 
each have their own strength (A RCT generates parameters to be utilised for 
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economic evaluation of a particular intervention/healthcare program whereas a 
decision analytic model provides economic evaluation framework by incorporating 
additional supplementary evidence and assumptions) and should be considered as 
compliments to each other rather than as alternatives (Sculpher et al., 1997; Claxton 
et al., 2002; Drummond and Sculpher, 2005; Petrou and Gray, 2011b). A mixture of 
both economic evaluation approaches with ‘within trial’ economic evaluation 
supporting wider secondary evidence in a decision analytic model would be more 
beneficial (Sculpher et al., 2006). However, considering the nature of intervention 
focused on in this thesis, trials to assess the impact of centralisation of emergency 
hospitals in this instance would be challenging. Although economic models are 
essential in healthcare intervention appraisals, it is not essential that those should be 
trial-based economic models (National Institute for Health and Care Excellence, 
2013). This requirement of NICE further justifies the use of DAM in this project. In the 
instances where RCTs are unworkable or unethical, data coming from quasi-
experimental studies (e.g. controlled before-after designs, interrupted time series) or 
observational studies (e.g. cohort, case-control, cross-sectional) could be used to 
inform the economic evaluation models (Centre for Review and Dissemination, 
2009). Therefore, a decision analytic model was considered the most appropriate 
economic evaluation approach in this project. 
 
5.4 Decision Analytic Model Framework 
A series of steps are involved in building a decision analytic model in economic 
evaluation (Briggs et al., 2006; Sun and Faunce, 2008; Petrou and Gray, 2011b). 
Briggs and colleagues have proposed six basic steps in building up a decision 
analytic model in economic evaluations in health care (Briggs et al., 2006).The first 
step is to specify the decision problem; the second step involves defining the 
boundaries of the model i.e. what goes into the model and what does not; the third 
step is to structure the decision model; the fourth step involves identifying and 
synthesizing evidence followed by the fifth step dealing with uncertainty and 
heterogeneity. The final step is to assess the value of additional research. These key 
steps are now discussed below. 
 
5.4.1 Specifying the decision problem 
In line with the objective of the economic evaluation, this step involves clear 
identification of the questions to be addressed by the analysis. The alternative 
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interventions or programmes being evaluated and the outcome measures used to 
compare them should be clearly specified. Additionally, the specific characteristics of 
the recipient population (e.g. the patients receiving the treatment) and their sub-
groups should be clearly defined. Other requirements include clear statement of the 
perspective of the analysis (e.g. health care provider or societal) and study location 
(e.g. UK NHS) and setting (e.g. Accident & Emergency Unit or primary care). The 
perspective is the view point used to determine what costs and outcomes are to be 
included in the economic evaluation and is determined by whose cost is of interest to 
the research. For example, the NHS perspective could include only costs of providing 
the treatment (intervention) along with costs of treating any adverse effects as 
incurred by the NHS such as later treatment costs, hospital admissions, follow-up 
visits but it does not include costs falling on the patient such as transportation, time-
off from work, or ‘over-the-counter’ payments. Whereas, the societal perspective 
includes broader range of costs such as incurred by the patients and their families 
(example: transportation costs, over the counter payments) and indirect effects to the 
society (example: productivity losses because of time-off from work). 
 
5.4.2 Defining the boundaries of the model 
Defining the boundaries of model is concerned on potential impacts of the options 
under evaluation and what is relevant and what is not. It will never be possible to 
include all possible consequences of the options under consideration, therefore 
choices need to be made about which consequences will be incorporated in the 
model (Briggs et al., 2006). For example, if the intervention under evaluation is a new 
drug treatment there could be side effects which may impact the costs and outcomes 
of the model, or these side effects may be negligible and may not have a large 
impact on the patient population. Therefore, researchers should be careful in 
considering what goes into the model and what does not. Important things to 
consider in an economic evaluation are time horizon and discounting. 
 
Time horizon is the duration over which the costs and outcomes are tracked in a 
model (Siebert et al., 2012). In the context of decision-making, the time horizon 
adopted in a model should be large enough to capture all important health effects 
and costs of the alternatives compared (Siebert et al., 2012). A time horizon shorter 
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than the expected impact of intervention do not usually provide best costs and effect 
estimates (National Institute for Health and Care Excellence, 2013). The question to 
be asked at this stage is what time horizon is appropriate to assess the costs and 
outcomes of intervention under study? For example is a life-time time horizon 
required or will a shorter time horizon of one year will be more appropriate to 
incorporate all the relevant costs and outcomes? Longer time horizons are more 
applicable to chronic conditions which need to be managed for a long-time (e.g. 
cancer), whereas shorter time horizons are more appropriate for acute conditions 
when there are no long-term sequelae where long-term consequences may not be 
important (e.g. acute infections). NICE recommends a life-time horizon for 
interventions that could have impact on costs and outcomes over the patient’s life 
time (National Institute for Health and Care Excellence, 2013). However, a time 
horizon shorter than the patient’s life-time could be justified when there are no 
differential mortality effects or other long-term sequelae between the alternatives 
compared and the costs and effects relate to the short time period (National Institute 
for Health and Care Excellence, 2013). 
 
Cost and outcomes at present are valued more than those occurring in the future. 
Therefore, cost-effectiveness analysis should reflect the present value of costs and 
outcomes which accrue over the time horizon of the economic evaluation (National 
Institute for Health and Care Excellence, 2013). Discounting is a method of adjusting 
the future costs and outcomes to the present value. The question that could be asked 
is whether both the costs and benefits will be discounted or only costs will be 
discounted and if so at what rate? NICE recommends that both the costs and QALY 
be discounted at 3.5% and sensitivity analysis could be carried out using rates of 
1.5% (National Institute for Health and Care Excellence, 2013). 
 
5.4.3 Structuring the decision model 
The structure of the decision model partly depends on the nature of the decision 
problem and model boundaries discussed earlier. Briggs and colleagues suggested 
that the choice of model structure is dependent on the nature of intervention 
evaluated, natural history of particular condition and the impact of options on that 
process (Briggs et al., 2006). In addition, Brennan and Akehurst suggested that 
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determination of the model structure should take practical consideration of decision 
maker’s requirement, the complexity of the intervention and health care system, the 
population size and often should weigh upon the modeller expertise, data and 
software availability (Brennan and Akehurst, 2000; Brennan et al., 2006). Although, it 
has been argued in the literature that the model structure is governed by the issue of 
data availability (Philips et al., 2006), it is recommended that the model structure be 
as simple as possible, consistent with the decision problem (Sculpher et al., 2000; 
Philips et al., 2006). Data availability alone should not determine the model structure 
(Sonnenberg et al., 1994; Sculpher et al., 2000; Philips et al., 2006). However, data 
availability may limit or refine the model structure and its scope (Philips et al., 2006). 
While inappropriate model structure will invalidate study findings, choices made while 
structuring the model may also influence study conclusions (Peñaloza Ramos et al., 
2015) (Brennan et al., 2006). Therefore, it is essential that the choice of the model 
structure is fit for purpose and is determined by the level of detail required and 
complexity (Roberts et al., 2012). 
 
Model structures used in economic evaluations in health care can be broadly 
categorised into aggregate cohort models or individual patient level models (Brennan 
et al., 2006). Cohort models examine costs and outcomes of an average patient from 
a population undergoing different events. Whereas, patient level models consider 
individual patients accounting for variability between patients and follow their 
progress overtime (Brennan et al., 2006; Briggs A et al., 2006). Depending on the 
decision problem and boundaries of economic evaluation, these model structures 
commonly use modelling techniques such as decision trees, Markov models and 
other alternative modelling approaches such as patient level simulation, discrete 
event simulations and dynamic models (Cooper et al., 2007a; Petrou and Gray, 
2011b). 
 
5.4.3.1 Decision trees 
Decision trees are the simplest and most common form of DAM in economic 
evaluation (Karnon and Brown, 1998; Barton et al., 2004; Petrou and Gray, 2011b). 
Decision trees are appropriate in decision models with short-time horizon and when 
the mortality between alternative interventions do not differ (Barton et al., 2004). All 
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possible patient pathways and their associated probabilities and outcome measures 
are explicitly shown on decision trees and branches. The key features of decision 
tree are the decision node (typically represented by a square symbol), also known as 
“choice node”, which indicates a decision point between alternatives, chance nodes 
(typically represented by circular symbols) which indicate the point where two or 
more alternative events are possible. The alternative patient pathways branching out 
at chance nodes are mutually exclusive events with their individual probabilities 
summing into one (Petrou and Gray, 2011b). The end points of the pathways are 
indicated by terminal nodes (typically represented by triangle symbols) where costs 
and effectiveness are assigned. The costs and effectiveness for each alternative is 
derived by summing up the costs and effects weighted against probabilities of each 
pathway. The probabilities for each pathway (also known as joint probability) is 
estimated by multiplying the probabilities along the pathways (Briggs et al., 2006). 
 
Figure 5.1 shows a hypothetical example of a simplified decision tree model, where a 
decision has to be made between intervention 1 and intervention 2 represented by 
the branches coming out of decision node. Each intervention leads to two mutually 
exclusive events of being dead and alive whose occurrence depends on their 
underlying probabilities. The total costs and benefits are then estimated for each 
intervention as the sum of the pathway values weighted by the probabilities in each 
pathways. 
 
Figure 5.1: Simple representation of decision tree model 
Decision node 
Chance nodes Terminal nodes 
Intervention 1 
Intervention 2 
Alive 
Dead 
Alive 
Dead 
Costs Benefits 
Probability Alive 
1-Probability Alive 
Probability Alive 
1-Probability 
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However, decision trees may not be suitable in situations such as modelling chronic 
conditions, where the need to reflect large number of recurring events and 
consequences over longer time horizon would make them lengthy, unwieldy and 
complex to programme (Briggs et al., 2006; Petrou and Gray, 2011b). In addition, 
decision trees are limited by the inability to implicitly account for the progression of 
time making incorporation of time dependency in model difficult (Karnon and Brown, 
1998; Briggs et al., 2006). 
 
5.4.3.2 Markov model 
Markov models are useful when an easier representation of complex and repeated 
set of events over time is necessary (Sonnenberg and Beck, 1993; Brennan et al., 
2006). Patient events are modelled to transit from one state to another, over series of 
discrete time intervals or cycles. The choice of the cycle length in a Markov model 
depends on the problem being assessed; the remaining life expectancy in patients; 
and computational efficiency, but the cycle length should be short enough to 
represent the intervention being assessed (Siebert et al., 2012). 
 
In a Markov model, at any point of time patients are assumed to be one of the finite 
number of states. A set of transition probabilities determine the movement of patients 
from one state to another in each cycle (Petrou and Gray, 2011b). Transitions are 
usually modelled to occur either at the beginning or the end of a cycle, but in reality 
they may occur half-way through the cycle on an average (Naimark et al., 2008). 
Therefore, to account for this, a half-cycle correction is applied to the costs and 
effects in the first cycle and also in the last cycle if life time horizon is not used 
(Siebert et al., 2012). Costs and effects (typically utility and quality of life weights) are 
attached to models as mean value per state per cycle, thereby allowing the analyst to 
estimate expected values as a sum total across cycles (Briggs et al., 2006). 
 
Figure 5.2 provides a hypothetical example of a Markov model, where there are three 
states (Healthy, Injured and Dead). At the end of the Markov cycle, a cohort in the 
healthy state can either remain in the healthy state or progress to injured state or 
dead state depending on the transition probabilities between states. Those in the 
injured state can either remain injured or recover to be healthy or die. Those dead 
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cannot be healthy or injured again, therefore cohort can enter the dead state but 
cannot leave it (this is called an “absorbing state”). The arrows indicate the 
movement of the cohort. 
 
 
Figure 5.2: A simple Markov model 
 
Markov models are widely used in economic evaluations (Barton et al., 2004), 
however the main limitation with Markov models is that the probabilities of 
transitioning from one state to another only depends on the current health state and 
is independent of historical experience. This is known as the Markov assumption or 
memoryless feature. The implications of the Markov assumption is that all patients 
are treated as being homogenous regardless of the time spent in a given state or the 
previous history (Karnon and Brown, 1998). However, this limitation could be 
overcome by adding additional states to the model and by incorporating time 
dependency into transition probabilities (Briggs et al., 2006). However, the addition of 
states and the incorporation of time dependencies may increase the computational 
burden and may make the model unmanageable. 
 
5.4.3.3 Other types of decision models 
Other type of decision models commonly used in health economic evaluations are 
patient level simulation, discrete event simulation and dynamic models. Patient level 
simulation, also known as micro-simulations, models the progression of individuals 
with potentially heterogeneous characteristics one at a time rather than in cohorts 
Healthy 
Injured 
Dead 
106 
(Briggs et al., 2006; Petrou and Gray, 2011b). Interaction is not allowed in patient 
level simulation and individuals progress through the model independently of each 
other and the environment (Brennan et al., 2006). Unlike Markov models, individuals 
follow “time to next event” rather than equal time periods for the group(Brennan et al., 
1997). Patient level simulation allows accumulation of individual patient history to 
determine transitions between states, costs and health outcomes (Briggs et al., 
2006). However, patient level simulation models are limited by the fact that they can 
be more demanding of data, have high computational burden and can have less 
flexibility to assess uncertainty because of that computational burden (Briggs et al., 
2006). 
 
A discrete event simulation (DES) is similar to the Markov Model in several aspects, 
however DES offers advantages over Markov model by not being restricted by the 
Markov assumption or by the use of equal time to event (Brennan et al., 2006). DES 
operates at the individual level but unlike the patient simulation models it allows the 
interactions between individuals for example when resources are limited a particular 
treatment provision to one individual will affect the treatment given to another (Barton 
et al., 2004; Petrou and Gray, 2011b). DES is particularly useful for complex models 
where the patient history, interactions and nonlinear behaviour of individuals in the 
model need to be taken into account (Cooper et al., 2007a; Roberts et al., 2012). 
However, the benefits DES offers over Markov model could be outweighed by the far 
greater time and programming skills required to develop and evaluate the DES model 
(Karnon, 2003). 
 
Dynamic models are particularly valuable when interactions between groups 
influence the outcomes, particularly in infectious disease modelling (Barton et al., 
2004; Pitman et al., 2012). Interactions between individuals should be accounted for 
in instances such as modelling infectious diseases where presence of disease in a 
group at a given point in time will determine the risk of an individual getting infected. 
A dynamic model is distinguished from other models by its feature that typically 
captures the interactions between the entire health system or population and 
outcomes under consideration, for example the effect of herd immunity on the 
likelihood of infection over time (Petrou and Gray, 2011b; Pitman et al., 2012). 
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However, dynamic models might become unmanageable when a large number of 
complex interactions because of more detailed characterisation of the problem under 
consideration (Roberts et al., 2012). 
 
5.4.4 Identifying and synthesizing evidence 
This stage involves systematic approach to identifying, bringing together all relevant 
evidence from a range of sources and appropriately synthesizing the intervention 
effect(s) as model input parameters (Briggs et al., 2006). The synthesized 
effectiveness parameter is combined with other data parameters such as cost and 
utilities to estimate the costs and benefits of an intervention. Although well conducted 
RCTs are considered the best source of evidence to evaluate the effectiveness of an 
intervention, trial data may be unavailable for a number of reasons (practicality, cost 
etc) (Centre for Review and Dissemination, 2009; Lathyris et al., 2010; Estellat and 
Ravaud, 2012). In the event of RCTs data not being available for the interventions of 
interest, evidence will have to be taken from quasi-experimental designs (e.g. 
controlled before-after designs, interrupted time series) or observational studies 
(example: cohort, case-control, cross-sectional, case series) (Centre for Review and 
Dissemination, 2009). The hierarchy and potential biases in the evidence may be 
dependent on the type of evidence used. The need to combine evidence from range 
of sources to be used in economic evaluation models could potentially lead to several 
issues such as differences in the measure of outcomes, differences in follow-up 
times between sources, heterogeneity in the sample studied. Lack of guidance on the 
appropriate methodology for the identification of evidence to inform model 
parameters other than RCTs of clinical effectiveness has been previously reported 
(Cooper et al., 2007b). However, issues arising out of combination of evidence, 
mainly related to relative effects and clinical end-points, are increasingly dealt with 
the use of indirect and mixed treatment comparisons and meta-regression (Lumley, 
2002; Lu and Ades, 2004; Donegan et al., 2010; Jansen et al., 2011). Furthermore, 
time dependency in transition probabilities is an important issue that need to be 
considered when identifying and utilizing the evidence from secondary sources in 
Markov models. Time dependency in transition probability is summarised in the 
following sections. 
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5.4.4.1 Time dependency in transition probabilities 
An important parameter in an economic evaluation model is the transition probability 
from one state to another, which may be time dependent. Assuming a constant 
transition probability may not be practical in some of the models, where transition 
probabilities may change as the model progresses (Briggs et al., 2006). For example 
the probability of death increases as the cohort ages and probability of transitioning 
to death state in the second year may be higher than the first year. Probabilities may 
also change according to the time spent in a particular state in a model. For example 
the probability of dying from a particular disease may increase with time spent with 
that disease. A practical problem in Markov models is in identifying and applying 
transition probabilities obtained from a range of literature where events may be 
reported as rates rather than probabilities (Sun and Faunce, 2008) or rarely available 
for the time frame required (Fleurence and Hollenbeak, 2007). Rate is the 
instantaneous potential for the occurrence of an event and is expressed as per 
number of persons at risk, whereas probability is the likelihood of occurrence of an 
event over a specific period of time and reported as a number ranging between 0 and 
1 (Briggs et al., 2006). Therefore, the time period used in estimates of event rates 
may not be equal to the cycle length in the model where they are applied as 
transition probabilities between states. Simply copying these rates from the literature 
and applying them in the model could influence the inferences from the model. But it 
is possible to translate the rates of events into probabilities using the following 
equation, if the rate is assumed constant over the time period considered: 
𝑝 = 1 − exp (−𝑟𝑡)                                                                                                    (5.1) 
where 𝑝 is transition probability, 𝑟 is the rate of event, and 𝑡 is the time period of 
interest (Briggs et al., 2006; Fleurence and Hollenbeak, 2007). 
 
Similarly when transition probabilities will have to be varied according to the model 
cycles, instantaneous rate of event (𝑟) could be derived from the transition 
probability (𝑝) for a given time period (𝑡) using the following formula (Briggs A et al., 
2006; Fleurence and Hollenbeak, 2007): 
𝑟 = −[ln(1 − 𝑝)]/𝑡                                                                                                   (5.2) 
The calculated instantaneous rate could then be used to generate the transition 
probability for the time period of interest using equation 5.1. 
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However, these translation of rates and probabilities only apply to two states model 
where one state is an absorbing state and a more complex method is recommended 
for multi-state models with more than two state models (Nicky and Ades, 2005; 
Fleurence and Hollenbeak, 2007; Jagpreet et al., 2016). Furthermore, these rates 
and probabilities may not be always readily available in the literature. Hence, time 
dependent probabilities are commonly derived from patient-level time to event data 
using survival analysis (Briggs et al., 2006). 
 
5.4.4.2 Using survival analysis to implement time dependency 
Survival analysis involves modelling the time to event data and analyses the 
expected time until the occurrence of the event of interest (for example death, 
readmission). The main feature of survival analysis is that it allows the censored data 
(uninformative) to be included in the analysis. Censored data are those individuals 
lost to follow-up or those with no event until the end of the study follow-up. Briggs et 
al (2006) provide a detail description and examples of using survival analysis to 
implement time dependency in transition probabilities used in Markov models (Briggs 
et al., 2006) but will be briefly considered here. 
 
Standard survival analysis mainly uses three concepts: probability density function, 
survival function and hazard function. The probability density function (𝑓(𝑡)) is the 
probability of an event occurring at time 𝑡, and is associated with cumulative density 
function 𝐹(𝑡) = 𝑃(𝑇 ≤ 𝑡) which is the cumulative probability of event up to time 𝑡. The 
survival function, 𝑆(𝑡) = 𝑃(𝑇 > 𝑡) = 1 − 𝐹(𝑡) indicates the probability of surviving 
beyond time 𝑡. The hazard function is the instantaneous rate of failure (event) at 
time 𝑡, conditional upon the survival (no occurrence of event of interest) until time 𝑡 
and is expressed as the ratio of probability density function and survival function: 
ℎ(𝑡) = 𝑓(𝑡)/𝑆(𝑡) 
The survival function expressed in terms of cumulative hazard function, 𝑆(𝑡) =
exp (−𝐻(𝑡)) is central to derive time dependent transition probabilities in Markov 
models and is of particular interest in economic evaluations (Briggs et al., 2006). 
However, these hazard functions are rates and need to be translated to probabilities 
as discussed earlier. 
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A range of different survival models and distributions can be used in the survival 
analysis. The most common form of survival analysis is the semiparametric Cox 
proportional hazard model. However, it does not specify how the risk of an event 
varies with time and is therefore limited in terms of generating time dependent 
transition probabilities required in Markov models (Briggs et al., 2006). Alternatively, 
a parametric survival model may be used for analysing time to event data in 
economic evaluation. Commonly used distributions in the parametric models are 
exponential, weibull, gompertz, log-logistic, log-normal and generalised gamma, each 
having their unique characteristics and vary in their functional forms (Latimer, 2011). 
However, exponential distributions are only suitable when the transition probabilities 
are constant over time (Briggs et al., 2006). A variety of approaches are used to 
assess the suitability of the distributions used in survival models such as visual 
inspection, Log-cumulative hazard plots and Akaike’s Information Criterion (AIC) and 
the Bayesian Information Criterion (BIC). AIC and BIC are defined in Chapter 4. 
Further details on survival analysis models, properties of distribution, and their use in 
economic evaluations will not be described here, but can be available in a report by 
the NICE Decision Support Unit (Latimer, 2011). 
 
An important issue that researchers need to be careful in survival analysis is 
“competing risks”. A competing risk in a survival analysis is defined an event whose 
occurrence either precludes the occurrence of another event under examination or 
fundamentally alters the probability of occurrence of this other event (Gooley et al., 
1999), For example, the discharge from the hospital is the event of interest in survival 
analysis, but if the patient dies while in hospital then there is no chance of discharge 
from the hospital for that patient. So, death in the hospital is the competing risk in this 
instance. Common approaches such as Kaplan-Meier method treat any censored 
observations at equal risk of experiencing the event of interest as non-censored 
observations. Failure to account for competing risks may lead to biased estimate of 
the cumulative events of interest (hazard functions) (Brock et al., 2011; Noordzij et 
al., 2013; Austin et al., 2016) which in turn may bias the transition probabilities 
derived from them. 
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However, common statistical programming language such as R facilitates survival 
analysis in multistate models in presence of competing risks using packages such as 
“flexsurv” which also allows fitting of appropriate survival distributions and takes 
account of conversion of hazard rates into time dependent transition probabilities 
(Jackson, 2016). 
 
5.4.5 Dealing with uncertainty and heterogeneity 
The economic evaluation is undertaken once the model is populated with point 
estimates of all parameters required by the model. This form of economic evaluation 
will estimate the expected costs and outcomes (effects) for each intervention 
compared and is known as deterministic analysis. However, uncertainty is an 
unavoidable phenomenon in any decision-making process and should be handled 
appropriately if decision-makers are to be confident in the results of the decision 
analytic model (Barton et al., 2004; Briggs et al., 2006). Uncertainties in decision 
analytic models could arise out of number of reasons, but have been broadly 
categorised as variability, heterogeneity and uncertainty (Briggs et al., 2006). 
 
Variability, also referred to as first order uncertainty in medical literature (Stinnett and 
Paltiel, 1997) or Monte Carlo uncertainty (Petrou and Gray, 2011b), is the differences 
that occur between patients by chance (Briggs et al., 2006). Variability occurs in 
models due to the modelling process itself because the probability of an event 
happening or not in a given cycle or run is typically determined by random probability 
distributions due to which identical individuals will experience different outcomes as 
they progress through the model (Petrou and Gray, 2011b). This kind of variability 
cannot be addressed by collection of additional data (Briggs et al., 2006), but has to 
be eliminated by repeatedly running the model large number of times until a stable 
estimate of central tendency is observed (Weinstein, 2006). Though there exists no 
guideline or indication on the number of runs needed (Petrou and Gray, 2011b), it is 
acceptable to use model iterations higher than 1000 (Briggs et al., 2006), but it could 
be worth testing the stability of results and computational efficiency of the software 
used over higher number of iterations. 
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Heterogeneity relates to differences in individual characteristics such as age, sex and 
disease specification that can be explained by variations in the sub-group (Briggs et 
al., 2006). For example, men and women could have differences in their mortality 
rate. Heterogeneity can be addressed by re-running the model for a specific sub-
group of interest. Alternatively, heterogeneity can be addressed by making model 
parameters the function of patient characteristics, such as incorporating transition 
probabilities between states in the model according to the age or disease severity 
(Petrou and Gray, 2011b)  
 
Therefore, rather than variability or heterogeneity, it is uncertainty that models should 
seek to capture (Briggs et al., 2006). The two most widely reported forms of 
uncertainties in health economics are structural uncertainty and parameter 
uncertainty (Briggs et al., 2006). Structural uncertainty arises due to uncertainties 
around the structure of the model and assumptions in the model framework. For 
example, whether the model structure and the number of health states used can 
simulate the disease progression and the possible outcomes (Briggs et al., 2006; 
Sun and Faunce, 2008; Petrou and Gray, 2011b)? An illustration of this would be a 
study that investigated the impact of structural uncertainty on cost-effectiveness of 
the treatment of advanced breast cancer by comparing the results of four common 
Markov models varying in the number of health states and assumptions considered 
(Bhattarai et al., 2016). 
 
Structural uncertainty is commonly addressed with deterministic sensitivity analysis 
or scenario analysis in which the impact of varying one (univariate) or more 
(multivariate) model assumptions on robustness of results is investigated (Weinstein 
et al., 2003; Afzali and Karnon, 2015). Alternatively, structural uncertainties could be 
handled with model averaging techniques (Bojke et al., 2009; Jackson et al., 2009; 
Jackson et al., 2011), where model results are weighted by model adequacy 
measures. 
 
Parameter uncertainty, also sometimes known as second order uncertainty (Briggs et 
al., 2006), relates to the precision around the estimation of value of model 
parameters such as transition probabilities, costs and utilities (Petrou and Gray, 
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2011b). For example, a study utilised probabilistic sensitivity analysis to quantify the 
effect of parameter uncertainty in cost-effectiveness of varicella vaccination by using 
a range of possible input parameters derived by assigning distributions to the 
parameters (Brisson and Edmunds, 2006). Parameter uncertainty can be addressed 
with number of techniques such as univariate, multivariate or probabilistic sensitivity 
analysis, or analysis of extremes, bootstrapping, or microsimulation, however there is 
no agreement on appropriate approach to use (Bilcke et al., 2011; Briggs et al., 
2012). It has been recommended previously that either deterministic or probabilistic 
sensitivity analysis can be used in addressing parameter uncertainty, with 
probabilistic sensitivity analysis more appropriate in case of cohort simulations 
(Weinstein et al., 2003). Others (Sonnenberg et al., 1994; Sculpher et al., 2000) 
however have argued that parameter uncertainty is best addressed by using data as 
distributions rather than point estimates. The National Institute of Health and Care 
Excellence (NICE) in the UK also requires model parameters to be specified as 
probability distributions rather than point estimates (National Institute for Health and 
Care Excellence, 2013), though there could be some exceptions such as discount 
rates which are point estimates. The advantage of probabilistic sensitivity analysis 
over deterministic sensitivity analysis is the fact that it provides an assessment of the 
joint effect of uncertainty over all parameters incorporated in the model (Briggs, 
2000). Probabilistic sensitivity analyses involves randomly varying all parameters 
simultaneously across specified distributions (described later in this Chapter) 
informed by best available point estimates of sample mean and standard error and 
are usually executed by repeating this random draw several thousand times 
estimating costs and effects across repetition for each intervention under comparison 
(Petrou and Gray, 2011b). The uncertainty is illustrated by plotting incremental costs 
and effects for each of the iterations on cost effectiveness plane (Briggs, 2000). Cost 
effectiveness acceptability curves (CEAC) which show the probability that each 
intervention is cost-effective across a range of assumed monetary thresholds of 
willingness to pay can also be derived from probabilistic sensitivity analysis (Fenwick 
et al., 2004). Both the cost-effectiveness plane and the CEAC are described in more 
detail later in this Chapter. Therefore, probabilistic sensitivity analysis is the most 
appropriate approach to handle parameter uncertainty in a decision model (Briggs, 
2000; Philips et al., 2006). 
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In making parameters probabilistic, there are numerous forms of distributions which 
can be fitted across parameters. A distribution in simple terms is the spread of values 
of a random parameter of interest. However, the choice of these distributions to 
reflect uncertainty in model parameters is not arbitrary, but rather guided by the type 
of parameter, type of data and the estimation process (Claxton et al., 2005; Briggs et 
al., 2006). Briggs and colleagues describe the forms of distribution and their 
appropriateness into parameters and also provide details including the step by step 
guideline in estimating these distributions (Briggs et al., 2006), but will be 
summarised in the following sections. 
 
5.4.5.1 Normal (Gaussian) distribution 
It is the most common form of continuous distributions used in capturing parameter 
uncertainties and represents the sampling distribution of the mean parameter value. 
A random parameter in a normal distribution can assume any value between 
negative and positive infinity. The central limit theorem assumes that with a 
sufficiently large sample size the sampling distribution of the mean will be normally 
distributed regardless of underlying distribution of the data (Briggs et al., 2006). This 
would mean that a normal distribution could be used for representing uncertainty in 
any model parameters as long as the sample size remains sufficient to justify the 
normal assumption. Usually the mean and the standard deviation from the mean is 
used to estimate normal distribution of a random parameter. 
 
5.4.5.2 Lognormal distribution 
It is a continuous distribution of a random parameter whose logarithm is normally 
distributed. A lognormal distributed parameter takes only positive real value and 
therefore ranges from zero to infinity with distributions skewed to the left (Limpert and 
Stahel, 2017). Lognormal distribution is generally suitable for parameters that are 
non-negative, highly right skewed or have a multiplicative format such as ratios 
(Limpert and Stahel, 2011; Limpert and Stahel, 2017). Usually, the mean and the 
standard deviation from the mean is used to compute the lognormal distribution of a 
random parameter. 
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5.4.5.3 Beta (Binomial) distribution 
It is also a continuous probability distribution defined on the interval 0-1 and is 
characterised by two positive shape parameters, typically denoted by 𝛼 and 𝛽. Beta 
distribution is appropriate in representing uncertainty in binomial data, such as 
proportions. The 𝛼 and 𝛽 are computed as follows: 
𝛼 = 𝜇[
𝜇(1−𝜇)
𝑆2
− 1]                      𝛽 = [
𝜇(1−𝜇)
𝑆2
− 1 − 𝛼] 
where, 𝜇 is the mean of the sample, 𝑆2 is the variance. 
 
5.4.5.4 Dirichlet distribution 
It is a continuous multivariate probability distribution parameterised by a vector 𝛼 of 
positive counts. It is the multivariate equivalent of the beta distribution (Briggs et al., 
2003). It is used to represent numerous categories in a multinomial data, individual 
proportions of which sum into 1. 
 
5.4.5.5 Gamma distribution 
It is another widely used continuous probability distribution and is defined on the 
scale ranging from zero to infinity and is suitable for data that is right skewed. The 
gamma distribution is typically denoted by the shape parameter 𝛼 and scale 
parameter 𝛽. The 𝛼 and 𝛽 are computed as follows: 
𝛼 =
𝜇2
𝑆2
                      𝛽 =
𝑆2
𝜇
 
where, 𝜇 is the mean of the sample, 𝑆2 is the variance. 
 
5.4.5.6 Choice of distributions 
Even though there exist numerous probability distributions the choice of these 
distributions should be guided by parameter type and standard statistical methods of 
estimation, for example beta distributions for binomial data, Dirichlet for multinomial 
data, gamma or lognormal for right skewed data and lognormal for relative risks or 
ratios (Claxton et al., 2005; Briggs et al., 2006). 
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Probability parameters range between zero to one and where these are estimated 
from proportions the natural choice would be beta distributions. However, if 
probabilities are estimated from a logistic regression, then a lognormal distribution 
would be appropriate. On the other hand if there are numerous categories of 
proportions which sum into 1, then a Dirichlet distribution would be representative of 
the uncertainty. Uncertainties in disease prevalence and diagnostic test accuracy are 
commonly represented using beta distributions. 
 
Cost data range from zero to infinity and are non-negative figures based on counts of 
resource use weighted by resource unit costs. Therefore, it would be appropriate to 
use gamma or lognormal distribution. However, when the cost estimate is not highly 
skewed and is from sufficiently large data, then the central limit theory could be 
applied fitting the normal distribution to the cost estimates. 
 
Theoretically, utilities take the value ranging from zero representing worst health 
state or death to one representing perfect health. But negative utility scores which 
indicate a poor health state valued even less than the death is possible from some 
scoring instruments such as EQ-5D-5L (Devlin and Shah, 2018). Beta distribution is 
a commonly used to represent uncertainties in utility parameters. However, a beta 
distribution is not appropriate when negative utility values are possible in instances 
such as some forms of cancer which are considered worse than death. Therefore, in 
such situations it will be appropriate to use gamma or lognormal distribution for 
disutility. Disutility is a simple transformation of utility (disutility=1-utility) that ranges 
from zero to infinity (Briggs et al., 2006). 
 
5.4.6 Assessing the value of additional research  
Probabilistic sensitivity analysis (PSA) assesses uncertainties surrounding model 
parameters and uncertainties are displayed using cost effectiveness acceptability 
curves (CEAC) (Fenwick et al., 2004). However, the true values of costs and effects 
estimates from a decision model are never certain, which implies that there is always 
a risk of making wrong decisions which may have costs implications to the healthcare 
system in terms of costs or health benefits forgone (Claxton, 1999). For example, in 
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Figure 5.4 the CEAC displays a 70% probability that the intervention under 
consideration would be cost-effective at a willingness to pay threshold of £30,000, 
which would be an optimal choice. However, the decisions to adopt the intervention 
may still go wrong 30% of the time which represents the uncertainty in a decision to 
adopt the intervention. Uncertainty could be reduced with additional information, 
however it could mean incurring higher costs of conducting additional research and 
incur the opportunity costs of health benefits of new intervention forgone while 
waiting for the additional information (Claxton, 1999; Eckermann and Willan, 2007). 
Therefore, it would be beneficial to assess the value of additional research in 
reducing decision uncertainty. 
 
Value of information (VOI) analysis is a valuable extension of the probabilistic 
sensitivity analysis (Felli and Hazen, 1999) and provides information on the 
consequences of making wrong decisions arising out of uncertainties surrounding 
costs and effects estimates. The VOI analysis quantifies the value of additional 
research to reduce the uncertainties in decision-making (Claxton and Posnett, 1996). 
The VOI technique mainly considers whether the technology or intervention be 
adopted (rejected) at the current level of evidence and whether additional information 
is required to support the decision-making (Briggs et al., 2006). The expected cost 
(value) of uncertainty is commonly generated by combining the cost of making 
incorrect decision with the probability of making incorrect decision (Oostenbrink et al., 
2008; Petrou and Gray, 2011b). 
 
A range of VOI analysis methods could be undertaken to inform decisions. Expected 
Value of Perfect Information (EVPI), the most common measure used in VOI 
analysis, is the monetary value of conducting additional research to eliminate 
uncertainty in all parameters and decision uncertainty (Claxton, 1999). For example, 
if the objective is to maximise health outcomes under budget constraints, then EVPI 
is the maximum the decision maker is willing to pay for additional information 
eliminating all uncertainties (Briggs et al., 2006). 
 
However, it would be useful to indicate parameters whose additional information 
would be most valuable in reducing uncertainties. Therefore, Expected Value of 
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Perfect Parameter Information (EVPPI), an extended form of EVPI, guides the focus 
of the study by identifying those parameters for which additional information would be 
most valuable (Claxton, 1999; Briggs et al., 2006). EVPPI is simply the difference 
between the expected value with perfect information for identified parameter(s) and 
expected value with current information about the parameter(s) (Briggs et al., 2006). 
Though with the same definition, EVPPI is also denoted as Expected Value of Partial 
Perfect Information (Ades et al., 2004; Petrou and Gray, 2011b). Understanding what 
drives the uncertainty is the essence of EVPPI. 
 
Both the EVPI and EVPPI place an upper bound on the potential value of additional 
research which is a necessary but not a sufficient condition for conducting further 
research (Claxton, 1999; Briggs et al., 2006). To establish a sufficient condition for 
value of additional research, marginal benefit and marginal cost of sample 
information needs to be considered (Claxton, 1999; Briggs et al., 2006; Eckermann 
and Willan, 2007). Therefore, Expected Value of Sample Information (EVSI) is used 
to estimate the value of collecting additional sample information (Claxton, 1999; Ades 
et al., 2004). EVSI focusses on optimal design issues for further studies such as 
optimal sample size, optimal allocation of study population, appropriate follow-up and 
outcomes (Ades et al., 2004; Briggs et al., 2006). EVSI is calculated as the difference 
between the expected value of sample information and the expected value of current 
information. The Expected Net Benefit of Sampling (ENBS) is the difference between 
the EVSI and the expected costs of the study and it implies that higher the ENBS the 
more worthwhile the study is (Ades et al., 2004). 
 
VOI techniques such as EVPI have been increasingly reported in cost-effectiveness 
analysis, however the reporting of EVSI and ENBS is limited (Steuten et al., 2013; 
Tuffaha et al., 2014);with few studies being reported that have based their sample 
size estimate on EVSI or ENBS estimates (Cook et al., 2014). Further details on VOI 
and the framework for the techniques utilised are described in the literature (Claxton, 
1999; Ades et al., 2004; Briggs et al., 2006). The next section of this Chapter will 
discuss the presentation of results from decision analytic models. 
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5.5 Presenting Results of Decision Analytic Models 
Finally, in a decision model the estimates of costs and effects associated with two or 
more interventions and cost-effectiveness are presented. The cost-effectiveness is 
normally summarised in terms of Incremental Cost-Effectiveness Ratio (ICER). An 
ICER represents the additional costs that will be incurred per unit effect gained by an 
intervention compared with another (Briggs, 1999). The ICER is calculated as the 
difference in cost of the intervention under consideration and the comparator (∆𝐶) 
divided by the difference in their effects (∆𝐸) using the following equation: 
𝐼𝐶𝐸𝑅 =
𝐶𝑖 − 𝐶𝑐
𝐸𝑖 − 𝐸𝑐
=
Δ𝐶
Δ𝐸
 
where 𝐶𝑖 and 𝐶𝑐 represent mean costs in the intervention and comparator,  
respectively, 𝐸𝑖 and 𝐸𝑐 represent effects, Δ𝐶 and Δ𝐸 represent incremental cost and 
effects. 
 
A cost-effectiveness plane is used to visually illustrate the differences in costs and 
effects between the alternatives compared in an economic evaluation (Figure 5.3). A 
cost-effectiveness plane is divided into four quadrants where the incremental costs 
(Δ𝐶) are illustrated on the vertical axis and the incremental effectiveness (Δ𝐸) are 
illustrated on horizontal axis. If the intervention under consideration is more effective 
but less costly than the control, the cost-effectiveness estimates fall in the South-East 
(SE) quadrant, and therefore the intervention under consideration dominates the 
control and the intervention is the cost-effective strategy. Alternatively, if the 
intervention under consideration is less effective and costs more than the control, the 
estimates fall into the North-West (NW) quadrant which demonstrates that the control 
dominates the intervention and thus the control is the recommended strategy. In 
these circumstances, it is clear that the least costly and more effective intervention 
should be implemented and a ICER will not be necessary (Briggs et al., 2006). 
However, a trade-off is involved if the estimates are more effective and more costly 
(i.e. when they fall into the North-East (NE) quadrant) or less effective and less costly 
(i.e. when they fall into South-West (SW) quadrants). 
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Figure 5.3: Cost-effectiveness plane 
 
In situations where the cost-effectiveness estimates fall into either NE or SW 
quadrants of the cost-effectiveness plane, decisions on cost-effectiveness of 
interventions will depend on the decision maker’s willingness to pay value. In the 
Figure 5.3, the willingness to pay threshold (λ), also known as ceiling ratio, is 
represented by the dotted diagonal line passing crossing through the origin of the 
cost-effectiveness plane and across the NE and SW quadrants. The intervention is 
considered cost-effective at a given value of λ, if the incremental values fall below 
(values fall to the right of the dotted line). Whereas it will not be considered cost-
effective if the incremental values fall above (values fall to the left of the dotted line). 
In other words, the intervention is deemed cost-effective and said to offer a good 
value for money if the ICER is less than the ceiling ratio λ, otherwise not (Fenwick et 
al., 2006). The ceiling ratios are generally subjective, however they are also 
considered to reflect the opportunity costs of implementing the intervention under 
consideration (McCabe et al., 2008). In the UK, NICE recommends a ceiling ratio in 
the range of £20,000 to £30,000 per QALY (National Institute for Health and Care 
Excellence, 2013). A range rather than a fixed amount allows reflection of 
uncertainties in the ICER estimates and flexibility to use criteria other than cost-
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effectiveness in decision-making (Appleby, 2016). ICER’s less than £20,000 per 
QALY are normally considered cost-effective by NICE, however decisions on ICER’s 
above £20,000 per QALY take account of factors such as i) the degree of certainties 
around the ICER, ii) whether the intervention under consideration is innovative in 
nature and adds demonstrable and distinctive benefits which may not have been 
captured by QALYs, iii) whether intervention involves benefits on broader social 
considerations other than health, iv) whether the QALYs have been adequately 
captured, v) whether the intervention meets the criteria for special consideration as a 
“life extending treatment at the end of life” (National Institute for Health and Care 
Excellence, 2013; Dakin et al., 2015). 
 
In a PSA, a Monte Carlo simulation generates a large number of estimated costs and 
effects. The average of these estimated costs and effects across simulations, and the 
resulting ICER represent uncertainties in the decision model. However, another way 
of illustrating uncertainty is to plot the incremental costs and incremental effects in 
each of these simulations as a cloud of points in a cost effectiveness plane. In 
probabilistic analysis where the range of incremental values spread across cost-
effectiveness plane quadrants there will be some negative ICERs which do not have 
a meaningful interpretation (Stinnett and Mullahy, 1998) and there will often be 
problems in interval estimation of ICER (Briggs et al., 2006). Therefore, to avoid the 
problem with interpretation of negative ICER, the use of CEAC is recommended 
(Fenwick et al., 2001; Briggs et al., 2006). Furthermore, the exact value of the CEAC 
is ceiling ratio λ is not known in practice. However, the probability of cost-
effectiveness of an intervention over a range of ceiling ratios can be illustrated in the 
CEAC. A hypothetical example of CEAC is presented in Figure 5.4 where the 
intervention and the control both have 50% cost-effectiveness probability at the 
ceiling ratio of £20,000. But, at the ceiling ratio of £30,000 the cost-effectiveness 
probability increases to 70% for the intervention and decreases to 25% for the 
control. 
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Figure 5.4: A CEAC for intervention versus control 
 
As described earlier for the cost-effectiveness plane in Figure 5.3, the incremental 
values falling below and to the right of the line representing the maximum willingness 
to pay (ceiling ratio) illustrates the estimates that are cost-effective. Therefore, CEAC 
involves calculating the probability of intervention is cost-effective as the proportion of 
incremental values falling below the threshold line for each of the range of willingness 
to pay. Then the probability estimates of intervention being cost-effective for the 
range of ceiling ratio are summarised in the CEAC plot. 
 
Alternatively, incremental net benefit (INB) which is a simple rearrangement of the 
ICER based on decision rule of cost-effectiveness, is used to overcome problems 
associated with ICERs explained earlier (Stinnett and Mullahy, 1998; Briggs et al., 
2006). The decision rule stated earlier in this section explains that the intervention 
under consideration should be implemented only if its ICER is lower than the 
threshold λ, i.e. if  
Δ𝐶
Δ𝐸
< λ. This decision rule can be re-arranged into either cost 
(monetary) or effect (benefit) scales in the net-benefit framework as follows (Briggs et 
al., 2006): 
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𝑁𝑒𝑡 𝑀𝑜𝑛𝑒𝑡𝑎𝑟𝑦 𝐵𝑒𝑛𝑒𝑓𝑖𝑡 (𝑁𝑀𝐵) =  λ ∗ Δ𝐸 −  Δ𝐶 > 0 
                             𝑁𝑒𝑡 𝐻𝑒𝑎𝑙𝑡ℎ 𝐵𝑒𝑛𝑒𝑓𝑖𝑡 (𝑁𝐻𝐵) =  Δ𝐸 −  
Δ𝐸
λ
 > 0 
According to these decision rules, which are equivalent to the standard rule in the 
ICER, a positive net benefit indicate that the intervention is cost-effective and good 
value for money, whereas a negative net benefit is not (Drummond et al., 2005). 
 
5.6 Summary 
The economic evaluations on centralisation of specialised healthcare services is 
dominated by studies with limited methodological quality. This Chapter provided a 
methodological background to the economic evaluation methods used in this thesis. 
Considering, the nature of the case considered in the next Chapter, a RCT to assess 
the impact of centralisation of emergency hospitals in this instance would be 
challenging. Decision analytic models enable a wide range of costs and effects from 
various sources to be synthesized within a model framework to generate cost-
effectiveness outcomes of an intervention and are particularly useful when RCTs are 
difficult to conduct or when the existing economic data is very limited. This Chapter 
described the methodological development of an economic evaluation model with the 
focus on decision analytic model framework. It demonstrated methods of assessing 
and presenting uncertainties in the cost-effectiveness estimate. The decision analytic 
modelling framework will be applied in the next Chapter. 
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Chapter 6. Application of Decision Analytic Model in Economic 
Evaluation of Centralised Emergency Medical Care 
 
6.1 Introduction 
The aim of this Chapter is to describe the economic evaluation of centralised 
specialised emergency medical service compared with those provided at local 
hospitals in a UK setting. The Chapter addresses the third and fourth research 
questions set out in Chapter 1. Chapter 2 systematically reviewed and discussed the 
economic evaluation methods used in assessing the centralisation of specialised 
health care services. Chapter 5 described the development of an economic 
evaluation model with an emphasis on a decision analytic model framework. 
Chapters 2 and 5 informed the development and conceptualisation of economic 
evaluation reported in this Chapter. Many of the approaches described in Chapter 5 
are used in this Chapter. 
 
The Chapter first describes the use of the decision analytic framework to conduct the 
economic evaluation of centralised provision of emergency medical care compared 
with the local provision and then presents the summary of the results. The rest of the 
Chapter is structured as follows: section 6.2 describes the economic evaluation 
model development, section 6.3 describes what additional analysis were considered, 
section 6.4 presents the results, section 6.5 discusses the findings highlighting some 
major strengths and limitations of the study and this is followed by the conclusions 
which are reported in section 6.6. 
 
6.2 Model Development 
This section describes the use of economic evaluation techniques to build the model. 
The model conceptualisation and development adhered to a practical guide to 
Markov models in decision-making (Sonnenberg and Beck, 1993) and the guidelines 
and practices outlined by ISPOR-SMDM Task Force on Modelling Good Research 
Practices (Caro et al., 2012; Roberts et al., 2012; Siebert et al., 2012). 
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6.2.1  Alternatives compared 
The concentration of care into specialised centres is one of the new care models 
suggested by the “Five year forward view” in NHS England (NHS England, 2014). 
Furthermore, Sir Bruce Keogh also recommended the centralisation of emergency 
medical services into specialised units providing efficient and high quality care to 
those with serious and life threatening conditions (NHS England, 2013a). Grounded 
on these recommendations, a new specialised emergency care hospital was built at 
Cramlington in Northumberland, the first of its kind in the UK, with the aim to provide 
improved quality of care by providing faster access to consultants and diagnostics 
(O'Neill et al., 2017). Before June 2015, the emergency medical services were 
provided from the A&E departments at three general hospitals within the area: North 
Tyneside, Wansbeck and Hexham. All of these hospitals are operated by 
Northumbria Healthcare NHS Foundation Trust and they accounted for 90% of all 
A&E visits by the population of Northumberland (O'Neill et al., 2017). The emergency 
care provided by the three general hospitals was centralised into the new specialised 
hospital. Although this represents a major system change, the cost and effectiveness 
of the change was not known. Therefore, the aim of the economic evaluation 
described in this Chapter is to assess the impact of these changes on A&E service 
provision in Northumberland. Thus, the emergency medical services provided at 
centralised specialised emergency hospital is compared to those at the general 
hospitals. From here on, in this Chapter, emergency medical services provided at the 
centralised specialised emergency hospital will be referred as “central hospital” (i.e. 
intervention) and those at the local general hospitals as “local hospital” (i.e. control). 
 
6.2.2 Choice of the model 
As stated in Chapter 5, a mixture of economic evaluation approaches with within trial 
economic evaluation supporting wider secondary evidence in the decision analytic 
model would be most beneficial (Sculpher et al., 2006). However, considering the 
nature of centralised care a trial comparing centralisation with non-centralised care 
would not be feasible. Costs and effectiveness of centralisation of healthcare 
services is a much debated topic as discussed in Chapter 1 and these are often not 
known with certainty. As described in Chapter 5, decision analytic models are 
established framework used to inform decision-making under conditions of 
uncertainty. Therefore, in the context of uncertainties in costs and outcomes, an 
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economic evaluation based on a decision analytic model was considered the most 
appropriate approach in assessing the costs and effects of centralisation of 
emergency medical services. 
 
Common variations in the decision analytic model structures, their strengths and 
limitations are described in Chapter 5. Decision trees were not appropriate in 
assessing centralisation of emergency hospitals because of difficulties in 
incorporating time dependency and complexity in modelling interventions with shorter 
cycle lengths over a long time horizon (Briggs et al., 2006; Petrou and Gray, 2011b). 
The patients attending the emergency hospitals were regarded independent of each 
other and absence of interaction between patients ruled out the need to use dynamic 
models or discrete event simulation with interaction. Thus, the decision analytic 
model alternatives left for the work described in this Chapter were either a Markov 
(cohort) model or a patient level simulation. Patient level simulation offers several 
advantages over a Markov model as they allow accumulation of individual patient 
history to determine transitions between states, costs and health outcomes (Briggs et 
al., 2006). However, the benefits of a patient level simulation can be outweighed by 
the parametrisation and computational burden it requires compared to a Markov 
model. Therefore, given the nature of the decision problem the model is seeking to 
inform and the relative simplicity and transparency of the Markov model compared to 
the patient level simulation, a Markov modelling approach was adopted. The choice 
of Markov model is further supported by existing literature which argue that the 
substantially increased analytic input for the patient level simulation compared to a 
Markov model may not have any impact on ultimate decisions (Karnon, 2003; Griffin 
et al., 2007). 
 
6.2.3 Markov model structure 
The Markov model seeks to represent the patient care pathways in emergency 
healthcare need. The Markov model structure is depicted in Figure 6.1 and consisted 
of four possible states: Community, A&E, Admission and Dead. These states, 
defined in Table 6.1, closely represented the pathways of emergency patients in NHS 
England. In Figure 6.1, the ovals represent the Markov states and the arrows 
represent the possible transitions from one state to another. The arrows leading to 
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the state itself indicate the possibility that the patient may remain in the same state in 
the consecutive cycles. These Markov states are mutually exclusive which means 
that at a certain time point a patient can be only in one state. A hypothetical cohort of 
1000 patients were modelled with changes between states depending on the 
transition probabilities between the Markov states. In both the central and local 
hospitals the following transition between states were possible at the end of each 
Markov cycle: 
 Patients in the community state can either transit to A&E state or 
remain in their current state or die. 
 Patients in the A&E state either get discharged back into the 
community or get admitted or die. Patients were not expected to 
stay in the A&E at the end of each cycle. This reflected the 
current provisions in the NHS where patients attending the A&E 
either get discharged or get admitted or declared dead (if they 
die in the A&E). 
 Patients in the admission state either get discharged or continue 
to be admitted or die. 
 Death is the absorbing state of the model and patients who die 
remain in the dead state until the model terminates. 
 
 
Figure 6.1: The Markov model 
 
 
Community 
A&E Admission 
Dead 
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Table 6.1: Definition of states in the Markov model 
Markov state Description 
Community This is the usual place of residence of the patients. 
A&E This is the Accident and Emergency (A&E) department of the 
hospital that patients visit in the event of emergency health care 
need. 
Admission This is where patients are admitted in the hospital after visiting 
the A&E department for the treatment. 
Dead This is the dead state and is the absorbing state of the model. 
 
6.2.4 Time horizon 
The model employed a 10 year time horizon. However, the cost and outcomes were 
estimated for three different time points of 30 days, one year and 10 years. The first 
30 days was modelled to generate the most precise estimates of the costs and 
outcomes of centralisation of emergency medical service. One year and 10 years 
were employed to project the relevant costs and outcomes over a longer period of 
time. The 10 year time horizon was deemed sufficient to capture the relevant long 
term costs and outcomes of the two models of emergency hospitals compared in this 
thesis. 
 
6.2.5 Cycle length 
Two different cycle lengths were used. A cycle length of one day was used for the 
first 30 days of the model. One day cycles were considered to capture better 
approximate the costs and outcomes occurring within one month. Thereby reflecting 
the NHS indicator of quality of healthcare service provided by hospitals. For the 
remainder of the 10 year time horizon cycle length of one-months (i.e. 30 days) were 
fitted and hence there were 119 monthly cycles in the model. The monthly cycles 
were used to reduce the complexity of the model that would have resulted had one 
day cycle lengths been used for the entire 10 years. Nevertheless, the first monthly 
cycle was accounted for by the costs and outcomes in the 30 days model. The non-
homogenous cycle lengths in the entire model was accounted for by adjusting the 
corresponding model input parameters of transition probabilities and costs. The 
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proportion of patients in each state at the end of 30 daily cycles were used to 
populate the model states in the first monthly cycle (i.e. after 30 days). 
 
6.2.6 Model parameters 
The parameters used to populate the Markov model were transition probabilities 
between the Markov states, and the costs and utilities attributed to each Markov 
state. The transition probabilities used in the local hospital and the central hospital 
are reported in Appendix C, Tables C1 and C2 respectively. The unit costs 
considered in both the models are reported in Table 6.3 and the utilities are in Table 
6.4. The approaches used to derive these model parameters are described as 
follows. 
 
6.2.6.1 Transition probabilities 
The transition probabilities for both the local and central hospitals were derived from 
the Hospital Episode Statistics (HES) (Health and Social Care Information Centre, 
2015) of consecutive patients attending the emergency department (ED). Caldicott 
approval was in place for the ethical use of HES patient data (Appendix B-B3 & 
B4).The cases without a local postcode were removed because it was considered 
unlikely that they would have had a future chance for a readmission. In addition, 
patients aged 18 years or younger were removed as it was believed that there would 
be a different nature of healthcare issues and resource utilisation in this age group. 
The data for the local hospital comprised 230,669 HES records of patients attending 
the A&E services of three general hospitals-North Tyneside, Wansbeck and Hexham 
between 1 January 2010 and 31 May 2015. The data for the central hospital 
comprised of 52,721 HES records of patients attending the specialised emergency 
care hospital in Cramlington, Northumberland in between 16 July 2015 and 30 
September 2016. All of these hospitals belong to the Northumbria Health Care NHS 
Foundation Trust (NHCT) in North East England. 
The characteristics of patients are presented in Table 6.2. 
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Table 6.2: Characteristics of patients used to derive transition probabilities in 
the local and central hospital 
Patient Characteristics Local 
hospital 
Central 
hospital Mean Age (SE)  62.12 (0.045) 63.97 (0.087) 
Male (%) 43.04 45.54 
Female (%) 56.96 54.46 
   
Age groups (%)   
<=29  10.83 7.67 
30-64 36.37 36.57 
65+ 52.80 55.77 
   
IMD Quintiles (%)   
Missing 3.20 4.48 
1st (<=8.49)  14.03 13.88 
2nd(8.5-13.79) 14.93 15.00 
3rd (13.8-21.35) 17.26 17.78 
4th (21.36-34.17) 24.07 23.61 
5th (>=34.18) 26.51 25.24 
   
CCI (%)   
0 51.54 44.79 
1 24.21 25.09 
2 9.95 12.14 
3 4.42 5.42 
>=4 9.88 12.56 
   
Primary Diagnosis (ICD10 Classification) (%)   
Missing Information 0.01 1.23 
Certain infectious and parasitic diseases 2.78 3.65 
Neoplasms 2.97 3.25 
Diseases of blood or blood forming organs 0.92 0.87 
Endocrine, nutritional and metabolic disease 2.07 2.48 
Mental and behavioural disorders 2.58 2.11 
Diseases of the nervous system 3.39 3.56 
Diseases of the eye and adnexa 0.23 0.19 
Diseases of the ear and mastoid 0.28 0.32 
Diseases of the circulatory system 11.02 11.32 
Diseases of the respiratory system 11.88 11.89 
Diseases of the digestive system 10.14 10.89 
Diseases of skin and subcutaneous tissue 2.21 3.45 
Diseases of musculo-skeletal system 6.42 7.39 
Diseases of genito-urinary system 6.89 6.52 
Pregnancy, child birth, puerperium 4.29 0.94 
Conditions originating from puerperium 0.00 0.00 
Congenital malformations 0.02 0.06 
Abnormal clinical laboratory findings 17.42 16.46 
Injury, poisoning and certain consequences 14.00 12.91 
External causes of morbidity (falls, accidents) 0.00 0.00 
Factors influencing health status 0.49 0.50 
SE= Standard error; IMD= Index of mean deprivation; CCI= Charlson’s comorbidity index 
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Transition probabilities were derived using survival analysis to model “time to event” 
where the event was the movement out of a state. Patients were only included in the 
survival analysis if they had a record of date of A&E attendance and discharge or 
death. A parametric model with a weibull distribution was used and any competing 
risks (events) were accounted for. The AIC for weibull distribution indicated a better 
model fit compared to other distributions that were applicable. Survival analysis, 
distributions used, approaches for assessing suitability of the distributions and the 
impact of not accounting for competing risks are described in section 5.4.4 in Chapter 
5. Separate survival analysis models were run for community and admission states. 
In the survival analysis conducted for the community state, the maximum follow-up 
time for the re-attendance of the A&E department and death in the community was 
28 days. Death in the community was the competing event for re-attendance and 
vice versa. The transition probabilities were then estimated from these data for the 
first 30 days. The follow-up time of 28 days reflected the indicator of hospital care 
quality in the NHS. Multiple re-attendances were considered in the survival analysis 
and the previous discharge was considered the index case for any re-attendance 
within 28 days of a previous discharge from hospital. In the survival analysis for the 
admission state, the maximum follow-up time for any discharge from hospital and 
death in the hospital was 60 days. Death whilst in the hospital was the competing 
event for discharge back into the community and vice versa. The follow-up time of 60 
days was arbitrarily taken. Such an approach of setting a follow-up time in survival 
analysis for competing events is common in existing literature (Brock et al., 
2011).The transition probabilities out of admission state were generated for the first 
30 days. 
 
The flexsurv package was used as a platform for parametric survival modelling in R 
(Jackson, 2016; R Core Team, 2016). Transition probabilities were time dependent 
and varied with the number of days passed in the daily cycles of the Markov model. 
However, it was assumed that the transition probabilities after the first 30 days (i.e. 
the monthly cycles) did not change with time. The transition probabilities are reported 
in Appendix C, Tables C1 and C2. 
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Survival analysis was not used for the computation of transition probabilities out of 
A&E state. The patients in the A&E state were discharged or admitted or die on the 
same day which meant the length of stay in the A&E state was less than one day. 
Therefore, the proportions were used as transition probabilities of patients moving 
out of A&E state to community, admission and dead state. Transition probabilities 
from A&E state were not time dependent. 
 
6.2.6.2 Costs 
Each Markov state was assigned a value that reflected the cost of being in that state 
in each cycle. The perspective of analysis was that of the NHS and therefore did not 
include any costs falling on the patients. The cost components included in the model 
were cost of ambulance journey to the hospital, cost of A&E attendance and cost of 
hospital admission. The costs after discharge from the hospital or death were not 
considered in the model and were assumed zero. The costs of nursing staff and 
other healthcare professionals were not accounted for separately, since it was 
assumed that these costs were included in the unit costs for A&E and admission 
state. In addition, the cost of additional consultant time was included in the central 
hospital. However, this assumption of additional consultant costs was investigated in 
the sensitivity analysis (described later in this Chapter) examining how the results 
look like if costs of additional specialised consultant was not included in the central 
hospital. The resource utilisation and the cost components considered in the model 
were derived as follows: 
 
 Ambulance journey time was considered as the time taken to drive via the fastest 
route between the patient postcode and hospital postcode. The postcodes were 
taken from the HES records of patients attending the hospital A&E services. The 
driving times between the patient and hospital postcodes were computed using 
the Google Maps Geocoding API and XML package in R (R Core Team, 2016). 
The mean travel times were derived for each hospital model from the journey 
times of HES records of patients used in this Chapter. Journeys for repeated 
attendances of patients were accounted for in the mean travel time. The cost per 
minute of ambulance journey obtained from secondary literature (Curtis, 2008) 
was then applied to the mean travel time for each of the hospital model to 
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generate the mean cost of ambulance journeys to the hospital. The cost per 
minute of ambulance journey was reported to account for the overheads and 
management costs, buildings and land, ambulance and equipment, and 
ambulance crew salaries and wages (Curtis, 2008). 
 
 Cost of A&E attendance was the cost of one event of A&E attendance and was 
taken from a secondary source (Curtis, 2010). The cost of mean ambulance 
journey was added to the cost of A&E attendance to obtain the total cost of A&E 
state in the model. Only the costs for ambulance travel into the hospital was 
considered. It was assumed that patient travelled privately after they got 
discharged from the hospital and no costs of travel after discharge were 
considered from the NHS perspective. 
 
 Cost of hospital admission was the cost per day of individual stay in the hospital 
and was taken from a secondary source (Curtis, 2010). 
 
Table 6.3: Cost parameters used in the models 
Resource  Unit (95% Confidence Interval) Reference 
 Local hospital Central hospital  
Mean travel time to the 
A&E 
14.41 min 
(14.36-14.88) 
19.55 min 
(19.43-19.67) 
Estimated from HES data 
Cost per minute of 
ambulance journey 
£8.18 £8.18 PSSRU 2008 
Cost of mean travel 
time to the A&E 
£117.87  
(117.49-118.26) 
£159.92  
(158.97-160.87) 
Product of mean travel time 
and cost per minute 
ambulance journey 
Cost per attendance of 
A&E 
£115.01 
(90.11-132.8) 
£115.01 
(90.11-132.8) 
PSSRU 2010 
Cost per day admitted 
in the hospital 
£155.32 
 (112.64-177.85) 
£155.32  
(112.64-177.85) 
PSSRU 2010 
Cost per day in the 
community 
0 0 Assumed 
Cost per 20 minutes 
time of emergency 
medicine consultant 
0 £35.67 PSSRU 2016/17- assumed 
same as consultant-
surgical and computed 
from £107 per hour cost 
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Costs derived were considered as per day costs and were applied in the daily cycles 
of the Markov model. The costs for the 30 day cycles were computed as thirty times 
the costs in the daily cycles. However, the A&E state costs used in the daily cycles 
were constant throughout the model because it was expected that patients attend the 
A&E for less than a day and the time they spent in the A&E state always remained 
the same. 
 
Costs are expressed in 2016/17 UK sterling (GBP, £). Wherever unit costs were only 
available from previous years, were inflated to the price year 2016/17 using the 
hospital and community health services (HCHS) pay and price inflation indices 
(Curtis and Burns, 2017). 
 
6.2.6.3 Utilities 
Health utility weights were attached to each Markov states. The utilities were derived 
from the published literature (Sullivan et al., 2011; Goodacre et al., 2012). The 
utilities for A&E state and admission state were assumed to be same. The utility for 
the dead state was assumed zero. Table 6.4 presents the utility values used in the 
model. 
 
Table 6.4: Utility values associated with each state in the model 
Markov state Utility value SE* Reference 
A&E 0.45 0.006 Goodacre et al 2012 
Admission 0.45 0.006 Goodacre et al 2012 
Community 0.828 0.0015 Sullivan et al 2011 
Dead 0 0 Assumed 
*SE=standard error 
 
Utility estimates were used to generate the Quality Adjusted Life Years (QALY) 
estimates in each state of the alternatives compared. In the daily cycles, the utility 
estimates for each state were converted to daily QALYs by dividing the value by 
365.25. In the monthly cycles, these daily QALYS were multiplied by 30 to generate 
the monthly estimates of QALYs (please note that use of 30 days in a month will only 
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add up as 360 days in a year, a limitation in the calculation but one that affects both 
comparators). However, in the A&E state the QALYs used in the daily cycles 
remained the same for the monthly cycles because it was expected that patients 
attend the A&E for less than a day and the time they spent in the A&E state always 
remained the same throughout the model. 
 
6.2.7 Model outcomes 
The outcomes considered in the model were “cost per QALY gained” and “cost per 
death averted”. Total QALYs were calculated for each state by multiplying the cohort 
in each state in each cycle with the respective QALY for each patient in the state. 
Total costs were calculated in the same way as a product of cohort and costs 
associated in each state. Total mortality in each cycle was calculated as the number 
of people who die after the end of the cycle. Separate calculations were conducted 
for central and local hospital models. 
 
6.3 Analysis  
Cost-effectiveness analysis was carried out as the incremental cost per QALY gained 
and incremental cost per death averted at 30 days, one year and 10 years. These 
were calculated as the difference in total costs in the central hospital and local 
hospital divided by the difference in QALYs or death averted. The following 
approaches were considered in the analysis. 
 
6.3.1 Discounting 
The costs and outcomes (QALYs and deaths) after the first year were discounted at 
3.5% as recommended by NICE (National Institute for Health and Care Excellence, 
2014). 
 
6.3.2 Half cycle correction 
It was uncertain when the transitions happen within the cycles in the model. 
Therefore, a half-cycle correction was employed in the first and final cycle of the 
model as a recommended best practice (Siebert et al., 2012). 
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6.3.3 Handling uncertainties and heterogeneity 
Assessments of uncertainties and heterogeneity in the model parameters were 
incorporated in the analysis. The following approaches were considered to assess 
the impact of uncertainties and heterogeneity on the model outcomes. 
 
6.3.3.1 One-way sensitivity analysis 
One way sensitivity analysis was conducted to assess the consequence of not 
considering an additional costs of consultant service in the central hospital. In 
addition, one way sensitivity analysis was also conducted to assess the impacts of 
discounting the costs and outcomes at 1.5% and 5%. NICE recommends conducting 
a sensitivity analysis on discounting the costs and outcomes at a lower rate of 1.5% 
(National Institute for Health and Care Excellence, 2014). One-way sensitivity 
analysis was not considered for utility estimates used in the model because of the 
negligible standard error figures in the utility data available. Likewise, one-way 
sensitivity analysis was not considered for the transition probabilities used, as 
imprecision was captured using PSA as described below. 
 
6.3.3.2 Probabilistic sensitivity analysis 
PSA, defined in Chapter 5, was carried out to determine the impact of the uncertainty 
surrounding the model input parameters i.e. transition probabilities, costs and utilities. 
Distributions were fitted to all the input parameters of the model and 10,000 
simulations were run, with each simulation picking up random values from each 
distribution and generating the cost-effectiveness results. Transition probabilities 
were assigned the dirichlet distribution however the transition probabilities of moving 
out of the A&E state which were derived as proportions were assigned the beta 
distributions. Utilities were assigned beta distribution and costs the gamma 
distribution. The cost-effectiveness plane and the CEAC were used to present results 
of PSA at 30 days, one year and 10 years. The distributions for costs, utility and 
transition probabilities were estimated using the alpha and beta parameters 
generated using the formula described in section 5.4.5 of Chapter 5. 
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6.3.3.3 Value of information analysis  
VOI analysis was carried out at 10 years (i.e. at the end of the time horizon set for 
the cost-effectiveness model) as described in section 5.4.6 in Chapter 5. VOI 
analysis is expected to establish whether further research is warranted considering 
the uncertainties surrounding the cost-effectiveness results.  
 
6.3.3.4 Scenario analysis/ modelling heterogeneity 
Scenarios analysis was conducted to account for any impact of heterogeneity in the 
patient characteristics in both the central and local hospitals. Scenario analysis and 
heterogeneity are described in section 5.4.5 in Chapter 5. The analysis was run 
repeatedly using the same starting cohort but each time with specific model 
parameters accounting for each of the patient characteristics. The patient 
characteristics considered in the scenario analysis were gender (male and female), 
age (≤ 29 years, 30-64 years, 65+), Charlson’s Comorbidity Index (CCI) (CCI=0, 
CCI≥4), Index of Mean Deprivation (IMD) (least deprived quintile i.e. ≤8.49 and most 
deprived quintile i.e.≥ 34.18) and according to some ICD 10 primary diagnosis 
classifications (diseases of the circulatory system, diseases of respiratory system, 
diseases of the digestive system, abnormal clinical laboratory findings, injury 
poisoning and certain consequences) with which the patients attended the 
emergency. These patient sub-groups were considered in the scenario analysis 
because it was expected that any differences in their characteristics could influence 
the resource utilisations and ultimately the model outcomes. 
 
The transition probabilities varied with the sub-groups. These transition probabilities 
for each sub-groups were estimated using the same methods for the base case 
models described in section 6.2.6.1. The cost parameters were assumed to remain 
the same across the scenarios. However, the cost of ambulance journey to the A&E 
varied in each sub-group because of the differences in the mean travel times to the 
hospital in each sub-group, which in turn led to the differences in the costs used in 
the A&E state of the model. Where available from secondary sources, the utility 
values for each state in each of the sub-group models were also varied. However, in 
the instances where utility estimates were not available for a particular sub-group, 
these were assumed to be the same as the ones used in the base case models. The 
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parameters used in the sub-group models are in Appendix C of this thesis. 
Deterministic estimates of cost-effectiveness were generated for each scenario 
analysed. PSA was also carried out for each sub-group considered in this economic 
evaluation and followed the same approach as described in section 6.3.3.2. Multiple 
CEACs were produced for each sub-group, where the probability of central hospital 
model being cost-effective was plotted against the willingness to pay (WTP) 
threshold. 
 
6.3.4 Incorporating DCE results into the economic evaluation 
This Chapter also looked into methods of incorporating the results of the DCE 
described in Chapter 4 into the economic evaluation. Whilst DCEs are widely used in 
health economics to elicit preferences, the application of these preferences values 
into economic evaluations is limited (de Bekker-Grob et al., 2015). Terris-Prestholt 
and colleagues showed that in the absence of observed uptake data DCE can be 
used in parameterising user uptake in economic evaluations (Terris-Prestholt et al., 
2016). Furthermore, in a recent systematic review and meta-analysis DCEs are 
reported to provide reasonable predictions of health-related behaviours outside of 
experimental context (Quaife et al., 2018). However, only a few studies have 
attempted to apply the monetary values in terms of WTP estimates from a DCE 
within an economic evaluation in the form of cost-benefit analysis (Vale, 2005; Petrou 
and McIntosh, 2009; van der Pol et al., 2010; Burr et al., 2012; Tinelli et al., 2016). It 
was not possible to generate the WTP monetary values for the hospital models 
assessed in this Chapter because cost was not included as an attribute in the DCE 
for reasons explained in Chapter 4. Nevertheless, the travel time was used as a 
proxy for costs and marginal willingness to travel were converted to marginal WTP 
using the average weekly earnings and average weekly hours worked in the UK 
(Office for National Statistics, 2018a). Hence, a cost-benefit analysis was conducted 
using the marginal WTP value estimates derived from marginal willingness to travel 
results from the DCE in Chapter 4. 
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6.4 Results 
 
6.4.1 Base case analysis 
The results of the base-case analysis showed that in all of the time points i.e. 30 
days, one year and 10 years assessed the central hospital was more costly and more 
effective compared to the local hospital. However, at 30 days, both the deterministic 
(£32,730 per QALY gained) and probabilistic (£31,338 per QALY gained) estimates 
of ICER were above the £20,000 to £30,000 per QALY gained benchmark used in 
England and Wales (National Institute for Health and Care Excellence, 2013). Hence, 
the results at 30 days suggested that the central hospital was on average not a cost-
effective alternative to local hospital. Nevertheless, the ICER estimates for one year 
and 10 years were well below the £20,000 to £30,000 per QALY gained benchmark 
set by NICE and suggested that the central hospital may be a cost-effective 
alternative compared to the local hospital. The results also indicated that there were 
fewer deaths (which were generally consistent over time) in the central hospital 
compared to the local hospital. Therefore, the results suggested that the central 
hospital saved lives and produced more QALYs compared to the local hospital. A 
detail breakdown of the deterministic and probabilistic estimates of incremental costs, 
incremental QALYs and mortality averted observed in the base case analysis is 
presented in Table 6.5. The results reflect that the cost-effectiveness of the central 
hospital increases in the long term and supports any decisions to adopt it from the 
NHS perspective. 
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Table 6.5: Results of cost-effectiveness analysis: central hospital minus local 
hospital 
Time Horizon Incremental 
cost (£) 
Difference 
total 
death 
Incremental 
QALYs 
Incremental 
cost (£) 
/Death 
averted 
Incremental 
cost (£) 
/QALY 
gained 
30 days      
Base case 
(deterministic) 
51,385 -26.55 1.57 1,935 32,730 
Base case 
(probabilistic) 
49,201 -26.55 1.57 1,853 31,338 
1 year      
Base case 
(deterministic) 
310,946 -31.47 310 9,881 1,004 
Base case 
(probabilistic) 
312,999 -31.43 310 9,959 1,011 
10 years      
Base case 
(deterministic) 
1,986,329 -31.57 3,123 62,918 636 
Base case 
(probabilistic) 
2,003,944 -31.60 3,121 63,416 642 
Note: Incremental cost, Difference total death and Incremental QALYs expressed as per 1000 people 
 
The overall uncertainty in the base-case analysis is presented in the form of cost-
effectiveness plane and CEAC. Figures 6.2, 6.3 and 6.4 show the CE planes at 30 
days, one year and 10 years of estimates respectively and the numbers in the cost-
effectiveness planes are expressed per 1000 people. These cost-effectiveness 
planes show the difference in QALYs against the difference in costs (central hospital 
minus local hospital). 
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Figure 6.2: Cost-effectiveness plane of central hospital vs local hospital at 30 
days (base-case analysis) 
 
These cost-effectiveness planes at 30 days, one year and 10 years show the results 
from the 10,000 simulations where the majority of the results fall in the north-east 
quadrant of the plane suggesting that the central hospital is more costly and more 
effective than the local hospital. However, a smaller portion of the results also fall in 
the south-east quadrant of the plane which also indicate the possiblity that the central 
hospital to be less costly and more effective. 
 
The uncertainty in the results at 30 days, one year and 10 years are also represented 
in the CEAC in Figures 6.5, 6.6 and 6.7 respectively. At 30 days, there is only 28% 
probability for central hospital being cost-effective at the decision-makers willingness 
to pay value of £20,000 per QALY. The CEAC in Figure 6.5 shows that both the 
models have equal probability of being cost-effective at 30 days if the decision maker 
is willing to pay around £30,000 per QALY. However, at one year and 10 years time, 
the probability of central hospital being cost-effective increases to 100% at around 
WTP £4000 per QALY. These CEACs indicated that central hospital is more likely to 
be cost-effective in the long run. 
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Figure 6.3: Cost-effectiveness plane of central hospital vs local hospital at one 
year (base-case analysis) 
 
 
 
Figure 6.4: Cost-effectiveness plane of central hospital vs local hospital at 10 
years (base-case analysis) 
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Figure 6.5: Cost-effectiveness acceptability curve for central hospital vs local 
hospital at 30 days (base-case analysis) 
 
 
Figure 6.6: Cost-effectiveness acceptability curve for central hospital vs local 
hospital at one year (base-case analysis) 
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Figure 6.7: Cost-effectiveness acceptability curve for central hospital vs local 
hospital at 10 years (base-case analysis) 
 
6.4.2 Univariate (one-way) sensitivity analysis 
The results of the one-way sensitivity analysis are presented in Table 6.6. Not 
considering the cost of consultant in the central hospital in the cost-effectiveness 
analysis, would make it dominant (i.e. cheaper and more effective than the local 
hospital) at 30 days, one year and 10 years’ time horizon. The probabilistic and 
deterministic estimates of incremental costs, incremental QALYs and mortality 
averted at were generally similar at each of the time points studied. 
 
At 10 years, discounting the costs and QALYs at 1.5% resulted in the deterministic 
estimate of ICER of £630 per QALY gained and £67,131 per death averted. When 
costs and QALYs were discounted at 5% the deterministic ICER was £641 per QALY 
gained and £60,090 per death averted. The probabilistic and deterministic estimates 
only differed by a small amount. The use of alternative discount rates also changed 
the cost-effectiveness results by a small amount. In the sensitivity analysis, the cost-
effectiveness results remained the same at 30 days and one year because 
discounting was applied only after one year time horizon. 
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Table 6.6: Results of one-way sensitivity analysis: central hospital minus local 
hospital 
Scenarios Incremental 
cost (£) 
Difference 
total 
death 
Incremental 
QALYs 
Incremental 
cost (£) 
/Death 
averted 
Incremental 
cost (£) 
/QALY 
gained 
30 days      
Not considering 
the cost of a 
consultant in the 
central hospital 
(deterministic)  
-24,232 -26.55 1.57 Dominant Dominant 
Not considering 
the cost of a 
consultant in the 
central hospital 
(probabilistic) 
-26,198 -26.56 1.57 Dominant Dominant 
1 Year      
Not considering 
the cost of a 
consultant in the 
central hospital 
(deterministic)  
-131,865 -31.47 310 Dominant Dominant 
Not considering 
the cost of a 
consultant in the 
central hospital 
(probabilistic) 
-133,298 -31.50 310 Dominant Dominant 
10 years      
Not considering 
the cost of a 
consultant in the 
central hospital 
(deterministic)  
-323,886 -31.57 3,123 Dominant Dominant 
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Table 6.6 continued: Results of one-way sensitivity analysis: central hospital 
minus local hospital 
Scenarios Incremental 
cost (£) 
Difference 
total 
death 
Incremental 
QALYs 
Incremental 
cost (£) 
/Death 
averted 
Incremental 
cost (£) 
/QALY 
gained 
Not considering 
the cost of a 
consultant in the 
central hospital 
(probabilistic) 
-324,483 -31.78 3,132 Dominant Dominant 
Costs & QALYs 
discounted at 
1.5% 
(deterministic) 
2,119,335 
 
-31.57 
 
3,365 
 
67,131 630 
Costs & QALYs 
discounted at 
1.5% 
(probabilistic) 
1,871,119 
 
-31.54 
 
2,955 
 
59,325 633 
Costs & QALYs 
discounted at 5% 
(deterministic) 
1,897,026 
 
-31.57 
 
2,960 
 
60,090 641 
Costs & QALYs 
discounted at 5% 
(probabilistic) 
1,886,049 
 
-31.70 
 
2,964 
 
59,497 636 
Note: Incremental cost, Difference in total death and Incremental QALYs expressed as per 1000 people; QALY: Quality 
adjusted life year 
 
6.4.3 Modelling heterogeneity 
The probabilistic and deterministic incremental cost per death averted and 
incremental cost per QALY gained for various sub-groups analysed at 30 days, one 
year and 10 years are presented in Tables 6.7, 6.8 and 6.9 respectively. Only the 
deterministic cost-effectiveness estimates are presented for the sub-group of age 29 
or less because for this group there was hardly any uncertainty in the transition 
probabilities (standard error was almost equivalent to zero) which did not allow for 
the computation of distributions needed for probabilistic analysis. 
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Table 6.7 presents the cost-effectiveness results in the sub-groups at 30 days. In 
those aged 65 or over, the probabilistic cost-effectiveness analysis showed that the 
central hospital is dominant (less costly and more effective in terms of deaths averted 
and QALY gained) over the local hospital. But the deterministic estimates showed 
that incremental cost per death averted and incremental cost per QALY gained for 
age group 65 and over was £792 and £14,443 respectively. However, both the 
deterministic and probabilistic results in the age-group of 30-64 indicate that the 
central hospital was more costly and had more deaths and therefore was dominated 
by the local hospital which was cheaper and had fewer deaths. Furthermore, the 
incremental cost per QALY in the age group 30-64 was well above the £20,000-
£30,000 threshold set by NICE. 
 
Among the sub-groups assessed, age group 29 or less had the lowest deterministic 
estimates of incremental cost per death averted (£559) and incremental cost per 
QALY gained (£13,468). Both the deterministic and probabilistic estimates in the 
group with diseases of the circulatory system showed that the central hospital was 
the dominant alternative. The deterministic and probabilistic estimates of incremental 
cost per QALY gained for sub-groups IMD 5th quintile, CCI0 and CCI4 were below 
the £30,000 threshold. Both the deterministic and probabilistic estimates in terms of 
incremental cost per death averted for all sub-groups analysed were lower than the 
£30,000. The cost-effectiveness estimates in the males and females were somewhat 
similar but males had a higher ICER. These results suggest that the cost-
effectiveness of central hospital at 30 days could be possibly higher in those aged 65 
and over, those who are most deprived, those with diseases of the circulatory 
diseases and those presenting with a greater number of co-morbidities. 
 
At one year, the cost-effectiveness in the sub-groups improved in general (Table 
6.8). The central hospital was no longer a dominant alternative in the age group 65 
and over. However, both the deterministic and probabilistic estimates of the 
incremental cost per death averted and incremental cost per QALY gained were low. 
With the deterministic estimates of incremental cost of £443 per QALY gained and 
£4,167 per death averted, the age group 29 or less had the lowest incremental cost-
effectiveness ratio (ICER). In the age group 30-34, central hospital was still 
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dominated by the local hospital (more expensive and less beneficial compared to the 
local hospital) in terms of incremental cost per death averted. Nevertheless, the 
incremental cost per QALY gained was £15,963 (deterministic estimate) and £15,589 
(probabilistic estimate) were much lower than £226,250 (deterministic estimate) and 
£155,935 (probabilistic estimate) observed at 30 days. Both the deterministic and 
probabilistic estimates in the group with diseases of the circulatory system continued 
to show that the central hospital was the dominant alternative. The incremental costs 
per QALY gained (both for the deterministic and probabilistic analyses) for sub-
groups of IMD 5th quintile, CCI0, CCI4 and age 65 years and over were much lower 
than the £20,000- £30,000 threshold. 
 
Table 6.7: Results of sub-group analysis at 30 days: central hospital minus 
local hospital 
Scenarios Incremental 
cost (£) 
Difference 
total 
death 
Incremental 
QALYs 
Incremental 
cost (£) 
/Death 
averted 
Incremental 
cost (£) 
/QALY 
gained 
Male (deterministic) 41,987 -15.83 1.23 2,652 34,136 
Male (probabilistic) 42,330 -15.84 1.23 2,672 34,415 
Female (deterministic) 54,248 -23.75 1.52 2,284 35,689 
Female (probabilistic) 54,652 -23.75 1.52 2,301 35,955 
Age <=29 
(deterministic) 
25,724 -46.05 1.91 559 13,468 
Age 30-64 
(deterministic) 
70,137 0.47 0.31 Dominated 226,250 
Age 30-64 
(probabilistic) 
70,171 0.32 0.45 Dominated 155,935 
Age 65+ (deterministic) 32,496 -41.02 2.25 792 14,443 
Age 65+ (probabilistic) -9,923 -41 2.25 Dominant Dominant 
IMD 1 (deterministic) 54,024 -14.38 1.19 3,757 45,398 
IMD 1 (probabilistic) 54,185 -14.48 1.2 3,742 45,154 
IMD 5 (deterministic) 63,661 -72.68 2.99 876 21,291 
IMD 5 (probabilistic) 63,742 -72.66 2.99 877 21,318 
CCI 0 (deterministic) 35,204 -22.17 1.25 1,588 28,164 
CCI 0 (probabilistic) 35,526 -22.15 1.25 1,604 28,421 
 Table Continued 
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Table 6.7 continued: Results of sub-group analysis at 30 days: central hospital 
minus local hospital 
Scenarios Incremental 
cost (£) 
Difference 
total 
death 
Incremental 
QALYs 
Incremental 
cost (£) 
/Death 
averted 
Incremental 
cost (£) 
/QALY 
gained 
CCI4 (deterministic) 61,659 -54.47 3.62 1,132 17,033 
CCI4 (probabilistic) 61,425 -54.49 3.62 1,127 16,968 
Circulatory 
(deterministic) 
-17,311 -32.28 2.24 Dominant Dominant 
Circulatory 
(probabilistic) 
-17,292 -32.31 2.24 Dominant Dominant 
Respiratory 
(deterministic) 
89,681 -51.26 2.70 1,750 33,215 
Respiratory 
(probabilistic) 
89,718 -51.27 2.71 1,750 33,106 
Digestive 
(deterministic) 
157,217 -42.41 1.62 3,707 97,047 
Digestive (probabilistic) 157,244 -42.43 1.62 3,706 97,064 
Abnormal 
(deterministic) 
33,110 -5.19 0.78 6,380 42,449 
Abnormal 
(probabilistic) 
32,481 -5.26 0.78 6,175 41,642 
Injury (deterministic) 104,746 -3.59 0.47 29,177 222,863 
Injury (probabilistic) 104,976 -3.56 0.47 29,488 223,352 
Note: Incremental cost, Difference total death and Incremental QALYs expressed as per 1000 people; QALY: Quality adjusted 
life year; IMD1: Index of mean deprivation 1st quintile; IMD5: Index of mean deprivation 5th quintile; CCI0: Charlson’s co-
morbidity index=0; CCI4: Charlson’s co-morbidity index>=4; Circulatory: diseases of the circulatory system; Respiratory: 
diseases of respiratory system; Digestive: diseases of the digestive system; Abnormal: abnormal clinical laboratory findings; 
Injury: injury poisoning and certain consequences 
 
At one year, the incremental costs per death averted were higher and the 
incremental QALYs were lower compared to those at 30 days. Age group 29 or less 
continued to have lowest deterministic ICER (excluding the scenarios where 
intervention was dominant) among the sub-groups. The ICER for males and females 
were generally similar but males still had higher incremental cost per death averted. 
However, the incremental cost per QALY gained were lower in males compared with 
females. The ICER in the sub-group IMD5 was lower compared to that of sub-group 
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IMD1 and it was higher in the sub-group CCI4 compared to the CCI0. This suggests 
that the central hospital is more cost-effective in the more deprived populations 
compared to the less deprived. Nevertheless, the central hospital appears to be less 
cost-effective for those with higher number of Charlson’s co-morbidities compared to 
those with zero Charlson’s co-morbidities. Among the disease groups, the central 
hospital was most cost-effective (where central hospital was dominant) in the sub-
group of “diseases of circulatory system” and the least cost-effective in the “injury 
poisoning and certain consequences”. 
 
The cost-effectiveness results of sub-group analysis at 10 years are presented in 
Table 6.9. The analysis showed that central hospital was dominated (more costly and 
less effective) by the local hospital in the sub-groups of age 30-64 years and for 
those belonging to the group “injury, poisoning and certain consequences”. The 
central hospital was not dominant in any of the sub-groups. Nevertheless, the 
incremental costs per QALY gained in all the sub-groups were much lower than the 
£20,000 per QALY. Similar to the one year results, the ICER of males and females at 
10 years were generally similar but males still had higher incremental cost per death 
averted and a lower incremental cost per QALY gained compared to females. Those 
aged 29 year or less had the nearly half of the incremental costs per QALY gained 
(deterministic estimate) of that age group 65 years or over. The ICER in the sub-
group IMD5 was lower compared with that of sub-group IMD1 and it was higher in 
the sub-group CCI4 compared with the CCI0. At 10 years, the central hospital was no 
longer dominant over the local hospital in the sub-group of “diseases of circulatory 
system”. Among the disease groups, the incremental cost per QALY gained was 
lowest in the sub-group of “diseases of circulatory system” and was dominated by the 
local hospital in the “injury poisoning and certain consequences”. The incremental 
costs per death averted were very high at 10 years compared to those at one year, 
while the incremental costs per QALY gained were lower. It appears that the 
difference in deaths between the two models remained generally similar over time 
but the difference in costs and QALYs increased. 
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Table 6.8: Results of sub-group analysis at one year: central hospital minus 
local hospital 
Scenarios Incremental 
cost (£) 
Difference 
total 
death 
Incremental 
QALYs 
Incremental 
cost (£) 
/Death 
averted 
Incremental 
cost (£) 
/QALY 
gained 
Male (deterministic) 229,932 -17.57 207.06 13,087 1,110 
Male (probabilistic) 233,319 -17.57 206.94 13,279 1,127 
Female (deterministic) 348,692 -27.27 278.04 12,787 1,254 
Female (probabilistic) 349,298 -27.27 277.94 12,809 1,257 
Age <=29 
(deterministic) 
289,710 -69.53 654.13 4,167 443 
Age 30-64 
(deterministic) 
318,309 2.02 19.94 Dominated 15,963 
Age 30-64 
(probabilistic) 
317,089 1.98 20.34 Dominated 15,589 
Age 65+ 
(deterministic) 
240,364 -44.94 411.79 5,349 584 
Age 65+ (probabilistic) 196,270 -45 411.85 4,362 477 
IMD 1 (deterministic) 238,052 -14.60 180.29 16,305 1,320 
IMD 1 (probabilistic) 242,658 -14.78 181.36 16,418 1,338 
IMD 5 (deterministic) 511,751 -90.37 743.87 5,663 688 
IMD 5 (probabilistic) 512,342 -90.42 744.01 5,666 689 
CCI 0 (deterministic) 141,619 -29.72 306.28 4,765 462 
CCI 0 (probabilistic) 141,877 -29.68 306 4,780 464 
CCI4 (deterministic) 442,620 -43.55 423.88 10,163 1,044 
CCI4 (probabilistic) 442,176 -43.63 424.28 10,135 1,042 
Circulatory 
(deterministic) 
-66,503 -36.07 405.57 Dominant Dominant 
Circulatory 
(probabilistic) 
-67,202 -36.08 405.66 Dominant Dominant 
Respiratory 
(deterministic) 
649,545 -52.92 461.32 12,274 1,408 
Respiratory 
(probabilistic) 
646,389 -52.92 461.59 12,214 1,400 
Digestive 
(deterministic) 
856,819 -53.11 396.97 16,133 2,158 
 Table Continued 
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Table 6.8 continued: Results of sub-group analysis at one year: central hospital 
minus local hospital 
Scenarios Incremental 
cost (£) 
Difference 
total 
death 
Incremental 
QALYs 
Incremental 
cost (£) 
/Death 
averted 
Incremental 
cost (£) 
/QALY 
gained 
Digestive 
(probabilistic) 
856,681 -53.24 397.47 16,091 2,155 
Abnormal 
(deterministic) 
84,040 -5.46 127.34 15,392 660 
Abnormal 
(probabilistic) 
79,001 -5.48 128.17 14,416 616 
Injury (deterministic) 614,474 -1.22 24.05 503,667 25,550 
Injury (probabilistic) 614,514 -1.18 23.98 520,775 25,626 
Note: Incremental cost, Difference total death and Incremental QALYs expressed as per 1000 people; QALY: Quality adjusted 
life year; IMD1: Index of mean deprivation 1st quintile; IMD5: Index of mean deprivation 5th quintile; CCI0: Charlson’s co-
morbidity index=0; CCI4: Charlson’s co-morbidity index>=4; Circulatory: diseases of the circulatory system; Respiratory: 
diseases of respiratory system; Digestive: diseases of the digestive system; Abnormal: abnormal clinical laboratory findings; 
Injury: injury poisoning and certain consequences 
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Table 6.9: Results of sub-group analysis at 10 years: central hospital minus 
local hospital 
Scenarios Incremental 
cost (£) 
Difference 
total  
death 
Incremental 
QALYs 
Incremental 
cost (£) 
/Death 
averted 
Incremental 
cost (£) 
/QALY 
gained 
Male (deterministic) 1,231,406 -13.25 1,711.42 92,936 720 
Male (probabilistic) 1,250,691 -13.46 1,718.33 92,919 728 
Female (deterministic) 2,211,414 -29.39 2,781.31 75,244 795 
Female (probabilistic) 2,216,837 -29.71 2,791.12 74,616 794 
Age <=29 
(deterministic) 
3,758,917 -270.41 14,855.4 13,901 253 
Age 30-64 
(deterministic) 
1,977,480 11.37 -287.97 Dominated Dominated 
Age 30-64 
(probabilistic) 
1,971,794 10.83 -268.45 Dominated Dominated 
Age 65+ 
(deterministic) 
1,497,510 -20.23 2,992.05 74,024 500 
Age 65+ 
(probabilistic) 
1,400,130 -20.45 3,004.53 68,466 466 
IMD 1 (deterministic) 1,243,788 -10.28 1,384.90 120,991 898 
IMD 1 (probabilistic) 1,283,603 -11.53 1,437.58 111,327 893 
IMD 5 (deterministic) 4,024,245 -86.83 8,188.11 46,346 491 
IMD 5 (probabilistic) 4,036,196 -87.61 8,219.30 46,070 491 
CCI 0 (deterministic) 1,387,852 -73.38 4,765.78 18,913 291 
CCI 0 (probabilistic) 1,388,099 -73.48 4,764.13 18,891 291 
CCI4 (deterministic) 1,215,305 -1.07 1,382.26 1,135,799 879 
CCI4 (probabilistic) 1,220,507 -1.17 1,392.05 1,043,168 877 
Circulatory 
(deterministic) 
105,515.6 -25.52 3,305.43 4,135 32 
Circulatory 
(probabilistic) 
114,169.5 -26.58 3,343.64 4,295 34 
Respiratory 
(deterministic) 
2,891,465 -14.49 2,905.70 199,549 995 
Respiratory 
(probabilistic) 
2,888,883 -14.89 2,926 194,015 987 
Digestive 
(deterministic) 
6,225,723 -80.03 5,552.69 77,792 1,121 
Table Continued 
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Table 6.9 continued: Results of sub-group analysis at 10 years: central hospital 
minus local hospital 
Scenarios Incremental 
cost (£) 
Difference 
total  
death 
Incremental 
QALYs 
Incremental 
cost (£) 
/Death 
averted 
Incremental 
cost (£) 
/QALY 
gained 
Digestive 
(probabilistic) 
6,249,368 -81.58 5,607.98 76,604 1,114 
Abnormal 
(deterministic) 
435,681 -6.69 1,124.75 65,124 387 
Abnormal 
(probabilistic) 
403,306 -7.68 1,153.17 52,514 350 
Injury (deterministic) 3,670,059 10.09 -345.95 Dominated Dominated 
Injury (probabilistic) 3,679,515 8.99 -315.78 Dominated Dominated 
Note: Incremental cost, Difference total death and Incremental QALYs expressed as per 1000 people; QALY: Quality adjusted 
life year; IMD1: Index of mean deprivation 1st quintile; IMD5: Index of mean deprivation 5th quintile; CCI0: Charlson’s co-
morbidity index=0; CCI4: Charlson’s co-morbidity index>=4; Circulatory: diseases of the circulatory system; Respiratory: 
diseases of respiratory system; Digestive: diseases of the digestive system; Abnormal: abnormal clinical laboratory findings; 
Injury: injury poisoning and certain consequences 
 
For each of the sub-groups of patients, the uncertainty in the results at 30 days, one 
year and 10 years were also represented by a different CEAC. But only selected 
multiple CEACs are presented here in this Chapter and the rest are shown in 
Appendix C of this thesis. CEACs in the sub-groups allow the assessment of 
variation in cost-effectiveness results. The results in the sub-groups show that there 
is a variation in the probability of cost-effectiveness of central hospital among the 
sub-groups analysed. The CEACs for males and females were very close to each 
other in all the time points studied, however the probability that the central hospital 
would be cost-effective at £20,000 WTP value at 30 days was only 28% for male and 
22% for female (Appendix C, Figure C1), which increased to 100% for both male and 
females at one year and 10 years time (Appendix C, Figure C2 and C3). The CEAC 
for the age groups at 30 days show that at £20,000 WTP value there is about 94% 
probability that the central hospital is cost-effective in the age group of 65 or over and 
nearly 0% probability for the age group 30-64 (Appendix C, Figure C4). Furthermore, 
the cost-effectiveness probabilities were higher in the age group 65 compared to the 
age group 30-64 at 1 year and 10 years (Appendix C, Figure C5 & 6.8). The results 
show a higher probability of cost-effectiveness of central hospital model in CCI4 
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compared to CCI0 at 30 days (Appendix C, Figure C6). However, at one year and 10 
years, the probabilities of cost-effectiveness in CCI0 and CCI4 were very close to 
each other (Appendix C, Figure C7 and C8). The probabiliy that central hospital is 
cost-effective is also higher in the most deprived quintile (IMD5) compared to the 
least deprived qunitile (IMD1) (Figure C9 & C10 and Figure 6.9). However, at one 
year the probability that the central hospital is cost-effective in the IMD1 and IMD5 
were closer to each other (Appendix C, Figure C10). The probability in this two 
groups again differed at 10 years with IMD5 having higher probability of cost-
effectiveness compared to IMD1 (Figure 6.9). At 30 days, among the disease groups, 
the highest probability of cost-effectiveness for the central hospital was observed in 
the sub-group of diseases of the circulatory system and the lowest probability was 
observed in the sub-group of  injury (Appendix C, Figure C11). However, at one year, 
the CEACs in all the disease groups except the injury group were very close to each 
other (Appendix C, Figure C12). Similarly, at 10 years, the CEACs in all the disease 
groups were close to each other but this time abnormal and injury group had much 
lower probabilities of cost-effectiveness of central hospital (Figure 6.10). The CEACs 
reflect the differences in the uncertainty in cost-effectiveness of the central hospital in 
the sub-groups of patients. Therefore, considering these differences in the probability 
of cost-effectiveness of central hospital, different decisions could be made across 
different categories of patients. 
 
 
Figure 6.8: Multiple CEAC for sub-groups of age 30-64 and age 65 or over at 10 
years 
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Figure 6.9: Multiple CEAC for sub-groups of IMD1 and IMD5 at 10 years 
 
 
Figure 6.10: Multiple CEAC for sub-groups of disease at 10 years 
 
6.4.4 Value of information 
Value of information (VOI) was used to evaluate whether further research was 
necessary to support the decision-making. A description of VOI analysis can be 
found in section 5.4.6 in Chapter 5. 
 
The EVPI was calculated using the probabilities of cost-effectiveness for each central 
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ranging from 0 to £100,000. The estimates of EVPI were generated from the base-
case model. The results showed that at 10 years the EVPI per decision to treat a 
person in a central hospital at a willingness to pay threshold of £20,000 per QALY 
gained is £0. However, this result is not surprising as it is in line with the CEAC in 
Figure 6.7 which demonstrates the decision uncertainty at 10 years. At £20,000 WTP 
per QALY gained, the probability that a central hospital was cost-effective was 100%. 
Therefore, it is reasonable to get the EVPI value of 0 when there is 0% probability 
that the central hospital will not be cost-effective at 10 years at £20,000 per QALY 
gained. In this case, it suggests that existing information can be regarded as 
sufficient to support the decision to adopt the central hospital. Given this finding, 
estimation of population EVPI, EVPPI or EVSI was not relevant. 
 
6.4.5 Cost benefit analysis 
The marginal willingness to travel estimates from the DCE in Chapter 4 were used as 
the proxy for marginal willingness to pay estimates to carry out the cost-benefit 
analysis. As of figures released on 17 April 2018, the average weekly hours worked 
in the UK is 37.2 and the average weekly earnings is £513 (Office for National 
Statistics, 2018a). Therefore, the earnings per working minute is calculated as £0.23 
(i.e. £13.79 per hour). In Chapter 4, Table 4.9 shows that the respondents were 
willing to travel 37.88 minutes (model 1A) for 1 in 100 person reduction in mortality. 
Thus, this translates to the WTP value of £8.71 (i.e. 37.88*£0.23) for 1 in 100 
reduction in mortality and £0.871 for 1 in 1000 reduction in mortality. Therefore, if 
26.55 deaths per 1000 persons visiting the emergency hospitals are averted in a 
month, the WTP value would be £23.13 (i.e. 26.55*£0.871) per month. If 31.47 
deaths per 1000 persons visiting the emergency hospitals are averted in 1 year, the 
WTP value would be £27.41 (i.e.31.47*£0.871). Similarly, the WTP value would be 
£27.52 (i.e. 31.57*£0.871) at 10 years. The estimates of the WTP values drawn using 
the probabilistic and deterministic estimates of costs and mortality differences at 30 
days, one year and 10 years’ time reported in Table 6.5 were used in the cost-benefit 
analysis of the hospital models assessed. The method of calculation of net monetary 
benefit has been described in Section 5.5 of Chapter 5. For example, at a WTP value 
of £0.871 for 1 in 1000 reduction in mortality, the net monetary benefit (NMB) at 30 
days (deterministic estimates) would be - £51,362 (i.e. ((£0.871*26.55)-£51,385). 
Table 6.10 shows the incremental NMB for a cohort of 1000 people. 
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Table 6.10: Cost-benefit analysis of the base-case scenario 
Scenarios Incremental 
Cost (£) 
Mortality 
Averted 
Incremental 
Benefit (£) 
Net Monetary 
Benefit (NMB) 
(£) 
30 days     
Deterministic 51385 26.55 23.13 -51,362 
Probabilistic 49201 26.55 23.13 -49,178 
One Year     
Deterministic 310946 31.47 27.41 -310,919 
Probabilistic 312999 31.43 27.36 -312,971 
10 Years     
Deterministic 1986329 31.57 27.50 -1,986,301 
Probabilistic 2003944 31.60 27.52 -2,003,917 
 Note: figures expressed are per 1000 people. 
 
The incremental benefits generated for every scenario were far less than the 
incremental costs of central hospital model vs local hospital model. Hence, the NMB 
at all the time horizons were negative. This suggests that compared with the local 
hospital model the central hospital model would not be regarded as being worthwhile. 
The main driver for these results appeared to be the very low valuation placed on 
mortality averted in the central hospital model. 
 
6.5 Discussion 
 
6.5.1 Summary of results 
The study described in this Chapter demonstrated that emergency medical services 
in a central hospital can be a cost-effective alternative to those at multiple local 
hospitals. Although, both the deterministic and probabilistic results of the economic 
analysis at 30 days showed that the incremental cost per QALY was slightly above 
the upper bound of £30,000 threshold for willingness to pay value, the cost-
effectiveness of the central hospital greatly improved over one year and 10-year time 
horizon. The incremental cost per QALY gained over one year and 10-year time 
horizon was much lower than the £20,000 lower bound threshold for willingness to 
pay. Furthermore, the cost-effectiveness probability of 100% at £20,000 WTP 
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threshold indicated that there would be a zero chance that choosing the central 
hospital over the local hospital would be a wrong decision. The EVPI value of zero 
further suggested that existing information can be regarded as sufficient to support 
the decision to adopt the central hospital. Therefore, the results indicate that the 
incremental QALY resulting from the central hospital appear to be worth the 
incremental costs over one year and 10-year time horizons. In addition, the results 
also suggested that higher number of deaths were avoided in the central hospital 
compared to the local hospital. 
 
The sensitivity analysis carried out to assess the robustness of the results indicated 
that the base case results were largely robust when higher and lower discount rates 
were applied to costs and QALYs. However, the results were quite sensitive to the 
assumption of no additional costs of consultant in the central hospital. Under this 
assumption of no additional cost, the central hospital was observed to be less costly 
and more effective than the local hospital in the base-case analysis.  
 
The sub-group analysis showed that central hospital is even more cost-effective for a 
cohort of patients aged 65 or over, for those with CCI4 or more, most deprived, and 
in those presenting with primary diagnosis of diseases of the circulatory system. In 
addition, central hospital is also very cost-effective in the cohort of patients with 
primary diagnosis of diseases of the respiratory system and in those with primary 
diagnosis of diseases of the digestive system. However, central hospital could be 
more expensive and less effective for the cohort of patients aged 30-64 years and in 
those patient cohort with the injury, poisoning and certain consequences. These 
results suggest that the central hospital can be more cost-effective if delivered to a 
population more likely to present with more severe health issues. 
 
The results of the cost-benefit analysis suggested a negative monetary benefit which 
indicates that central hospital would not be worthwhile compared to the local hospital. 
These negative monetary benefits could be possibly related to the lower willingness 
to pay values placed by individuals (i.e. potential users) on the central hospital. This 
lower values for central hospital could possibly be justified by the value and 
emotional attachment or sense of belonging individuals have for their local hospital in 
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general. However, the mismatch between the scope of evaluation between the DCE 
and economic evaluation model could be an important issue in the results of the cost-
benefit analysis. In particular, the mismatch can be highlighted in terms of the time 
horizon used to assess costs and benefits and the elements considered for the 
assessment of benefits. 
 
The DCE in Chapter 4 did not consider the cost attribute needed to generate the 
WTP estimate, instead the attribute “travel time to hospital” was monetised though 
the alternative specific constant (ASC) was not. A time horizon for the travel time 
would not be appropriate and was not specified. In contrast, the economic evaluation 
presented in this Chapter was conducted for time horizons of 30 days, one year and 
10 years. Therefore, it is possible that the willingness to pay value used in the cost-
benefit analysis were influenced by the differences in the way DCE and economic 
evaluation model were framed. 
 
Another concern is the differences in the DCE attributes/levels and outcomes 
considered in the economic evaluation; which raises the question whether the same 
good were valued by both the frameworks. The DCE considered travel time, waiting 
time, risk of re-admission, risk of mortality, length of stay and follow-up in the local 
hospital. However, all of the attributes considered in the DCE could not be reflected 
in the economic evaluation because of the unavailability of data and the complexity in 
modelling. For example, the economic evaluation did not consider the follow-up at 
local hospital and waiting times which would have influenced the costs and in the 
other hand the DCE did not consider cost as one of the attributes which could have 
influenced the willingness to pay value. Nevertheless, the incorporation of the DCE 
results into the economic evaluation provided some indication of patients’ willingness 
to pay and potential cost-benefits of centralisation of emergency medical services. 
 
The review by Sir Bruce Keogh recommends reconfiguration of emergency care and 
the development of centralised and more specialised emergency units that benefits 
patients with more serious and life threatening condition by providing best expertise 
and potentially better quality of care (NHS England, 2013a). In addition, consolidation 
of specialised medical care is one of the new care models envisaged by the NHS 
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“Five year forward view” (NHS England, 2014). Therefore, in general, the findings of 
the economic evaluation described in this study provides some support for the 
reorganisation of healthcare services taking place in the NHS England. 
 
6.5.2 Comparison with earlier studies 
The findings of the economic evaluation described in this Chapter are consistent with 
the findings of earlier studies assessing the impact of centralisation of emergency 
medical services. The Health Foundation briefing on the impact of redesigning urgent 
and emergency care in Northumberland, UK which was based on similar data and 
context of this Chapter suggested that centralisation of urgent and emergency care 
resulted in increased service utilisation, shorter A&E visits, and increased discharge 
or transfer from the A&E within four hours- all of these outcomes could be related to 
efficient and better quality of care provided at the central hospital (O'Neill et al., 
2017). Improved efficiency and better quality of care observed by O’Neill et al (2017) 
are reflected in the estimates of cost-effectiveness results discussed in this Chapter. 
 
Another study on centralisation of the A&E services in Sheffield, UK showed 
improvement in both quantity and quality overall, though the waiting time to see a 
clinician further worsened after centralisation (Simpson et al., 2001). The economic 
evaluation model in this Chapter did not consider the waiting time to be seen by the 
consultant, however The Health Foundation briefing (O'Neill et al., 2017) was 
conducted in the same setting observed shorter A&E visits which indicated shorter 
waiting times. 
 
The results of the study described in this Chapter also reflect the findings from 
studies assessing centralisation of specialised health care services. Hunter and 
colleagues who examined the clinical and cost outcomes of centralised approach to 
acute stroke care in London suggested that centralised stroke care could be less 
costly and more effective in terms of QALY gained and mortality averted (Hunter et 
al., 2013). Another study which used a decision analytic model to assess the 
difference-in differences in costs and outcomes before and after the implementation 
of two models of reconfiguration of stroke care in London and Greater Manchester in 
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England showed that centralised stroke services may result in a net monetary benefit 
at a threshold of £20,000-£30,000 for a QALY gained (Hunter et al., 2018). Stroke 
could not be used as one of the sub-groups analysed in this thesis because of limited 
stroke specific data. However, the central hospital in the sub-group of diseases of 
circulatory system, a broad category which also includes stroke, was found less 
costly and more effective compared to the local hospital over 30 days and one year 
of time and showed very minimum incremental costs at 10 years. 
 
A study which conducted the economic evaluation of trauma care in a tertiary trauma 
hospital in Canada showed that the specialised trauma centre would be a cost-
effective alternative to other treatment programs (Seguin et al., 1999). Another study 
in the US showed that transferring patients with subarachnoid haemorrhage (an 
uncommon type of stroke) from a low to high volume hospitals would be cost-
effective suggesting the regionalization of care may be justified (Bardach et al., 
2004). Furthermore, the results of a study comparing the effectiveness of ST-
segment-elevation myocardial infarction regionalization strategies in the United 
States indicated that transporting every patient to a central hospital with a facility for 
primary coronary central hospital would be cheaper and more effective compared to 
all hospital expansion options with the treatment facility (Concannon et al., 2010). 
This may indicate that having a specialised treatment facility would be better in terms 
of costs and effects than having less specialised facilities in several locations. Other 
studies assessing the centralisation of cancer care in the US and the Netherlands 
also suggested that specialised treatment centres would be cost-effective 
alternatives to the treatment in general hospitals (Bristow et al., 2007; Greving et al., 
2009). 
 
A number of other studies included in the systematic review in Chapter 2, though 
most of them limited in terms of the methodology, have justified the centralisation of 
specialised healthcare in terms of costs and effects, but will not be discussed here. 
 
The incorporation of willingness to pay values derived from a DCE into the economic 
evaluation in the form of CBA is relatively novel. Only a few examples attempting to 
incorporate a DCE into economic evaluation were identified. Two studies (Petrou and 
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McIntosh, 2009; van der Pol et al., 2010) conducted a CBA using the DCE data but 
did not have comparable QALY data. Three studies (Vale, 2005; Burr et al., 2012; 
Tinelli et al., 2016) compared the net monetary benefits using DCE with the QALY 
data. Vale (2005) attempted to incorporate the WTP estimates from an existing DCE 
into an economic evaluation of alternative methods of surgical repair of inguinal 
hernia, and reported differences in the conclusions drawn from the DCE derived CBA 
compared with those derived from QALY data (Vale, 2005). It was argued that one 
reason for these differences was a mismatch between the DCE design and the 
economic evaluation model. The DCE used was not initially designed to be used in 
the economic evaluation model. Therefore there were restrictions in incorporating the 
WTP estimates in the economic model. 
 
Burr and colleagues attempted to use the WTP values from a DCE explicitly 
designed to facilitate its incorporation into the economic model involving a discrete 
event simulation evaluating surveillance for ocular hypertension (Burr et al., 2012).  
This study attempted to learn from the earlier Vale (2005) study and attempted to 
design the DCE and model iteratively. However, respondents in the Burr et al. (2012) 
study placed very little valuation on prevention of the progression of open angle 
glaucoma. Consequently this led to negative net benefits of the intervention 
(surveillance) compared with a hypothetical reference pathway (no surveillance), 
which was in sharp contrast to the cost-utility results observed for the intervention. 
Among the five alternatives compared only the “surveillance for ocular hypertension 
hospital” pathway relative to “no surveillance” had a positive net benefit. 
 
Another study (Tinelli et al., 2016) assessed the value of pharmacy services 
(intervention) and reported no statistically significant differences in the costs and 
QALY estimates in both the intervention and control; however the net monetary 
benefit from the intervention when derived from the DCE data was positive. This 
indicated the value of the intervention to the respondents (which supports the 
introduction of intervention). However, this study was underpowered (The Community 
Pharmacy Medicines Management Project Evaluation, 2007) and the conclusion of 
no statistically significant differences in the costs and QALY estimates in the 
intervention and control should be interpreted with caution.  
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These differences in the results between studies could be because of issues such as 
mismatch in the respondent characteristics, differences in time horizon, differences in 
goods being valued that could be faced while trying to incorporate DCE into 
economic evaluations (McIntosh, 2006). It could be argued that these are general 
issues faced when trying to combine a DCE into an economic evaluation model and 
the differences in the results observed in this thesis are not unusual. However, future 
research should look into better approaches of combining a DCE into an economic 
model. 
 
6.5.3 Strengths and limitations 
Attempting to assess the cost-effectiveness of centralisation of emergency care in a 
new specialised hospital in Northumberland, England, the first of its kind in the UK, is 
in itself the key strength of the study presented in this Chapter. No studies hitherto 
have explored this topic. The analysis in this study provides the policy-makers the 
real-world implications of the centralisation of emergency care in terms of costs and 
outcomes and hence can inform the decision-making around centralisation in the 
future. 
 
Furthermore, the economic evaluation in this Chapter addressed some of the 
limitations identified in the systematic review of economic evaluation methods in 
Chapter 2 and presents the results in a way that is helpful to decision-makers. One 
finding of the systematic review was most of the economic evaluation studies 
assessing the centralisation of specialised healthcare services did not report results 
over different time horizons and for other clinical outcomes alongside QALYs. But, 
decision-makers may find clinical outcomes easier to understand and thus, prefer 
them over QALYs in economic evaluation (Eddama and Coast, 2009; Sullivan et al., 
2015). Therefore, this study reported mortality alongside QALYs over different time 
horizons which may make it easier for the decision-makers to understand the 
benefits of centralisation of emergency care. 
 
However, the results of this study needs to be interpreted with caution in light of 
some limitations. 
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First, the results are based on estimates of transitional probabilities derived from 
observational routinely collected hospital data which might be prone to recording 
errors (Burns et al., 2012). It is likely that any inaccuracies in the data recording could 
have influenced the transition probabilities used in the economic evaluation model. 
However, it was assumed that the likelihood of this errors would be random and be 
equal in both central and local hospital models. 
 
Second, the retrospective nature of the study also meant that the information that 
was available on the cost and utility of central and local hospital models was limited. 
The cost and utility data assumed from the secondary sources may not be the true 
representation of costs and utility in practice. For example, it was assumed that all 
patients discharged from hospital would go to the community and no additional costs 
were incurred once discharged into the community. However, in practice patients 
may be discharged into one of the several destinations in the community, such as 
nursing homes, residential care homes and some may attend their local hospital for 
follow-up. There could be additional costs of care involved when patients are 
discharged into these specific community destinations. If one of the hospitals results 
in more disability in the long term then the costs for that option over time will be 
higher. Furthermore, in the absence of data, the cost of 20 minutes of time for an 
additional emergency consultant was assumed in the central hospital. However, in 
practice the consultant time could be subject to severity/complexity of the patient 
condition, which could mean more or less time than the 20 minutes assumed in this 
study. Hence, consideration of costs in the community and any differences in 
consultant time input is likely to influence the results observed in this study. However, 
sensitivity analysis and several sub-group analysis were conducted to assess the 
results in different scenarios to assess the results arising out of uncertainties in costs 
and utility parameters. 
 
Third, the before-and-after approach of the study means that there could be potential 
confounders and biases that could have influenced the study results. For example, 
some of the effect observed in the central hospital could be because of the effect of 
other changes that were taking place in Northumberland or England at the same time 
or could be because of the differences in patient characteristics. There were 
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differences in the characteristics of patients in the data records for the both groups 
(Table 6.2) and there could be other unobserved confounders that could have 
influenced the results. Hence, the results in this study are based on the conservative 
assumptions that there were no confounders and biases arising solely out of the 
design used. 
 
Fourth, the cost-benefit estimates could have been influenced by the mismatch 
between the DCE and the economic evaluation and a perfect compatibility of these 
two approaches may have generated different estimates of cost benefits. However, a 
similar problem has been noted in the literature (Burr et al., 2012) and could be a 
general problem faced while trying to combine a DCE and the economic evaluation. 
 
Fifth, the data used to derive transition probabilities in the central hospital were those 
recorded in the first 15 months since the opening of the centralised emergency 
hospital. The first fifteen months could possibly be too short to assess the impact of 
such a major service reorganisation where both the patient and healthcare 
professionals may not have been fully prepared to respond to unexpected 
circumstances caused by the introduction of a central hospital. It could be possible 
that the true impact of such large scale changes could be only observed after a long 
period of time. Therefore, it is possible that the central hospital could be more cost-
effective than presented in this Chapter. 
 
Finally, it is important to draw attention to the narrow perspective of this study and a 
number of potential costs might have been left out. A broader perspective, for 
example inclusion of costs and benefits to the family and friends would have been 
important in the cost-effectiveness analysis. 
 
6.5.4 Implications for future research 
A number of further research priorities can be outlined from the work presented in 
this Chapter. The model could be extended to include the costs in the community 
after the discharge from hospital, provided additional data is available. Sub-group 
analysis based on broader ICD-10 disease classification is presented in this Chapter 
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because of insufficient data, but more specific disease/condition analysis such as for 
stroke could prove useful to the decision-makers. 
 
DCE with cost as one of the attributes conducted in patients who have recently 
attended the emergency medical services could generate more representative 
willingness to pay and results of cost-benefit. There could be other approaches to 
incorporate the DCE results into economic evaluation than the one presented in this 
Chapter. One of the approaches could be to assign the utility weights for each states 
derived from the DCE into the economic evaluation (Burr et al., 2007). Different 
methods for converting DCE values into QALYs have been discussed in the literature 
(Rowen et al., 2015). Exploration of these approaches was beyond the scope of this 
PhD, nevertheless future studies could look into these approaches of incorporating 
DCE into economic models. 
 
6.6 Conclusion 
The results of the economic evaluation presented in this Chapter demonstrated that 
the centralised emergency medical care could be more cost-effective alternative 
(when outcomes are measured in QALYs) to the emergency medical services 
provided through a number of local hospitals. It appears the cost-effectiveness of 
centralised services improves in the long-term. In addition, the study findings also 
suggest that the centralised emergency medical services would be more cost-
effective in some specific population groups such as the elderly, the most deprived 
and those presenting with diseases of circulatory system. However, the findings also 
indicated that it is also possible for the centralised service to be more expensive and 
less effective in the 30-64 years of age group of population. In contrast to the cost-
effective analysis, the cost-benefit analysis suggested that people may place little 
value to the centralised services compared to their service provided at their local 
hospitals. However, these results should be interpreted with caution in the light of 
limitations in the DCE and its incorporation into an economic evaluation. 
Nevertheless, this economic evaluation is consistent with findings of many other 
studies supporting the implementation of major system change similar to 
centralisation of emergency medical services. Furthermore, the findings also support 
the recommendations to centralise urgent and emergency care services in the NHS 
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England and current and future consolidation of specialised care services aimed at 
providing quality care with increased efficiency. The next Chapter presents the 
summary of each Chapters of this thesis and discusses the major findings and 
presents the overall conclusion of this thesis. 
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Chapter 7. Discussion  
7.1 Introduction 
Chapter 6 demonstrated that the centralised emergency medical care could be more 
cost-effective alternative to the emergency medical services provided through a 
number of local hospitals. This Chapter revisits the aims and objectives of the thesis 
set out in Chapter 1 and then summarises and discusses the empirical research 
findings reported in Chapter 2, Chapter 4 and Chapter 6. It then highlights the main 
contributions of the thesis and policy implications followed by the outline of major 
limitations and areas for further research. Finally, the overall conclusion of the 
research is presented. 
 
Within the UK, emergency medical services are typically provided by the local 
hospitals. There is a perception that emergency medical services are struggling to 
cope with the increasing demand and extra pressures on NHS resources. Therefore, 
there is pressure to centralise these services into fewer more specialised units that 
cater for a larger population. The underlying premise is that this centralisation will 
benefit patients with more serious and life threatening condition by providing them 
access to the best expertise and hence potentially better quality of care. Little is 
known about economic implications of centralisation of emergency medical services 
or about societal preferences around equality of access. The aim of this thesis was to 
examine the impact of centralisation of emergency medical services in terms of costs 
and quality of care and then quantify the strength of individual preferences towards 
centralised emergency medical services. 
 
7.2 Summary of the Main Findings 
Chapter 2 systematically reviewed and critically appraised the methodological quality 
of published economic evaluations that considered centralisation of specialised 
healthcare services. The systematic review showed that most of the studies used 
non-experimental designs, when quasi-experimental designs such as controlled 
before-after studies, interrupted time series and repeated measures studies (Centre 
for Review and Dissemination, 2009) could have generated more robust and 
convincing evidence compared with non-experimental designs. QALYs are widely 
used in health economics because they provide a summary measure of both quantity 
and quality of life outcomes but they were used in only a few studies. Most of the 
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previous economic evaluations were constrained because their results were based 
on short follow-ups. It is possible that their outcomes would have been different if 
they had considered a longer time frame. 
 
Cost-effectiveness may vary with the perspective and an intervention which is cost-
effective from one view point and may not be from another (Drummond et al., 2005), 
however a large majority of previous economic evaluation failed to state the 
perspective of their analysis. It was difficult to infer the perspective of analysis by 
looking at the cost and effects included. The systematic review demonstrated a 
considerable variation in conduct and limited methodological quality of the economic 
evaluations of centralisation of specialised healthcare services in general. In addition, 
the studies reviewed generally did not adhere to the standards for reporting 
economic evaluations (Drummond and Jefferson, 1996; Husereau et al., 2013). 
Evidence coming from methodologically poor studies may force decision-makers to 
make poorly informed decisions on centralisation of specialised health care services. 
Therefore, it is important to improve the methodology and reporting of economic 
evaluations so that decisions on centralisation are informed by more robust evidence. 
Chapter 2 informed the development of economic model for the economic evaluation 
of centralisation of emergency medical services, which is presented in Chapter 6. 
 
Chapter 4 presented a DCE which explored and quantified the strength of individuals’ 
preferences towards centralised emergency medical services. It demonstrated how 
individuals’ weigh-up and trade-off between attributes of hospitals in an emergency. 
Hospital attributes that were considered in the DCE were travel to hospital, waiting 
time in the emergency department, length of stay in the hospital, risk of death, risk of 
re-admission, outpatient follow-up care at a local hospital. These attributes were 
derived from the literature and reflected the key quality measures of emergency 
medical services. The results suggested that individuals prefer less travel time to 
hospital, less waiting time, fewer number of days in hospital, low risk of death, low 
risk of readmission and outpatient follow-up care in their local hospital. The results of 
the DCE highlighted that follow-up outpatient care at a local hospital is more 
important to individuals than any other hospital attributes considered in the analysis. 
Individuals were willing to trade-off increased travel time and waiting time for the 
lower risk of death, lower risk of readmission, fewer number of days in the hospital 
and follow-up outpatient care in their local hospital. In general, the results suggested 
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that people can compromise on other attributes for high quality of healthcare 
provided by centralised emergency medical services. 
 
Chapter 6 described the economic evaluation of centralised specialised emergency 
medical service compared to those provided at local hospital in a UK setting. A 
Markov model using the cohort simulation approach for a 10 year time horizon was 
constructed. The analysis compared both the deterministic and probabilistic 
estimates of costs, QALYs and mortality outcomes in centralised hospital model and 
local hospital models. The results demonstrated that emergency medical services in 
a centralised hospital can be a cost-effective alternative to those provided at multiple 
local hospitals, although cost-effectiveness may vary in specific population sub-
groups. It was also observed that the centralised emergency medical services can be 
more cost-effective if delivered to a population more likely to present with more 
severe health issues. Chapter 6 also attempted to incorporate the results of the DCE 
in Chapter 4 into the economic evaluation framework. In sharp contrast to the 
findings on cost-effectiveness, the cost benefit analysis suggested that centralised 
emergency medical services could have negative societal value when compared to 
services provided in local hospitals. 
 
7.3 Thesis Contribution and Policy Implications 
The empirical contribution of this thesis are the findings from the systematic review of 
economic evaluation methods used in centralisation of specialised healthcare; the 
DCE eliciting the preferences for centralised emergency medical services and the 
findings from the economic evaluation assessing the costs and outcomes of 
centralisation of emergency medical services. The contributions and policy 
implications of findings in each of these components are outlined as follows. 
 
7.3.1 Systematic review 
The systematic review highlighted the need to improve the methodology and 
reporting of economic evaluations assessing centralisation of specialised healthcare 
so that decisions on centralisation are informed by reliable evidence in healthcare 
quality and efficiency. A number of economic evaluations on centralisation of 
specialised healthcare services have been conducted, however studies assessing 
the methodological quality of these economic evaluations are lacking. An earlier 
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review of economic evaluations considering centralisation was narrower and 
focussed only on specific health issues like cancer (Ke et al., 2012). To the best of 
my knowledge, this is the first systematic review to comprehensively attempt to 
assess the methodological quality of economic evaluations assessing centralisation 
of specialised healthcare services irrespective of their speciality.  
 
7.3.2 Discrete choice experiment 
The DCE suggested that patients are prepared to travel further and wait longer for a 
better quality of emergency medical services in terms of risk of death, risk of 
readmissions, length of stay in the hospital and outpatient follow-up care. However, 
they value the outpatient follow-up care at their local hospital more than anything else 
considered in this thesis. These findings are consistent with the findings of other 
relevant DCE studies (Ryan et al., 2000; Gerard et al., 2004; Burge et al., 2005; 
Gerard and Lattimer, 2005; Schwappach and Strasmann, 2007; Harris et al., 2015; 
Vallejo-Torres et al., 2018) and other studies assessing choice of healthcare using 
methods other than DCE (Beckert et al., 2012; Landau et al., 2013; Gutacker et al., 
2016; Moscelli et al., 2016). However, these current studies differ with the DCE 
undertaken in this thesis in terms of healthcare context, design, attributes and 
attribute levels. Hence, the DCE in this thesis provides valuable insights into patient 
preferences of emergency medical services and would help decision-makers make 
informed decisions on future centralisation of emergency medical services or similar 
specialised healthcare services in a similar healthcare setting. Consideration of 
individual preferences in future centralisation of emergency medical services may 
mean increased value and satisfaction across the population and provide efficiency 
gains. 
 
7.3.3 Economic evaluation 
The economic evaluation utilised a real world data and demonstrated that emergency 
medical services in a centralised hospital can be a cost-effective alternative to those 
at multiple local hospitals, although cost-effectiveness may vary in specific population 
sub-groups. No studies have hitherto explored the economic evaluation of 
centralisation of emergency healthcare in Northumberland, England. Furthermore, 
the combination of DCE and economic evaluation in the form cost-benefit analysis is 
a relatively novel approach. The economic evaluation in this thesis provides the 
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policy-makers the insights into real-world implications of the centralisation of 
emergency care in terms of costs and outcomes and hence can inform the decision-
making around centralisation in the future. 
Healthcare resources are limited and therefore decision-makers have to make tough 
decisions on provision of health care services. There is a pressure to consolidate the 
emergency medical services provided by the multiple district hospitals into fewer 
specialised units catering a large population with efficient and high quality care in the 
NHS England. The concentration of care into specialised centres is one of the new 
care models suggested by the “Five year forward view” and also recommended by 
the Keogh report (NHS England, 2013a; NHS England, 2014). The findings of this 
thesis, adds to the evidence that centralisation offers cost-effective provision of 
emergency medical services by concentrating and enhancing expertise. Hence, 
these results back up the NHS effort to centralise emergency medical services into 
specialised hospitals. However, the thesis also cautions that cost-effectiveness could 
vary in population sub-groups and any future centralisation efforts should be 
supported by methodologically strong evidence of cost-effectiveness. 
 
This thesis also addresses the concern that centralisation may have impact on 
healthcare access. Centralisation of emergency medical services in this thesis has 
shown to increase the travel times which suggests that centralised healthcare may 
not be closer to people’s home and the better quality and specialised health care 
services may come only at the cost of increased travel times to the point of care. 
However, the DCE results suggested that whilst people may place a high value on 
their local hospital, they may be willing to trade-off the increased journey time to be 
treated at a specialised hospital providing better quality service. Hence, the issue of 
distance decay where the utilisation of healthcare services decreases with the 
increase in travel distance to the healthcare facility may not apply to emergency 
medical services, at least in this context. Moreover, there could be other strategies 
such as investments on better road networks and improved ambulance services 
which may offset the increased journey times noted here in this thesis. More recently 
it was observed that patients attending the centralised specialised emergency 
medical service studied in this thesis, spend less time in the A&E with a higher 
percentage of patients admitted, transferred or discharged within four hours 
compared to a synthetic control area (O'Neill et al., 2017). Therefore, it appears that 
the availability of a specialised team in a centralised emergency services may 
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improve access and reduce the in house delay in getting appropriate clinical 
treatment; this may compensate for the increased journey time to arrival. All of these 
efforts are likely to result in an increase in the cost savings and health care quality 
beyond those estimated in this thesis. 
 
7.4 Major Strengths and Limitations 
The strengths and limitations of the analysis undertaken in this thesis are discussed 
in detail individual empirical Chapters. Only the most substantive issues will be 
summarised here. The strengths and limitations can be divided into those relating to 
the DCE and those relating to the economic evaluation. 
 
Strengths and limitations related to DCEs can be summarised as follows: 
 
1. The sample used in the DCE was considered most appropriate to represent 
the preferences of potential users of a newly built specialised emergency 
hospital- the focus of this PhD. A wide cross section of the local general 
population accessed via Healthwatch and NHCT were surveyed. However, the 
sample size could possibly have been too small. Therefore the possibility of 
poor representation of preferences cannot be ruled out. It is likely that some 
specific population groups from the general population may be under 
represented, particularly those not registered with the Healthwatch or NHCT. 
The EQ-5D-5L and EQ-VAS scores of the respondents included in the survey 
were lower than those of the general population in England (see section 4.4.1, 
Chapter 4). Therefore, it is likely that the healthiest groups may have been left 
out. Hence, the study would have benefitted from a larger and more diverse 
sample of respondents (also representative of very young, very old and those 
with special needs). 
 
2. Cost was not included as one of the attributes in the DCE. Hence the 
generation of a marginal willingness to pay from the marginal rates of 
substitution between cost and the other attributes was not possible. The 
attribute “travel time to hospital” was used as the basis of a calculation of the 
marginal willingness to pay incorporated into the cost benefit analysis 
conducted in Chapter 6. Use of national average wage rate to value patients’ 
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time is considered appropriate in analyses designed to inform policy decisions 
of public interest (Russell, 2009). This approach of estimating the willingness 
to pay was useful when framing of a cost attribute was difficult in the context 
where individuals are not used to out of pocket payments for healthcare at the 
point of use. One advantage of monetisation of travel time instead of including 
cost as one of the attributes was that it prevented potential protest responses 
in the DCE i.e. the risk of respondents trading off only against the cost 
attribute by always choosing the cheapest alternative or not making a choice 
at all (Pedersen et al., 2011). However, the monetary valuation of patient time 
is not straight forward and at times challenging (Russell, 2009).The estimate of 
monetary value of travel time in this thesis required several assumptions and 
steps (see section 6.4.5 in Chapter 6). In the case of patients active in the 
labour market (example, those with paid jobs, self-employed) the wage rate 
could appropriately shadow the monetary value of travel time spent, but may 
not be a true representation for patients not in the labour market (such as 
those retired or unable to work because of health problems) (Borisova and 
Goodman, 2003). Evidence shows systematic differences between the wage 
rate and the willingness to pay value of time, which suggests these two are not 
necessarily equivalent (Borisova and Goodman, 2003). 
 
Another point to note is that the economic evaluation was considered for a 10 
years’ time horizon, whereas it was inappropriate to include a time-frame for 
the travel time attribute considered in the DCE. Therefore, it is possible that 
the mismatch in framing of the DCE and the economic evaluation could have 
influenced the willingness to pay value and by extension inferences drawn 
from the cost-benefit analysis. However, the mismatch in the framing of the 
DCE and the economic evaluation is a general problem faced while trying to 
combine these two approaches (Burr et al., 2012). 
 
3. There could be other attributes that could be more important to the potential 
users of emergency medical services but which were not covered in the DCE. 
Therefore, it is likely that the DCE results could have suffered from the bias 
resulting from the failure to include any other important attributes. 
Nevertheless, relevant literature was explored and the attributes chosen 
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balanced the need to identify important attributes with the need to reflect key 
hospital quality indicators in the context of this thesis. 
 
Strengths and limitations related to the economic evaluation can be summarised as 
follows: 
 
1. Utility parameters were taken from the secondary literature (which was not 
systematically assembled) and were assumed to be similar for the both the 
models, but in practice these assumptions may not be true which could 
influence the QALY outcomes in the economic evaluation. For example, 
specialised hospitals are expected to provide a very high quality service, 
therefore the utility value of A&E attendance or admissions at a specialised 
hospital could be higher compared to those at a local hospital. Evidence 
suggests that centralisation of healthcare in general can offer patients a good 
care experience (Perry et al., 2018). This means that the QALY gains from 
centralised specialised hospital could be much higher in practice than the 
ones observed in this thesis but this would not change the conclusion of this 
thesis. 
 
2. The perspective of analysis followed in the economic evaluation i.e. the NHS 
perspective is quite narrow compared to a much broader societal perspective 
which could have taken other costs borne by the patient, their families or the 
society into consideration. Therefore, it is possible that the results observed 
might have suffered from the narrow perspective of analysis taken in this 
thesis. However, given the better quality of care at the centralised hospital, the 
consideration of societal costs would still go in favour of the centralised 
hospital (which is less likely to change the conclusions of this thesis) though at 
a risk of increase in journey time for patients and their relatives. Furthermore, 
the economic evaluation did not consider costs of waiting times to be seen 
and resource utilisation after the discharge into the community such as follow- 
up care in local hospitals, GP surgery visits; this could have undermined the 
savings from centralisation. Evidence coming from the setting same as the 
one considered in this thesis suggested that the centralisation of emergency 
medical services resulted in increased service utilisation, shorter A&E visits, 
and increased discharge or transfer from the A&E within four hours. All of 
177 
these outcomes could be related to efficient and better quality of care provided 
at the centralised specialised hospital (O'Neill et al., 2017). Therefore, 
consideration of additional costs such as waiting times or resource utilisation 
in the community in the economic evaluation model may result in greater 
savings than those estimated in this thesis. 
 
3. Utilisation of data from a relatively short-time frame to derive transition 
probabilities in the centralised model could have under-estimated the true 
impact of centralisation of emergency medical services. However, the data 
from a longer time frame was not available during the conduct of economic 
evaluation in this thesis. Repeating the economic evaluation model with post 
centralisation data from longer time frame may be useful. 
 
4. The travel time to hospital considered in the Markov model, taken from google 
maps, are actually average normal car driving time between postcode 
locations. However, in emergencies, ambulance may travel faster than cars 
(considering the no restrictions on traffic signals/lanes for ambulances driven 
in emergency, though ambulances are limited to 60 miles an hour) and it is 
possible that the costs associated with the travel time to hospital used in the 
Markov model were over-estimated. But, at the same time, travel time during 
peak times or essential road works would mean additional travel time to 
hospital. However, these limitations on travel time affects both the local as well 
as centralised services and are therefore less likely to change the conclusions 
of this thesis. Furthermore, other model parameters mainly based on 
assumptions, may not be transferable to other setting. 
 
5. Apart from the Markov model used in this thesis, a number of other decision 
models such as patient level simulation, discrete event simulation and 
dynamic models are commonly used in health economic evaluations. 
However, in this thesis, as interaction between individuals attending the 
emergency is ruled out then the use of discrete event simulation (with 
interactions) and dynamic models is not necessary. However, an economic 
evaluation using patient level simulation (also known as micro-simulation) 
which models the progression of individuals one at a time (rather than in 
cohorts in Markov model) (Briggs et al., 2006; Petrou and Gray, 2011b), could 
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have generated more accurate estimates of costs and effects than those 
estimated in this thesis. A recent economic evaluation assessing the 
centralisation of stroke services has used patient level simulation model the 
patient level simulations (Lahr et al., 2017). However, the benefits of such 
models over Markov model can be outweighed by their complexity and high 
computational burden (Briggs et al., 2006). 
 
7.5  Areas for Further Research 
This section outlines a number of outstanding areas for further research which are 
mainly based on the limitations in the analysis of this thesis highlighted in section 7.4. 
Although most these areas were noted early on, these could not be adequately 
addressed for reasons such as unavailability of data (for example: ambulance 
journey times to hospitals; utility estimates for each state in the model; costs and 
resource utilisation after the discharge from hospital) or time and resource constraints 
imposed by the requirements of this thesis (for example: qualitative research on 
hospital attributes, larger respondent sample in DCE). These areas of further 
research can be divided into those relating to the DCE and those relating to the 
economic evaluation model. 
 
Areas of further research related to DCE can be summarised as follows: 
 
1. A respondent sample larger than the one used in the DCE in this thesis may 
be more representative and may generate more reliable estimates of 
preferences. A high majority of respondents in this thesis were above 55 years 
of age- generally high consumers of healthcare. Therefore, the sample in 
future studies could also include the healthiest group, the most elderly and the 
ones with special needs possibly left out in this thesis. A respondent sample 
composed of general public (who have no recent experience of emergency 
medical services) and patients (with recent experience of emergency medical 
services) with similar representation from all age-groups of general public 
could provide further insights on preferences of emergency medical services. 
 
2. As discussed in section 7.4, wage rates are not necessarily equivalent to the 
value of patient’s time. The mismatch in framing of the DCE and economic 
evaluation is likely to influence the inferences drawn from the cost-benefit 
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analysis. Inclusion of a cost attribute and construction of DCE scenarios more 
compatible with the decision problem as expressed by the economic 
evaluation model may provide a better estimate of willingness to pay value 
than the one used in the cost-benefit analysis reported in this thesis. 
 
3. Qualitative research exploring the attributes in the DCE scenarios was 
challenging in terms of time and resource constraints of this PhD thesis. 
Getting the required sample for the qualitative work within a limited time was 
difficult. Focus group discussion, brain-storming exercises and interviews with 
the users of emergency medical services and other stakeholders would 
generate attributes that were not considered in this thesis but could be more 
important to the users/potential users. 
 
Areas of further research related to economic evaluation can be summarised as 
follows: 
 
1. The utility estimates used in the model were taken from secondary literature. 
However, direct measurement of utilities from patients attending the 
emergency medical services could be more valuable. Health utilities, also 
known as health-related quality of life (HRQoL) weights, can be measured 
using a range of direct (for example VAS, TTO) or indirect (generic preference 
based measures such as EQ-5D) methods (Whitehead and Ali, 2010). Some 
of these are also described in Chapter 3 of this thesis. However, considering 
the seriousness of patients attending the emergency medical services it may 
not be practical and ethical to administer these utility measurement tools while 
they are in A&E or admitted in hospital. But, a possibility could be to measure 
the utility weights from patients with recent experience of utilising the 
emergency medical services. Health utility parameters assigned to health 
states in each of the models compared in this thesis were assumed to be the 
same, but in practice the utilities could be influenced by the differences in 
hospital care quality. Further research should also explore whether the utilities 
assigned into local and centralised hospital models are different. 
 
2. The model could be extended to include the costs in the community after the 
discharge from hospital, provided additional data is available. In practice 
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patients may be discharged into one of the several destinations in the 
community, such as nursing homes, residential care homes and some may 
attend their local hospital or GP surgeries for follow-up. Patients could be 
discharged after the initial treatment at the centralised specialised hospital to 
their local hospitals for further care. Therefore, there could be additional costs 
of care involved when patients are discharged into these specific community 
destinations. If one of the hospitals results in more disability in the long-term 
then the costs for that option over time will be higher. Hence the “Community” 
state in the Markov model described in this thesis could be replaced by 
several other states such as “Nursing home”, “Rehabilitation”, “Local Hospital” 
(only for the centralised model) and “Home” to better represent the resource 
utilisation in the community after the discharge from hospitals. Consideration 
of resource utilisation in the community could show a different picture of cost-
effectiveness. 
 
3. Comparison of average ambulance journey times before and after 
centralisation may give a more realistic picture of journey times to hospital. 
The ambulance journey times could be available from records of local 
ambulance service providers. 
 
4. Consideration of improvement in road networks to centralised hospital, better 
equipped and skilled ambulance paramedic staff responding to emergency 
calls and changes in the waiting times to be seen may suggest further cost 
savings and improvements in effectiveness. Improvement in road networks to 
centralised hospital would mean less travel time to access the emergency 
medical service. Better skilled ambulance paramedic staff responding to 
emergency calls would mean less serious cases are treated at their homes (or 
point of call or before arrival at the hospital) and may not need to attend the 
hospital. Decreases in waiting times or time in hospital would mean less 
utilisation of resources. All of these are likely to generate further savings 
without compromising the quality of care. 
 
5. Centralisation of emergency medical services in itself is a major service re-
organisation where both the patients and professionals may not be fully 
accustomed to the new re-organisation and may not be prepared to respond 
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to any unexpected events in the outset of centralised hospital. It could be 
possible that the true impact of such large scale changes could be only 
observed after a long period of time. In fact, one of the paradoxes of 
innovation is that the quality improvement systems in healthcare often fails to 
keep pace with innovation which disrupts the healthcare service (Dixon-Woods 
et al., 2011). For example, the consultant presence and different physical 
configurations of the centralised hospital (compared to those at local hospitals) 
may give rise to a whole new set of quality challenges. It takes time for people 
and the quality assurance systems to catch up with the new configurations of 
care (Dixon-Woods et al., 2011). Therefore, research using post centralisation 
data collected over a longer term than the one used in this thesis could be 
valuable. 
 
6. Future studies could look into better approaches of incorporating DCE into 
economic models than the one used in this thesis. One of the approaches 
could be to assign the utility weights for each states derived from the DCE into 
the economic evaluation (Burr et al., 2007). Different methods for converting 
DCE values into QALYs have been discussed in the literature (Rowen et al., 
2015). 
 
7. Economic evaluation models are generally based on assumptions around 
parameters used to populate the model. It is always beneficial to repeat a 
similar model in the context other than the one used in this thesis. 
 
8. The perspective of the analysis governs the costs and outcomes considered in 
an economic evaluation and can ultimately influence the resource allocation 
decisions. Analysis of centralisation of emergency medical services from a 
societal perspective considering the costs such as those of social care, 
informal care and patient out of pocket access costs could help exploration of 
any differences in results than the ones observed from NHS perspective taken 
in this thesis. 
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7.6 Conclusion 
This thesis explored the economic evaluation methods used in previous studies 
assessing centralisation of specialised healthcare services, conducted a DCE to 
assess people’s preferences of centralised healthcare services, and conducted an 
economic evaluation comparing the emergency medical services provided from the 
local hospitals with those provided from a centralised specialised hospital. It is 
important to ensure that decisions to centralise specialised healthcare services are 
informed by robust evidence of improvements in healthcare quality and efficiency 
arising out of centralisation. Centralisation of emergency medical services could be 
cost-effective and patients would be willing to trade-off increased journey times with 
the better quality of service provided at the centralised specialised facility. Hence, 
this thesis contributes to the evidence base recommending the centralisation of 
emergency medical services into fewer more specialised units.  
 
Decision-makers should consider centralisation of similar specialised healthcare 
services in the NHS. Nonetheless, there are important limitations in the research 
conducted in this thesis and further investigations are to be undertaken. To conclude, 
this research is an evidence supporting the centralisation of emergency medical 
services in terms of costs, quality and preferences. 
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Appendix A 
 
   Table A1: Search strategy used in the review 
EMBASE  
 
#1 ((Emergency adj (medici* OR service* OR department)) OR Trauma OR (Speciali* adj (health OR center OR care 
OR unit OR medical OR service)) OR care OR health OR clinical OR Hospital OR Acute) 
 
#2 (Centrali* OR Regionali* OR Reconfigurat* OR Reorgani* OR Redesign* OR Consolidat* OR Merg*) 
 
#3 1 AND 2 
 
#4 (cost OR cost adj (effective* OR utility* OR saving* OR minimi* OR analysis* OR benefi* OR illness*)) 
 
#5 3 AND 4 
 
PubMed  
 
#1 ((Emergency adj (medici* OR service* OR department) OR “ED” OR “A&E” OR Trauma OR (Speciali* adj (health 
OR center OR care OR unit OR medical OR service)) OR care OR health OR “clinical service*” OR Hospital OR 
Acute)) 
 
#2 (Centrali* OR Regionali* OR Reconfigurat* OR Reorgani* OR Redesign* OR Consolidat* OR Merg* OR Volume) 
 
#3 1 AND 2 
 
#4 (cost OR cost adj (effective* OR utility* OR saving* OR minimi* OR analysis* OR benefi* OR illness*)  
#5 3 AND 4  
 
NHS EED  
 
#1 (centralisation OR concentration OR volume OR specialization OR regionalization OR multidisciplinary OR 
reconfiguration OR Reorganization)  
 
#2 (“Emergency Medical Services” OR “Emergency Department” OR A&E OR Specialized OR Trauma OR “Acute 
Care” OR Hospital OR “Healthcare” OR “Health Care Service” OR “Clinical Service” OR “Vascular Service” OR 
Cancer OR Stroke) 
 
#3 Cost OR Economic OR Saving OR Outcome OR Impact OR Implication OR “health economic” 
 
HEED 
 
#1 Hospital OR “health care” OR “health care service” OR Emergency OR Trauma OR “Acute Care” OR “Vascular 
Service” OR Centre OR Stroke OR Cancer 
 
#2 Centrali* OR Region* OR Reconfigur* OR Consolidat* OR Merg* OR Concentrat* OR Reorgani* OR Redesign* 
OR “high volume”  
 
#3 1 AND 2 
 
#4 Cost OR Economic OR “health economic” OR Impact OR Implication OR Evaluation OR Outcome OR Effect OR 
Efficiency OR Sustain 
 
#5 3 AND 4 
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Table A2: Checklist used to assess the methodological quality in included 
studies 
1. Is a clear description of the study objective and comparators provided? 
2. Are the characteristics of target population and subgroups described and analysed?  
3. Is the setting and location of the study stated? 
4. Is the study perspective clearly stated? 
5. Is the time horizon of costs and benefits clear? 
6. Is the discount rate stated or an explanation is given if costs or benefits are not discounted 
(where applicable)? 
7. Are the source and methods used to collect effectiveness data described? 
8. Are the primary outcome measure(s) for economic evaluation clearly stated? 
9. Are the quantities of resources reported separately from their unit costs? 
10.  Are approaches used to estimate resource use and cost clear? 
11. Are the cost components clearly stated? 
12.  Is the currency/price year explicitly stated? 
13.  Are the analytic methods supporting the evaluation including methods for dealing with skewed, 
missing, or censored data, extrapolation methods, methods for pooling data, approaches to 
validate or make adjustments to a model, methods for handling population heterogeneity and 
uncertainty described in details?  
14. Are the incremental costs and outcomes reported (If applicable incremental cost-effectiveness 
ratios reported)? 
15. Is sensitivity analysis carried out? 
16. Are the study limitations discussed? 
17. Is the study generalisability discussed?  
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Table A3: Basic information on included studies 
Study 
Reference  
Study  Population sample 
assessed 
Healthcare 
assessed 
Alternatives 
compared 
Costs analysed  Outcomes assessed 
1 Nallamothu BK, Saint S, Ramsey SD, et 
al. The role of hospital volume in 
coronary artery bypass grafting: is 
more always better? J Am Coll Cardiol 
2001;38(7):1923-30. 
N=13,644 
, >35years age, having 
undergone isolated, 
non-emergent CABG, 
mean age=64.5 years 
Non emergent 
coronary artery 
bypass grafting 
Low Vs High volume 
hospitals 
Direct and indirect 
hospital costs are 
said to be included - 
but cost components 
not clear 
In-hospital mortality 
rate, length of hospital 
stay  
2 Dimick JB, Cattaneo SM, Lipsett PA, et 
al. Hospital volume is related to clinical 
and economic outcomes of esophageal 
resection in Maryland. The Annals of 
Thoracic Surgery 2001;72(2):334-40. 
N=1,136, All patients 
discharged from 
hospitals with 
esophageal resection 
during the study 
period, mean age=61 
years 
Esophageal 
resection 
High Vs Medium Vs 
Low volume 
hospitals 
Hospital charges-but 
cost components not 
clear 
In-hospital mortality 
rate, length of hospital 
stay  
3 Lyman S, Jones EC, Bach PB, et al. The 
association between hospital volume 
and total shoulder arthroplasty 
outcomes. Clin Orthop Relat Res 
2005(432):132-7. 
N=1,307, All patients 
undergoing elective 
shoulder arthroplasty 
during the study 
period, mean 
age=65.6 years 
Shoulder 
arthroplasty 
High Vs Medium Vs 
Low volume 
hospitals 
Hospital charges 
reported on the 
inpatient bill- but 
cost components not 
clear 
Re-admission rate 
within 60 days, revision 
rate within 12 or 24 
months, mortality rate 
within 60 days, length 
of hospital stay  
4 Bardach NS, Olson SJ, Elkins JS, et al. 
Regionalization of treatment for 
subarachnoid hemorrhage: a cost-
utility analysis. Circulation 
2004;109(18):2207-12. 
 
Base case of 59 year 
old woman with 
subarachnoid 
hemorrhage 
modelled 
Treatment of 
Subarachnoid 
Hemorrhage 
High Vs Low volume 
hospitals 
Hospital costs, costs 
of transfer from low 
volume to high 
volume hospital, cost 
of caring disabled,  
QALYs 
5 Concannon TW, Kent DM, Normand SL, 
et al. Comparative effectiveness of ST-
segment-elevation myocardial 
infarction regionalization strategies. 
Circ Cardiovasc Qual Outcomes 
2010;3(5):506-13. 
 
2000 patients 
simulated, 55.5-66.6 
years mean age in 
different subgroups 
Primary 
percutaneous 
coronary 
intervention (PCI)  
Standard care Vs 
Diverting patients to 
hospitals with PCI 
facilities Vs 
scenarios adding PCI 
facilities to existing 
hospitals 
Not clear what cost 
components were 
analysed 
QALYs 
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Table A3 continued: Basic information on included studies 
Study 
Reference  
Study  Population sample 
assessed 
Healthcare 
assessed 
Alternatives 
compared 
Costs analysed  Outcomes assessed 
6 Gandjour A, Weyler EJ. Cost-
effectiveness of referrals to high-volume 
hospitals: an analysis based on a 
probabilistic Markov model for hip 
fracture surgeries. Health Care Manag 
Sci 2006;9(4):359-69. 
Hypothetical hip 
fracture patients 
hospitalized for 
surgery, mean age=74 
years modelled. 
Hip fracture surgery High Vs Low volume 
hospitals 
Hospital costs 
including labor and 
materials costs for 
clinical care and 
ancillary services 
such as radiology, 
catering and 
cleaning; costs of 
hospital 
infrastructure, travel 
costs to hospital 
Mortality rate, QALYs 
7 Geomini PM, Kruitwagen RF, Bremer GL, 
et al. Should we centralise care for the 
patient suspected of having ovarian 
malignancy? Gynecol Oncol 
2011;122(1):95-9. 
 
N=7,598 women who 
received surgery for 
an adnexal mass, No 
mean age reported 
Centralised and 
regular care for 
ovarian malignancy 
General 
gynaecologists in a 
general hospital Vs 
gyanecological 
oncologist whether 
or not in a 
specialised center 
Vs systematic 
diagnostic 
evaluation prior to 
surgery 
Doctors’ cost for 
diagnosis and 
surgical treatment, 
salary costs for 
gyanecological 
oncologist,  costs of 
chemotherapy 
Life years gained 
8 Sutton JM, Wilson GC, Paquette IM, et 
al. Cost effectiveness after a 
pancreaticoduodenectomy: bolstering 
the volume argument. HPB (Oxford) 
2014;16(12):1056-61. 
N=9883, >18 years 
age, undergone 
pancreatico-
duodenectomy, 
modelled 
Pancreatic surgery Lowest Vs Low Vs 
Middle Vs High Vs 
Highest volume 
hospitals 
Total direct costs 
said to be included-
but not clear on cost 
components 
Post-operative death 
prior to discharge 
9 Chan T, Kim J, Minich LL, et al. Surgical 
Volume, Hospital Quality, and 
Hospitalization Cost in Congenital Heart 
Surgery in the United States. Pediatric 
Cardiology 2015;36(1):205-13. 
N=24,992, <18 years 
age, underwent 
congenital cardiac  
surgery 
Congenital cardiac 
surgery 
High Vs Medium Vs 
Low volume 
hospitals 
Hospital costs but 
cost components not 
clear 
Mortality rate, number 
of complications 
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Table A3 continued: Basic information on included studies 
Study 
Reference  
Study  Population sample 
assessed 
Healthcare 
assessed 
Alternatives 
compared 
Costs analysed  Outcomes assessed 
10 Hunter RM, Davie C, Rudd A, et al. 
Impact on Clinical and Cost Outcomes of 
a Centralized Approach to Acute Stroke 
Care in London: A Comparative 
Effectiveness Before and After Model. 
PLoS ONE 2013;8(8):e70420. 
N=3463, had ischemic 
or hemorrhagic 
stroke, mean age=71-
72.8 years, modelled 
Acute stroke care Local hospitals Vs 
Centralised hyper 
acute stroke units 
Costs of transport, 
acute hospitalisation, 
imaging and surgical 
interventions, staff 
contacts and 
medications during 
acute hospitalisation 
and post-discharge 
care 
QALYs, deaths averted 
11 Tanke MAC, Ikkersheim DE. A new 
approach to the tradeoff between 
quality and accessibility of health care. 
Health Policy 2012;105(2–3):282-87. 
 
Women undergoing 
breast cancer 
treatment- modelled 
Breast cancer care Local hospitals Vs 
Centralised hospital 
Travel costs for 
patients that stem 
from centralisation 
QALYs 
12 Losina E, Walensky RP, Kessler CL, et al. 
Cost-effectiveness of total knee 
arthroplasty in the United States: 
patient risk and hospital volume. Arch 
Intern Med 2009;169(12):1113-21; 
discussion 21-2. 
N=121,432, >65 years 
with end stage knee 
Osteoarthritis, 
modelled 
Total knee 
arthroplasty(TKA) 
Low Vs Medium Vs 
High volume 
hospitals 
TKA costs-Hospital 
costs, physician 
costs, costs of 
complications, costs 
of rehabilitation 
following discharge; 
Osteoarthritis(OA) 
cost-Inpatient and 
ambulatory visits, 
Knee OA 
medications, MRIs 
and radiograms 
QALYs 
13 Seguin J, Garber BG, Coyle D, et al. An 
economic evaluation of trauma care in a 
Canadian lead trauma hospital. J 
Trauma 1999;47(3 Suppl):S99-103. 
N=484, median 
age=39 years, trauma 
admissions with an 
Injury Severity Score 
(ISS)>12 
Trauma care Tertiary trauma care 
center Vs Non 
trauma center 
hospital 
Direct costs of 
treatment (e.g. staff, 
consumables) and 
indirect costs(e.g. 
overheads)- cost 
component not clear 
QALYs 
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Table A3 continued: Basic information on included studies 
Study 
Reference  
Study  Population sample 
assessed 
Healthcare 
assessed 
Alternatives 
compared 
Costs analysed  Outcomes assessed 
14 MacKenzie EJ, Weir S, Rivara FP, et al. 
The value of trauma center care. J 
Trauma 2010;69(1):1-10. 
 
N=5043, 18-84 years, 
treated for a 
moderately severe to 
severe injury 
Trauma care Level I trauma 
center Vs non 
trauma center 
hospital 
Costs associated 
with-Index 
hospitalisation, 
transport, hospital 
transfers, re-
hospitalisation, 
inpatient 
rehabilitation, stays 
in long-term care, 
nursing facilities, 
outpatient care, 
informal care by 
friends and family  
Incremental lives 
saved, incremental life 
years gained, 
incremental QALY 
gained 
15 Tsao SY, Lee WC, Loong CC, et al. High-
surgical-volume hospitals associated 
with better quality and lower cost of 
kidney transplantation in Taiwan. J Chin 
Med Assoc 2011;74(1):22-7. 
 
N=1060, >18 years of 
age, patients with 
kidney transplants 
Kidney 
transplantation 
High Vs Low volume 
hospitals 
Total medical cost of 
the transplant, 
annual medical cost 
for 3 years after the 
transplant 
Complications-
infection, mortality, 
readmission in 14 days, 
patient survival at 1,2, 
and 3 years of 
transplantation 
16 Yoshioka R, Yasunaga H, Hasegawa K, et 
al. Impact of hospital volume on hospital 
mortality, length of stay and total costs 
after pancreaticoduodenectomy. British 
Journal of Surgery 2014;101(5):523-29. 
N=10652, mean 
age=67.3 years, 
patients undergoing 
pancreatico-
duodenectomy 
Pancreatic surgery Very high Vs High Vs 
Medium Vs Low Vs 
Very low volume 
hospitals 
Costs of surgical, 
pharmaceutical, 
laboratory and other 
inpatient services- 
but cost components 
not clear 
Post-operative 
mortality, length of 
hospital stay 
17 Joynt KE, Orav EJ, Jha AK. The 
association between hospital volume 
and processes, outcomes, and costs of 
care for congestive heart failure. Ann 
Intern Med 2011;154(2):94-102. 
 
N=1,029,497, median 
age=80 years, 
patients >65 years of 
age with discharge 
diagnosis of 
congestive heart 
failure 
Congestive heart 
failure care 
High Vs Medium Vs 
Low volume 
hospitals 
No clear information 
on cost 
Mortality, readmission 
rates 
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Table A3 continued: Basic information on included studies 
Study 
Reference  
Study  Population sample 
assessed 
Healthcare 
assessed 
Alternatives 
compared 
Costs analysed  Outcomes assessed 
18 Ellison LM, Heaney JA, Birkmeyer JD. 
The effect of hospital volume on 
mortality and resource use after radical 
prostatectomy. J Urol 2000;163(3):867-
9. 
N=66,693 men, mean 
age= 65 years, patients 
undergoing radical 
prostatectomy 
Radical 
prostatectomy 
High Vs Low volume 
hospitals 
Hospital charges- but 
no clear information 
on cost components 
In-hospital mortality, 
length of hospital stay  
19 Nathan H, Atoria CL, Bach PB, et al. 
Hospital Volume, Complications, and 
Cost of Cancer Surgery in the Elderly. 
Journal of Clinical Oncology 2014 
N=60,361, >66 years of 
age, patients diagnosed 
with cancer of the 
bladder, colon, lung, 
pancreas, prostate, or 
rectum and undergone 
surgical resection 
Cancer surgery- 
included 
colectomy, 
cystectomy, 
pancreatectomy, 
proctectomy, 
prostatectomy, 
and pulmonary 
lobectomy 
High Vs Mid Vs Low 
volume hospitals 
Medicare payments 
for diagnosis related 
group, index 
hospitalisation and 
readmissions within 
30 days from 
discharge; home 
health agencies, 
rehabilitation 
hospital, skilled 
nursing facilities in 
the corresponding 30 
days after discharge. 
However unit costs 
of each not 
presented. 
Post-operative patient 
outcomes- mortality, 
complications, 
readmissions, and 
emergency room visits 
within 30 days after 
surgery 
20 Sosa JA, Bowman HM, Gordon TA, et al. 
Importance of hospital volume in the 
overall management of pancreatic 
cancer. Ann Surg 1998;228(3):429-38. 
N=1236, mean age=67 
years, patients with 
pancreatic cancer and 
undergoing a primary 
treatment procedure 
Palliative 
procedures and 
curative surgery 
for pancreatic 
cancer 
High Vs Medium Vs 
Low volume 
hospitals 
Hospital charges- but 
not clear on its 
components 
In-hospital mortality 
rate, length of hospital 
stay,  
21 Mitsuyasu S, Hagihara A, Horiguchi H, et 
al. Relationship Between Total 
Arthroplasty Case Volume and Patient 
Outcome in an Acute Care Payment 
System in Japan. The Journal of 
Arthroplasty 2006;21(5):656-63. 
N=1561, mean age=69.8 
years, patients who had 
undergone joint 
arthroplasty 
Total 
Arthroplasty 
High Vs Low volume 
hospitals  
Hospital costs- but 
not clear on its 
components 
Length of hospital stay  
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Table A3 continued: Basic information on included studies 
Study 
Reference  
Study  Population sample 
assessed 
Healthcare 
assessed 
Alternatives 
compared 
Costs analysed  Outcomes assessed 
22 Swisher SG, Deford L, Merriman KW, et 
al. Effect of operative volume on 
morbidity, mortality, and hospital use 
after esophagectomy for cancer. J 
Thorac Cardiovasc Surg 
2000;119(6):1126-32. 
N=340, age not 
specified, patients who 
underwent  esophageal 
resection for cancer 
Esophagectomy High Vs Low 
volume; Cancer 
Specialised Vs 
Community 
hospitals 
Hospital charge- but 
not clear on its 
components 
Operative mortality, 
complications of care 
23 Gordon TA, Burleyson GP, Tielsch JM, et 
al. The effects of regionalization on cost 
and outcome for one general high-risk 
surgical procedure. Ann Surg 
1995;221(1):43-9. 
N=502, mean age=62 
years, patients 
undergone pancreatico-
duodenectomies 
Pancreatic 
surgery 
High volume 
regional hospital Vs 
numerous lower-
volume hospitals 
Hospital charges-but 
not clear on its 
components 
In-hospital mortality, 
length of ICU and 
hospital stay  
24 Yu HY, Hevelone ND, Patel S, et al. 
Hospital surgical volume, utilization, 
costs and outcomes of retroperitoneal 
lymph node dissection for testis cancer. 
Adv Urol 2012;2012:189823. 
N=993, >18 years of 
age, undergone 
retroperitoneal lymph 
node dissection for 
testis cancer, mean 
age=30.9 years 
Retroperitoneal 
lymph node 
dissection for 
testis cancer 
High Vs Low volume 
hospitals 
Inpatient charges-
but not clear on its 
components 
Mortality, Length of 
hospital stay, 
25 Glasgow RE, Mulvihill SJ. Hospital 
volume influences outcome in patients 
undergoing pancreatic resection for 
cancer. West J Med 1996;165(5):294-
300. 
N=1705, median age=65 
years (range 2-85 
years), patients 
undergoing pancreatic 
resection 
Pancreatic 
resection 
Comparison of 
several different 
volume hospitals 
Hospital charges- but 
not clear on its 
components 
Operative mortality, 
Length of hospital stay, 
patient discharged to 
home 
26 Dimick JB, Pronovost PJ, Lipsett PA. The 
Effect of ICU Physician Staffing and 
Hospital Volume on Outcomes After 
Hepatic Resection. Journal of Intensive 
Care Medicine 2002;17(1):41-47. 
N=569,>18 years of age, 
having primary 
procedure code for 
hepatectomy; mean 
age=57 years,  
Managing 
Hepatic resection 
ICU physician 
rounds and no ICU 
physician rounds in  
High Vs Low volume 
hospitals, High Vs 
Low volume 
surgeons, (only 
hospital volume was 
considered in this 
review) 
Hospital charges-but 
not clear on its 
components 
In-hospital mortality, 
length of hospital stay 
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Table A3 continued: Basic information on included studies 
Study 
Reference  
Study  Population sample 
assessed 
Healthcare 
assessed 
Alternatives 
compared 
Costs analysed  Outcomes assessed 
27 Slover JD, Tosteson AN, Bozic KJ, et al. 
Impact of hospital volume on the 
economic value of computer navigation 
for total knee replacement. J Bone Joint 
Surg Am 2008;90(7):1492-500. 
Hypothetical cohort of 
65 year old patients 
with end-stage arthritis 
of the knee were 
modelled. 
Computer 
assisted surgery 
in end-stage 
arthritis of the 
knee 
Conventional total 
knee replacement 
without computer 
navigation and 
computer assisted 
surgery compared in 
high vs low volume 
hospitals 
Reimbursement 
costs of primary and 
revision total knee 
replacement and 
computer navigation 
including cost of 
computer software 
and service contract- 
no information on 
breakdown of unit 
costs and resource 
consumption 
QALYs, revision rates 
28 Nguyen NT, Paya M, Stevens CM, et al. 
The relationship between hospital 
volume and outcome in bariatric surgery 
at academic medical centers. Ann Surg 
2004;240(4):586-93; discussion 93-4. 
N=24,166, patients who 
underwent Roux-en-Y 
gastric bypass for the 
treatment of morbid 
obesity, No age 
restrictions,  
Bariatric surgery High Vs Medium Vs 
Low volume 
hospitals 
Not clear- but 
appears to be cost of 
surgery 
Perioperative 
outcomes- length of 
hospital stay, 
complications, 
readmissions; In-
hospital mortality 
29 Vogel TR, Dombrovskiy VY, Graham AM, 
et al. The impact of hospital volume on 
the development of infectious 
complications after elective abdominal 
aortic surgery in the Medicare 
population. Vasc Endovascular Surg 
2011;45(4):317-24. 
N=59365 elective aortic 
surgery procedures, >65 
years of age with 
nonruptured abdominal 
aortic aneurysms 
Elective aortic 
surgery 
High Vs Low volume 
hospitals 
Hospital charges- but 
not clear on its 
components 
In-hospital mortality, 
postoperative 
infectious 
complications, length 
of ICU stay, length of 
hospital stay 
30 Ananthakrishnan AN, McGinley EL, 
Saeian K. Higher hospital volume is 
associated with lower mortality in acute 
nonvariceal upper-GI hemorrhage. 
Gastrointest Endosc 2009;70(3):422-32. 
N=391,119 discharges 
with a primary diagnosis 
of nonvariceal upper-GI 
hemorrhage, >18 years 
of age 
Treatment of 
acute nonvariceal 
upper-GI 
hemorrhage 
High Vs Medium Vs 
Low volume 
hospitals 
Hospital charges- but 
components not 
clear 
In-hospital mortality, 
length of hospital stay 
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Table A3 continued: Basic information on included studies 
Study 
Reference  
Study  Population sample 
assessed 
Healthcare 
assessed 
Alternatives 
compared 
Costs analysed  Outcomes assessed 
31 Simpson AN, Wardrope J, Burke D. The 
Sheffield experiment: the effects of 
centralising accident and emergency 
services in a large urban setting. 
Emergency Medicine Journal 
2001;18(3):193-97. 
N=371,293 annual new 
patient attendances 
analysed 
Centralisation of 
accident and 
emergency 
services 
Before 
centralisation Vs 
after centralisation 
The cost of A&E 
services as a whole, 
the cost per case in 
the A&E; do not 
include capital 
expenditure 
generated by 
building 
works/equipment 
costs as a result of 
centralisation 
Quality of patient care 
in terms of time to see 
a doctor or nurse 
practitioner, time to 
admission 
32 Shen HN, Lu CL, Li CY. The effect of 
hospital volume on patient outcomes in 
severe acute pancreatitis. BMC 
Gastroenterol 2012;12:112. 
N=22,551 patients with 
severe acute 
pancreatitis, age range 
(38-73) years 
Treatment of 
severe acute 
pancreatitis 
Comparison of 
several different 
volume quartiles 
Hospital charges- but 
components not 
clear 
Hospital mortality,  
length of hospital stay 
33 Singla A, Simons J, Li Y, et al. Admission 
Volume Determines Outcome for 
Patients With Acute Pancreatitis. 
Gastroenterology 2009;137(6):1995-
2001. 
N=416, 489, >18 years 
of age patients with 
primary diagnosis of 
acute pancreatitis, 
mean age=53 years 
Treatment of 
acute 
pancreatitis 
High Vs Low volume 
hospitals 
Hospital charges- but 
components not 
clear 
In-hospital mortality, 
length of hospital stay 
34 Koo JJ, Wang J, Thompson CB, et al. 
Impact of Hospital Volume and 
Specialization on the Cost of Orbital 
Trauma Care. Ophthalmology 
2013;120(12):2741-46. 
N=499, patients who 
underwent orbital 
reconstruction, mean 
age=34 years (range 3-
94) 
Orbital trauma 
care 
Specialised eye 
trauma center Vs 
Local hospitals 
Hospital charges-but 
components not 
clear 
Readmission, length of 
hospital stay 
35 Gordon TA, Bowman HM, Bass EB, et al. 
Complex gastrointestinal surgery: 
impact of provider experience on clinical 
and economic outcomes. J Am Coll Surg 
1999;189(1):46-56. 
N=4,561, patients 
discharged after 
complex 
gastrointestinal surgical 
procedures, mean 
age=61.6 years 
Complex 
gastrointestinal 
surgical 
procedures 
High Vs Medium Vs 
Low volume 
hospitals 
Hospital charges-but 
components not 
clear 
In-hospital mortality,  
length of hospital stay 
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Table A3 continued: Basic information on included studies 
Study 
Reference  
Study  Population sample 
assessed 
Healthcare 
assessed 
Alternatives 
compared 
Costs analysed  Outcomes assessed 
36 Choti MA, Bowman HM, Pitt HA, et al. 
Should hepatic resections be performed 
at high-volume referral centers? J 
Gastrointest Surg 1998;2(1):11-20. 
N=606, patients 
undergone hepatic 
resection, mean 
age=54.8 years 
Hepatic 
resections 
High Vs Low volume 
hospitals 
Hospital charges-but 
components not 
clear 
In-hospital mortality, 
length of hospital stay 
37 Harmon JW, Tang DG, Gordon TA, et al. 
Hospital volume can serve as a 
surrogate for surgeon volume for 
achieving excellent outcomes in 
colorectal resection. Ann Surg 
1999;230(3):404-11; discussion 11-3. 
N=9739, >18 years of 
age, patients who 
underwent colorectal 
section as the primary 
procedure, mean 
age=69.2 years 
Colorectal 
resections 
High Vs Medium Vs 
Low volume 
hospitals and 
surgeons (but 
surgeons not 
included in this 
review) 
Hospital charges-but 
components not 
clear 
In-hospital mortality, 
length of hospital stay 
38 Díaz-Montes TP, Zahurak ML, Giuntoli Ii 
RL, et al. Concentration of uterine 
cancer surgical care among the elderly: 
A population-based perspective. 
Gynecologic Oncology 2007;107(3):436-
40. 
N=6181, >18 years of 
age women with 
primary surgical 
procedure for a 
malignant uterine 
neoplasm,  
Uterine cancer 
surgical care 
High Vs Low volume 
hospitals and 
surgeons (but 
surgeons not 
included in this 
review) 
Hospital costs- but 
components not 
clear 
Peri-operative 
mortality rates, length 
of hospital stay, length 
of ICU stay 
39 Wright JD, Hershman DL, Burke WM, et 
al. Influence of surgical volume on 
outcome for laparoscopic hysterectomy 
for endometrial cancer. Ann Surg Oncol 
2012;19(3):948-58. 
N=4,137, women who 
underwent laparoscopic 
hysterectomy for 
endometrial cancer 
Laparoscopic 
hysterectomy 
High Vs 
Intermediate Vs Low 
volume hospitals 
and surgeons (but 
surgeons not 
included in this 
review) 
Hospital costs-but 
components not 
clear 
Perioperative 
morbidity and 
mortality, length of 
hospital stay, 
readmissions within 60 
days 
40 Diaz-Montes TP, Giuntoli RL. Volume-
Based Care among Young Women 
Diagnosed with Uterine Cancer. ISRN 
Surg 2011;2011:541461. 
N=6,181, >18 years of 
age women with 
primary surgical 
procedure for a 
malignant uterine 
neoplasm 
Caring uterine 
cancer 
High Vs Low volume 
hospitals and 
surgeons (but 
surgeons not 
included in this 
review) 
Hospital costs- but 
components not 
clear 
Length of hospital stay, 
length of ICU stay, in-
hospital mortality 
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Table A3 continued: Basic information on included studies 
Study 
Reference  
Study  Population sample 
assessed 
Healthcare 
assessed 
Alternatives 
compared 
Costs analysed  Outcomes assessed 
41 Lee JA, Park JH, Lee EJ, et al. High-
quality, low-cost gastrectomy care at 
high-volume hospitals: results from a 
population-based study in South Korea. 
Arch Surg 2011;146(8):930-6. 
N=48,938, patient 
undergoing gastrectomy, 
mean age=58 years 
Gastrectomy 
care 
Very high Vs high Vs 
Very low Vs Low 
volume hospitals 
Hospital costs-but 
components not clear 
Length of hospital 
stay, standard 
mortality ratio 
42 Tsugawa Y, Kumamaru H, Yasunaga H, et 
al. The association of hospital volume 
with mortality and costs of care for 
stroke in Japan. Med Care 
2013;51(9):782-8. 
N=66,406, primary 
admission diagnosis of 
stroke,  
Stroke care High Vs Medium Vs 
Low volume 
hospitals 
Total costs of hospital 
care- costs components 
broken down into: costs 
of oral medications, 
injectables, surgical and 
non-surgical procedures, 
tests, imaging studies 
In-hospital 
mortality 
43 Chiu CC, Wang JJ, Tsai TC, et al. The 
relationship between volume and 
outcome after bariatric surgery: a 
nationwide study in Taiwan. Obes Surg 
2012;22(7):1008-15. 
N=2,674, >18 years of age 
patients who had 
undergone bariatric 
surgery, mean age=32.21 
years 
Bariatric 
surgery 
High Vs Low volume 
hospitals and 
surgeons (but 
surgeons not 
included in this 
review) 
Hospital treatment cost-
but components not 
clear 
Length of hospital 
stay 
44 Safford SD, Pietrobon R, Safford KM, et 
al. A study of 11,003 patients with 
hypertrophic pyloric stenosis and the 
association between surgeon and 
hospital volume and outcomes. J Pediatr 
Surg 2005;40(6):967-72; discussion 72-3. 
N=11,003, children with 
hypertrophic pyloric 
stenosis, mean age=41.1 
days 
Hypertrophic 
pyloric stenosis 
surgery 
High Vs Medium Vs 
Low volume 
hospitals and 
surgeons (but 
surgeons not 
included in this 
review) 
Cost components not 
clear 
Length of hospital 
stay, complications, 
mortality 
45 Long DM, Gordon T, Bowman H, et al. 
Outcome and cost of craniotomy 
performed to treat tumors in regional 
academic referral centers. Neurosurgery 
2003;52(5):1056-63; discussion 63-5. 
N= 4,723, patient 
undergoing a craniotomy 
for a benign tumor, 
primary or secondary 
malignant neoplasm, 
mean age=54.5 years 
Craniotomy High Vs Low volume 
hospitals 
Hospitals charges-but 
components not clear 
In-hospital 
mortality, length of 
hospital stay 
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Table A3 continued: Basic information on included studies 
Study 
Reference  
Study  Population sample 
assessed 
Healthcare 
assessed 
Alternatives 
compared 
Costs analysed  Outcomes assessed 
46 Clement RC, Carr BG, Kallan MJ, et al. 
Volume-outcome relationship in 
neurotrauma care. J Neurosurg 
2013;118(3):687-93. 
N=61,067, patient with 
neurological trauma 
Neurotrauma 
care 
Several different 
volume hospitals 
Hospital costs-but 
components not clear 
Mortality, length of 
hospital stay, poor 
outcomes (not 
clearly defined) 
47 Hamada T, Yasunaga H, Nakai Y, et al. 
Impact of hospital volume on outcomes 
in acute pancreatitis: a study using a 
nationwide administrative database. J 
Gastroenterol 2014;49(1):148-55. 
N=17,415, >20 years age 
patients with acute 
pancreatitis, mean 
age=61.1 years 
Acute 
pancreatitis 
care 
High Vs Low volume 
hospitals 
Hospital costs- reported 
the inclusion of item by 
item price for surgical, 
pharmaceutical, 
laboratory and other 
inpatient services, 
however cost details not 
provided 
In-hospital 
mortality, length of 
hospital stay 
48 Gutierrez B, Culler SD, Freund DA. Does 
hospital procedure-specific volume 
affect treatment costs? A national study 
of knee replacement surgery. Health 
Serv Res 1998;33(3 Pt 1):489-511. 
N=67,041 patient 
hospitalisation in which 
knee replacement surgery 
had been performed, 
mean age=74 years 
Knee 
replacement 
surgery 
High Vs Medium Vs 
Low volume 
hospitals 
Hospital costs-but 
components not clear 
Mortality, 
complications 
49 Auerbach AD, Hilton JF, Maselli J, et al. 
Case volume, quality of care, and care 
efficiency in coronary artery bypass 
surgery. Arch Intern Med 
2010;170(14):1202-8. 
N=81,289 patients who 
underwent coronary 
artery bypass surgery, 
mean age=65 years 
Coronary artery 
bypass surgery 
Several volume 
quartiles hospitals 
and surgeons (but 
surgeons not 
included in this 
review) 
Hospital costs-but 
components not clear 
Length of hospital 
stay, care quality 
50 Gourin CG, Forastiere AA, Sanguineti G, 
et al. Impact of surgeon and hospital 
volume on short-term outcomes and 
cost of oropharyngeal cancer surgical 
care. Laryngoscope 2011;121(4):746-52. 
N=1,534, >18 years of age 
patients with a diagnosis 
of oropharyngeal cancer, 
mean age=58.3 years 
Oropharyngeal 
cancer surgical 
care 
High Vs low volume 
hospitals and 
surgeons (but 
surgeons not 
included in this 
review) 
Hospital costs-but 
components not clear 
In-hospital 
mortality, length of 
hospital stay, 
readmissions 
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Table A3 continued: Basic information on included studies 
Study 
Reference  
Study  Population sample 
assessed 
Healthcare 
assessed 
Alternatives 
compared 
Costs analysed  Outcomes assessed 
51 Lu CC, Chiu CC, Wang JJ, et al. Volume-
outcome associations after major 
hepatectomy for hepatocellular 
carcinoma: a nationwide Taiwan study. J 
Gastrointest Surg 2014;18(6):1138-45. 
N=23,107, patients 
undergone major 
hepatectomy for 
hepatocellular carcinoma, 
mean age=58.1 years 
Major 
Hepatectomy 
High Vs Low volume 
hospitals and 
surgeons (but 
surgeons not 
included in this 
review) 
Hospital costs- reported 
inclusion of cost of 
operating room, 
radiology, physical 
therapy, hospital room, 
anesthetist, pharmacy, 
laboratory, special 
materials, surgeon and 
others, however cost 
details not provided 
Length of hospital 
stay, survival 
52 Macomber CW, Shaw JJ, Santry H, et al. 
Centre volume and resource 
consumption in liver transplantation. 
HPB (Oxford) 2012;14(8):554-9. 
N=5310, patients who 
underwent liver 
transplants, age range:18-
81 years 
Liver 
transplantation 
High Vs Medium Vs 
Low volume 
hospitals 
Reported as directed 
costs of transplant-but 
cost components not 
clear 
Mortality, 
Transplant to 
length of hospital 
stay, ICU length of 
stay 
53 Kuo EY, Chang Y, Wright CD. Impact of 
hospital volume on clinical and 
economic outcomes for esophagectomy. 
Ann Thorac Surg 2001;72(4):1118-24. 
N=1,193, patients who 
underwent 
esophagectomy, mean 
age=64.3 years 
Esophagectomy High Vs Low volume 
hospitals 
Hospital costs-but 
components not clear 
Length of hospital 
stay, length of ICU 
stay, In-hospital 
mortality, discharge 
destination 
54 Bristow RE, Santillan A, Diaz-Montes TP, 
et al. Centralisation of care for patients 
with advanced-stage ovarian cancer: a 
cost-effectiveness analysis. Cancer 
2007;109(8):1513-22. 
Hypothetical cohort of 
women with advanced-
stage ovarian cancer-
modelled 
Advanced-stage 
ovarian cancer 
care 
Expert center Vs 
Less experienced 
center 
Direct costs-costs of 
primary surgery, 
chemotherapy 
regimens, 
hospitalisation costs for 
treatment related 
toxicity 
Indirect costs- cost of 
lost productivity, care 
giver support. Cost 
components clearly 
stated. 
QALYs 
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Table A3 continued: Basic information on included studies 
Study 
Reference  
Study  Population sample 
assessed 
Healthcare 
assessed 
Alternatives 
compared 
Costs analysed  Outcomes assessed 
55 Greving JP, Vernooij F, Heintz AP, et al. 
Is centralisation of ovarian cancer care 
warranted? A cost-effectiveness 
analysis. Gynecol Oncol 2009;113(1):68-
74. 
N=879 ,Hypothetical 
cohort of women with 
ovarian cancer and a 
mean age of 63 years 
Ovarian cancer 
care 
General Vs Semi-
specialised Vs 
Tertiary hospitals 
Direct costs and 
included- personnel 
costs, operating room 
costs, costs of follow-up 
monitoring and 
treatment. Indirect costs 
were not included.  
QALYs, overall 
survival 
56 Fader DJ, Wise CG, Normolle DP, et al. 
The multidisciplinary melanoma clinic: a 
cost outcomes analysis of specialty care. 
J Am Acad Dermatol 1998;38(5 Pt 
1):742-51. 
N=208 for cost analysis, 
N=954 for long-term 
survival,  patients with 
melanoma (study suffers 
from a fragmented 
effectiveness analyses) 
Melanoma care All treatment at 
Multi-disciplinary 
Melanoma Clinic Vs 
Traditional strategy 
of treating patients 
referred by 
physicians for 
second opinion 
Direct costs- costs of 
office 
visits/consultations, 
surgeries, radiology, 
medical tests, 
laboratories, pathology, 
facility and anesthesia 
included.  Indirect costs 
were not considered. 
Short-term 
outcomes- surgical 
morbidity, length of 
hospital stay 
Long-term 
outcomes – 5 year 
survival 
57 Regenbogen SE, Gust C, Birkmeyer JD. 
Hospital Surgical Volume and Cost of 
Inpatient Surgery in the Elderly. Journal 
of the American College of Surgeons 
2012;215(6):758-65. 
N=101,349,Patients 
undergoing coronary 
artery bypass grafting, 
elective abdominal aortic 
aneurysm, or colectomy; 
older than 65 years and 
younger than 99 years of 
age; mean age=78.4 years 
Inpatient  
operations for 
colectomy, 
coronary artery 
bypass grafting 
and elective 
abdominal 
aortic 
aneurysm 
Several volume 
quintiles hospitals 
Hospital costs- included 
costs of index 
hospitalization, 
readmissions, physician 
services, post-discharge 
ancillary care 
Complication, 
mortality 
58 Avritscher EB, Cooksley CD, Rolston KV, 
et al. Serious postoperative infections 
following resection of common solid 
tumors: outcomes, costs, and impact of 
hospital surgical volume. Support Care 
Cancer 2014;22(2):527-35. 
N=37,582, >75 years of 
age patients who 
underwent resection of 
cancer of the lung, 
esophagus, stomach, 
pancreas, colon, or 
rectum; 
Resection of 
common 
surgical tumors 
High Vs 
Intermediate Vs Low 
volume hospitals 
Hospital costs-but cost 
components not clear 
Serious 
postoperative 
infection, length of 
hospital stay, In-
hospital mortality 
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Table A3 continued: Basic information on included studies 
Study 
Reference  
Study  Population sample 
assessed 
Healthcare 
assessed 
Alternatives 
compared 
Costs analysed  Outcomes assessed 
59 Kilic A, Shah AS, Conte JV, et al. 
Operative outcomes in mitral valve 
surgery: Combined effect of surgeon 
and hospital volume in a population-
based analysis. The Journal of Thoracic 
and Cardiovascular Surgery 
2013;146(3):638-46. 
N=50,152, patients 
undergoing isolated 
mitral valve surgery for 
mitral regurgitation, 
mean age=61.9 years 
Mitral valve 
surgery 
High Vs 
Intermediate Vs Low 
volume hospitals 
and surgeons 
(surgeons not 
included in this 
review) 
Hospital costs- but cost 
components not clear 
Operative 
mortality, mitral 
valve repair rate 
60 Sutton JM, Hoehn RS, Ertel AE, et al. 
Cost-Effectiveness in Hepatic 
Lobectomy: the Effect of Case Volume 
on Mortality, Readmission, and Cost of 
Care. Journal of Gastrointestinal Surgery 
2015;20(2):253-61. 
N= 4163, >18 years of age 
patients who underwent 
hepatic lobectomy, mean 
age= 58 years,  
Hepatic 
lobectomy 
High Vs Medium Vs 
Low volume 
hospitals 
Hospital costs- but 
components not clear 
Peri-operative 
mortality, 
Readmissions 
61 Kim A, Yoon SJ, Kim YA, et al. The 
burden of acute myocardial infarction 
after a regional cardiovascular center 
project in Korea. Int J Qual Health Care 
2015;27(5):349-55. 
N=1469 in each of the 
two  regions, >18 years 
age patients with acute 
myocardial infarction 
Acute 
myocardial 
infarction care 
Before 
regionalisation Vs 
After regionalisation 
Hospital costs-but 
components not clear 
Length of stay 
62 Arora S, Panaich SS, Patel N, et al. 
Impact of Hospital Volume on Outcomes 
of Lower Extremity Endovascular 
Interventions (Insights from 
the Nationwide Inpatient Sample [2006 
to 2011]). The American Journal of 
Cardiology 2015;116(5):791-800. 
N=92,714, >18 years of 
age patients undergoing 
peripheral endovascular 
interventions 
Peripheral 
endovascular  
interventions 
Several volume 
quartiles hospitals 
Hospital costs-but 
components not clear 
In-hospital 
mortality and peri-
procedural 
complications 
63 Wakeam E, Hyder JA, Lipsitz SR, et al. 
Outcomes and Costs for Major Lung 
Resection in the United States: Which 
Patients Benefit Most From High-
Volume Referral? The Annals of Thoracic 
Surgery 2015;100(3):939-46. 
N= 37,746, >18 years of 
age patients who 
underwent a major lung 
resection 
Major lung 
resection 
Very high Vs High Vs 
Moderate Vs Low 
volume hospitals 
according to risk 
groups 
Inpatient costs- but 
components not clear 
In-hospital 
mortality 
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Table A3 continued: Basic information on included studies 
Study 
Reference  
Study  Population sample 
assessed 
Healthcare 
assessed 
Alternatives 
compared 
Costs analysed  Outcomes assessed 
64 Bhatt P, Patel NJ, Patel A, et al. Impact 
of Hospital Volume on Outcomes of 
Endovascular Stenting for Adult Aortic 
Coarctation. The American Journal of 
Cardiology 2015;116(9):1418-24. 
N=105, >18 years of age 
patients with coarctation 
of aorta, mean age= 36.9 
years,  
Treatment of 
coarctation of 
aorta 
High Vs Low volume 
hospitals 
Hospital costs- but 
components not clear 
Length of stay, 
complications 
QALYs= Quality Adjusted Life Years; ICU= Intensive Care Unit 
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B1. Ethical approval document from the Ethics Committee 
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B2. One of the two blocks of questionnaire used in the DCE survey 
 
Survey on Hospital Preferences 
 (Block-1) 
This survey is being carried out by a researcher in health economics at the Institute 
of Health & Society, Newcastle University. We would like to know what is important to 
you when thinking about hospitals which provide accident and emergency care. To 
do this we will ask you to make a series of choices between two hospitals which 
do not exist, but this will allow us to understand what people think is important when 
designing emergency services. We would like to know which hospital you personally 
would prefer to go to if you were suddenly unwell and had called 999, and whether 
your view would change if the hospitals performed differently e.g. reduced or 
increased waiting times or survival rates. We have not suggested a reason why you 
would be unwell, but it is not a painful condition. You would require treatment on the 
same day to feel better and this can only be given in hospital.   
The answers you provide here will only be used for research purposes and will not 
directly affect the healthcare that you need. There are no right or wrong choices, we 
are just interested in knowing your views. You cannot be identified from your 
answers. Please do not write anything which might give away your identity.  
The hospitals differ in terms of the following ways:  
1) Travel time to the hospital: This is the time it takes you to reach the hospital 
by ambulance.  
2) Waiting time in the A&E department to be seen by a doctor or nurse who 
can provide treatment: This is the time you need to wait at the A&E to be 
given specific treatment for your problem by a doctor or nurse.    
3) Length of stay at the hospital before going home: This is the number of 
days you need to stay in this hospital. 
4) Risk of dying from the illness: This is a comparison of the average number 
of persons dying because of this illness after attending hospital.  
5) Risk of being re-admitted to the hospital after going home: This is the 
likelihood of being re-admitted to the hospital after you are discharged. 
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6) Outpatient care after emergency treatment: This is the hospital you need to 
go for outpatient care after discharge following your emergency treatment. 
All other aspects of the two hospitals are the same.  
Example of the task (Please do not fill this one) 
Imagine you have an emergency healthcare need which requires calling an 
ambulance. Below are two hospitals, Hospital A and Hospital B, each with 
different characteristics. If you have a choice, which hospital would you 
choose from below?  
 Hospital A Hospital B 
Travel time to hospital 1 and half hours 1 hour 
Waiting time in the A&E 
department to be seen by a 
doctor or nurse who can provide 
treatment 
4 hours or more Less than 30 minutes 
Length of stay at the hospital 
before going home 
3 days 5 days 
Risk of dying from the illness  Moderate (5 in 100 patients) Mild (3 in 100 patients) 
Risk of being re-admitted to the 
hospital after going home 
Mild (3 in 100 patients)  Moderate (5 in 100 
patients) 
Outpatient care after emergency 
treatment 
At a hospital which is about 
an extra 1 hour travel time 
from your local hospital 
At your local hospital 
Which hospital would you 
choose to go in an emergency? 
(Please tick one box) 
☐ ☐ 
 In this example, 
 It takes 1 and half hours to reach hospital A and takes 1 hour to reach 
hospital B. 
  You need to wait 4 hours or more in the A&E to be treated in hospital A, but 
less than 30 minutes hospital B.  
  The length of stay in Hospital A is 3 days whereas it is 5 days in Hospital B. 
  Patient has moderate risks of death in Hospital A but has mild risks in 
Hospital B.  
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  The risk of being re-admitted is mild for Hospital A and is moderate for 
Hospital B. 
  Outpatient care, after emergency treatment, at hospital B is provided at local 
hospital and at hospital A is provided at a hospital which is about 1 hour travel 
time away from the local hospital.  
Here if hospital B is chosen, the box in the Hospital B column is 
marked with a √ in the box. Or if hospital A is chosen, the box in 
the Hospital A column is marked with √.  
In addition, we will ask you few other questions about you, but remain assured 
that no questions will identify who you are.  
It takes about 15 minutes to complete the survey. Your participation in this survey is 
voluntary and you can stop at any time without providing any reason. If you do 
complete the survey it is not possible to remove your answers later. We cannot 
identify them, but nobody else will know your answers either. Should you have any 
queries regarding the survey you can contact the researcher on this telephone 
01912087821, or email: nawaraj.bhattarai@ncl.ac.uk . 
If you agree to take part in this survey, then please choose which emergency hospital 
you would like to go to in the following situations.  Please note that in each of the 
situations the characteristics of hospitals change.  
For each situation please indicate which hospital you prefer by putting a tick (√ ) in 
the appropriate box.  
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Scenario 1 
Imagine you have an emergency healthcare need which requires calling an 
ambulance. Below are two hospitals, hospital A and hospital B, each with 
different characteristics. If you have a choice, which hospital would you 
choose from below? 
 
Hospital A     Hospital B     
Travel time to hospital 
1 hour     
1 and half 
hours     
Waiting time in the A&E department to be seen 
by a doctor or nurse who can provide treatment 
2 and half 
hours     
1 hour     
Length of stay at the hospital before going home 3 days     5 days     
Risk of dying from the illness  Mild (3 in 100 
patients)     
Moderate (5 in 
100 patients)     
Risk of being re-admitted to the hospital after 
going home 
Mild (3 in 100 
patients)     
Moderate (5 in 
100 patients)     
Outpatient care after emergency treatment 
At your local 
hospital     
At a hospital 
which is about 
an extra 1 hour 
travel time from 
your local 
hospital 
Which hospital would you choose to go in an 
emergency? (Please tick one box)     
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Scenario 2  
Imagine you have an emergency healthcare need which requires calling an 
ambulance. Below are two hospitals, hospital A and hospital B, each with 
different characteristics. If you have a choice, which hospital would you 
choose from below? 
 
Hospital A     Hospital B     
Travel time to hospital 
1 hour     
1 and half 
hours     
Waiting time in the A&E department to be seen by 
a doctor or nurse who can provide treatment 
1 hour     
2 and half 
hours     
Length of stay at the hospital before going home 5 days     3 days     
Risk of dying from the illness  High (7 in 100 
patients)     
Mild (3 in 100 
patients)     
Risk of being re-admitted to the hospital after 
going home 
Moderate (5 in 
100 patients)     
Mild (3 in 100 
patients)     
Outpatient care after emergency treatment At a hospital 
which is about an 
extra 1 hour 
travel time from 
your local 
hospital 
At your local 
hospital     
Which hospital would you choose to go in an 
emergency? (Please tick one box)     
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Scenario 3 
Imagine you have an emergency healthcare need which requires calling an 
ambulance. Below are two hospitals, hospital A and hospital B, each with 
different characteristics. If you have a choice, which hospital would you 
choose from below? 
    Hospital A     Hospital B     
Travel time to hospital 2 hours or 
more     
Less than 30 
minutes     
Waiting time in the A&E department to be seen 
by a doctor or nurse who can provide treatment 
4 hours or 
more     
1 hour     
Length of stay at the hospital before going 
home 
1 day or less     6 days or more     
Risk of dying from the illness  Low (1 in 100 
patients)     
High (7 in 100 
patients)     
Risk of being re-admitted to the hospital after 
going home 
High (7 in 100 
patients)     
Low (1 in 100 
patients)     
Outpatient care after emergency treatment 
At your local 
hospital 
At a hospital 
which about an 
extra 1 hour travel 
time from your 
local hospital     
Which hospital would you choose to go in an 
emergency? (Please tick one box)     
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Scenario 4 
Imagine you have an emergency healthcare need which requires calling an 
ambulance. Below are two hospitals, hospital A and hospital B, each with 
different characteristics. If you have a choice, which hospital would you 
choose from below? 
     Hospital A     Hospital B     
Travel time to hospital 
1 hour     
1 and half 
hours     
Waiting time in the A&E department to be seen by 
a doctor or nurse who can provide treatment 
4 hours or 
more     
 Less than 30 
minutes     
Length of stay at the hospital before going home 5 days     3 days     
Risk of dying from the illness  Moderate (5 in 
100 patients)     
Mild (3 in 100 
patients)     
Risk of being re-admitted to the hospital after 
going home 
Moderate (5 in 
100 patients)     
Mild (3 in 100 
patients)     
Outpatient care after emergency treatment 
At your local 
hospital     
At a hospital 
which is about 
an extra 1 hour 
travel time 
from your local 
hospital     
Which hospital would you choose to go in an 
emergency? (Please tick one box)     
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Scenario 5 
Imagine you have an emergency healthcare need which requires calling an 
ambulance. Below are two hospitals, hospital A and hospital B, each with 
different characteristics. If you have a choice, which hospital would you 
choose from below? 
 
Hospital A     Hospital B     
Travel time to hospital 1 and half 
hours     
1 hour     
Waiting time in the A&E department to be seen 
by a doctor or nurse who can provide 
treatment 
2 and half 
hours     
1 hour     
Length of stay at the hospital before going 
home 
3 days     5 days 
Risk of dying from the illness  Moderate (5 in 
100 patients)     
Mild (3 in 100 
patients)     
Risk of being re-admitted to the hospital after 
going home 
Mild (3 in 100 
patients)     
Moderate (5 in 
100 patients)     
Outpatient care after emergency treatment At a hospital 
which is about an 
extra 1 hour travel 
time from your 
local hospital 
At your local 
hospital     
Which hospital would you choose to go in an 
emergency? (Please tick one box)     
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Scenario 6 
Imagine you have an emergency healthcare need which requires calling an 
ambulance. Below are two hospitals, hospital A and hospital B, each with 
different characteristics. If you have a choice, which hospital would you 
choose from below? 
 
Hospital A     Hospital B     
Travel time to hospital Less than 30 
minutes     
1 and half 
hours     
Waiting time in the A&E department to be seen 
by a doctor or nurse who can provide treatment 
1 hour     
2 and half 
hours     
Length of stay at the hospital before going 
home 
6 days or more     3 days     
Risk of dying from the illness  High (7 in 100 
patients)     
Mild (3 in 100 
patients)     
Risk of being re-admitted to the hospital after 
going home 
Low (1 in 100 
patients)     
Mild (3 in 100 
patients)     
Outpatient care after emergency treatment At a hospital 
which is about an 
extra 1 hour travel 
time from your 
local hospital 
At your local 
hospital     
Which hospital would you choose to go in an 
emergency? (Please tick one box)     
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Scenario 7 
Imagine you have an emergency healthcare need which requires calling an 
ambulance. Below are two hospitals, hospital A and hospital B, each with 
different characteristics. If you have a choice, which hospital would you 
choose from below? 
     Hospital A     Hospital B     
Travel time to hospital 2 hours or 
more     
Less than 30 
minutes     
Waiting time in the A&E department to be 
seen by a doctor or nurse who can provide 
treatment 
Less than 30 
minutes     
4 hours or 
more     
Length of stay at the hospital before going 
home 
6 days or more     1 day or less     
Risk of dying from the illness  Moderate (5 in 
100 patients)     
Mild (3 in 100 
patients)     
Risk of being re-admitted to the hospital after 
going home 
Low (1 in 100 
patients)     
High (7 in 100 
patients)     
Outpatient care after emergency treatment At a hospital 
which is about an 
extra 1 hour 
travel time from 
your local hospital  
At your local 
hospital     
Which hospital would you choose to go in an 
emergency? (Please tick one box)     
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Scenario 8 
Imagine you have an emergency healthcare need which requires calling an 
ambulance. Below are two hospitals, hospital A and hospital B, each with 
different characteristics. If you have a choice, which hospital would you 
choose from below? 
 
Hospital A     Hospital B     
Travel time to hospital 1 and half hours     1 hour     
Waiting time in the A&E department to be 
seen by a doctor or nurse who can provide 
treatment 
1 hour     
2 and half 
hours     
Length of stay at the hospital before going 
home 
3 days      5 days     
Risk of dying from the illness  Mild (3 in 100 
patients)     
Moderate (5 in 
100 patients)     
Risk of being re-admitted to the hospital 
after going home 
Mild (3 in 100 
patients)     
Moderate (5 in 
100 patients)     
Outpatient care after emergency treatment 
At your local 
hospital     
At a hospital 
which is about an 
extra 1 hour travel 
time from your 
local hospital 
Which hospital would you choose to go in 
an emergency? (Please tick one box)     
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Scenario 9 
Imagine you have an emergency healthcare need which requires calling an 
ambulance. Below are two hospitals, hospital A and hospital B, each with 
different characteristics. If you have a choice, which hospital would you 
choose from below? 
 
Hospital A     Hospital B     
Travel time to hospital 2 hours or more     1 and half hours     
Waiting time in the A&E department to be 
seen by a doctor or nurse who can provide 
treatment 
4 hours or more     2 and half hours     
Length of stay at the hospital before going 
home 
1 day or less     3 days     
Risk of dying from the illness  Low (1 in 100 
patients)     
Mild (3 in 100 
patients)     
Risk of being re-admitted to the hospital 
after going home 
High (7 in 100 
patients)     
Mild (3 in 100 
patients)     
Outpatient care after emergency treatment At your local 
hospital 
At your local 
hospital     
Which hospital would you choose to go in 
an emergency? (Please tick one box)     
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Scenario 10 
Imagine you have an emergency healthcare need which requires calling an 
ambulance. Below are two hospitals, hospital A and hospital B, each with 
different characteristics. If you have a choice, which hospital would you 
choose from below? 
    Hospital A     Hospital B     
Travel time to hospital Less than 30 
minutes     
2 hours or more     
Waiting time in the A&E department to be 
seen by a doctor or nurse who can provide 
treatment 
1 hour     2 and half hours     
Length of stay at the hospital before going 
home 
1 day or less     6 days or more     
Risk of dying from the illness  High (7 in 100 
patients)     
Low (1 in 100 
patients)     
Risk of being re-admitted to the hospital 
after going home 
Low (1 in 100 
patients)     
High (7 in 100 
patients)     
Outpatient care after emergency treatment At a hospital which 
is about an extra 1 
hour travel time 
from your local 
hospital     
At your local 
hospital 
Which hospital would you choose to go in 
an emergency? (Please tick one box)     
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Scenario 11 
Imagine you have an emergency healthcare need which requires calling an 
ambulance. Below are two hospitals, hospital A and hospital B, each with 
different characteristics. If you have a choice, which hospital would you 
choose from below? 
     Hospital A     Hospital B     
Travel time to hospital Less than 30 
minutes     
2 hours or more     
Waiting time in the A&E department to be 
seen by a doctor or nurse who can provide 
treatment 
2 and half hours     1 hour     
Length of stay at the hospital before going 
home 
6 days or more     1 day or less     
Risk of dying from the illness  Low (1 in 100 
patients)     
High (7 in 100 
patients)     
Risk of being re-admitted to the hospital 
after going home 
Moderate (5 in 100 
patients)     
Mild (3 in 100 
patients)     
Outpatient care after emergency treatment At a hospital which 
is about an extra 1 
hour travel time 
from your local 
hospital 
At your local 
hospital     
Which hospital would you choose to go in 
an emergency? (Please tick one box)     
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Scenario 12 
Imagine you have an emergency healthcare need which requires calling an 
ambulance. Below are two hospitals, hospital A and hospital B, each with 
different characteristics. If you have a choice, which hospital would you 
choose from below? 
     Hospital A     Hospital B     
Travel time to hospital 
2 hours or more     
Less than 30 
minutes     
Waiting time in the A&E department to be 
seen by a doctor or nurse who can provide 
treatment 
4 hours or more     
Less than 30 
minutes     
Length of stay at the hospital before going 
home 
6 days or more     1 day or less     
Risk of dying from the illness  High (7 in 100 
patients)     
Low (1 in 100 
patients)     
Risk of being re-admitted to the hospital 
after going home 
High (7 in 100 
patients)     
Low (1 in 100 
patients)     
Outpatient care after emergency treatment At a hospital which 
is about an extra 1 
hour travel time 
from your local 
hospital 
At your local 
hospital     
Which hospital would you choose to go in 
an emergency? (Please tick one box)     
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Scenario 13 
Imagine you have an emergency healthcare need which requires calling an 
ambulance. Below are two hospitals, hospital A and hospital B, each with 
different characteristics. If you have a choice, which hospital would you 
choose from below? 
 
Hospital A     Hospital B     
Travel time to hospital 1 and half hours     1 hour     
Waiting time in the A&E department to be 
seen by a doctor or nurse who can provide 
treatment 
Less than 30 
minutes     
4 hours or more     
Length of stay at the hospital before going 
home 
5 days      3 days     
Risk of dying from the illness  Mild (3 in 100 
patients)     
Moderate (5 in 100 
patients)     
Risk of being re-admitted to the hospital 
after going home 
High (7 in 100 
patients)     
Low (1 in 100 
patients)     
Outpatient care after emergency treatment 
At your local 
hospital 
At a hospital which 
is about an extra 1 
hour travel time 
from your local 
hospital 
Which hospital would you choose to go in 
an emergency? (Please tick one box)     
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Could you please indicate how easy or difficult it has been to complete the above 
choice sets (Please tick only one of the boxes)  
Very difficult                ☐  
Difficult                        ☐                                  
Somewhat Difficult       ☐                              
Neutral                         ☐ 
Somewhat Easy           ☐ 
Easy                             ☐ 
Very Easy                   ☐ 
 
Finally, we would be grateful if you could provide the following information 
about you. (Remain assured that no questions will identify who you are)  
Are you a male or female? (Please tick one of the boxes below) 
Male                    ☐  
Female                ☐  
Prefer not to say ☐ 
Which of the following age group do you belong to? (Please tick one of the 
boxes below)   
16-29  ☐                             30-34   ☐                             35-39    ☐   
40-44  ☐                             45-49  ☐                              50-54  ☐   
55-59  ☐                             60-64   ☐                              65-69 ☐  
70-75  ☐                             75-79  ☐                              80-84    ☐   
85+     ☐  
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What is your post code? (Please fill in below; we only need your partial post code, 
not the house/flat or street name, example NE30)   
    
 
 
What is the name of the GP surgery you are registered with? (Please write in the 
space below. Please note we will not contact them. This is simply to help understand 
the results of the survey better).  
 
………………………………………………………………… 
 
 
In the last 12 months how many times have you visited the hospital with 
emergency healthcare need?  
0 ☐    1☐            2 ☐                 3 ☐                4 or more ☐  
 
Under each heading, please tick the ONE box that best describes your current 
state of health. 
MOBILITY 
I have no problems in walking about   
I have slight problems in walking about   
I have moderate problems in walking about  
I have severe problems in walking about  
I am unable to walk about  
 
SELF-CARE 
I have no problems washing or dressing myself  
I have slight problems washing or dressing myself  
I have moderate problems washing or dressing myself   
I have severe problems washing or dressing myself  
I am unable to wash or dress myself  
219 
 
 
USUAL ACTIVITIES (e.g. work, study, housework, family or leisure activities) 
I have no problems doing my usual activities   
I have slight problems doing my usual activities  
I have moderate problems doing my usual activities   
I have severe problems doing my usual activities    
I am unable to do my usual activities   
 
PAIN / DISCOMFORT 
I have no pain or discomfort   
I have slight pain or discomfort  
I have moderate pain or discomfort  
I have severe pain or discomfort  
I have extreme pain or discomfort  
 
ANXIETY / DEPRESSION 
I am not anxious or depressed  
I am slightly anxious or depressed   
I am moderately anxious or depressed  
I am severely anxious or depressed  
I am extremely anxious or depressed  
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How would you rate the current state of your health? (Please indicate by marking 
whichever point on the scale below indicates how good or bad your health state is 
today, imagining best state is marked 100 and the worst state is marked 0)  
 
  
 
Now please write the number you marked on the scale in the box 
below 
Your health today =  
 
 
 
 
 
 
 
 
 
 
 
 
 
                     
 
 
 
 
 
 
Thank you for taking part in this survey. 
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B3. Email confirming the approval of Caldicott proposal 
form regarding the use of HES data 
 
From: Christopher Price 
Sent: 20 November 2018 13:59 
To: Nawaraj Bhattarai; Peter McMeekin 
Subject: FW: Caldicott Request Re-organisation of Emergency Medical Services 
Attachments: CaldicottApprovalFormv912112012  Chris Price.pdf 
 
Hi – here’s the Caldicott form and the email confirming approval. 
Chris 
 
 
From: Hetherington Ellis (RTF) NHCT  
Sent: Tuesday, July 23, 2013 11:00 AM 
To: Price Christopher (RTF) NHCT 
Subject: Caldicott Request Re-organisation of Emergency Medical Services 
 
Your Caldicott proposal form entitled Re-organisation of Emergency Medical Services which has been 
given reference C2678 has been approved, but with the following security /confidentiality instruction: 
1. No patient identifiable data is to be stored on a laptop.  
2. No patient identifiable data to be stored on any removable media for example CD, floppy disc or 
USB.  
 
3. Patient identifiable data must be stored on the secure systems and networks only. 
4. No identifiable patient information can be used in any reports, publications or presentations.  
If you disregard any of the above you are in breach of Caldicott approval and may result in disciplinary 
action.  
The signed form is being returned to you today. 
 
Ellis Hetherington 
Business Admin Apprentice 
Computer Services 
Cobalt Business Park  
 
Tel: 0191 2031278 
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B4. Caldicott proposal form regarding the use of HES data 
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Appendix C 
 
 
Figure C1: Multiple CEAC for sub-groups of Males and Females at 30 days 
 
 
Figure C2: Multiple CEAC for sub-groups of Males and Females at one year 
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Figure C3: Multiple CEAC for sub-groups of Males and Females at 10 years 
 
 
 
Figure C4: Multiple CEAC for sub-groups of Age 30-64 and Age 65 or over at 30 
days 
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 Figure C5: Multiple CEAC for sub-groups of Age 30-64 and Age 65 or over at 
one year 
 
 
 
Figure C6: Multiple CEAC for sub-groups of CCI0 and CCI4 at 30 days 
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Figure C7: Multiple CEAC for sub-groups of CCI0 and CCI4 at one year 
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Figure C8: Multiple CEAC for sub-groups of CCI0 and CCI4 at 10 years 
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Figure C9: Multiple CEAC for sub-groups of IMD1 and IMD5 at 30 days 
 
 
Figure C10: Multiple CEAC for sub-groups of IMD1 and IMD5 at one year 
 
 
 
 
 
 
 
0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
0.9
1
0 20000 40000 60000 80000 100000
P
ro
b
ab
ili
ty
 c
o
st
-e
ff
ec
ti
ve
Willingness to pay value (£)
IMD1
IMD5
0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
0.9
1
0 20000 40000 60000 80000 100000
P
ro
b
ab
ili
ty
 c
o
st
-e
ff
ec
ti
ve
Willingness to pay value (£)
IMD1
IMD5
232 
 
 
Figure C11: Multiple CEAC for sub-groups of disease at 30 days 
 
 
Figure C12: Multiple CEAC for sub-groups of disease at one year 
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Table C1: Transition probabilities for the first 30 days used in the local hospital – Base case 
Day Transition probability (Standard Error) 
Community to A&E to Admission to 
Community  A&E (SE) Dead (SE) Community Admission (SE) Dead (SE) Admission  Community(SE) Dead(SE) 
1 0.9744 0.0215 (0.0002) 0.0041 (0.0001) 0.3754 0.6215 (0.0010) 0.0031 (0.0001) 0.7669 0.22 (0.0008) 0.0131 (0.0002) 
2 0.9669 0.0283 (0.0003) 0.0048 (0.0001) 0.3754 0.6215 (0.0010) 0.0031 (0.0001) 0.6547 0.3238 (0.0009) 0.0215 (0.0003) 
3 0.9614 0.0333 (0.0003) 0.0053 (0.0001) 0.3754 0.6215 (0.0010) 0.0031 (0.0001) 0.5726 0.3992 (0.001) 0.0282 (0.0003) 
4 0.9570 0.0373 (0.0003) 0.0057 (0.0001) 0.3754 0.6215 (0.0010) 0.0031 (0.0001) 0.5076 0.4585 (0.001) 0.0339  (0.0004) 
5 0.9533 0.0407 (0.0003) 0.006   (0.0001) 0.3754 0.6215 (0.0010) 0.0031 (0.0001) 0.4541 0.5071 (0.001) 0.0388  (0.0004) 
6 0.9499 0.0438 (0.0004) 0.0063 (0.0001) 0.3754 0.6215 (0.0010) 0.0031 (0.0001) 0.4089 0.548 (0.001) 0.0431 (0.0004) 
7 0.9470 0.0465 (0.0004) 0.0065 (0.0001) 0.3754 0.6215 (0.0010) 0.0031 (0.0001) 0.3702 0.583 (0.001) 0.0468 (0.0004) 
8 0.9442 0.0491 (0.0004) 0.0067 (0.0002) 0.3754 0.6215 (0.0010) 0.0031 (0.0001) 0.3365 0.6133 (0.0009) 0.0502 (0.0004) 
9 0.9417 0.0514 (0.0004) 0.0069 (0.0002) 0.3754 0.6215 (0.0010) 0.0031 (0.0001) 0.3070 0.6398 (0.0009) 0.0532 (0.0004) 
10 0.9393 0.0536 (0.0004) 0.0071 (0.0002) 0.3754 0.6215 (0.0010) 0.0031 (0.0001) 0.2810 0.6631 (0.0009) 0.0559 (0.0004) 
11 0.9372 0.0556 (0.0004) 0.0072 (0.0002) 0.3754 0.6215 (0.0010) 0.0031 (0.0001) 0.2578 0.6839 (0.0009) 0.0583 (0.0005) 
12 0.9351 0.0575 (0.0004) 0.0074 (0.0002) 0.3754 0.6215 (0.0010) 0.0031 (0.0001) 0.2372 0.7023 (0.0009) 0.0605 (0.0005) 
13 0.9331 0.0594 (0.0004) 0.0075 (0.0002) 0.3754 0.6215 (0.0010) 0.0031 (0.0001) 0.2186 0.7189 (0.0009) 0.0625 (0.0005) 
14 0.9313 0.0611 (0.0004) 0.0076 (0.0002) 0.3754 0.6215 (0.0010) 0.0031 (0.0001) 0.2018 0.7338 (0.0009) 0.0644 (0.0005) 
15 0.9294 0.0628 (0.0004) 0.0078 (0.0002) 0.3754 0.6215 (0.0010) 0.0031 (0.0001) 0.1866 0.7473 (0.0009) 0.0661 (0.0005) 
16 0.9277 0.0644 (0.0004) 0.0079 (0.0002) 0.3754 0.6215 (0.0010) 0.0031 (0.0001) 0.1729 0.7595 (0.0008) 0.0676 (0.0005) 
17 0.9261 0.0659 (0.0004) 0.008  (0.0002) 0.3754 0.6215 (0.0010) 0.0031 (0.0001) 0.1604 0.7706 (0.0008) 0.069  (0.0005) 
18 0.9245 0.0674 (0.0004) 0.0081 (0.0002) 0.3754 0.6215 (0.0010) 0.0031 (0.0001) 0.1490 0.7807 (0.0008) 0.0703 (0.0005) 
19 0.9229 0.0689 (0.0004) 0.0082 (0.0002) 0.3754 0.6215 (0.0010) 0.0031 (0.0001) 0.1386 0.7899 (0.0008) 0.0715 (0.0005) 
20 0.9214 0.0703 (0.0005) 0.0083 (0.0002)  0.3754 0.6215 (0.0010) 0.0031 (0.0001) 0.1289 0.7984 (0.0008) 0.0727 (0.0005) 
21 0.9200 0.0716 (0.0005) 0.0084 (0.0002) 0.3754 0.6215 (0.0010) 0.0031 (0.0001) 0.1202 0.8061 (0.0008) 0.0737 (0.0005) 
22 0.9186 0.0729 (0.0005) 0.0085 (0.0002) 0.3754 0.6215 (0.0010) 0.0031 (0.0001) 0.1121 0.8132 (0.0008) 0.0747 (0.0005) 
23 0.9173 0.0742 (0.0005) 0.0085 (0.0002) 0.3754 0.6215 (0.0010) 0.0031 (0.0001) 0.1047 0.8198 (0.0008) 0.0755 (0.0005) 
24 0.9160 0.0754 (0.0005) 0.0086 (0.0002) 0.3754 0.6215 (0.0010) 0.0031 (0.0001) 0.0978 0.8258 (0.0007) 0.0764 (0.0005) 
25 0.9147 0.0766 (0.0005) 0.0087 (0.0002) 0.3754 0.6215 (0.0010) 0.0031 (0.0001) 0.0916 0.8313 (0.0007) 0.0771 (0.0005) 
26 0.9134 0.0778 (0.0005) 0.0088 (0.0002) 0.3754 0.6215 (0.0010) 0.0031 (0.0001) 0.0857 0.8365 (0.0007) 0.0778 (0.0005) 
27 0.9121 0.079   (0.0005) 0.0089 (0.0002) 0.3754 0.6215 (0.0010) 0.0031 (0.0001) 0.0803 0.8412 (0.0007) 0.0785 (0.0005) 
28 0.9110 0.0801 (0.0005) 0.0089 (0.0002) 0.3754 0.6215 (0.0010) 0.0031 (0.0001) 0.0753 0.8456 (0.0007) 0.0791 (0.0005) 
29 0.9098 0.0812 (0.0005) 0.009  (0.0002) 0.3754 0.6215 (0.0010) 0.0031 (0.0001) 0.0706 0.8497 (0.0007) 0.0797 (0.0005) 
30 0.9086 0.0823 (0.0005) 0.0091 (0.0002) 0.3754 0.6215 (0.0010) 0.0031 (0.0001) 0.0662 0.8535 (0.0007) 0.0803 (0.0005) 
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Table C2: Transition probabilities for the first 30 days used in the central hospital- Base case 
Day Transition probability (Standard Error) 
Community to A&E to Admission to 
Community  A&E (SE) Dead (SE) Community Admission(SE) Dead(SE) Admission  Community(SE) Dead (SE) 
1 0.9830 0.0137 (0.0004) 0.0033 (0.0002) 0.3670 0.6298 (0.0021) 0.0032 (0.0002) 0.7828 0.2112 (0.0016) 0.006 (0.0002) 
2 0.9765 0.0194 (0.0005) 0.0041 (0.0002) 0.3670 0.6298 (0.0021) 0.0032 (0.0002) 0.6615 0.3272 (0.002) 0.0113 (0.0004) 
3 0.9718 0.0236 (0.0005) 0.0046 (0.0003) 0.3670 0.6298 (0.0021) 0.0032 (0.0002) 0.5702 0.4139 (0.0021) 0.0159 (0.0004) 
4 0.9676 0.0273 (0.0006) 0.0051 (0.0003) 0.3670 0.6298 (0.0021) 0.0032 (0.0002) 0.4971 0.4829 (0.0021) 0.02  (0.0005) 
5 0.9642 0.0304 (0.0006) 0.0054 (0.0003) 0.3670 0.6298 (0.0021) 0.0032 (0.0002) 0.4366 0.5397 (0.0021) 0.0237 (0.0006) 
6 0.9609 0.0333 (0.0006) 0.0058 (0.0003) 0.3670 0.6298 (0.0021) 0.0032 (0.0002) 0.3858 0.5872 (0.0021) 0.027  (0.0006) 
7 0.9580 0.0359 (0.0007) 0.0061 (0.0003) 0.3670 0.6298 (0.0021) 0.0032 (0.0002) 0.3425 0.6276 (0.0021) 0.0299  (0.0006) 
8 0.9554 0.0383 (0.0007) 0.0063 (0.0003) 0.3670 0.6298 (0.0021) 0.0032 (0.0002) 0.3051 0.6623 (0.002) 0.0326  (0.0007) 
9 0.9528 0.0406 (0.0007) 0.0066 (0.0003) 0.3670 0.6298 (0.0021) 0.0032 (0.0002) 0.2728 0.6923 (0.002) 0.0349  (0.0007) 
10 0.9505 0.0427 (0.0007) 0.0068 (0.0003) 0.3670 0.6298 (0.0021) 0.0032 (0.0002) 0.2444 0.7185 (0.0019) 0.0371  (0.0007) 
11 0.9482 0.0448 (0.0008) 0.007  (0.0003) 0.3670 0.6298 (0.0021) 0.0032 (0.0002) 0.2196 0.7414 (0.0019) 0.039  (0.0007) 
12 0.9461 0.0467 (0.0008) 0.0072 (0.0003) 0.3670 0.6298 (0.0021) 0.0032 (0.0002) 0.1977 0.7615 (0.0018) 0.0408  (0.0007) 
13 0.9440 0.0486 (0.0008) 0.0074 (0.0003) 0.3670 0.6298 (0.0021) 0.0032 (0.0002) 0.1784 0.7793 (0.0017) 0.0423 (0.0007) 
14 0.9421 0.0504 (0.0008) 0.0075 (0.0003) 0.3670 0.6298 (0.0021) 0.0032 (0.0002) 0.1612 0.795   (0.0017) 0.0438 (0.0007) 
15 0.9402 0.0521 (0.0008) 0.0077 (0.0003) 0.3670 0.6298 (0.0021) 0.0032 (0.0002) 0.1459 0.809   (0.0016) 0.0451 (0.0008) 
16 0.9383 0.0538 (0.0008) 0.0079 (0.0003) 0.3670 0.6298 (0.0021) 0.0032 (0.0002) 0.1322 0.8215 (0.0016) 0.0463 (0.0008) 
17 0.9366 0.0554 (0.0008) 0.008 (0.0003) 0.3670 0.6298 (0.0021) 0.0032 (0.0002) 0.1199 0.8327 (0.0015) 0.0474 (0.0008) 
18 0.9350 0.0569 (0.0009) 0.0081 (0.0003) 0.3670 0.6298 (0.0021) 0.0032 (0.0002) 0.1090 0.8426 (0.0015) 0.0484 (0.0008) 
19 0.9333 0.0584 (0.0009) 0.0083 (0.0004) 0.3670 0.6298 (0.0021) 0.0032 (0.0002) 0.0991 0.8516 (0.0014) 0.0493 (0.0008) 
20 0.9317 0.0599 (0.0009) 0.0084 (0.0004) 0.3670 0.6298 (0.0021) 0.0032 (0.0002) 0.0903 0.8596 (0.0014) 0.0501 (0.0008) 
21 0.9302 0.0613 (0.0009) 0.0085 (0.0004) 0.3670 0.6298 (0.0021) 0.0032 (0.0002) 0.0823 0.8669 (0.0014) 0.0508 (0.0008) 
22 0.9286 0.0627 (0.0009) 0.0087 (0.0004) 0.3670 0.6298 (0.0021) 0.0032 (0.0002) 0.0751 0.8734 (0.0013) 0.0515 (0.0008) 
23 0.9271 0.0641 (0.0009) 0.0088 (0.0004) 0.3670 0.6298 (0.0021) 0.0032 (0.0002) 0.0685 0.8793 (0.0013) 0.0522 (0.0008) 
24 0.9257 0.0654 (0.0009) 0.0089 (0.0004) 0.3670 0.6298 (0.0021) 0.0032 (0.0002) 0.0626 0.8846 (0.0013) 0.0528 (0.0008) 
25 0.9243 0.0667 (0.0009) 0.009 (0.0004) 0.3670 0.6298 (0.0021) 0.0032 (0.0002) 0.0573 0.8894 (0.0012) 0.0533 (0.0008) 
26 0.9229 0.068 (0.0009) 0.0091 (0.0004) 0.3670 0.6298 (0.0021) 0.0032 (0.0002) 0.0524 0.8938 (0.0012) 0.0538 (0.0008) 
27 0.9215 0.0693 (0.0009) 0.0092 (0.0004) 0.3670 0.6298 (0.0021) 0.0032 (0.0002) 0.0481 0.8977 (0.0012) 0.0542 (0.0008) 
28 0.9202 0.0705 (0.0009) 0.0093 (0.0004) 0.3670 0.6298 (0.0021) 0.0032 (0.0002) 0.0441 0.9013 (0.0011) 0.0546 (0.0008) 
29 0.9189 0.0717 (0.001) 0.0094 (0.0004) 0.3670 0.6298 (0.0021) 0.0032 (0.0002) 0.0404 0.9046 (0.0011) 0.055 (0.0008) 
30 0.9176 0.0729 (0.001) 0.0095 (0.0004) 0.3670 0.6298 (0.0021) 0.0032 (0.0002) 0.0370 0.9076 (0.0011) 0.0554 (0.0008) 
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Table C3: Transition probabilities for the first 30 days used in the local hospital- Age group <=29 
Day Transition Probability (Standard Error) 
Community to A&E to Admission to 
Community  A&E (SE) Dead (SE) Community Admission (SE) Dead (SE) Admission  Community(SE) Dead(SE) 
1 0.9784 0.0215(0.0007) 0.0001 (0.0001) 0.646 0.353 (0.003) 0.000 (0.0001) 0.7618 0.2261 (0.0012) 0.0121 (0.0003) 
2 0.9726 0.0273(0.0008) 0.0001 (0.0001) 0.646 0.353 (0.003) 0.000 (0.0001) 0.6479 0.3313 (0.0013) 0.0208 (0.0004) 
3 0.9686 0.0313 (0.0009) 0.0001 (0.0001) 0.646 0.353 (0.003) 0.000 (0.0001) 0.5646 0.4073 (0.0014) 0.0281 (0.0005) 
4 0.9653 0.0346 (0.001) 0.0001 (0.0002) 0.646 0.353 (0.003) 0.000 (0.0001) 0.4989 0.4668 (0.0014) 0.0343 (0.0005) 
5 0.9626 0.0373 (0.001) 0.0001 (0.0002) 0.646 0.353 (0.003) 0.000 (0.0001) 0.4449 0.5154 (0.0014) 0.0397 (0.0006) 
6 0.9602 0.0397(0.001) 0.0001 (0.0002) 0.646 0.353 (0.003) 0.000 (0.0001) 0.3994 0.5561 (0.0014) 0.0445 (0.0006) 
7 0.9579 0.0419 (0.0011) 0.0002 (0.0002) 0.646 0.353 (0.003) 0.000 (0.0001) 0.3604 0.5908 (0.0014) 0.0488 (0.0006) 
8 0.956 0.0438 (0.0011) 0.0002 (0.0002) 0.646 0.353 (0.003) 0.000 (0.0001) 0.3266 0.6207 (0.0014) 0.0527 (0.0006) 
9 0.9542 0.0456 (0.0011) 0.0002 (0.0002) 0.646 0.353 (0.003) 0.000 (0.0001) 0.2971 0.6468 (0.0014) 0.0561 (0.0006) 
10 0.9525 0.0473 (0.0011) 0.0002 (0.0002) 0.646 0.353 (0.003) 0.000 (0.0001) 0.2710 0.6697 (0.0014) 0.0593 (0.0007) 
11 0.951 0.0488 (0.0012) 0.0002 (0.0002) 0.646 0.353 (0.003) 0.000 (0.0001) 0.2480 0.6899 (0.0013) 0.0621 (0.0007) 
12 0.9495 0.0503 (0.0012) 0.0002 (0.0002) 0.646 0.353 (0.003) 0.000 (0.0001) 0.2274 0.7079 (0.0013) 0.0647 (0.0007) 
13 0.9481 0.0517 (0.0012) 0.0002 (0.0003)  0.646 0.353 (0.003) 0.000 (0.0001) 0.2089 0.724 (0.0013) 0.0671 (0.0007) 
14 0.9468 0.053 (0.0012) 0.0002 (0.0003) 0.646 0.353 (0.003) 0.000 (0.0001) 0.1922 0.7385 (0.0013) 0.0693 (0.0007) 
15 0.9455 0.0543 (0.0012) 0.0002 (0.0003) 0.646 0.353 (0.003) 0.000 (0.0001) 0.1772 0.7515 (0.0013) 0.0713 (0.0007) 
16 0.9443 0.0555 (0.0012) 0.0002 (0.0003) 0.646 0.353 (0.003) 0.000 (0.0001) 0.1637 0.7632 (0.0013) 0.0731 (0.0007) 
17 0.9432 0.0566 (0.0013) 0.0002 (0.0003) 0.646 0.353 (0.003) 0.000 (0.0001) 0.1514 0.7738 (0.0012) 0.0748 (0.0007) 
18 0.9421 0.0577 (0.0013) 0.0002 (0.0003) 0.646 0.353 (0.003) 0.000 (0.0001) 0.1401 0.7835 (0.0012) 0.0764 (0.0007) 
19 0.941 0.0588 (0.0013) 0.0002 (0.0003) 0.646 0.353 (0.003) 0.000 (0.0001) 0.1300 0.7922 (0.0012) 0.0778 (0.0007) 
20 0.94 0.0598 (0.0013) 0.0002 (0.0003) 0.646 0.353 (0.003) 0.000 (0.0001) 0.1207 0.8002 (0.0012) 0.0791 (0.0007) 
21 0.939 0.0608 (0.0013) 0.0002 (0.0003) 0.646 0.353 (0.003) 0.000 (0.0001) 0.1120 0.8076 (0.0012) 0.0804 (0.0008) 
22 0.938 0.0618 (0.0013) 0.0002 (0.0003) 0.646 0.353 (0.003) 0.000 (0.0001) 0.1042 0.8143 (0.0012) 0.0815 (0.0008) 
23 0.9371 0.0627 (0.0013) 0.0002 (0.0003) 0.646 0.353 (0.003) 0.000 (0.0001) 0.0970 0.8204 (0.0011) 0.0826 (0.0008) 
24 0.9362 0.0636 (0.0013) 0.0002 (0.0003) 0.646 0.353 (0.003) 0.000 (0.0001) 0.0904 0.826  (0.0011) 0.0836 (0.0008) 
25 0.9353 0.0645 (0.0013) 0.0002 (0.0003) 0.646 0.353 (0.003) 0.000 (0.0001) 0.0843 0.8312 (0.0011) 0.0845 (0.0008) 
26 0.9345 0.0653 (0.0014) 0.0002 (0.0003) 0.646 0.353 (0.003) 0.000 (0.0001) 0.0787 0.836 (0.0011) 0.0853 (0.0008) 
27 0.9336 0.0662 (0.0014) 0.0002 (0.0003) 0.646 0.353 (0.003) 0.000 (0.0001) 0.0735 0.8404 (0.0011) 0.0861 (0.0008) 
28 0.9328 0.067 (0.0014) 0.0002 (0.0004) 0.646 0.353 (0.003) 0.000 (0.0001) 0.0686 0.8445 (0.0011)  0.0869 (0.0008) 
29 0.932 0.0678 (0.0014) 0.0002 (0.0004) 0.646 0.353 (0.003) 0.000 (0.0001) 0.0642 0.8482 (0.001) 0.0876 (0.0008) 
30 0.9312 0.0686 (0.0014) 0.0002 (0.0004) 0.646 0.353 (0.003) 0.000 (0.0001) 0.0601 0.8517 (0.0011) 0.0882 (0.0008) 
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Table C4: Transition probabilities for the first 30 days used in the central hospital-Age group <=29 
Day Transition Probability (Standard Error) 
Community to A&E to Admission to 
Community  A&E (SE) Dead (SE) Community Admission(SE) Dead(SE) Admission  Community(SE) Dead (SE) 
1 0.9848 0.0152 (0) 0 (0) 0.5838 0.4160 (0.0078) 0.0002 (0.0002) 0.6326 0.3674 (0) 0 (0) 
2 0.9801 0.0199 (0) 0 (0) 0.5838 0.4160 (0.0078) 0.0002 (0.0002) 0.3105 0.6895 (0) 0 (0) 
3 0.9767 0.0233 (0) 0 (0) 0.5838 0.4160 (0.0078) 0.0002 (0.0002) 0.1300 0.87 (0) 0 (0) 
4 0.9739 0.0261 (0) 0 (0) 0.5838 0.4160 (0.0078) 0.0002 (0.0002) 0.0476 0.9524 (0) 0 (0) 
5 0.9716 0.0284 (0)  0 (0) 0.5838 0.4160 (0.0078) 0.0002 (0.0002) 0.0154 0.9846 (0) 0 (0) 
6 0.9695 0.0305 (0) 0 (0) 0.5838 0.4160 (0.0078) 0.0002 (0.0002) 0.0045 0.9955 (0) 0 (0) 
7 0.9676 0.0324 (0) 0 (0) 0.5838 0.4160 (0.0078) 0.0002 (0.0002) 0.0012 0.9988 (0) 0 (0) 
8 0.9659 0.0341 (0) 0 (0) 0.5838 0.4160 (0.0078) 0.0002 (0.0002) 0.0003 0.9997 (0) 0 (0) 
9 0.9643 0.0357 (0) 0 (0) 0.5838 0.4160 (0.0078) 0.0002 (0.0002) 0.0001 0.9999 (0) 0 (0) 
10 0.9628 0.0372 (0) 0 (0) 0.5838 0.4160 (0.0078) 0.0002 (0.0002) 0.0000 1 (0) 0 (0) 
11 0.9614 0.0386 (0) 0 (0) 0.5838 0.4160 (0.0078) 0.0002 (0.0002) 0.0000 1 (0) 0 (0) 
12 0.9601 0.0399 (0) 0 (0) 0.5838 0.4160 (0.0078) 0.0002 (0.0002) 0.0000 1 (0) 0 (0) 
13 0.9588 0.0412 (0) 0 (0) 0.5838 0.4160 (0.0078) 0.0002 (0.0002) 0.0000 1 (0) 0 (0) 
14 0.9577 0.0423 (0) 0 (0) 0.5838 0.4160 (0.0078) 0.0002 (0.0002) 0.0000 1 (0) 0 (0) 
15 0.9565 0.0435 (0) 0 (0) 0.5838 0.4160 (0.0078) 0.0002 (0.0002) 0.0000 1 (0) 0 (0) 
16 0.9554 0.0446 (0)  0 (0) 0.5838 0.4160 (0.0078) 0.0002 (0.0002) 0.0000 1 (0) 0 (0) 
17 0.9544 0.0456 (0) 0 (0) 0.5838 0.4160 (0.0078) 0.0002 (0.0002) 0.0000 1 (0) 0 (0) 
18 0.9533 0.0467 (0) 0 (0) 0.5838 0.4160 (0.0078) 0.0002 (0.0002) 0.0000 1 (0) 0 (0) 
19 0.9524 0.0476 (0) 0 (0) 0.5838 0.4160 (0.0078) 0.0002 (0.0002) 0.0000 1 (0) 0 (0) 
20 0.9514 0.0486 (0)  0 (0) 0.5838 0.4160 (0.0078) 0.0002 (0.0002) 0.0000 1 (0) 0 (0) 
21 0.9505 0.0495 (0) 0 (0) 0.5838 0.4160 (0.0078) 0.0002 (0.0002) 0.0000 1 (0) 0 (0) 
22 0.9496 0.0504 (0) 0 (0) 0.5838 0.4160 (0.0078) 0.0002 (0.0002) 0.0000 1 (0) 0 (0) 
23 0.9487 0.0513 (0) 0 (0) 0.5838 0.4160 (0.0078) 0.0002 (0.0002) 0.0000 1 (0) 0 (0) 
24 0.9479 0.0521 (0) 0 (0) 0.5838 0.4160 (0.0078) 0.0002 (0.0002) 0.0000 1 (0) 0 (0) 
25 0.9471 0.0529 (0) 0 (0) 0.5838 0.4160 (0.0078) 0.0002 (0.0002) 0.0000 1 (0) 0 (0) 
26 0.9463 0.0537 (0) 0 (0) 0.5838 0.4160 (0.0078) 0.0002 (0.0002) 0.0000 1 (0) 0 (0) 
27 0.9455 0.0545 (0) 0 (0) 0.5838 0.4160 (0.0078) 0.0002 (0.0002) 0.0000 1 (0) 0 (0) 
28 0.9447 0.0553 (0)  0 (0) 0.5838 0.4160 (0.0078) 0.0002 (0.0002) 0.0000 1 (0) 0 (0) 
29 0.944 0.056 (0) 0 (0) 0.5838 0.4160 (0.0078) 0.0002 (0.0002) 0.0000 1 (0) 0 (0) 
30 0.9432 0.0568 (0) 0 (0) 0.5838 0.4160 (0.0078) 0.0002 (0.0002) 0.0000 1 (0) 0 (0) 
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Table C5: Transition probabilities for the first 30 days used in the local hospital- Age group 30-64 
Day Transition Probability (Standard Error) 
Community to A&E to Admission to 
Community  A&E (SE) Dead (SE) Community Admission (SE) Dead (SE) Admission  Community(SE) Dead(SE) 
1 0.9789 0.0196 (0.0004) 0.0015 (0.0001) 0.479 0.520 (0.0017) 0.001 (0.0001) 0.6964 
(0.0015) 
0.3001 (0.0015) 0.0035 (0.0001) 
2 0.9728 0.0254 (0.0004) 0.0018 (0.0001) 0.479 0.520 (0.0017) 0.001 (0.0001) 0.5467 0.4466 (0.0017) 0.0067 (0.0002) 
3 0.9686 0.0295 (0.0005) 0.0019 (0.0001) 0.479 0.520 (0.0017) 0.001 (0.0001) 0.4424 0.5483 (0.0017) 0.0093 (0.0003) 
4 0.9651 0.0328 (0.0005) 0.0021 (0.0001) 0.479 0.520 (0.0017) 0.001 (0.0001) 0.3640 0.6243 (0.0017) 0.0117 (0.0003) 
5 0.9621 0.0357 (0.0005) 0.0022 (0.0001) 0.479 0.520 (0.0017) 0.001 (0.0001) 0.3031 0.6833 (0.0016) 0.0136 (0.0003) 
6 0.9595 0.0382 (0.0005) 0.0023 (0.0001) 0.479 0.520 (0.0017) 0.001 (0.0001) 0.2545 0.7301 (0.0015) 0.0154 (0.0004) 
7 0.9573 0.0404 (0.0006) 0.0023 (0.0001) 0.479 0.520 (0.0017) 0.001 (0.0001) 0.2153 0.7679 (0.0015) 0.0168 (0.0004) 
8 0.9552 0.0424 (0.0006) 0.0024 (0.0001) 0.479 0.520 (0.0017) 0.001 (0.0001) 0.1830 0.7989 (0.0014) 0.0181 (0.0004) 
9 0.9532 0.0443 (0.0006) 0.0025 (0.0002) 0.479 0.520 (0.0017) 0.001 (0.0001) 0.1563 0.8244 (0.0013) 0.0193 (0.0004) 
10 0.9514 0.0461 (0.0006) 0.0025 (0.0002) 0.479 0.520 (0.0017) 0.001 (0.0001) 0.1341 0.8457 (0.0013)  0.0202 (0.0004) 
11 0.9497 0.0477 (0.0006)  0.0026 (0.0002) 0.479 0.520 (0.0017) 0.001 (0.0001) 0.1154 0.8635 (0.0012) 0.0211 (0.0004) 
12 0.9481 0.0493 (0.0006) 0.0026 (0.0002) 0.479 0.520 (0.0017) 0.001 (0.0001) 0.0997 0.8785 (0.0011) 0.0218 (0.0004) 
13 0.9465 0.0508 (0.0006) 0.0027 (0.0002) 0.479 0.520 (0.0017) 0.001 (0.0001) 0.0863 0.8912 (0.0011) 0.0225 (0.0004) 
14 0.9451 0.0522 (0.0006) 0.0027 (0.0002) 0.479 0.520 (0.0017) 0.001 (0.0001) 0.0749 0.902 (0.001) 0.0231 (0.0005) 
15 0.9437 0.0535 (0.0006) 0.0028 (0.0002) 0.479 0.520 (0.0017) 0.001 (0.0001) 0.0652 0.9112 (0.0011) 0.0236 (0.0005) 
16 0.9424 0.0548 (0.0007) 0.0028 (0.0002) 0.479 0.520 (0.0017) 0.001 (0.0001) 0.0569 0.9191 (0.0009) 0.024 (0.0005) 
17 0.9412 0.056 (0.0007) 0.0028 (0.0002) 0.479 0.520 (0.0017) 0.001 (0.0001) 0.0497 0.9259 (0.0009) 0.0244 (0.0005) 
18 0.9399 0.0572 (0.0007) 0.0029 (0.0002)  0.479 0.520 (0.0017) 0.001 (0.0001) 0.0435 0.9318 (0.0008) 0.0247 (0.0005) 
19 0.9387 0.0584 (0.0007) 0.0029 (0.0002) 0.479 0.520 (0.0017) 0.001 (0.0001) 0.0382 0.9368 (0.0008) 0.025 (0.0005) 
20 0.9376 0.0595 (0.0007) 0.0029 (0.0002) 0.479 0.520 (0.0017) 0.001 (0.0001) 0.0335 0.9412 (0.0008) 0.0253 (0.0005) 
21 0.9365 0.0605 (0.0007) 0.003 (0.0002) 0.479 0.520 (0.0017) 0.001 (0.0001) 0.0294 0.945 (0.0007) 0.0256 (0.0005) 
22 0.9354 0.0616 (0.0007) 0.003 (0.0002) 0.479 0.520 (0.0017) 0.001 (0.0001) 0.0259 0.9483 (0.0007) 0.0258 (0.0005) 
23 0.9344 0.0626 (0.0007) 0.003 (0.0002) 0.479 0.520 (0.0017) 0.001 (0.0001) 0.0228 0.9512 (0.0007) 0.026 (0.0005) 
24 0.9333 0.0636 (0.0007) 0.0031 (0.0002) 0.479 0.520 (0.0017) 0.001 (0.0001) 0.0202 0.9537 (0.0006) 0.0261 (0.0005) 
25 0.9324 0.0645 (0.0007) 0.0031 (0.0002) 0.479 0.520 (0.0017) 0.001 (0.0001) 0.0178 0.9559 (0.0006) 0.0263 (0.0005) 
26 0.9314 0.0655 (0.0007) 0.0031 (0.0002) 0.479 0.520 (0.0017) 0.001 (0.0001) 0.0158 0.9578 (0.0006) 0.0264 (0.0005) 
27 0.9305 0.0664 (0.0007) 0.0031 (0.0002) 0.479 0.520 (0.0017) 0.001 (0.0001) 0.0140 0.9595  (0.0006) 0.0265 (0.0005) 
28 0.9295 0.0673 (0.0007) 0.0032 (0.0002) 0.479 0.520 (0.0017) 0.001 (0.0001) 0.0124 0.961 (0.0006) 0.0266 (0.0005)  
29 0.9287 0.0681 (0.0007) 0.0032 (0.0002) 0.479 0.520 (0.0017) 0.001 (0.0001) 0.0110 0.9623 (0.0006) 0.0267 (0.0005) 
30 0.9278 0.069 (0.0007) 0.0032 (0.0002) 0.479 0.520 (0.0017) 0.001 (0.0001) 0.0098 0.9634 (0.0006) 0.0268 (0.0005) 
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Table C6: Transition probabilities for the first 30 days used in the central hospital-Age group 30-64 
Day Transition Probability (Standard Error) 
Community to A&E to Admission to 
Community  A&E (SE) Dead (SE) Community Admission(SE) Dead(SE) Admission  Community(SE) Dead (SE) 
1 0.9842 0.0144 (0.0007) 0.0014 (0.0002) 0.484 0.515 (0.0036) 0.001 (0.0002) 0.7110 0.2866 (0.0032) 0.0024 (0.0002) 
2 0.9786 0.0197 (0.0008) 0.0017 (0.0003) 0.484 0.515 (0.0036) 0.001 (0.0002) 0.5396 0.4555 (0.0036) 0.0049 (0.0004) 
3 0.9745 0.0236 (0.0009) 0.0019 (0.0003) 0.484 0.515 (0.0036) 0.001 (0.0002) 0.4176 0.5753 (0.0035) 0.0071 (0.0005) 
4 0.9712 0.0268 (0.001) 0.002 (0.0003) 0.484 0.515 (0.0036) 0.001 (0.0002) 0.3269 0.664 (0.0033) 0.0091 (0.0006) 
5 0.9682 0.0296 (0.001) 0.0022 (0.0003) 0.484 0.515 (0.0036) 0.001 (0.0002) 0.2581 0.7312 (0.0031) 0.0107 (0.0006) 
6 0.9656 0.0321 (0.0011) 0.0023 (0.0003) 0.484 0.515 (0.0036) 0.001 (0.0002) 0.2050 0.7829 (0.0028) 0.0121 (0.0007) 
7 0.9632 0.0344 (0.0011) 0.0024 (0.0003) 0.484 0.515 (0.0036) 0.001 (0.0002) 0.1637 0.8231 (0.0026) 0.0132 (0.0007) 
8 0.9610 0.0365 (0.0012) 0.0025 (0.0003) 0.484 0.515 (0.0036) 0.001 (0.0002) 0.1312 0.8546 (0.0024) 0.0142 (0.0007) 
9 0.9590 0.0384 (0.0012) 0.0026 (0.0003) 0.484 0.515 (0.0036) 0.001 (0.0002) 0.1056 0.8794 (0.0021) 0.015 (0.0007) 
10 0.9570 0.0403 (0.0012) 0.0027 (0.0003) 0.484 0.515 (0.0036) 0.001 (0.0002) 0.0852 0.8991 (0.0019) 0.0157 (0.0007) 
11 0.9553 0.042 (0.0013) 0.0027 (0.0003) 0.484 0.515 (0.0036) 0.001 (0.0002) 0.0690 0.9148 (0.0018) 0.0162 (0.0008) 
12 0.9536 0.0436 (0.0013) 0.0028 (0.0003) 0.484 0.515 (0.0036) 0.001 (0.0002) 0.0559 0.9274 (0.0016) 0.0167 (0.0008) 
13 0.9519 0.0452 (0.0013) 0.0029 (0.0003) 0.484 0.515 (0.0036) 0.001 (0.0002) 0.0454 0.9375 (0.0015) 0.0171 (0.0008) 
14 0.9504 0.0467 (0.0013) 0.0029 (0.0003) 0.484 0.515 (0.0036) 0.001 (0.0002) 0.0370 0.9456 (0.0013) 0.0174 (0.0008) 
15 0.9488 0.0482 (0.0013) 0.003 (0.0004) 0.484 0.515 (0.0036) 0.001 (0.0002) 0.0303 0.9521 (0.0012) 0.0176 (0.0008) 
16 0.9473 0.0496 (0.0014) 0.0031 (0.0004) 0.484 0.515 (0.0036) 0.001 (0.0002) 0.0247 0.9574 (0.0012) 0.0179 (0.0008) 
17 0.9460 0.0509 (0.0014) 0.0031 (0.0004) 0.484 0.515 (0.0036) 0.001 (0.0002) 0.0202 0.9617 (0.0011) 0.0181 (0.0008) 
18 0.9446 0.0522 (0.0014) 0.0032 (0.0004) 0.484 0.515 (0.0036) 0.001 (0.0002) 0.0166 0.9652 (0.001) 0.0182 (0.0008) 
19 0.9433 0.0535 (0.0014) 0.0032 (0.0004) 0.484 0.515 (0.0036) 0.001 (0.0002) 0.0137 0.968 (0.001) 0.0183 (0.0008) 
20 0.9420 0.0547 (0.0014) 0.0033 (0.0004) 0.484 0.515 (0.0036) 0.001 (0.0002) 0.0112 0.9704 (0.0009) 0.0184 (0.0008) 
21 0.9408 0.0559 (0.0014) 0.0033 (0.0004) 0.484 0.515 (0.0036) 0.001 (0.0002) 0.0093 0.9722 (0.0009) 0.0185 (0.0008) 
22 0.9396 0.057 (0.0014) 0.0034 (0.0004) 0.484 0.515 (0.0036) 0.001 (0.0002) 0.0076 0.9738 (0.0009) 0.0186 (0.0008) 
23 0.9385 0.0581 (0.0015) 0.0034 (0.0004) 0.484 0.515 (0.0036) 0.001 (0.0002) 0.0062 0.9751 (0.0009) 0.0187 (0.0008) 
24 0.9374 0.0592 (0.0015) 0.0034 (0.0004) 0.484 0.515 (0.0036) 0.001 (0.0002) 0.0052 0.9761 (0.0008) 0.0187 (0.0008) 
25 0.9362 0.0603 (0.0015) 0.0035 (0.0004) 0.484 0.515 (0.0036) 0.001 (0.0002) 0.0042 0.977 (0.0008) 0.0188 (0.0008) 
26 0.9352 0.0613 (0.0015) 0.0035 (0.0004) 0.484 0.515 (0.0036) 0.001 (0.0002) 0.0035 0.9777 (0.0008) 0.0188 (0.0008) 
27 0.9340 0.0624 (0.0015) 0.0036 (0.0004) 0.484 0.515 (0.0036) 0.001 (0.0002) 0.0030 0.9782 (0.0008) 0.0188 (0.0008) 
28 0.9330 0.0634 (0.0015) 0.0036 (0.0004) 0.484 0.515 (0.0036) 0.001 (0.0002) 0.0024 0.9787 (0.0008) 0.0189 (0.0008) 
29 0.9320 0.0644 (0.0015) 0.0036 (0.0004) 0.484 0.515 (0.0036) 0.001 (0.0002) 0.0020 0.9791 (0.0008) 0.0189 (0.0008) 
30 0.9310 0.0653 (0.0015) 0.0037 (0.0004) 0.484 0.515 (0.0036) 0.001 (0.0002) 0.0017 0.9794 (0.0008) 0.0189 (0.0008) 
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Table C7: Transition probabilities for the first 30 days used in the local hospital- Age group 65+ 
Day Transition Probability (Standard Error) 
Community to A&E to Admission to 
Community  A&E (SE) Dead (SE) Community Admission (SE) Dead (SE) Admission  Community(SE) Dead(SE) 
1 0.9722  0.0211 (0.0003) 0.0067 (0.0002) 0.248 0.747 (0.0012) 0.005 (0.0002) 0.8374 0.1533 (0.0009) 0.0093 (0.0002) 
2 0.9631 0.0288 (0.0004) 0.0081 (0.0002) 0.248 0.747 (0.0012) 0.005 (0.0002) 0.7439 0.2394 (0.0011) 0.0167 (0.0003) 
3 0.9566 0.0345 (0.0004) 0.0089 (0.0002) 0.248 0.747 (0.0012) 0.005 (0.0002) 0.6708 0.3061 (0.0012) 0.0231 (0.0003) 
4 0.9512 0.0392 (0.0005) 0.0096 (0.0002) 0.248 0.747 (0.0012) 0.005 (0.0002) 0.6100 0.3612 (0.0012) 0.0288 (0.0004) 
5 0.9466 0.0432 (0.0005) 0.0102 (0.0003) 0.248 0.747 (0.0012) 0.005 (0.0002) 0.5579 0.4081 (0.0013) 0.034 (0.0004) 
6 0.9424 0.0469 (0.0005) 0.0107 (0.0003) 0.248 0.747 (0.0012) 0.005 (0.0002) 0.5125 0.4488 (0.0013) 0.0387 (0.0004)  
7 0.9387 0.0502 (0.0005) 0.0111 (0.0003) 0.248 0.747 (0.0012) 0.005 (0.0002) 0.4725 0.4846 (0.0013) 0.0429 (0.0005) 
8 0.9353 0.0532 (0.0006) 0.0115 (0.0003) 0.248 0.747 (0.0012) 0.005 (0.0002) 0.4368 0.5164 (0.0013) 0.0468 (0.0005) 
9 0.9321 0.0561 (0.0006) 0.0118 (0.0003) 0.248 0.747 (0.0012) 0.005 (0.0002) 0.4047 0.5449 (0.0013) 0.0504 (0.0005) 
10 0.9292 0.0587 (0.0006) 0.0121 (0.0003) 0.248 0.747 (0.0012) 0.005 (0.0002) 0.3757 0.5705 (0.0013) 0.0538 (0.0005) 
11 0.9263 0.0613 (0.0006) 0.0124 (0.0003) 0.248 0.747 (0.0012) 0.005 (0.0002) 0.3495 0.5937 (0.0013) 0.0568 (0.0005) 
12 0.9237 0.0636 (0.0006) 0.0127 (0.0003) 0.248 0.747 (0.0012) 0.005 (0.0002) 0.3256 0.6147 (0.0012) 0.0597 (0.0006) 
13 0.9212 0.0659 (0.0006) 0.0129 (0.0003) 0.248 0.747 (0.0012) 0.005 (0.0002) 0.3038 0.6339 (0.0012) 0.0623 (0.0006) 
14 0.9187 0.0681 (0.0006) 0.0132 (0.0003) 0.248 0.747 (0.0012) 0.005 (0.0002) 0.2837 0.6515 (0.0012) 0.0648 (0.0006) 
15 0.9164 0.0702 (0.0007) 0.0134 (0.0003) 0.248 0.747 (0.0012) 0.005 (0.0002) 0.2653 0.6676 (0.0012) 0.0671 (0.0006) 
16 0.9142 0.0722 (0.0007) 0.0136 (0.0003) 0.248 0.747 (0.0012) 0.005 (0.0002) 0.2485 0.6823 (0.0012) 0.0692 (0.0006) 
17 0.9121 0.0741 (0.0007) 0.0138 (0.0003) 0.248 0.747 (0.0012) 0.005 (0.0002) 0.2328 0.696 (0.0012) 0.0712 (0.0006) 
18 0.9100 0.076 (0.0007) 0.014 (0.0003) 0.248 0.747 (0.0012) 0.005 (0.0002) 0.2184 0.7085 (0.0012) 0.0731 (0.0006)  
19 0.9080 0.0778 (0.0007) 0.0142 (0.0003) 0.248 0.747 (0.0012) 0.005 (0.0002) 0.2050 0.7202 (0.0012) 0.0748 (0.0006) 
20 0.9060 0.0796 (0.0007) 0.0144 (0.0003) 0.248 0.747 (0.0012) 0.005 (0.0002) 0.1926 0.7309 (0.0011) 0.0765 (0.0006) 
21 0.9041 0.0813 (0.0007) 0.0146 (0.0003) 0.248 0.747 (0.0012) 0.005 (0.0002) 0.1811 0.7409 (0.0011) 0.078 (0.0006) 
22 0.9024 0.0829 (0.0007) 0.0147 (0.0003) 0.248 0.747 (0.0012) 0.005 (0.0002) 0.1704 0.7502 (0.0011) 0.0794 (0.0006) 
23 0.9005 0.0846 (0.0007) 0.0149 (0.0003) 0.248 0.747 (0.0012) 0.005 (0.0002) 0.1604 0.7588 (0.0011) 0.0808 (0.0006) 
24 0.8988 0.0861 (0.0007) 0.0151 (0.0003) 0.248 0.747 (0.0012) 0.005 (0.0002) 0.1511 0.7668 (0.0011) 0.0821 (0.0006) 
25 0.8971 0.0877 (0.0007) 0.0152 (0.0003) 0.248 0.747 (0.0012) 0.005 (0.0002) 0.1424 0.7743 (0.0011) 0.0833 (0.0007) 
26 0.8954 0.0892 (0.0007) 0.0154 (0.0003) 0.248 0.747 (0.0012) 0.005 (0.0002) 0.1343 0.7813 (0.0011) 0.0844 (0.0007) 
27 0.8939 0.0906 (0.0007) 0.0155 (0.0003) 0.248 0.747 (0.0012) 0.005 (0.0002) 0.1267 0.7878 (0.001) 0.0855  (0.0007) 
28 0.8923 0.0921 (0.0008) 0.0156 (0.0003) 0.248 0.747 (0.0012) 0.005 (0.0002) 0.1197 0.7939 (0.001) 0.0864 (0.0007) 
29 0.8907 0.0935 (0.0008) 0.0158 (0.0003) 0.248 0.747 (0.0012) 0.005 (0.0002) 0.1130 0.7996 (0.001) 0.0874 (0.0007) 
30 0.8892 0.0949 (0.0008) 0.0159 (0.0003) 0.248 0.747 (0.0012) 0.005 (0.0002) 0.1068 0.8049 (0.001) 0.0883 (0.0007) 
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Table C8: Transition probabilities for the first 30 days used in the central hospital-Age group 65+ 
Day Transition Probability (Standard Error) 
Community to A&E to Admission to 
Community  A&E (SE) Dead (SE) Community Admission(SE) Dead(SE) Admission  Community(SE) Dead (SE) 
1 0.9822 0.0128 (0.0005) 0.005 (0.0003) 0.261 0.735 (0.0026) 0.005 (0.0004) 0.8315 0.1607 (0.0018) 0.0078 (0.0003) 
2 0.9750 0.0187 (0.0006) 0.0063 (0.0004) 0.261 0.735 (0.0026) 0.005 (0.0004) 0.7285 0.2571 (0.0022) 0.0144 (0.0005) 
3 0.9695 0.0233 (0.0007) 0.0072 (0.0004) 0.261 0.735 (0.0026) 0.005 (0.0004) 0.6472 0.3325 (0.0025) 0.0203 (0.0006) 
4 0.9648 0.0273 (0.0008) 0.0079 (0.0005) 0.261 0.735 (0.0026) 0.005 (0.0004) 0.5797 0.3947 (0.0026) 0.0256 (0.0007) 
5 0.9607 0.0308 (0.0009) 0.0085 (0.0005) 0.261 0.735 (0.0026) 0.005 (0.0004) 0.5223 0.4474 (0.0026) 0.0303 (0.0008) 
6 0.9569 0.034 (0.0009) 0.0091 (0.0005) 0.261 0.735 (0.0026) 0.005 (0.0004) 0.4725 0.4929 (0.0026) 0.0346 (0.0009) 
7 0.9536 0.0369 (0.0009) 0.0095 (0.0005) 0.261 0.735 (0.0026) 0.005 (0.0004) 0.4289 0.5326 (0.0026) 0.0385 (0.0009) 
8 0.9503 0.0397 (0.001) 0.01 (0.0005) 0.261 0.735 (0.0026) 0.005 (0.0004) 0.3904 0.5675 (0.0026) 0.0421 (0.001) 
9 0.9473 0.0423 (0.001) 0.0104 (0.0005) 0.261 0.735 (0.0026) 0.005 (0.0004) 0.3563 0.5984 (0.0025) 0.0453 (0.001) 
10 0.9445 0.0448 (0.0011) 0.0107 (0.0005) 0.261 0.735 (0.0026) 0.005 (0.0004) 0.3257 0.626  (0.0025) 0.0483 (0.001) 
11 0.9418 0.0471 (0.0011) 0.0111 (0.0005) 0.261 0.735 (0.0026) 0.005 (0.0004) 0.2983 0.6507 (0.0025) 0.051 (0.0011) 
12 0.9392 0.0494 (0.0011) 0.0114 (0.0005) 0.261 0.735 (0.0026) 0.005 (0.0004) 0.2737 0.6728 (0.0024) 0.0535 (0.0011) 
13 0.9368 0.0515 (0.0011) 0.0117 (0.0006) 0.261 0.735 (0.0026) 0.005 (0.0004) 0.2514 0.6928 (0.0024) 0.0558 (0.0011) 
14 0.9344 0.0536 (0.0012) 0.012 (0.0006) 0.261 0.735 (0.0026) 0.005 (0.0004) 0.2313 0.7108 (0.0023) 0.0579 (0.0011) 
15 0.9321 0.0556 (0.0012) 0.0123 (0.0006) 0.261 0.735 (0.0026) 0.005 (0.0004) 0.2131 0.7271 (0.0023) 0.0598 (0.0012) 
16 0.9299 0.0576 (0.0012) 0.0125 (0.0006) 0.261 0.735 (0.0026) 0.005 (0.0004) 0.1965 0.7419 (0.0023) 0.0616 (0.0012) 
17 0.9277 0.0595 (0.0012) 0.0128 (0.0006) 0.261 0.735 (0.0026) 0.005 (0.0004) 0.1813 0.7554 (0.0022) 0.0633 (0.0012) 
18 0.9257 0.0613 (0.0013) 0.013 (0.0006) 0.261 0.735 (0.0026) 0.005 (0.0004) 0.1675 0.7677 (0.0022) 0.0648 (0.0012) 
19 0.9237 0.0631 (0.0013) 0.0132 (0.0006) 0.261 0.735 (0.0026) 0.005 (0.0004) 0.1549 0.7789 (0.0021) 0.0662 (0.0012) 
20 0.9217 0.0649 (0.0013) 0.0134 (0.0006) 0.261 0.735 (0.0026) 0.005 (0.0004) 0.1433 0.7892 (0.0021) 0.0675 (0.0012) 
21 0.9197 0.0666 (0.0013) 0.0137 (0.0006) 0.261 0.735 (0.0026) 0.005 (0.0004) 0.1327 0.7986 (0.0021) 0.0687 (0.0012) 
22 0.9178 0.0683 (0.0013) 0.0139 (0.0006) 0.261 0.735 (0.0026) 0.005 (0.0004) 0.1229 0.8072 (0.002) 0.0699 (0.0012) 
23 0.9160 0.0699 (0.0013) 0.0141 (0.0006) 0.261 0.735 (0.0026) 0.005 (0.0004) 0.1140 0.8151 (0.002) 0.0709 (0.0012) 
24 0.9142 0.0715 (0.0014) 0.0143 (0.0006) 0.261 0.735 (0.0026) 0.005 (0.0004) 0.1058 0.8223 (0.0019) 0.0719 (0.0013) 
25 0.9125 0.073 (0.0014) 0.0145 (0.0006) 0.261 0.735 (0.0026) 0.005 (0.0004) 0.0982 0.829 (0.0019) 0.0728 (0.0013) 
26 0.9108 0.0746 (0.0014) 0.0146 (0.0006) 0.261 0.735 (0.0026) 0.005 (0.0004) 0.0913 0.8351 (0.0019) 0.0736 (0.0013) 
27 0.9091 0.0761 (0.0014) 0.0148 (0.0006) 0.261 0.735 (0.0026) 0.005 (0.0004) 0.0848 0.8408 (0.0018) 0.0744 (0.0013) 
28 0.9074 0.0776 (0.0014)  0.015 (0.0006) 0.261 0.735 (0.0026) 0.005 (0.0004) 0.0789 0.846 (0.0018) 0.0751 (0.0013) 
29 0.9058 0.079 (0.0014) 0.0152 (0.0006) 0.261 0.735 (0.0026) 0.005 (0.0004) 0.0734 0.8508 (0.0018)  0.0758 (0.0013) 
30 0.9043 0.0804 (0.0014) 0.0153 (0.0006) 0.261 0.735 (0.0026) 0.005 (0.0004) 0.0684 0.8552 (0.0018) 0.0764 (0.0013) 
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Table C9: Transition probabilities for the first 30 days used in the local hospital- Male 
Day Transition Probability (Standard Error) 
Community to A&E to Admission to 
Community  A&E (SE) Dead (SE) Community Admission (SE) Dead (SE) Admission  Community(SE) Dead(SE) 
1 0.9738 0.0216 (0.0003) 0.0046 (0.0002) 0.357 0.640 (0.0015) 0.003 (0.0002) 0.7618 0.2261 (0.0012) 0.0121 (0.0003) 
2 0.9662 0.0284 (0.0004) 0.0054 (0.0002) 0.357 0.640 (0.0015) 0.003 (0.0002) 0.6479 0.3313 (0.0014) 0.0208 (0.0004) 
3 0.9607 0.0334 (0.0005) 0.0059 (0.0002) 0.357 0.640 (0.0015) 0.003 (0.0002) 0.5646 0.4073 (0.0015) 0.0281 (0.0005) 
4 0.9562 0.0374 (0.0005) 0.0064 (0.0002) 0.357 0.640 (0.0015) 0.003 (0.0002) 0.4989 0.4668 (0.0015) 0.0343 (0.0005) 
5 0.9525 0.0408 (0.0005) 0.0067 (0.0002) 0.357 0.640 (0.0015) 0.003 (0.0002) 0.4449 0.5154 (0.0015) 0.0397 (0.0006) 
6 0.9491 0.0439 (0.0005) 0.007 (0.0002) 0.357 0.640 (0.0015) 0.003 (0.0002) 0.3994 0.5561 (0.0015) 0.0445 (0.0006) 
7 0.9462 0.0466 (0.0006) 0.0072 (0.0002) 0.357 0.640 (0.0015) 0.003 (0.0002) 0.3604 0.5908 (0.0015) 0.0488 (0.0006) 
8 0.9434 0.0491 (0.0006) 0.0075 (0.0002) 0.357 0.640 (0.0015) 0.003 (0.0002) 0.3266 0.6207 (0.0015) 0.0527 (0.0006) 
9 0.9408 0.0515 (0.0006) 0.0077 (0.0002) 0.357 0.640 (0.0015) 0.003 (0.0002) 0.2971 0.6468 (0.0014) 0.0561 (0.0007) 
10 0.9385 0.0536 (0.0006) 0.0079 (0.0002) 0.357 0.640 (0.0015) 0.003 (0.0002) 0.2710 0.6697 (0.0014) 0.0593 (0.0007) 
11 0.9362 0.0557 (0.0006) 0.0081 (0.0002) 0.357 0.640 (0.0015) 0.003 (0.0002) 0.2480 0.6899 (0.0014) 0.0621 (0.0007) 
12 0.9342 0.0576 (0.0006) 0.0082 (0.0002) 0.357 0.640 (0.0015) 0.003 (0.0002) 0.2274 0.7079 (0.0014) 0.0647 (0.0007) 
13 0.9322 0.0594 (0.0006) 0.0084 (0.0002) 0.357 0.640 (0.0015) 0.003 (0.0002) 0.2089 0.724 (0.0013) 0.0671 (0.0007) 
14 0.9303 0.0612 (0.0007) 0.0085 (0.0003) 0.357 0.640 (0.0015) 0.003 (0.0002) 0.1922 0.7385 (0.0013) 0.0693 (0.0007) 
15 0.9284 0.0629 (0.0007) 0.0087 (0.0003) 0.357 0.640 (0.0015) 0.003 (0.0002) 0.1772 0.7515 (0.0013) 0.0713 (0.0007) 
16 0.9267 0.0645 (0.0007) 0.0088 (0.0003) 0.357 0.640 (0.0015) 0.003 (0.0002) 0.1637 0.7632 (0.0013) 0.0731 (0.0007) 
17 0.9251 0.066 (0.0007) 0.0089 (0.0003) 0.357 0.640 (0.0015) 0.003 (0.0002) 0.1514 0.7738 (0.0013) 0.0748 (0.0008) 
18 0.9235 0.0675 (0.0007) 0.009 (0.0003) 0.357 0.640 (0.0015) 0.003 (0.0002) 0.1401 0.7835 (0.0012) 0.0764 (0.0008) 
19 0.922 0.0689 (0.0007)  0.0091 (0.0003) 0.357 0.640 (0.0015) 0.003 (0.0002) 0.1300 0.7922 (0.0012) 0.0778 (0.0008) 
20 0.9205 0.0703 (0.0007) 0.0092 (0.0003) 0.357 0.640 (0.0015) 0.003 (0.0002) 0.1207 0.8002 (0.0012) 0.0791 (0.0008) 
21 0.9189 0.0717 (0.0007) 0.0094 (0.0003) 0.357 0.640 (0.0015) 0.003 (0.0002) 0.1120 0.8076 (0.0012) 0.0804 (0.0008) 
22 0.9175 0.073 (0.0007) 0.0095 (0.0003) 0.357 0.640 (0.0015) 0.003 (0.0002) 0.1042 0.8143 (0.0012) 0.0815 (0.0008) 
23 0.9163 0.0742 (0.0007) 0.0095 (0.0003) 0.357 0.640 (0.0015) 0.003 (0.0002) 0.0970 0.8204 (0.0012) 0.0826 (0.0008) 
24 0.9149 0.0755 (0.0007) 0.0096 (0.0003) 0.357 0.640 (0.0015) 0.003 (0.0002) 0.0904 0.826 (0.0011) 0.0836 (0.0008) 
25 0.9136 0.0767 (0.0007) 0.0097 (0.0003) 0.357 0.640 (0.0015) 0.003 (0.0002) 0.0843 0.8312 (0.0011) 0.0845 (0.0008) 
26 0.9124 0.0778 (0.0007) 0.0098 (0.0003) 0.357 0.640 (0.0015) 0.003 (0.0002) 0.0787 0.836 (0.0011) 0.0853 (0.0008) 
27 0.9111 0.079 (0.0007) 0.0099 (0.0003) 0.357 0.640 (0.0015) 0.003 (0.0002) 0.0735 0.8404 (0.0011) 0.0861 (0.0008) 
28 0.9099 0.0801 (0.0008) 0.01 (0.0003) 0.357 0.640 (0.0015) 0.003 (0.0002) 0.0686 0.8445 (0.0011) 0.0869 (0.0008) 
29 0.9087 0.0812 (0.0008) 0.0101 (0.0003) 0.357 0.640 (0.0015) 0.003 (0.0002) 0.0642 0.8482 (0.0011) 0.0876 (0.0008) 
30 0.9076 0.0823 (0.0008) 0.0101 (0.0003) 0.357 0.640 (0.0015) 0.003 (0.0002) 0.0601 0.8517 (0.0011) 0.0882 (0.0008) 
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Table C10: Transition probabilities for the first 30 days used in the central hospital-Male 
Day Transition Probability (Standard Error) 
Community to A&E to Admission to 
Community  A&E (SE) Dead (SE) Community Admission(SE) Dead(SE) Admission  Community(SE) Dead (SE) 
1 0.9823 0.0137 (0.0006) 0.004 (0.0003) 0.365 0.632 (0.0031) 0.003 (0.0004) 0.7766 0.2169 (0.0024) 0.0065 (0.0004) 
2 0.9758 0.0193 (0.0007) 0.0049 (0.0004) 0.365 0.632 (0.0031) 0.003 (0.0004) 0.6514 0.3363 (0.0028) 0.0123 (0.0006) 
3 0.9708 0.0236 (0.0008) 0.0056 (0.0004) 0.365 0.632 (0.0031) 0.003 (0.0004) 0.5574 0.4253 (0.003) 0.0173 (0.0007) 
4 0.9666 0.0273 (0.0009) 0.0061 (0.0004) 0.365 0.632 (0.0031) 0.003 (0.0004) 0.4825 0.4957 (0.0031) 0.0218 (0.0008) 
5 0.9629 0.0305 (0.0009) 0.0066 (0.0005) 0.365 0.632 (0.0031) 0.003 (0.0004) 0.4209 0.5533 (0.0031) 0.0258 (0.0009) 
6 0.9597 0.0333 (0.001) 0.007 (0.0005) 0.365 0.632 (0.0031) 0.003 (0.0004) 0.3694 0.6013 (0.003) 0.0293 (0.0009) 
7 0.9567 0.036 (0.001) 0.0073 (0.0005) 0.365 0.632 (0.0031) 0.003 (0.0004) 0.3257 0.6419 (0.003) 0.0324 (0.001) 
8 0.954 0.0384 (0.0011) 0.0076 (0.0005) 0.365 0.632 (0.0031) 0.003 (0.0004) 0.2883 0.6765 (0.0029) 0.0352 (0.001) 
9 0.9514 0.0407 (0.0011) 0.0079 (0.0005) 0.365 0.632 (0.0031) 0.003 (0.0004) 0.2560 0.7063 (0.0028) 0.0377 (0.001) 
10 0.9489 0.0429 (0.0011) 0.0082 (0.0005)  0.365 0.632 (0.0031) 0.003 (0.0004) 0.2279 0.7321 (0.0028) 0.04 (0.0011) 
11 0.9467 0.0449 (0.0012) 0.0084 (0.0005) 0.365 0.632 (0.0031) 0.003 (0.0004) 0.2035 0.7545 (0.0027) 0.042 (0.0011) 
12 0.9444 0.0469 (0.0012) 0.0087 (0.0005) 0.365 0.632 (0.0031) 0.003 (0.0004) 0.1820 0.7742 (0.0026) 0.0438 (0.0011) 
13 0.9423 0.0488 (0.0012) 0.0089 (0.0005) 0.365 0.632 (0.0031) 0.003 (0.0004) 0.1631 0.7914 (0.0025) 0.0455 (0.0011) 
14 0.9403 0.0506 (0.0012) 0.0091 (0.0005) 0.365 0.632 (0.0031) 0.003 (0.0004) 0.1465 0.8066 (0.0025) 0.0469 (0.0012) 
15 0.9384 0.0523 (0.0013) 0.0093 (0.0005) 0.365 0.632 (0.0031) 0.003 (0.0004) 0.1317 0.82 (0.0024) 0.0483 (0.0012) 
16 0.9365 0.054 (0.0013) 0.0095 (0.0005) 0.365 0.632 (0.0031) 0.003 (0.0004) 0.1187 0.8318 (0.0023) 0.0495 (0.0012) 
17 0.9347 0.0556 (0.0013) 0.0097 (0.0005) 0.365 0.632 (0.0031) 0.003 (0.0004) 0.1070 0.8424 (0.0022) 0.0506 (0.0012) 
18 0.933 0.0572 (0.0013) 0.0098 (0.0006) 0.365 0.632 (0.0031) 0.003 (0.0004) 0.0966 0.8518 (0.0022) 0.0516 (0.0012) 
19 0.9313 0.0587 (0.0013) 0.01 (0.0006) 0.365 0.632 (0.0031) 0.003 (0.0004) 0.0873 0.8602 (0.0021) 0.0525 (0.0012) 
20 0.9297 0.0602 (0.0014) 0.0101 (0.0006) 0.365 0.632 (0.0031) 0.003 (0.0004) 0.0791 0.8676 (0.0021) 0.0533 (0.0012) 
21 0.9281 0.0616 (0.0014) 0.0103 (0.0006) 0.365 0.632 (0.0031) 0.003 (0.0004) 0.0716 0.8743 (0.002) 0.0541 (0.0012) 
22 0.9266 0.063 (0.0014) 0.0104 (0.0006) 0.365 0.632 (0.0031) 0.003 (0.0004) 0.0650 0.8803 (0.0019) 0.0547 (0.0012) 
23 0.925 0.0644 (0.0014)  0.0106 (0.0006) 0.365 0.632 (0.0031) 0.003 (0.0004) 0.0589 0.8857 (0.0019) 0.0554 (0.0012) 
24 0.9236 0.0657 (0.0014) 0.0107 (0.0006) 0.365 0.632 (0.0031) 0.003 (0.0004) 0.0536 0.8905 (0.0018) 0.0559 (0.0012) 
25 0.922 0.0671 (0.0014) 0.0109 (0.0006) 0.365 0.632 (0.0031) 0.003 (0.0004) 0.0487 0.8949 (0.0018) 0.0564 (0.0012) 
26 0.9207 0.0683 (0.0015) 0.011 (0.0006) 0.365 0.632 (0.0031) 0.003 (0.0004) 0.0443 0.8988 (0.0018) 0.0569 (0.0012) 
27 0.9193 0.0696 (0.0015) 0.0111 (0.0006) 0.365 0.632 (0.0031) 0.003 (0.0004) 0.0404 0.9023 (0.0017) 0.0573 (0.0013) 
28 0.918 0.0708 (0.0015) 0.0112 (0.0006) 0.365 0.632 (0.0031) 0.003 (0.0004) 0.0368 0.9055 (0.0017) 0.0577 (0.0013) 
29 0.9165 0.0721 (0.0015) 0.0114 (0.0006) 0.365 0.632 (0.0031) 0.003 (0.0004) 0.0335 0.9084 (0.0016) 0.0581 (0.0013) 
30 0.9152 0.0733 (0.0015) 0.0115 (0.0006) 0.365 0.632 (0.0031) 0.003 (0.0004) 0.0306 0.911 (0.0016) 0.0584 (0.0013) 
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Table C11: Transition probabilities for the first 30 days used in the local hospital- Female 
Day Transition Probability (Standard Error) 
Community to A&E to Admission to 
Community  A&E (SE) Dead (SE) Community Admission (SE) Dead (SE) Admission  Community(SE) Dead(SE) 
1 0.9748 0.0214 (0.0003) 0.0038 (0.0001) 0.389 0.608 (0.0013) 0.003 (0.0001) 0.8065 0.1869 (0.001) 0.0066 (0.0002) 
2 0.9674 0.0282 (0.0004) 0.0044 (0.0002) 0.389 0.608 (0.0013) 0.003 (0.0001) 0.6988 0.2893  (0.0012) 0.0119 (0.0002) 
3 0.9619 0.0332 (0.0004) 0.0049 (0.0002) 0.389 0.608 (0.0013) 0.003 (0.0001) 0.6165 0.367 (0.0013) 0.0165 (0.0003) 
4 0.9576 0.0372 (0.0004) 0.0052 (0.0002) 0.389 0.608 (0.0013) 0.003 (0.0001) 0.5496 0.4299 (0.0013) 0.0205 (0.0003) 
5 0.9538 0.0407 (0.0004) 0.0055 (0.0002) 0.389 0.608 (0.0013) 0.003 (0.0001) 0.4934 0.4825 (0.0013) 0.0241 (0.0004) 
6 0.9506 0.0437 (0.0005) 0.0057 (0.0002) 0.389 0.608 (0.0013) 0.003 (0.0001) 0.4453 0.5274 (0.0013) 0.0273 (0.0004) 
7 0.9476 0.0465 (0.0005) 0.0059 (0.0002) 0.389 0.608 (0.0013) 0.003 (0.0001) 0.4036 0.5662 (0.0013) 0.0302 (0.0004) 
8 0.9449 0.049 (0.0005) 0.0061 (0.0002) 0.389 0.608 (0.0013) 0.003 (0.0001) 0.3670 0.6002 (0.0013) 0.0328 (0.0004) 
9 0.9424 0.0513 (0.0005) 0.0063 (0.0002) 0.389 0.608 (0.0013) 0.003 (0.0001) 0.3347 0.6301 (0.0013) 0.0352 (0.0005) 
10 0.9401 0.0535 (0.0005) 0.0064 (0.0002) 0.389 0.608 (0.0013) 0.003 (0.0001) 0.3060 0.6566 (0.0013) 0.0374 (0.0005) 
11 0.9379 0.0555 (0.0005) 0.0066 (0.0002) 0.389 0.608 (0.0013) 0.003 (0.0001) 0.2804 0.6802 (0.0012) 0.0394 (0.0005) 
12 0.9358 0.0575 (0.0005) 0.0067 (0.0002) 0.389 0.608 (0.0013) 0.003 (0.0001) 0.2574 0.7014 (0.0012) 0.0412 (0.0005) 
13 0.9338 0.0593 (0.0006) 0.0069 (0.0002) 0.389 0.608 (0.0013) 0.003 (0.0001) 0.2367 0.7204 (0.0012) 0.0429 (0.0005) 
14 0.9319 0.0611 (0.0006) 0.007 (0.0002) 0.389 0.608 (0.0013) 0.003 (0.0001) 0.2180 0.7376 (0.0012) 0.0444 (0.0005) 
15 0.9301 0.0628 (0.0006) 0.0071 (0.0002) 0.389 0.608 (0.0013) 0.003 (0.0001) 0.2011 0.7531 (0.0011) 0.0458 (0.0005) 
16 0.9284 0.0644 (0.0006) 0.0072 (0.0002) 0.389 0.608 (0.0013) 0.003 (0.0001) 0.1857 0.7672 (0.0011) 0.0471 (0.0005) 
17 0.9268 0.0659 (0.0006) 0.0073 (0.0002) 0.389 0.608 (0.0013) 0.003 (0.0001) 0.1717 0.78 (0.0011) 0.0483 (0.0005) 
18 0.9252 0.0674 (0.0006) 0.0074 (0.0002) 0.389 0.608 (0.0013) 0.003 (0.0001) 0.1588 0.7917 (0.0011) 0.0495 (0.0005) 
19 0.9237 0.0688 (0.0006) 0.0075 (0.0002) 0.389 0.608 (0.0013) 0.003 (0.0001) 0.1472 0.8023 (0.0011) 0.0505 (0.0005) 
20 0.9222 0.0702 (0.0006) 0.0076 (0.0002) 0.389 0.608 (0.0013) 0.003 (0.0001) 0.1366 0.812 (0.001) 0.0514 (0.0005) 
21 0.9208 0.0716 (0.0006) 0.0076 (0.0002) 0.389 0.608 (0.0013) 0.003 (0.0001) 0.1268 0.8209 (0.001) 0.0523 (0.0006) 
22 0.9194 0.0729 (0.0006) 0.0077 (0.0002) 0.389 0.608 (0.0013) 0.003 (0.0001) 0.1177 0.8291 (0.001) 0.0532 (0.0006) 
23 0.9180 0.0742 (0.0006) 0.0078 (0.0002) 0.389 0.608 (0.0013) 0.003 (0.0001) 0.1095 0.8366 (0.001) 0.0539 (0.0006) 
24 0.9167 0.0754 (0.0006) 0.0079 (0.0002)  0.389 0.608 (0.0013) 0.003 (0.0001) 0.1019 0.8435 (0.001) 0.0546 (0.0006) 
25 0.9154 0.0766 (0.0006) 0.008 (0.0002) 0.389 0.608 (0.0013) 0.003 (0.0001) 0.0948 0.8499 (0.0009) 0.0553 (0.0006) 
26 0.9142 0.0778 (0.0006)  0.008 (0.0002) 0.389 0.608 (0.0013) 0.003 (0.0001) 0.0884 0.8557 (0.0009) 0.0559 (0.0006) 
27 0.9129 0.079 (0.0006) 0.0081 (0.0002) 0.389 0.608 (0.0013) 0.003 (0.0001) 0.0824 0.8611 (0.0009) 0.0565 (0.0006) 
28 0.9117 0.0801 (0.0006) 0.0082 (0.0002) 0.389 0.608 (0.0013) 0.003 (0.0001) 0.0769 0.8661 (0.0009) 0.057 (0.0006) 
29 0.9106 0.0812 (0.0006) 0.0082 (0.0002) 0.389 0.608 (0.0013) 0.003 (0.0001) 0.0718 0.8707 (0.0009) 0.0575 (0.0006) 
30 0.9094 0.0823 (0.0007) 0.0083 (0.0002) 0.389 0.608 (0.0013) 0.003 (0.0001) 0.0670 0.875 (0.0009) 0.058 (0.0006) 
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Table C12: Transition probabilities for the first 30 days used in the central hospital-Female 
Day Transition Probability (Standard Error) 
Community to A&E to Admission to 
Community  A&E (SE) Dead (SE) Community Admission(SE) Dead(SE) Admission  Community(SE) Dead (SE) 
1 0.9835 0.0138 (0.0005) 0.0027 (0.0003) 0.369 0.628 (0.0029) 0.003 (0.0003) 0.7881 0.2063 (0.0022) 0.0056 (0.0003) 
2 0.9772 0.0194 (0.0007) 0.0034 (0.0003) 0.369 0.628 (0.0029) 0.003 (0.0003) 0.6699 0.3196 (0.0026) 0.0105 (0.0005) 
3 0.9725 0.0237 (0.0008) 0.0038 (0.0003) 0.369 0.628 (0.0029) 0.003 (0.0003) 0.5807 0.4045 (0.0028) 0.0148 (0.0006) 
4 0.9685 0.0273 (0.0008) 0.0042 (0.0003) 0.369 0.628 (0.0029) 0.003 (0.0003) 0.5089 0.4725 (0.0029) 0.0186 (0.0007) 
5 0.9651 0.0304 (0.0009) 0.0045 (0.0003) 0.369 0.628 (0.0029) 0.003 (0.0003) 0.4495 0.5285 (0.0029) 0.022 (0.0008) 
6 0.9619 0.0333 (0.0009) 0.0048 (0.0003) 0.369 0.628 (0.0029) 0.003 (0.0003) 0.3992 0.5757 (0.0029) 0.0251 (0.0008) 
7 0.9591 0.0359 (0.001) 0.005 (0.0004) 0.369 0.628 (0.0029) 0.003 (0.0003) 0.3561 0.616 (0.0029) 0.0279 (0.0009) 
8 0.9565 0.0383 (0.001) 0.0052 (0.0004) 0.369 0.628 (0.0029) 0.003 (0.0003) 0.3188 0.6508 (0.0028) 0.0304 (0.0009) 
9 0.9540 0.0406 (0.001) 0.0054 (0.0004) 0.369 0.628 (0.0029) 0.003 (0.0003) 0.2863 0.681 (0.0027) 0.0327 (0.0009) 
10 0.9517 0.0427 (0.0011) 0.0056 (0.0004) 0.369 0.628 (0.0029) 0.003 (0.0003) 0.2579 0.7074 (0.0027) 0.0347 (0.001) 
11 0.9495 0.0447 (0.0011) 0.0058 (0.0004) 0.369 0.628 (0.0029) 0.003 (0.0003) 0.2328 0.7306 (0.0026) 0.0366 (0.001) 
12 0.9474 0.0467 (0.0011) 0.0059 (0.0004) 0.369 0.628 (0.0029) 0.003 (0.0003) 0.2107 0.7511 (0.0025) 0.0382 (0.001) 
13 0.9454 0.0485 (0.0011) 0.0061 (0.0004)  0.369 0.628 (0.0029) 0.003 (0.0003) 0.1909 0.7693 (0.0025) 0.0398 (0.001)) 
14 0.9435 0.0503 (0.0012) 0.0062 (0.0004) 0.369 0.628 (0.0029) 0.003 (0.0003) 0.1733 0.7855 (0.0024) 0.0412 (0.001) 
15 0.9416 0.052 (0.0012) 0.0064 (0.0004) 0.369 0.628 (0.0029) 0.003 (0.0003) 0.1575 0.8 (0.0023) 0.0425 (0.001) 
16 0.9399 0.0536 (0.0012) 0.0065 (0.0004) 0.369 0.628 (0.0029) 0.003 (0.0003) 0.1435 0.8129 (0.0023) 0.0436 (0.0011) 
17 0.9382 0.0552 (0.0012) 0.0066 (0.0004) 0.369 0.628 (0.0029) 0.003 (0.0003) 0.1308 0.8245 (0.0022) 0.0447 (0.0011) 
18 0.9364 0.0568 (0.0012) 0.0068 (0.0004) 0.369 0.628 (0.0029) 0.003 (0.0003) 0.1194 0.8349 (0.0021) 0.0457 (0.0011) 
19 0.9348 0.0583 (0.0012) 0.0069 (0.0004) 0.369 0.628 (0.0029) 0.003 (0.0003) 0.1091 0.8443 (0.0021) 0.0466 (0.0011) 
20 0.9333 0.0597 (0.0013) 0.007 (0.0004) 0.369 0.628 (0.0029) 0.003 (0.0003) 0.0998 0.8528 (0.002) 0.0474 (0.0011) 
21 0.9317 0.0612 (0.0013) 0.0071 (0.0004) 0.369 0.628 (0.0029) 0.003 (0.0003) 0.0913 0.8605 (0.002) 0.0482 (0.0011) 
22 0.9303 0.0625 (0.0013) 0.0072 (0.0004) 0.369 0.628 (0.0029) 0.003 (0.0003) 0.0837 0.8674 (0.0019) 0.0489 (0.0011) 
23 0.9288 0.0639 (0.0013) 0.0073 (0.0004) 0.369 0.628 (0.0029) 0.003 (0.0003) 0.0768 0.8737 (0.0019) 0.0495 (0.0011) 
24 0.9274 0.0652 (0.0013) 0.0074 (0.0004) 0.369 0.628 (0.0029) 0.003 (0.0003) 0.0705 0.8794 (0.0018) 0.0501 (0.0011) 
25 0.9260 0.0665 (0.0013) 0.0075 (0.0004) 0.369 0.628 (0.0029) 0.003 (0.0003) 0.0648 0.8846 (0.0018) 0.0506 (0.0011) 
26 0.9246 0.0678 (0.0013) 0.0076 (0.0004) 0.369 0.628 (0.0029) 0.003 (0.0003) 0.0596 0.8893 (0.0017) 0.0511 (0.0011) 
27 0.9233 0.069 (0.0014) 0.0077 (0.0004) 0.369 0.628 (0.0029) 0.003 (0.0003) 0.0548 0.8936 (0.0017) 0.0516 (0.0011) 
28 0.9220 0.0702 (0.0014) 0.0078 (0.0005) 0.369 0.628 (0.0029) 0.003 (0.0003) 0.0504 0.8976 (0.0016) 0.052 (0.0012) 
29 0.9208 0.0714 (0.0014) 0.0078 (0.0005) 0.369 0.628 (0.0029) 0.003 (0.0003) 0.0465 0.9011 (0.0016) 0.0524 (0.0012) 
30 0.9195 0.0726 (0.0014) 0.0079 (0.0005) 0.369 0.628 (0.0029) 0.003 (0.0003) 0.0428 0.9044 (0.0016) 0.0528 (0.0012) 
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Table C13: Transition probabilities for the first 30 days used in the local hospital- CCI0 
Day Transition Probability (Standard Error) 
Community to A&E to Admission to 
Community  A&E (SE) Dead (SE) Community Admission (SE) Dead (SE) Admission  Community(SE) Dead(SE) 
1 0.9801 0.0184 (0.0003) 0.0015 (0.0001) 0.502 0.496 (0.0015) 0.002 (0.0001) 0.7097 0.281 (0.0013) 0.0093 (0.0003) 
2 0.9742 0.024 (0.0004) 0.0018 (0.0001) 0.502 0.496 (0.0015) 0.002 (0.0001) 0.5891 0.3964 (0.0014)  0.0145 (0.0003) 
3 0.9699 0.0281 (0.0004) 0.002 (0.0001) 0.502 0.496 (0.0015) 0.002 (0.0001) 0.5051 0.4764 (0.0015) 0.0185 (0.0004) 
4 0.9665 0.0314 (0.0004) 0.0021 (0.0001) 0.502 0.496 (0.0015) 0.002 (0.0001) 0.4408 0.5375 (0.0015) 0.0217 (0.0004) 
5 0.9637 0.0341 (0.0004) 0.0022 (0.0001) 0.502 0.496 (0.0015) 0.002 (0.0001) 0.3892 0.5864 (0.0015) 0.0244 (0.0005) 
6 0.9611 0.0366 (0.0005)  0.0023 (0.0001) 0.502 0.496 (0.0015) 0.002 (0.0001) 0.3466 0.6267 (0.0015) 0.0267 (0.0005) 
7 0.9588 0.0388 (0.0005) 0.0024 (0.0001) 0.502 0.496 (0.0015) 0.002 (0.0001) 0.3107 0.6606 (0.0014) 0.0287 (0.0005)  
8 0.9568 0.0408 (0.0005) 0.0024 (0.0001) 0.502 0.496 (0.0015) 0.002 (0.0001) 0.2800 0.6896 (0.0014) 0.0304 (0.0005) 
9 0.9548 0.0427 (0.0005) 0.0025 (0.0001) 0.502 0.496 (0.0015) 0.002 (0.0001) 0.2536 0.7145 (0.0014) 0.0319 (0.0005) 
10 0.9529 0.0445 (0.0005) 0.0026 (0.0001) 0.502 0.496 (0.0015) 0.002 (0.0001) 0.2304 0.7363 (0.0014) 0.0333 (0.0005)  
11 0.9513 0.0461 (0.0005) 0.0026 (0.0001) 0.502 0.496 (0.0015) 0.002 (0.0001) 0.2100 0.7555 (0.0013) 0.0345 (0.0006) 
12 0.9496 0.0477 (0.0005) 0.0027 (0.0001) 0.502 0.496 (0.0015) 0.002 (0.0001) 0.1920 0.7724 (0.0013) 0.0356 (0.0006)  
13 0.9482 0.0491 (0.0006) 0.0027 (0.0001) 0.502 0.496 (0.0015) 0.002 (0.0001) 0.1760 0.7874 (0.0013) 0.0366 (0.0006) 
14 0.9468 0.0505 (0.0006) 0.0027 (0.0001) 0.502 0.496 (0.0015) 0.002 (0.0001) 0.1617 0.8008 (0.0013) 0.0375 (0.0006) 
15 0.9453 0.0519 (0.0006) 0.0028 (0.0001) 0.502 0.496 (0.0015) 0.002 (0.0001) 0.1489 0.8128 (0.0012) 0.0383 (0.0006) 
16 0.9441 0.0531 (0.0006) 0.0028 (0.0001) 0.502 0.496 (0.0015) 0.002 (0.0001) 0.1373 0.8236 (0.0012) 0.0391 (0.0006) 
17 0.9427 0.0544 (0.0006) 0.0029 (0.0001) 0.502 0.496 (0.0015) 0.002 (0.0001) 0.1269 0.8334 (0.0012) 0.0397 (0.0006) 
18 0.9415 0.0556 (0.0006) 0.0029 (0.0001) 0.502 0.496 (0.0015) 0.002 (0.0001) 0.1174 0.8422 (0.0012) 0.0404 (0.0006) 
19 0.9404 0.0567 (0.0006) 0.0029 (0.0001) 0.502 0.496 (0.0015) 0.002 (0.0001) 0.1088 0.8503 (0.0011) 0.0409 (0.0006) 
20 0.9392 0.0578 (0.0006) 0.003 (0.0001) 0.502 0.496 (0.0015) 0.002 (0.0001) 0.1009 0.8576 (0.0011) 0.0415 (0.0006) 
21 0.9381 0.0589 (0.0006) 0.003 (0.0001) 0.502 0.496 (0.0015) 0.002 (0.0001) 0.0938 0.8643 (0.0011) 0.0419 (0.0006) 
22 0.9371 0.0599 (0.0006) 0.003 (0.0001) 0.502 0.496 (0.0015) 0.002 (0.0001) 0.0872 0.8704 (0.0011) 0.0424 (0.0006) 
23 0.9359 0.061 (0.0006) 0.0031 (0.0001) 0.502 0.496 (0.0015) 0.002 (0.0001) 0.0813 0.8759 (0.001) 0.0428 (0.0006) 
24 0.935 0.0619 (0.0006) 0.0031 (0.0001) 0.502 0.496 (0.0015) 0.002 (0.0001) 0.0757 0.8811 (0.001) 0.0432 (0.0006) 
25 0.934 0.0629 (0.0006) 0.0031 (0.0001) 0.502 0.496 (0.0015) 0.002 (0.0001) 0.0707 0.8858 (0.001) 0.0435 (0.0006) 
26 0.9331 0.0638 (0.0006) 0.0031 (0.0001) 0.502 0.496 (0.0015) 0.002 (0.0001) 0.0661 0.8901 (0.001) 0.0438 (0.0006) 
27 0.9321 0.0647 (0.0006) 0.0032 (0.0001) 0.502 0.496 (0.0015) 0.002 (0.0001) 0.0618 0.8941 (0.001) 0.0441 (0.0006) 
28 0.9312 0.0656 (0.0006) 0.0032 (0.0001) 0.502 0.496 (0.0015) 0.002 (0.0001) 0.0578 0.8978 (0.001) 0.0444 (0.0006) 
29 0.9303 0.0665 (0.0006) 0.0032 (0.0001) 0.502 0.496 (0.0015) 0.002 (0.0001) 0.0541 0.9012 (0.0009) 0.0447 (0.0006) 
30 0.9294 0.0674 (0.0007) 0.0032 (0.0001) 0.502 0.496 (0.0015) 0.002 (0.0001) 0.0507 0.9044 (0.0009) 0.0449 (0.0006)  
CCI0: Charlson’s co-morbidity index=0 
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Table C14: Transition probabilities for the first 30 days used in the central hospital-CCI0 
Day Transition Probability (Standard Error) 
Community to A&E to Admission to 
Community  A&E (SE) Dead (SE) Community Admission(SE) Dead(SE) Admission  Community(SE) Dead (SE) 
1 0.986 0.0129 (0.0006) 0.0011 (0.0002) 0.505 0.494 (0.0033) 0.002 (0.0003) 0.7031 0.2934 (0.003) 0.0035 (0.0003) 
2 0.9811 0.0175 (0.0007) 0.0014 (0.0002) 0.505 0.494 (0.0033) 0.002 (0.0003) 0.5551 0.4386 (0.0033) 0.0063 (0.0004) 
3 0.9774 0.021 (0.0008) 0.0016 (0.0002) 0.505 0.494 (0.0033) 0.002 (0.0003) 0.4512 0.5401 (0.0034) 0.0087 (0.0005) 
4 0.9744 0.0239 (0.0009) 0.0017 (0.0002) 0.505 0.494 (0.0033) 0.002 (0.0003) 0.3729 0.6164 (0.0033) 0.0107 (0.0006) 
5 0.9718 0.0264 (0.0009) 0.0018 (0.0003) 0.505 0.494 (0.0033) 0.002 (0.0003) 0.3118 0.6758 (0.0031) 0.0124 (0.0007) 
6 0.9695 0.0286 (0.0009) 0.0019 (0.0003) 0.505 0.494 (0.0033) 0.002 (0.0003) 0.2629 0.7233 (0.003) 0.0138 (0.0007) 
7 0.9674 0.0306 (0.001) 0.002 (0.0003) 0.505 0.494 (0.0033) 0.002 (0.0003) 0.2232 0.7617 (0.0029) 0.0151 (0.0007) 
8 0.9654 0.0325 (0.001) 0.0021 (0.0003) 0.505 0.494 (0.0033) 0.002 (0.0003) 0.1905 0.7934 (0.0027) 0.0161 (0.0007)  
9 0.9636 0.0342 (0.001) 0.0022 (0.0003) 0.505 0.494 (0.0033) 0.002 (0.0003) 0.1634 0.8196 (0.0026) 0.017 (0.0008) 
10 0.962 0.0358 (0.0011) 0.0022 (0.0003) 0.505 0.494 (0.0033) 0.002 (0.0003) 0.1407 0.8415 (0.0024) 0.0178 (0.0008) 
11 0.9603 0.0374 (0.0011) 0.0023 (0.0003) 0.505 0.494 (0.0033) 0.002 (0.0003) 0.1216 0.8599 (0.0023) 0.0185 (0.0008) 
12 0.9587 0.0389 (0.0011) 0.0024 (0.0003) 0.505 0.494 (0.0033) 0.002 (0.0003) 0.1054 0.8755 (0.0022) 0.0191 (0.0008) 
13 0.9573 0.0403 (0.0011) 0.0024 (0.0003)  0.505 0.494 (0.0033) 0.002 (0.0003) 0.0915 0.8888 (0.002) 0.0197 (0.0008) 
14 0.9559 0.0416 (0.0011) 0.0025 (0.0003) 0.505 0.494 (0.0033) 0.002 (0.0003) 0.0798 0.9001 (0.0019) 0.0201 (0.0008) 
15 0.9546 0.0429 (0.0012) 0.0025 (0.0003) 0.505 0.494 (0.0033) 0.002 (0.0003) 0.0697 0.9098 (0.0018) 0.0205 (0.0008) 
16 0.9533 0.0441 (0.0012) 0.0026 (0.0003) 0.505 0.494 (0.0033) 0.002 (0.0003) 0.0610 0.9181 (0.0017) 0.0209 (0.0008) 
17 0.9521 0.0453 (0.0012) 0.0026 (0.0003) 0.505 0.494 (0.0033) 0.002 (0.0003) 0.0535 0.9253 (0.0016) 0.0212 (0.0008) 
18 0.9508 0.0465 (0.0012) 0.0027 (0.0003) 0.505 0.494 (0.0033) 0.002 (0.0003) 0.0470 0.9315 (0.0015) 0.0215 (0.0008) 
19 0.9497 0.0476 (0.0012) 0.0027 (0.0003) 0.505 0.494 (0.0033) 0.002 (0.0003) 0.0414 0.9369 (0.0015) 0.0217 (0.0008) 
20 0.9486 0.0487 (0.0012) 0.0027 (0.0003) 0.505 0.494 (0.0033) 0.002 (0.0003) 0.0365 0.9416 (0.0014) 0.0219 (0.0008) 
21 0.9475 0.0497 (0.0013) 0.0028 (0.0003) 0.505 0.494 (0.0033) 0.002 (0.0003) 0.0322 0.9457 (0.0013) 0.0221 (0.0008) 
22 0.9465 0.0507 (0.0013) 0.0028 (0.0003) 0.505 0.494 (0.0033) 0.002 (0.0003) 0.0284 0.9493 (0.0013) 0.0223 (0.0008) 
23 0.9454 0.0517 (0.0013) 0.0029 (0.0003) 0.505 0.494 (0.0033) 0.002 (0.0003) 0.0251 0.9524 (0.0012) 0.0225 (0.0008) 
24 0.9444 0.0527 (0.0013) 0.0029 (0.0003) 0.505 0.494 (0.0033) 0.002 (0.0003) 0.0223 0.9551 (0.0012) 0.0226 (0.0008) 
25 0.9434 0.0537 (0.0013) 0.0029 (0.0003) 0.505 0.494 (0.0033) 0.002 (0.0003) 0.0198 0.9575 (0.0011) 0.0227 (0.0008) 
26 0.9424 0.0546 (0.0013) 0.003 (0.0003) 0.505 0.494 (0.0033) 0.002 (0.0003) 0.0176 0.9596 (0.0011) 0.0228 (0.0008) 
27 0.9415 0.0555 (0.0013) 0.003 (0.0003) 0.505 0.494 (0.0033) 0.002 (0.0003) 0.0156 0.9615 (0.0011) 0.0229 (0.0008) 
28 0.9406 0.0564 (0.0013) 0.003 (0.0003) 0.505 0.494 (0.0033) 0.002 (0.0003) 0.0139 0.9631 (0.001) 0.023 (0.0009) 
29 0.9397 0.0573 (0.0013) 0.003 (0.0003) 0.505 0.494 (0.0033) 0.002 (0.0003) 0.0123 0.9646 (0.001) 0.0231 (0.0009) 
30 0.9388 0.0581 (0.0013) 0.0031 (0.0003) 0.505 0.494 (0.0033) 0.002 (0.0003) 0.0110 0.9659 (0.001) 0.0231 (0.0009) 
CCI0: Charlson’s co-morbidity index=0 
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Table C15: Transition probabilities for the first 30 days used in the local hospital- CCI4 
Day Transition Probability (Standard Error) 
Community to A&E to Admission to 
Community  A&E (SE) Dead (SE) Community Admission (SE) Dead (SE) Admission  Community(SE) Dead(SE) 
1 0.9574 0.0268 (0.0008) 0.0158 (0.0007) 0.146 0.847 (0.0024) 0.007 (0.0006) 0.8935 0.0951 (0.0015) 0.0114 (0.0005) 
2 0.9443 0.0364 (0.001) 0.0193 (0.0008) 0.146 0.847 (0.0024) 0.007 (0.0006) 0.8170 0.1614 (0.0021) 0.0216 (0.0007) 
3 0.935 0.0434 (0.0011) 0.0216 (0.0009) 0.146 0.847 (0.0024) 0.007 (0.0006) 0.7522 0.2169 (0.0024) 0.0309 (0.0009) 
4 0.9274 0.0492 (0.0012) 0.0234 (0.0009) 0.146 0.847 (0.0024) 0.007 (0.0006) 0.6954 0.2651 (0.0026) 0.0395 (0.001) 
5 0.9209 0.0542 (0.0013) 0.0249 (0.0009) 0.146 0.847 (0.0024) 0.007 (0.0006) 0.6447 0.3079 (0.0027) 0.0474 (0.0011) 
6 0.9152 0.0586 (0.0014) 0.0262 (0.0009) 0.146 0.847 (0.0024) 0.007 (0.0006) 0.5990 0.3462 (0.0028) 0.0548  (0.0012) 
7 0.91 0.0627 (0.0014) 0.0273 (0.001) 0.146 0.847 (0.0024) 0.007 (0.0006) 0.5575 0.3808 (0.0028) 0.0617 (0.0013) 
8 0.9052 0.0664 (0.0015) 0.0284 (0.001) 0.146 0.847 (0.0024) 0.007 (0.0006) 0.5197 0.4122 (0.0029) 0.0681 (0.0014) 
9 0.9009 0.0698 (0.0015) 0.0293 (0.001) 0.146 0.847 (0.0024) 0.007 (0.0006) 0.4851 0.4409 (0.0029) 0.074 (0.0014) 
10 0.8968 0.073 (0.0015) 0.0302 (0.001) 0.146 0.847 (0.0024) 0.007 (0.0006) 0.4532 0.4672 (0.0029) 0.0796 (0.0015) 
11 0.8929 0.0761 (0.0016) 0.031 (0.001) 0.146 0.847 (0.0024) 0.007 (0.0006) 0.4238 0.4914 (0.0029) 0.0848 (0.0015) 
12 0.8893 0.079  (0.0016) 0.0317 (0.001) 0.146 0.847 (0.0024) 0.007 (0.0006) 0.3968 0.5136 (0.0029) 0.0896 (0.0015) 
13 0.8859 0.0817 (0.0016) 0.0324 (0.0011) 0.146 0.847 (0.0024) 0.007 (0.0006) 0.3717 0.5341 (0.0029) 0.0942 (0.0016) 
14 0.8826 0.0843 (0.0017) 0.0331 (0.0011) 0.146 0.847 (0.0024) 0.007 (0.0006) 0.3485 0.5531 (0.0029) 0.0984 (0.0016) 
15 0.8795 0.0868 (0.0017) 0.0337 (0.0011) 0.146 0.847 (0.0024) 0.007 (0.0006) 0.3269 0.5707 (0.0028) 0.1024 (0.0016) 
16 0.8765 0.0892 (0.0017) 0.0343 (0.0011) 0.146 0.847 (0.0024) 0.007 (0.0006) 0.3068 0.587 (0.0028) 0.1062 (0.0017) 
17 0.8736 0.0916 (0.0017) 0.0348 (0.0011) 0.146 0.847 (0.0024) 0.007 (0.0006) 0.2881 0.6022 (0.0028) 0.1097 (0.0017) 
18 0.8708 0.0938 (0.0018) 0.0354 (0.0011) 0.146 0.847 (0.0024) 0.007 (0.0006) 0.2707 0.6163 (0.0028) 0.113 (0.0017) 
19 0.8681 0.096 (0.0018) 0.0359 (0.0011) 0.146 0.847 (0.0024) 0.007 (0.0006) 0.2545 0.6294 (0.0028)  0.1161 (0.0017) 
20 0.8655 0.0981 (0.0018) 0.0364 (0.0011) 0.146 0.847 (0.0024) 0.007 (0.0006) 0.2394 0.6416 (0.0027) 0.119 (0.0017) 
21 0.863 0.1001 (0.0018) 0.0369 (0.0011) 0.146 0.847 (0.0024) 0.007 (0.0006) 0.2252 0.653 (0.0027) 0.1218 (0.0017) 
22 0.8606 0.1021 (0.0018) 0.0373 (0.0011) 0.146 0.847 (0.0024) 0.007 (0.0006) 0.2120 0.6636 (0.0027) 0.1244 (0.0018) 
23 0.8582 0.104 (0.0019) 0.0378 (0.0012) 0.146 0.847 (0.0024) 0.007 (0.0006) 0.1996 0.6736 (0.0027) 0.1268 (0.0018) 
24 0.8559 0.1059 (0.0019) 0.0382 (0.0012) 0.146 0.847 (0.0024) 0.007 (0.0006) 0.1880 0.6829 (0.0026) 0.1291 (0.0018) 
25 0.8537 0.1077 (0.0019) 0.0386 (0.0012) 0.146 0.847 (0.0024) 0.007 (0.0006) 0.1772 0.6916 (0.0026) 0.1312 (0.0018) 
26 0.8515 0.1095 (0.0019) 0.039 (0.0012) 0.146 0.847 (0.0024) 0.007 (0.0006) 0.1670 0.6997 (0.0026) 0.1333 (0.0018) 
27 0.8494 0.1112 (0.0019) 0.0394 (0.0012) 0.146 0.847 (0.0024) 0.007 (0.0006) 0.1575 0.7073 (0.0026) 0.1352 (0.0018) 
28 0.8473 0.1129 (0.0019) 0.0398 (0.0012) 0.146 0.847 (0.0024) 0.007 (0.0006) 0.1486 0.7144 (0.0026) 0.137 (0.0018) 
29 0.8452 0.1146 (0.002) 0.0402 (0.0012) 0.146 0.847 (0.0024) 0.007 (0.0006) 0.1402 0.7211 (0.0025) 0.1387 (0.0018) 
30 0.8433 0.1162 (0.002) 0.0405 (0.0012) 0.146 0.847 (0.0024) 0.007 (0.0006) 0.1323 0.7274 (0.0025) 0.1403 (0.0019) 
CCI4: Charlson’s co-morbidity index>=4 
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Table C16: Transition probabilities for the first 30 days used in the central hospital-CCI4 
Day Transition Probability (Standard Error) 
Community to A&E to Admission to 
Community  A&E (SE) Dead (SE) Community Admission(SE) Dead(SE) Admission  Community(SE) Dead (SE) 
1 0.9733 0.0154 (0.0011) 0.0113 (0.0011) 0.141 0.854 (0.0043) 0.005 (0.0009) 0.8815 0.1099 (0.003) 0.0086 (0.0007) 
2 0.9626 0.0228 (0.0014) 0.0146 (0.0013) 0.141 0.854 (0.0043) 0.005 (0.0009) 0.7959 0.1869 (0.004) 0.0172 (0.0012) 
3 0.9543 0.0287 (0.0016) 0.017 (0.0014) 0.141 0.854 (0.0043) 0.005 (0.0009) 0.7237 0.2509 (0.0046) 0.0254 (0.0015) 
4 0.9475 0.0337 (0.0018) 0.0188 (0.0015) 0.141 0.854 (0.0043) 0.005 (0.0009) 0.6609 0.3061 (0.0049) 0.033 (0.0018) 
5 0.9414 0.0382 (0.002) 0.0204 (0.0016) 0.141 0.854 (0.0043) 0.005 (0.0009) 0.6052 0.3546 (0.005) 0.0402 (0.002) 
6 0.9359 0.0423 (0.0021) 0.0218 (0.0016) 0.141 0.854 (0.0043) 0.005 (0.0009) 0.5555 0.3976 (0.0051) 0.0469 (0.0021) 
7 0.9308 0.0461 (0.0022) 0.0231 (0.0017) 0.141 0.854 (0.0043) 0.005 (0.0009) 0.5109 0.436 (0.0052) 0.0531 (0.0023) 
8 0.9262 0.0496 (0.0023) 0.0242 (0.0017) 0.141 0.854 (0.0043) 0.005 (0.0009) 0.4705 0.4706 (0.0052) 0.0589 (0.0024) 
9 0.9218 0.053 (0.0024) 0.0252 (0.0018) 0.141 0.854 (0.0043) 0.005 (0.0009) 0.4338 0.5019 (0.0052) 0.0643 (0.0025) 
10 0.9176 0.0562 (0.0024) 0.0262 (0.0018) 0.141 0.854 (0.0043) 0.005 (0.0009) 0.4005 0.5302 (0.0051) 0.0693 (0.0026) 
11 0.9137 0.0592 (0.0025) 0.0271 (0.0018) 0.141 0.854 (0.0043) 0.005 (0.0009) 0.3701 0.5559 (0.0051) 0.074 (0.0026) 
12 0.9099 0.0621 (0.0026) 0.028 (0.0019) 0.141 0.854 (0.0043) 0.005 (0.0009) 0.3424 0.5793 (0.0051) 0.0783 (0.0027) 
13 0.9063 0.0649 (0.0026) 0.0288 (0.0019) 0.141 0.854 (0.0043) 0.005 (0.0009) 0.3169 0.6007 (0.005) 0.0824 (0.0028) 
14 0.9029 0.0676 (0.0027) 0.0295 (0.0019) 0.141 0.854 (0.0043) 0.005 (0.0009) 0.2935 0.6203 (0.0049) 0.0862 (0.0028) 
15 0.8995 0.0702 (0.0028) 0.0303 (0.002) 0.141 0.854 (0.0043) 0.005 (0.0009) 0.2721 0.6382 (0.0049) 0.0897 (0.0029) 
16 0.8963 0.0727 (0.0028) 0.031 (0.002) 0.141 0.854 (0.0043) 0.005 (0.0009) 0.2523 0.6547 (0.0048) 0.093 (0.0029) 
17 0.8932 0.0752 (0.0029) 0.0316 (0.002) 0.141 0.854 (0.0043) 0.005 (0.0009) 0.2341 0.6698 (0.0048) 0.0961 (0.0029) 
18 0.8901 0.0776 (0.0029) 0.0323 (0.002) 0.141 0.854 (0.0043) 0.005 (0.0009) 0.2173 0.6837 (0.0048) 0.099 (0.003) 
19 0.8872 0.0799 (0.003) 0.0329 (0.002) 0.141 0.854 (0.0043) 0.005 (0.0009) 0.2019 0.6964 (0.0047) 0.1017 (0.003) 
20 0.8844 0.0821 (0.003) 0.0335 (0.0021) 0.141 0.854 (0.0043) 0.005 (0.0009) 0.1876 0.7082 (0.0046) 0.1042 (0.003) 
21 0.8815 0.0844 (0.003) 0.0341 (0.0021) 0.141 0.854 (0.0043) 0.005 (0.0009) 0.1744 0.7191 (0.0046) 0.1065 (0.0031) 
22 0.8789 0.0865 (0.0031) 0.0346 (0.0021) 0.141 0.854 (0.0043) 0.005 (0.0009) 0.1622 0.7291 (0.0045) 0.1087 (0.0031) 
23 0.8763 0.0886 (0.0031) 0.0351 (0.0021) 0.141 0.854 (0.0043) 0.005 (0.0009) 0.1510 0.7383 (0.0045) 0.1107 (0.0031) 
24 0.8736 0.0907 (0.0032) 0.0357 (0.0021) 0.141 0.854 (0.0043) 0.005 (0.0009) 0.1405 0.7469 (0.0044) 0.1126 (0.0031) 
25 0.8711 0.0927 (0.0032) 0.0362 (0.0021) 0.141 0.854 (0.0043) 0.005 (0.0009) 0.1308 0.7548 (0.0044) 0.1144 (0.0031) 
26 0.8686 0.0947 (0.0032) 0.0367 (0.0022) 0.141 0.854 (0.0043) 0.005 (0.0009) 0.1218 0.7621 (0.0043) 0.1161 (0.0032) 
27 0.8662 0.0966 (0.0033) 0.0372 (0.0022) 0.141 0.854 (0.0043) 0.005 (0.0009) 0.1135 0.7689 (0.0043) 0.1176 (0.0032) 
28 0.8639 0.0985 (0.0033) 0.0376 (0.0022) 0.141 0.854 (0.0043) 0.005 (0.0009) 0.1057 0.7752 (0.0042) 0.1191 (0.0032) 
29 0.8615 0.1004 (0.0033)  0.0381 (0.0022)  0.141 0.854 (0.0043) 0.005 (0.0009) 0.0986 0.781 (0.0042) 0.1204 (0.0032) 
30 0.8592 0.1023 (0.0034) 0.0385 (0.0022) 0.141 0.854 (0.0043) 0.005 (0.0009) 0.0919 0.7864 (0.0041) 0.1217 (0.0032) 
CCI4: Charlson’s co-morbidity index>=4 
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Table C17: Transition probabilities for the first 30 days used in the local hospital- IMD1 
Day Transition Probability (Standard Error) 
Community to A&E to Admission to 
Community  A&E (SE) Dead (SE) Community Admission (SE) Dead (SE) Admission  Community(SE) Dead(SE) 
1 0.9768 0.0191 (0.0006) 0.0041 (0.0003) 0.375 0.623 (0.0027) 0.003 (0.0003) 0.7964 0.1968 (0.002) 0.0068 (0.0003) 
2 0.9701 0.0251 (0.0007) 0.0048 (0.0003) 0.375 0.623 (0.0027) 0.003 (0.0003) 0.6859 0.3019 (0.0024) 0.0122 (0.0005) 
3 0.9653 0.0294 (0.0008) 0.0053 (0.0004) 0.375 0.623 (0.0027) 0.003 (0.0003) 0.6024 0.3808 (0.0026) 0.0168 (0.0006) 
4 0.9614 0.0329 (0.0008) 0.0057 (0.0004) 0.375 0.623 (0.0027) 0.003 (0.0003) 0.5348 0.4443 (0.0026) 0.0209 (0.0007) 
5 0.9581 0.0359 (0.0009) 0.006 (0.0004) 0.375 0.623 (0.0027) 0.003 (0.0003) 0.4785 0.497 (0.0026) 0.0245 (0.0007) 
6 0.9553 0.0385 (0.0009) 0.0062 (0.0004) 0.375 0.623 (0.0027) 0.003 (0.0003) 0.4305 0.5418 (0.0026) 0.0277 (0.0008) 
7 0.9527 0.0409 (0.0009) 0.0064 (0.0004) 0.375 0.623 (0.0027) 0.003 (0.0003) 0.3890 0.5804 (0.0026)  0.0306 (0.0008) 
8 0.9503 0.0431 (0.0009) 0.0066 (0.0004) 0.375 0.623 (0.0027) 0.003 (0.0003) 0.3528 0.614 (0.0025) 0.0332 (0.0009) 
9 0.9481 0.0451 (0.001) 0.0068 (0.0004) 0.375 0.623 (0.0027) 0.003 (0.0003) 0.3209 0.6435 (0.0025) 0.0356 (0.0009) 
10 0.946 0.047 (0.001) 0.007 (0.0004) 0.375 0.623 (0.0027) 0.003 (0.0003) 0.2926 0.6696 (0.0024) 0.0378 (0.0009) 
11 0.9441 0.0488 (0.001) 0.0071 (0.0004) 0.375 0.623 (0.0027) 0.003 (0.0003) 0.2676 0.6927 (0.0024) 0.0397 (0.0009) 
12 0.9423 0.0504 (0.001) 0.0073 (0.0004) 0.375 0.623 (0.0027) 0.003 (0.0003) 0.2451 0.7134 (0.0023) 0.0415 (0.0009) 
13 0.9406 0.052 (0.0011) 0.0074 (0.0004)  0.375 0.623 (0.0027) 0.003 (0.0003) 0.2249 0.7319 (0.0023) 0.0432 (0.001) 
14 0.939 0.0535 (0.0011) 0.0075 (0.0004) 0.375 0.623 (0.0027) 0.003 (0.0003) 0.2067 0.7486 (0.0023) 0.0447 (0.001) 
15 0.9373 0.055 (0.0011) 0.0077 (0.0004) 0.375 0.623 (0.0027) 0.003 (0.0003) 0.1903 0.7636 (0.0022) 0.0461 (0.001) 
16 0.9358 0.0564 (0.0011) 0.0078 (0.0004) 0.375 0.623 (0.0027) 0.003 (0.0003) 0.1755 0.7772 (0.0022) 0.0473 (0.001) 
17 0.9344 0.0577 (0.0011) 0.0079 (0.0004) 0.375 0.623 (0.0027) 0.003 (0.0003) 0.1619 0.7896 (0.0021) 0.0485 (0.001) 
18 0.933 0.059 (0.0011) 0.008 (0.0004) 0.375 0.623 (0.0027) 0.003 (0.0003) 0.1496 0.8008 (0.0021) 0.0496 (0.001) 
19 0.9317 0.0602 (0.0011) 0.0081 (0.0004) 0.375 0.623 (0.0027) 0.003 (0.0003) 0.1384 0.811 (0.002) 0.0506 (0.001) 
20 0.9304 0.0614 (0.0011) 0.0082 (0.0004) 0.375 0.623 (0.0027) 0.003 (0.0003) 0.1282 0.8203 (0.002) 0.0515 (0.001) 
21 0.9291 0.0626 (0.0012) 0.0083 (0.0004) 0.375 0.623 (0.0027) 0.003 (0.0003) 0.1187 0.8289 (0.002) 0.0524 (0.0011) 
22 0.9279 0.0637 (0.0012) 0.0084 (0.0005) 0.375 0.623 (0.0027) 0.003 (0.0003) 0.1101 0.8367 (0.0019) 0.0532 (0.0011) 
23 0.9268 0.0648 (0.0012) 0.0084 (0.0005) 0.375 0.623 (0.0027) 0.003 (0.0003) 0.1023 0.8438 (0.0019) 0.0539 (0.0011) 
24 0.9256 0.0659 (0.0012) 0.0085 (0.0005) 0.375 0.623 (0.0027) 0.003 (0.0003) 0.0950 0.8504 (0.0018) 0.0546 (0.0011) 
25 0.9245 0.0669 (0.0012) 0.0086 (0.0005) 0.375 0.623 (0.0027) 0.003 (0.0003) 0.0883 0.8564 (0.0018) 0.0553 (0.0011) 
26 0.9234 0.0679 (0.0012) 0.0087 (0.0005) 0.375 0.623 (0.0027) 0.003 (0.0003) 0.0821 0.862 (0.0018) 0.0559 (0.0011) 
27 0.9223 0.0689 (0.0012) 0.0088 (0.0005) 0.375 0.623 (0.0027) 0.003 (0.0003) 0.0765 0.8671 (0.0017) 0.0564 (0.0011) 
28 0.9213 0.0699 (0.0012) 0.0088 (0.0005) 0.375 0.623 (0.0027) 0.003 (0.0003) 0.0713 0.8718 (0.0017) 0.0569 (0.0011) 
29 0.9203 0.0708 (0.0012) 0.0089 (0.0005) 0.375 0.623 (0.0027) 0.003 (0.0003) 0.0665 0.8761 (0.0017) 0.0574 (0.0011) 
30 0.9192 0.0718 (0.0012) 0.009 (0.0005) 0.375 0.623 (0.0027) 0.003 (0.0003) 0.0620 0.8802 (0.0016) 0.0578 (0.0011) 
IMD1: Index of mean deprivation 1st quintile 
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Table C18: Transition probabilities for the first 30 days used in the central hospital-IMD1 
Day Transition Probability (Standard Error) 
Community to A&E to Admission to 
Community  A&E (SE) Dead (SE) Community Admission(SE) Dead(SE) Admission  Community(SE) Dead (SE) 
1 0.9846 0.0123 (0.001) 0.0031 (0.0006) 0.378 0.619 (0.0057) 0.003 (0.0006) 0.7771 0.217 (0.0043) 0.0059 (0.0006) 
2 0.9788 0.0173 (0.0012) 0.0039 (0.0006) 0.378 0.619 (0.0057) 0.003 (0.0006) 0.6540 0.335 (0.0051) 0.011 (0.001)  
3 0.9745 0.0211 (0.0014) 0.0044 (0.0007) 0.378 0.619 (0.0057) 0.003 (0.0006) 0.5619 0.4227 (0.0054) 0.0154 (0.0012) 
4 0.9709 0.0242 (0.0015) 0.0049 (0.0007) 0.378 0.619 (0.0057) 0.003 (0.0006) 0.4885 0.4922 (0.0055) 0.0193 (0.0014) 
5 0.9678 0.027 (0.0016) 0.0052 (0.0007) 0.378 0.619 (0.0057) 0.003 (0.0006) 0.4280 0.5492 (0.0055) 0.0228 (0.0015) 
6 0.965 0.0295 (0.0017) 0.0055 (0.0008) 0.378 0.619 (0.0057) 0.003 (0.0006) 0.3773 0.5968 (0.0054) 0.0259 (0.0016) 
7 0.9624 0.0318 (0.0018) 0.0058 (0.0008) 0.378 0.619 (0.0057) 0.003 (0.0006) 0.3342 0.6371 (0.0053) 0.0287 (0.0017) 
8 0.96 0.0339 (0.0018) 0.0061 (0.0008) 0.378 0.619 (0.0057) 0.003 (0.0006) 0.2972 0.6716 (0.0052) 0.0312 (0.0018) 
9 0.9578 0.0359 (0.0019) 0.0063 (0.0008) 0.378 0.619 (0.0057) 0.003 (0.0006) 0.2651 0.7015 (0.005) 0.0334 (0.0018) 
10 0.9557 0.0378 (0.0019) 0.0065 (0.0008) 0.378 0.619 (0.0057) 0.003 (0.0006) 0.2372 0.7274 (0.0049) 0.0354 (0.0019) 
11 0.9537 0.0396 (0.002) 0.0067 (0.0008) 0.378 0.619 (0.0057) 0.003 (0.0006) 0.2128 0.75 (0.0047) 0.0372 (0.0019) 
12 0.9518 0.0413 (0.002) 0.0069 (0.0009) 0.378 0.619 (0.0057) 0.003 (0.0006) 0.1913 0.7699 (0.0046) 0.0388 (0.0019) 
13 0.95 0.0429 (0.0021) 0.0071 (0.0009) 0.378 0.619 (0.0057) 0.003 (0.0006) 0.1723 0.7874 (0.0045) 0.0403 (0.002) 
14 0.9483 0.0445 (0.0021) 0.0072 (0.0009) 0.378 0.619 (0.0057) 0.003 (0.0006) 0.1554 0.8029 (0.0043) 0.0417 (0.002) 
15 0.9466 0.046 (0.0022) 0.0074 (0.0009) 0.378 0.619 (0.0057) 0.003 (0.0006) 0.1404 0.8167 (0.0042) 0.0429 (0.002) 
16 0.9451 0.0474 (0.0022) 0.0075 (0.0009) 0.378 0.619 (0.0057) 0.003 (0.0006) 0.1271 0.8289 (0.0041) 0.044 (0.0021) 
17 0.9435 0.0488 (0.0022) 0.0077 (0.0009) 0.378 0.619 (0.0057) 0.003 (0.0006) 0.1152 0.8398 (0.004) 0.045 (0.0021) 
18 0.942 0.0502 (0.0023) 0.0078 (0.0009) 0.378 0.619 (0.0057) 0.003 (0.0006) 0.1045 0.8496 (0.0038) 0.0459 (0.0021) 
19 0.9406 0.0515 (0.0023) 0.0079 (0.0009)  0.378 0.619 (0.0057) 0.003 (0.0006) 0.0950 0.8583 (0.0037) 0.0467 (0.0021) 
20 0.9391 0.0528 (0.0023) 0.0081 (0.0009) 0.378 0.619 (0.0057) 0.003 (0.0006) 0.0863 0.8662 (0.0036) 0.0475 (0.0021) 
21 0.9378 0.054 (0.0023) 0.0082 (0.0009) 0.378 0.619 (0.0057) 0.003 (0.0006) 0.0786 0.8732 (0.0035) 0.0482 (0.0021) 
22 0.9365 0.0552 (0.0024) 0.0083 (0.001) 0.378 0.619 (0.0057) 0.003 (0.0006) 0.0716 0.8796 (0.0034) 0.0488 (0.0021) 
23 0.9352 0.0564 (0.0024) 0.0084 (0.001) 0.378 0.619 (0.0057) 0.003 (0.0006) 0.0653 0.8853 (0.0033) 0.0494 (0.0022) 
24 0.9339 0.0576 (0.0024) 0.0085 (0.001) 0.378 0.619 (0.0057) 0.003 (0.0006) 0.0597 0.8904 (0.0032) 0.0499 (0.0022) 
25 0.9326 0.0587 (0.0024) 0.0087 (0.001) 0.378 0.619 (0.0057) 0.003 (0.0006) 0.0545 0.8951 (0.0032) 0.0504 (0.0022) 
26 0.9314 0.0598 (0.0025) 0.0088 (0.001) 0.378 0.619 (0.0057) 0.003 (0.0006) 0.0498 0.8993 (0.0031) 0.0509 (0.0022) 
27 0.9302 0.0609 (0.0025) 0.0089 (0.001) 0.378 0.619 (0.0057) 0.003 (0.0006) 0.0456 0.9031 (0.003) 0.0513 (0.0022) 
28 0.929 0.062 (0.0025) 0.009 (0.001) 0.378 0.619 (0.0057) 0.003 (0.0006) 0.0418 0.9066 (0.003) 0.0516 (0.0022) 
29 0.9279 0.063 (0.0025) 0.0091 (0.001)  0.378 0.619 (0.0057) 0.003 (0.0006) 0.0382 0.9098 (0.0029) 0.052 (0.0022) 
30 0.9267 0.0641 (0.0025) 0.0092 (0.001) 0.378 0.619 (0.0057) 0.003 (0.0006) 0.0351 0.9126 (0.0028) 0.0523 (0.0022) 
IMD1: Index of mean deprivation 1st quintile 
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Table C19: Transition probabilities for the first 30 days used in the local hospital- IMD5 
Day Transition Probability (Standard Error) 
Community to A&E to Admission to 
Community  A&E (SE) Dead (SE) Community Admission (SE) Dead (SE) Admission  Community(SE) Dead(SE) 
1 0.9729 0.0232 (0.0005) 0.0039 (0.0002) 0.394 0.603 (0.002) 0.003 (0.0002) 0.7868 0.1759 (0.0013) 0.0373 (0.0009) 
2 0.9647 0.0307 (0.0005) 0.0046 (0.0002) 0.394 0.603 (0.002) 0.003 (0.0002) 0.6800 0.2658 (0.0016) 0.0542 (0.0011) 
3 0.9587 0.0362 (0.0006) 0.0051 (0.0003) 0.394 0.603 (0.002) 0.003 (0.0002) 0.6007 0.3329 (0.0017) 0.0664 (0.0012) 
4 0.954 0.0406 (0.0007) 0.0054 (0.0003) 0.394 0.603 (0.002) 0.003 (0.0002) 0.5372 0.3868 (0.0018) 0.076 (0.0013) 
5 0.9498 0.0445 (0.0007) 0.0057 (0.0003) 0.394 0.603 (0.002) 0.003 (0.0002) 0.4844 0.4317 (0.0018) 0.0839 (0.0013) 
6 0.9463 0.0478 (0.0007) 0.0059 (0.0003)  0.394 0.603 (0.002) 0.003 (0.0002) 0.4395 0.47 (0.0019) 0.0905 (0.0013) 
7 0.9429 0.0509 (0.0007) 0.0062 (0.0003) 0.394 0.603 (0.002) 0.003 (0.0002) 0.4006 0.5032 (0.0019) 0.0962 (0.0014) 
8 0.9399 0.0537 (0.0008) 0.0064 (0.0003) 0.394 0.603 (0.002) 0.003 (0.0002) 0.3666 0.5323 (0.0019) 0.1011 (0.0014) 
9 0.9372 0.0563 (0.0008) 0.0065 (0.0003) 0.394 0.603 (0.002) 0.003 (0.0002) 0.3366 0.558 (0.0019) 0.1054 (0.0014) 
10 0.9346 0.0587 (0.0008) 0.0067 (0.0003) 0.394 0.603 (0.002) 0.003 (0.0002) 0.3100 0.5808 (0.0019)  0.1092 (0.0014) 
11 0.9322 0.061 (0.0008) 0.0068 (0.0003)  0.394 0.603 (0.002) 0.003 (0.0002) 0.2861 0.6013 (0.002) 0.1126 (0.0014) 
12 0.9299 0.0631 (0.0008) 0.007 (0.0003) 0.394 0.603 (0.002) 0.003 (0.0002) 0.2646 0.6197 (0.002) 0.1157 (0.0015) 
13 0.9277 0.0652 (0.0009) 0.0071 (0.0003) 0.394 0.603 (0.002) 0.003 (0.0002) 0.2452 0.6364 (0.002) 0.1184 (0.0015) 
14 0.9257 0.0671 (0.0009) 0.0072 (0.0003) 0.394 0.603 (0.002) 0.003 (0.0002) 0.2276 0.6515 (0.002) 0.1209 (0.0015) 
15 0.9237 0.069 (0.0009) 0.0073 (0.0003) 0.394 0.603 (0.002) 0.003 (0.0002) 0.2117 0.6652 (0.002) 0.1231 (0.0015) 
16 0.9217 0.0708 (0.0009) 0.0075 (0.0003) 0.394 0.603 (0.002) 0.003 (0.0002) 0.1971 0.6778 (0.002) 0.1251 (0.0015) 
17 0.9199 0.0725 (0.0009) 0.0076 (0.0003) 0.394 0.603 (0.002) 0.003 (0.0002) 0.1838 0.6892 (0.002) 0.127 (0.0015) 
18 0.9181 0.0742 (0.0009) 0.0077 (0.0003) 0.394 0.603 (0.002) 0.003 (0.0002) 0.1716 0.6998 (0.0019) 0.1286 (0.0015) 
19 0.9165 0.0758 (0.0009) 0.0077 (0.0003) 0.394 0.603 (0.002) 0.003 (0.0002) 0.1603 0.7095 (0.0019) 0.1302 (0.0015) 
20 0.9149 0.0773 (0.0009) 0.0078 (0.0003) 0.394 0.603 (0.002) 0.003 (0.0002) 0.1500 0.7184 (0.0019) 0.1316 (0.0015) 
21 0.9133 0.0788 (0.0009) 0.0079 (0.0003) 0.394 0.603 (0.002) 0.003 (0.0002) 0.1405 0.7266 (0.0019) 0.1329 (0.0015) 
22 0.9117 0.0803 (0.001) 0.008 (0.0003) 0.394 0.603 (0.002) 0.003 (0.0002) 0.1317 0.7342 (0.0019) 0.1341 (0.0015) 
23 0.9102 0.0817 (0.001) 0.0081 (0.0003) 0.394 0.603 (0.002) 0.003 (0.0002) 0.1236 0.7412 (0.0019) 0.1352 (0.0015) 
24 0.9087 0.0831 (0.001) 0.0082 (0.0003) 0.394 0.603 (0.002) 0.003 (0.0002) 0.1159 0.7478 (0.0019) 0.1363 (0.0015) 
25 0.9074 0.0844 (0.001) 0.0082 (0.0003) 0.394 0.603 (0.002) 0.003 (0.0002) 0.1090 0.7538 (0.0019) 0.1372 (0.0015) 
26 0.9059 0.0858 (0.001) 0.0083 (0.0003) 0.394 0.603 (0.002) 0.003 (0.0002) 0.1025 0.7594 (0.0019) 0.1381 (0.0015) 
27 0.9046 0.087 (0.001) 0.0084 (0.0003) 0.394 0.603 (0.002) 0.003 (0.0002) 0.0964 0.7647 (0.0019) 0.1389 (0.0015) 
28 0.9032 0.0883 (0.001) 0.0085 (0.0003)  0.394 0.603 (0.002) 0.003 (0.0002) 0.0908 0.7695 (0.0018) 0.1397 (0.0015) 
29 0.902 0.0895 (0.001) 0.0085 (0.0003) 0.394 0.603 (0.002) 0.003 (0.0002) 0.0855 0.7741 (0.0018) 0.1404 (0.0015)  
30 0.9007 0.0907 (0.001) 0.0086 (0.0003) 0.394 0.603 (0.002) 0.003 (0.0002) 0.0807 0.7783 (0.0018) 0.141 (0.0015) 
IMD5: Index of mean deprivation 5th quintile 
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Table C20: Transition probabilities for the first 30 days used in the central hospital-IMD5 
Day Transition Probability (Standard Error) 
Community to A&E to Admission to 
Community  A&E (SE) Dead (SE) Community Admission(SE) Dead(SE) Admission  Community(SE) Dead (SE) 
1 0.9818 0.0149 (0.0008) 0.0033 (0.0004) 0.374 0.623 (0.0042) 0.003 (0.0005) 0.7789 0.2144 (0.0031) 0.0067  (0.0005) 
2 0.9747 0.0212 (0.001) 0.0041 (0.0005) 0.374 0.623 (0.0042) 0.003 (0.0005) 0.6542 0.3333 (0.0038) 0.0125 (0.0008) 
3 0.9694 0.026 (0.0011) 0.0046 (0.0005) 0.374 0.623 (0.0042) 0.003 (0.0005) 0.5605 0.422 (0.004) 0.0175 (0.0009) 
4 0.9649 0.03 (0.0012) 0.0051 (0.0006) 0.374 0.623 (0.0042) 0.003 (0.0005) 0.4858 0.4924 (0.0041) 0.0218 (0.0011) 
5 0.9609 0.0336 (0.0013) 0.0055 (0.0006) 0.374 0.623 (0.0042) 0.003 (0.0005) 0.4243 0.55 (0.004) 0.0257 (0.0012) 
6 0.9574 0.0368 (0.0014) 0.0058 (0.0006) 0.374 0.623 (0.0042) 0.003 (0.0005) 0.3727 0.5982 (0.004) 0.0291 (0.0012) 
7 0.9542 0.0397 (0.0014) 0.0061 (0.0006)  0.374 0.623 (0.0042) 0.003 (0.0005) 0.3289 0.6389 (0.0039) 0.0322 (0.0013) 
8 0.9512 0.0425 (0.0015) 0.0063 (0.0006) 0.374 0.623 (0.0042) 0.003 (0.0005) 0.2914 0.6737 (0.0038) 0.0349 (0.0013) 
9 0.9484 0.045 (0.0015) 0.0066 (0.0006) 0.374 0.623 (0.0042) 0.003 (0.0005) 0.2590 0.7037 (0.0037) 0.0373 (0.0014) 
10 0.9457 0.0475 (0.0016) 0.0068 (0.0006) 0.374 0.623 (0.0042) 0.003 (0.0005) 0.2310 0.7296 (0.0036) 0.0394 (0.0014) 
11 0.9432 0.0498 (0.0016) 0.007 (0.0007) 0.374 0.623 (0.0042) 0.003 (0.0005) 0.2063 0.7523 (0.0035) 0.0414 (0.0014) 
12 0.9408 0.052 (0.0017) 0.0072 (0.0007) 0.374 0.623 (0.0042) 0.003 (0.0005) 0.1848 0.7721  (0.0034) 0.0431 (0.0015) 
13 0.9386 0.0541 (0.0017) 0.0073 (0.0007) 0.374 0.623 (0.0042) 0.003 (0.0005) 0.1658 0.7895 (0.0033) 0.0447 (0.0015) 
14 0.9364 0.0561 (0.0017) 0.0075 (0.0007) 0.374 0.623 (0.0042) 0.003 (0.0005) 0.1490 0.8049 (0.0031) 0.0461 (0.0015) 
15 0.9343 0.058 (0.0018) 0.0077 (0.0007) 0.374 0.623 (0.0042) 0.003 (0.0005) 0.1341 0.8185 (0.003) 0.0474 (0.0015) 
16 0.9323 0.0599 (0.0018) 0.0078 (0.0007) 0.374 0.623 (0.0042) 0.003 (0.0005) 0.1209 0.8305 (0.003) 0.0486 (0.0015) 
17 0.9303 0.0617 (0.0018)  0.008 (0.0007) 0.374 0.623 (0.0042) 0.003 (0.0005) 0.1091 0.8413 (0.0029) 0.0496 (0.0015) 
18 0.9284 0.0635 (0.0019) 0.0081 (0.0007) 0.374 0.623 (0.0042) 0.003 (0.0005) 0.0986 0.8508 (0.0028) 0.0506 (0.0016) 
19 0.9265 0.0652 (0.0019) 0.0083 (0.0007) 0.374 0.623 (0.0042) 0.003 (0.0005) 0.0893 0.8593 (0.0027) 0.0514 (0.0016) 
20 0.9247 0.0669 (0.0019) 0.0084 (0.0007) 0.374 0.623 (0.0042) 0.003 (0.0005) 0.0809 0.8669 (0.0026) 0.0522 (0.0016) 
21 0.923 0.0685 (0.0019) 0.0085 (0.0007) 0.374 0.623 (0.0042) 0.003 (0.0005) 0.0733 0.8738 (0.0025) 0.0529 (0.0016) 
22 0.9213 0.0701 (0.0019) 0.0086 (0.0007) 0.374 0.623 (0.0042) 0.003 (0.0005) 0.0665 0.8799 (0.0025) 0.0536 (0.0016) 
23 0.9195 0.0717 (0.002) 0.0088 (0.0007) 0.374 0.623 (0.0042) 0.003 (0.0005) 0.0605 0.8854 (0.0024) 0.0541 (0.0016) 
24 0.9179 0.0732 (0.002) 0.0089 (0.0007) 0.374 0.623 (0.0042) 0.003 (0.0005) 0.0550 0.8903 (0.0023) 0.0547 (0.0016) 
25 0.9163 0.0747 (0.002) 0.009 (0.0007) 0.374 0.623 (0.0042) 0.003 (0.0005) 0.0500 0.8948 (0.0023) 0.0552 (0.0016) 
26 0.9148 0.0761 (0.002) 0.0091 (0.0008) 0.374 0.623 (0.0042) 0.003 (0.0005) 0.0456 0.8988 (0.0022) 0.0556 (0.0016) 
27 0.9133 0.0775 (0.0021) 0.0092 (0.0008) 0.374 0.623 (0.0042) 0.003 (0.0005) 0.0416 0.9024 (0.0022) 0.056 (0.0016) 
28 0.9118 0.0789 (0.0021) 0.0093 (0.0008) 0.374 0.623 (0.0042) 0.003 (0.0005) 0.0379 0.9057 (0.0021) 0.0564 (0.0016) 
29 0.9103 0.0803 (0.0021) 0.0094 (0.0008) 0.374 0.623 (0.0042) 0.003 (0.0005) 0.0346 0.9087 (0.0021) 0.0567 (0.0016) 
30 0.9089 0.0816 (0.0021) 0.0095 (0.0008) 0.374 0.623 (0.0042) 0.003 (0.0005) 0.0315 0.9114 (0.002) 0.0571 (0.0016) 
IMD5: Index of mean deprivation 5th quintile 
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Table C21: Transition probabilities for the first 30 days used in the local hospital- Circulatory 
Day Transition Probability (Standard Error) 
Community to A&E to Admission to 
Community  A&E (SE) Dead (SE) Community Admission (SE) Dead (SE) Admission  Community(SE) Dead(SE) 
1 0.9754 0.0196 (0.0007) 0.005 (0.0004) 0.187 0.806 (0.0025) 0.007 (0.0005) 0.8077 0.1824 (0.002) 0.0099 (0.0004) 
2 0.9676 0.0265 (0.0008) 0.0059 (0.0004) 0.187 0.806 (0.0025) 0.007 (0.0005) 0.6970 0.2856 (0.0024) 0.0174 (0.0006) 
3 0.962 0.0315 (0.0009) 0.0065 (0.0004) 0.187 0.806 (0.0025) 0.007 (0.0005) 0.6120 0.3644 (0.0026) 0.0236 (0.0008) 
4 0.9573 0.0357 (0.001) 0.007 (0.0004) 0.187 0.806 (0.0025) 0.007 (0.0005) 0.5427 0.4283 (0.0027) 0.029 (0.0009) 
5 0.9534 0.0393 (0.001) 0.0073 (0.0005) 0.187 0.806 (0.0025) 0.007 (0.0005) 0.4847 0.4816 (0.0027) 0.0337 (0.0009) 
6 0.9498 0.0425 (0.0011) 0.0077 (0.0005) 0.187 0.806 (0.0025) 0.007 (0.0005) 0.4350 0.5271 (0.0027) 0.0379 (0.001) 
7 0.9466 0.0454 (0.0011) 0.008 (0.0005) 0.187 0.806 (0.0025) 0.007 (0.0005) 0.3921 0.5663 (0.0027) 0.0416 (0.001) 
8 0.9437 0.0481 (0.0012) 0.0082 (0.0005) 0.187 0.806 (0.0025) 0.007 (0.0005) 0.3546 0.6005 (0.0026) 0.0449 (0.0011) 
9 0.941 0.0506 (0.0012) 0.0084 (0.0005)  0.187 0.806 (0.0025) 0.007 (0.0005) 0.3215 0.6306 (0.0026) 0.0479 (0.0011) 
10 0.9385 0.0529 (0.0012) 0.0086 (0.0005)  0.187 0.806 (0.0025) 0.007 (0.0005) 0.2923 0.6571 (0.0025) 0.0506 (0.0011) 
11 0.9361 0.0551 (0.0012) 0.0088 (0.0005) 0.187 0.806 (0.0025) 0.007 (0.0005) 0.2663 0.6807 (0.0025) 0.053 (0.0012) 
12 0.9338 0.0572 (0.0013) 0.009 (0.0005) 0.187 0.806 (0.0025) 0.007 (0.0005) 0.2431 0.7017 (0.0025) 0.0552 (0.0012) 
13 0.9316 0.0592 (0.0013) 0.0092 (0.0005) 0.187 0.806 (0.0025) 0.007 (0.0005) 0.2223 0.7205 (0.0024) 0.0572 (0.0012) 
14 0.9296 0.0611 (0.0013) 0.0093 (0.0005) 0.187 0.806 (0.0025) 0.007 (0.0005) 0.2035 0.7374 (0.0024) 0.0591 (0.0012) 
15 0.9276 0.0629 (0.0013) 0.0095 (0.0005) 0.187 0.806 (0.0025) 0.007 (0.0005) 0.1867 0.7526 (0.0023) 0.0607 (0.0012) 
16 0.9258 0.0646 (0.0014) 0.0096 (0.0005) 0.187 0.806 (0.0025) 0.007 (0.0005) 0.1714 0.7663 (0.0023) 0.0623 (0.0012) 
17 0.9239 0.0663 (0.0014) 0.0098 (0.0005)  0.187 0.806 (0.0025) 0.007 (0.0005) 0.1576 0.7788 (0.0022) 0.0636 (0.0012) 
18 0.9221 0.068 (0.0014) 0.0099 (0.0005) 0.187 0.806 (0.0025) 0.007 (0.0005) 0.1450 0.7901 (0.0022) 0.0649 (0.0013) 
19 0.9205 0.0695 (0.0014) 0.01 (0.0005) 0.187 0.806 (0.0025) 0.007 (0.0005) 0.1336 0.8003 (0.0021) 0.0661 (0.0013) 
20 0.9188 0.0711 (0.0014) 0.0101 (0.0005) 0.187 0.806 (0.0025) 0.007 (0.0005) 0.1232 0.8096 (0.0021)  0.0672 (0.0013) 
21 0.9172 0.0725 (0.0014) 0.0103 (0.0005) 0.187 0.806 (0.0025) 0.007 (0.0005) 0.1137 0.8181 (0.0021) 0.0682 (0.0013) 
22 0.9156 0.074 (0.0015) 0.0104 (0.0005) 0.187 0.806 (0.0025) 0.007 (0.0005) 0.1050 0.8259 (0.002) 0.0691 (0.0013) 
23 0.9141 0.0754 (0.0015) 0.0105 (0.0005) 0.187 0.806 (0.0025) 0.007 (0.0005) 0.0972 0.8329 (0.002) 0.0699 (0.0013) 
24 0.9127 0.0767 (0.0015) 0.0106 (0.0005) 0.187 0.806 (0.0025) 0.007 (0.0005) 0.0899 0.8394 (0.002) 0.0707 (0.0013) 
25 0.9112 0.0781 (0.0015) 0.0107 (0.0006) 0.187 0.806 (0.0025) 0.007 (0.0005) 0.0832 0.8454 (0.0019) 0.0714 (0.0013) 
26 0.9098 0.0794 (0.0015) 0.0108 (0.0006) 0.187 0.806 (0.0025) 0.007 (0.0005) 0.0771 0.8508 (0.0019) 0.0721 (0.0013) 
27 0.9084 0.0807 (0.0015) 0.0109 (0.0006) 0.187 0.806 (0.0025) 0.007 (0.0005) 0.0715 0.8558 (0.0019) 0.0727 (0.0013) 
28 0.9072 0.0819 (0.0015) 0.0109 (0.0006) 0.187 0.806 (0.0025) 0.007 (0.0005) 0.0664 0.8604 (0.0018) 0.0732 (0.0013) 
29 0.9059 0.0831 (0.0015) 0.011 (0.0006) 0.187 0.806 (0.0025) 0.007 (0.0005) 0.0615 0.8647 (0.0018) 0.0738 (0.0013) 
30 0.9046 0.0843 (0.0016) 0.0111 (0.0006) 0.187 0.806 (0.0025) 0.007 (0.0005) 0.0571 0.8686 (0.0018) 0.0743 (0.0013) 
Circulatory: diseases of the circulatory system 
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Table C22: Transition probabilities for the first 30 days used in the central hospital-Circulatory 
Day Transition Probability (Standard Error) 
Community to A&E to Admission to 
Community  A&E (SE) Dead (SE) Community Admission(SE) Dead(SE) Admission  Community(SE) Dead (SE) 
1 0.9851 0.0112 (0.001) 0.0037 (0.0007) 0.268 0.726 (0.0058) 0.006 (0.001) 0.7740 0.2153 (0.0046) 0.0107 (0.0009) 
2 0.9791 0.0162 (0.0013) 0.0047 (0.0008) 0.268 0.726 (0.0058) 0.006 (0.001) 0.6538 0.3276 (0.0054) 0.0186 (0.0013) 
3 0.9746 0.0201 (0.0015) 0.0053 (0.0009) 0.268 0.726 (0.0058) 0.006 (0.001) 0.5643 0.4105 (0.0057) 0.0252 (0.0016) 
4 0.9708 0.0234 (0.0016) 0.0058 (0.0009) 0.268 0.726 (0.0058) 0.006 (0.001) 0.4932 0.4761 (0.0058) 0.0307 (0.0018) 
5 0.9674 0.0264 (0.0017) 0.0062 (0.0009) 0.268 0.726 (0.0058) 0.006 (0.001) 0.4346 0.5298 (0.0058) 0.0356 (0.0019) 
6 0.9643 0.0291 (0.0019) 0.0066 (0.001) 0.268 0.726 (0.0058) 0.006 (0.001) 0.3855 0.5747 (0.0057) 0.0398 (0.002) 
7 0.9615 0.0316 (0.0019) 0.0069 (0.001) 0.268 0.726 (0.0058) 0.006 (0.001) 0.3435 0.6129 (0.0056) 0.0436 (0.0021) 
8 0.9589 0.0339 (0.002) 0.0072 (0.001) 0.268 0.726 (0.0058) 0.006 (0.001) 0.3074 0.6457 (0.0055) 0.0469  (0.0022) 
9 0.9564 0.0361 (0.0021) 0.0075 (0.001) 0.268 0.726 (0.0058) 0.006 (0.001) 0.2761 0.6741 (0.0053) 0.0498 (0.0022) 
10 0.954 0.0382 (0.0022) 0.0078 (0.001) 0.268 0.726 (0.0058) 0.006 (0.001) 0.2486 0.6989 (0.0052) 0.0525 (0.0023) 
11 0.9519 0.0401 (0.0022) 0.008 (0.0011) 0.268 0.726 (0.0058) 0.006 (0.001) 0.2244 0.7207 (0.0051) 0.0549 (0.0023) 
12 0.9498 0.042 (0.0023) 0.0082 (0.0011) 0.268 0.726 (0.0058) 0.006 (0.001) 0.2031 0.7399 (0.005) 0.057 (0.0024) 
13 0.9478 0.0438 (0.0023) 0.0084 (0.0011) 0.268 0.726 (0.0058) 0.006 (0.001) 0.1842 0.7569 (0.0049) 0.0589 (0.0024) 
14 0.9458 0.0456 (0.0024) 0.0086 (0.0011) 0.268 0.726 (0.0058) 0.006 (0.001) 0.1673 0.772 (0.0047) 0.0607 (0.0024) 
15 0.9439 0.0473 (0.0024) 0.0088 (0.0011) 0.268 0.726 (0.0058) 0.006 (0.001) 0.1523 0.7855 (0.0046) 0.0622 (0.0025) 
16 0.9421 0.0489 (0.0025) 0.009 (0.0011) 0.268 0.726 (0.0058) 0.006 (0.001) 0.1387 0.7976 (0.0045) 0.0637 (0.0025) 
17 0.9403 0.0505 (0.0025) 0.0092 (0.0011) 0.268 0.726 (0.0058) 0.006 (0.001) 0.1266 0.8084 (0.0044) 0.065 (0.0025) 
18 0.9387 0.052 (0.0026) 0.0093 (0.0011) 0.268 0.726 (0.0058) 0.006 (0.001) 0.1157 0.8181 (0.0043) 0.0662 (0.0025) 
19 0.937 0.0535 (0.0026) 0.0095 (0.0012) 0.268 0.726 (0.0058) 0.006 (0.001) 0.1058 0.8269 (0.0042) 0.0673 (0.0026) 
20 0.9354 0.055 (0.0027) 0.0096 (0.0012) 0.268 0.726 (0.0058) 0.006 (0.001) 0.0970 0.8348 (0.0041) 0.0682 (0.0026) 
21 0.9338 0.0564 (0.0027) 0.0098 (0.0012) 0.268 0.726 (0.0058) 0.006 (0.001) 0.0889 0.8419 (0.004) 0.0692 (0.0026) 
22 0.9323 0.0578 (0.0027) 0.0099 (0.0012) 0.268 0.726 (0.0058) 0.006 (0.001) 0.0816 0.8484 (0.0039) 0.07 (0.0026) 
23 0.9307 0.0592 (0.0028) 0.0101 (0.0012) 0.268 0.726 (0.0058) 0.006 (0.001) 0.0750 0.8543 (0.0039) 0.0707 (0.0026) 
24 0.9293 0.0605 (0.0028) 0.0102 (0.0012) 0.268 0.726 (0.0058) 0.006 (0.001) 0.0690 0.8596 (0.0038)  0.0714 (0.0026) 
25 0.9279 0.0618 (0.0028) 0.0103 (0.0012) 0.268 0.726 (0.0058) 0.006 (0.001) 0.0634 0.8645 (0.0037) 0.0721 (0.0026) 
26 0.9264 0.0631 (0.0028) 0.0105 (0.0012) 0.268 0.726 (0.0058) 0.006 (0.001) 0.0584 0.8689 (0.0036) 0.0727 (0.0027) 
27 0.925 0.0644 (0.0029) 0.0106 (0.0012) 0.268 0.726 (0.0058) 0.006 (0.001) 0.0539 0.8729 (0.0036) 0.0732 (0.0027) 
28 0.9237 0.0656 (0.0029) 0.0107 (0.0012) 0.268 0.726 (0.0058) 0.006 (0.001) 0.0497 0.8766 (0.0035) 0.0737 (0.0027) 
29 0.9224 0.0668 (0.0029) 0.0108 (0.0013) 0.268 0.726 (0.0058) 0.006 (0.001) 0.0458 0.88 (0.0035) 0.0742 (0.0027) 
30 0.9211 0.068 (0.003) 0.0109 (0.0013) 0.268 0.726 (0.0058) 0.006 (0.001) 0.0423 0.8831(0.0034) 0.0746 (0.0027) 
Circulatory: diseases of the circulatory system 
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Table C23: Transition probabilities for the first 30 days used in the local hospital- Respiratory 
Day Transition Probability (Standard Error) 
Community to A&E to Admission to 
Community  A&E (SE) Dead (SE) Community Admission (SE) Dead (SE) Admission  Community(SE) Dead(SE) 
1 0.9682 0.0243 (0.0007) 0.0075 (0.0004) 0.173 0.819 (0.0023) 0.008 (0.0005) 0.8786 0.1102 (0.0015) 0.0112 (0.0004) 
2 0.9583 0.0327 (0.0009) 0.009 (0.0005)  0.173 0.819 (0.0023) 0.008 (0.0005) 0.7821 0.196 (0.002) 0.0219 (0.0007) 
3 0.9512 0.0389 (0.001) 0.0099  (0.0005) 0.173 0.819 (0.0023) 0.008 (0.0005) 0.6993 0.269 (0.0023) 0.0317 (0.0008) 
4 0.9454 0.0439 (0.001) 0.0107 (0.0005) 0.173 0.819 (0.0023) 0.008 (0.0005) 0.6269 0.3324 (0.0025) 0.0407 (0.0009) 
5 0.9404 0.0483 (0.0011) 0.0113 (0.0006) 0.173 0.819 (0.0023) 0.008 (0.0005) 0.5631 0.388 (0.0026) 0.0489 (0.001) 
6 0.936 0.0522 (0.0012) 0.0118 (0.0006) 0.173 0.819 (0.0023) 0.008 (0.0005) 0.5064 0.4372 (0.0027) 0.0564 (0.0011) 
7 0.932 0.0557 (0.0012) 0.0123 (0.0006) 0.173 0.819 (0.0023) 0.008 (0.0005) 0.4561 0.4807 (0.0027) 0.0632 (0.0012) 
8 0.9284 0.0589 (0.0012) 0.0127 (0.0006) 0.173 0.819 (0.0023) 0.008 (0.0005) 0.4111 0.5195 (0.0027) 0.0694 (0.0012) 
9 0.9251 0.0619 (0.0013) 0.013 (0.0006) 0.173 0.819 (0.0023) 0.008 (0.0005) 0.3710 0.554 (0.0026) 0.075 (0.0013) 
10 0.9219 0.0647 (0.0013) 0.0134 (0.0006) 0.173 0.819 (0.0023) 0.008 (0.0005) 0.3350 0.5849 (0.0026) 0.0801 (0.0013) 
11 0.9189 0.0674 (0.0013) 0.0137 (0.0006) 0.173 0.819 (0.0023) 0.008 (0.0005) 0.3027 0.6126 (0.0026) 0.0847 (0.0014) 
12 0.9161 0.0699 (0.0014) 0.014 (0.0006) 0.173 0.819 (0.0023) 0.008 (0.0005) 0.2737 0.6374 (0.0025) 0.0889 (0.0014) 
13 0.9135 0.0722 (0.0014) 0.0143 (0.0006) 0.173 0.819 (0.0023) 0.008 (0.0005) 0.2476 0.6597 (0.0025) 0.0927 (0.0014) 
14 0.911 0.0745 (0.0014) 0.0145 (0.0006) 0.173 0.819 (0.0023) 0.008 (0.0005) 0.2241 0.6797 (0.0024) 0.0962 (0.0014) 
15 0.9085 0.0767 (0.0014) 0.0148 (0.0007) 0.173 0.819 (0.0023) 0.008 (0.0005) 0.2029 0.6977 (0.0024) 0.0994 (0.0015) 
16 0.9062 0.0788 (0.0015) 0.015 (0.0007) 0.173 0.819 (0.0023) 0.008 (0.0005) 0.1839 0.7139 (0.0023) 0.1022 (0.0015) 
17 0.904 0.0808 (0.0015) 0.0152 (0.0007) 0.173 0.819 (0.0023) 0.008 (0.0005) 0.1667 0.7285 (0.0023) 0.1048 (0.0015) 
18 0.9018 0.0828 (0.0015) 0.0154 (0.0007) 0.173 0.819 (0.0023) 0.008 (0.0005) 0.1511 0.7417 (0.0022) 0.1072 (0.0015) 
19 0.8998 0.0846 (0.0015) 0.0156 (0.0007) 0.173 0.819 (0.0023) 0.008 (0.0005) 0.1370 0.7536 (0.0022) 0.1094 (0.0015) 
20 0.8977 0.0865 (0.0015) 0.0158 (0.0007) 0.173 0.819 (0.0023) 0.008 (0.0005) 0.1243 0.7643 (0.0022) 0.1114 (0.0015) 
21 0.8958 0.0882 (0.0016) 0.016 (0.0007) 0.173 0.819 (0.0023) 0.008 (0.0005) 0.1129 0.774 (0.0021) 0.1131 (0.0015) 
22 0.8939 0.0899 (0.0016) 0.0162 (0.0007) 0.173 0.819 (0.0023) 0.008 (0.0005) 0.1024 0.7828 (0.0021) 0.1148 (0.0015) 
23 0.892 0.0916 (0.0016) 0.0164 (0.0007) 0.173 0.819 (0.0023) 0.008 (0.0005) 0.0930 0.7907 (0.002) 0.1163 (0.0015) 
24 0.8903 0.0932 (0.0016) 0.0165 (0.0007) 0.173 0.819 (0.0023) 0.008 (0.0005) 0.0845 0.7979 (0.002) 0.1176 (0.0016) 
25 0.8885 0.0948 (0.0016) 0.0167 (0.0007) 0.173 0.819 (0.0023) 0.008 (0.0005) 0.0768 0.8044 (0.002) 0.1188 (0.0016) 
26 0.8867 0.0964 (0.0016) 0.0169 (0.0007) 0.173 0.819 (0.0023) 0.008 (0.0005) 0.0697 0.8103 (0.0019) 0.12 (0.0016) 
27 0.8851 0.0979 (0.0016) 0.017 (0.0007) 0.173 0.819 (0.0023) 0.008 (0.0005) 0.0634 0.8156 (0.0019) 0.121 (0.0016) 
28 0.8834 0.0994 (0.0016) 0.0172 (0.0007) 0.173 0.819 (0.0023) 0.008 (0.0005) 0.0577 0.8204 (0.0019) 0.1219 (0.0016) 
29 0.8819 0.1008 (0.0017) 0.0173 (0.0007) 0.173 0.819 (0.0023) 0.008 (0.0005) 0.0524 0.8248 (0.0019) 0.1228 (0.0016) 
30 0.8804 0.1022 (0.0017) 0.0174 (0.0007) 0.173 0.819 (0.0023) 0.008 (0.0005) 0.0477 0.8288 (0.0018) 0.1235 (0.0016) 
Respiratory: diseases of respiratory system 
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Table C24: Transition probabilities for the first 30 days used in the central hospital-Respiratory 
Day Transition Probability (Standard Error) 
Community to A&E to Admission to 
Community  A&E (SE) Dead (SE) Community Admission(SE) Dead(SE) Admission  Community(SE) Dead (SE) 
1 0.979 0.0155 (0.0012) 0.0055 (0.0009) 0.154 0.840 (0.0046) 0.006 (0.001) 0.8622 0.1281 (0.0032) 0.0097 (0.0008) 
2 0.9706 0.0225 (0.0015) 0.0069 (0.001) 0.154 0.840 (0.0046) 0.006 (0.001) 0.7550 0.2257 (0.0044) 0.0193 (0.0013) 
3 0.9642 0.0279 (0.0017) 0.0079 (0.0011) 0.154 0.840 (0.0046) 0.006 (0.001) 0.6645 0.3074 (0.0049) 0.0281 (0.0016) 
4 0.9587 0.0326 (0.0019) 0.0087 (0.0011) 0.154 0.840 (0.0046) 0.006 (0.001) 0.5866 0.3772 (0.0052) 0.0362 (0.0018) 
5 0.9539 0.0367 (0.002) 0.0094 (0.0012) 0.154 0.840 (0.0046) 0.006 (0.001) 0.5190 0.4375 (0.0053) 0.0435 (0.002) 
6 0.9497 0.0404 (0.0021) 0.0099 (0.0012) 0.154 0.840 (0.0046) 0.006 (0.001) 0.4600 0.4899 (0.0054) 0.0501 (0.0021) 
7 0.9457 0.0439 (0.0022) 0.0104 (0.0012) 0.154 0.840 (0.0046) 0.006 (0.001) 0.4083 0.5357 (0.0053) 0.056 (0.0022) 
8 0.942 0.0471 (0.0023) 0.0109 (0.0012)  0.154 0.840 (0.0046) 0.006 (0.001) 0.3628 0.5758 (0.0052) 0.0614 (0.0023) 
9 0.9386 0.0501 (0.0024) 0.0113 (0.0013) 0.154 0.840 (0.0046) 0.006 (0.001) 0.3227 0.6111 (0.0052) 0.0662 (0.0024) 
10 0.9353 0.053 (0.0025) 0.0117 (0.0013) 0.154 0.840 (0.0046) 0.006 (0.001) 0.2872 0.6422 (0.005) 0.0706 (0.0025) 
11 0.9322 0.0557 (0.0025) 0.0121 (0.0013) 0.154 0.840 (0.0046) 0.006 (0.001) 0.2559 0.6696 (0.0049) 0.0745 (0.0025) 
12 0.9292 0.0584 (0.0026) 0.0124 (0.0013) 0.154 0.840 (0.0046) 0.006 (0.001) 0.2281 0.6939 (0.0048) 0.078 (0.0026) 
13 0.9264 0.0609 (0.0027) 0.0127 (0.0013) 0.154 0.840 (0.0046) 0.006 (0.001) 0.2036 0.7153 (0.0047) 0.0811 (0.0026) 
14 0.9237 0.0633 (0.0027) 0.013 (0.0014) 0.154 0.840 (0.0046) 0.006 (0.001) 0.1817 0.7343 (0.0046) 0.084 (0.0027) 
15 0.9211 0.0656 (0.0028) 0.0133 (0.0014) 0.154 0.840 (0.0046) 0.006 (0.001) 0.1623 0.7512 (0.0044) 0.0865 (0.0027) 
16 0.9185 0.0679 (0.0028) 0.0136 (0.0014) 0.154 0.840 (0.0046) 0.006 (0.001) 0.1450 0.7662 (0.0043) 0.0888 (0.0027) 
17 0.916 0.0701 (0.0029) 0.0139 (0.0014) 0.154 0.840 (0.0046) 0.006 (0.001) 0.1296 0.7795 (0.0042) 0.0909 (0.0027) 
18 0.9137 0.0722 (0.0029) 0.0141 (0.0014) 0.154 0.840 (0.0046) 0.006 (0.001) 0.1160 0.7913 (0.0041) 0.0927 (0.0028) 
19 0.9113 0.0743 (0.0029) 0.0144 (0.0014) 0.154 0.840 (0.0046) 0.006 (0.001) 0.1037 0.8019 (0.004) 0.0944 (0.0028) 
20 0.9091 0.0763 (0.003) 0.0146 (0.0014) 0.154 0.840 (0.0046) 0.006 (0.001) 0.0928 0.8113 (0.0039) 0.0959 (0.0028) 
21 0.9069 0.0783 (0.003) 0.0148 (0.0015) 0.154 0.840 (0.0046) 0.006 (0.001) 0.0831 0.8196 (0.0038) 0.0973 (0.0028) 
22 0.9048 0.0802 (0.0031) 0.015 (0.0015) 0.154 0.840 (0.0046) 0.006 (0.001) 0.0744 0.8271 (0.0037) 0.0985 (0.0028) 
23 0.9027 0.082 (0.0031) 0.0153 (0.0015) 0.154 0.840 (0.0046) 0.006 (0.001) 0.0667 0.8337 (0.0037) 0.0996 (0.0028) 
24 0.9006 0.0839 (0.0031) 0.0155 (0.0015) 0.154 0.840 (0.0046) 0.006 (0.001) 0.0597 0.8397 (0.0036) 0.1006 (0.0029) 
25 0.8986 0.0857 (0.0032) 0.0157 (0.0015) 0.154 0.840 (0.0046) 0.006 (0.001) 0.0536 0.845 (0.0035) 0.1014 (0.0029) 
26 0.8967 0.0874 (0.0032) 0.0159 (0.0015) 0.154 0.840 (0.0046) 0.006 (0.001) 0.0481 0.8497 (0.0034) 0.1022 (0.0029) 
27 0.8948 0.0892 (0.0032) 0.016 (0.0015) 0.154 0.840 (0.0046) 0.006 (0.001) 0.0431 0.8539 (0.0034) 0.103 (0.0029) 
28 0.8929 0.0909 (0.0032) 0.0162 (0.0015) 0.154 0.840 (0.0046) 0.006 (0.001) 0.0387 0.8577 (0.0033) 0.1036 (0.0029) 
29 0.8911 0.0925 (0.0033) 0.0164 (0.0015) 0.154 0.840 (0.0046) 0.006 (0.001) 0.0347 0.8611 (0.0033) 0.1042 (0.0029) 
30 0.8893 0.0941(0.0033) 0.0166 (0.0015) 0.154 0.840 (0.0046) 0.006 (0.001) 0.0312 0.8641 (0.0032) 0.1047 (0.0029) 
Respiratory: diseases of respiratory system 
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Table C25: Transition probabilities for the first 30 days used in the local hospital- Digestive 
Day Transition Probability (Standard Error) 
Community to A&E to Admission to 
Community  A&E (SE) Dead (SE) Community Admission (SE) Dead (SE) Admission  Community(SE) Dead(SE) 
1 0.9729 0.024 (0.0007) 0.0031 (0.0003) 0.233 0.764 (0.0028) 0.004 (0.0004) 0.8149 0.1799 (0.002) 0.0052 (0.0003) 
2 0.965 0.0313 (0.0009) 0.0037 (0.0003) 0.233 0.764 (0.0028) 0.004 (0.0004) 0.6913 0.2986 (0.0025) 0.0101 (0.0005) 
3 0.9593 0.0367 (0.001) 0.004 (0.0004) 0.233 0.764 (0.0028) 0.004 (0.0004) 0.5936 0.3919 (0.0026) 0.0145 (0.0006) 
4 0.9547 0.041 (0.001) 0.0043 (0.0004) 0.233 0.764 (0.0028) 0.004 (0.0004) 0.5136 0.4681 (0.0027) 0.0183 (0.0007) 
5 0.9508 0.0447 (0.0011) 0.0045 (0.0004) 0.233 0.764 (0.0028) 0.004 (0.0004) 0.4465 0.5317 (0.0027) 0.0218 (0.0007) 
6 0.9474 0.0479 (0.0011) 0.0047 (0.0004) 0.233 0.764 (0.0028) 0.004 (0.0004) 0.3897 0.5855 (0.0026) 0.0248 (0.0008) 
7 0.9443 0.0508 (0.0012) 0.0049 (0.0004) 0.233 0.764 (0.0028) 0.004 (0.0004) 0.3412 0.6312 (0.0026) 0.0276 (0.0008) 
8 0.9414 0.0535 (0.0012) 0.0051 (0.0004) 0.233 0.764 (0.0028) 0.004 (0.0004) 0.2995 0.6705 (0.0025) 0.03 (0.0009) 
9 0.9388 0.056 (0.0012) 0.0052 (0.0004) 0.233 0.764 (0.0028) 0.004 (0.0004) 0.2636 0.7043 (0.0024) 0.0321 (0.0009) 
10 0.9364 0.0583 (0.0012) 0.0053 (0.0004) 0.233 0.764 (0.0028) 0.004 (0.0004) 0.2324 0.7336 (0.0023) 0.034 (0.0009) 
11 0.9342 0.0604 (0.0013) 0.0054 (0.0004) 0.233 0.764 (0.0028) 0.004 (0.0004) 0.2053 0.759 (0.0023) 0.0357 (0.0009) 
12 0.9319 0.0625 (0.0013) 0.0056 (0.0004) 0.233 0.764 (0.0028) 0.004 (0.0004) 0.1816 0.7812 (0.0022) 0.0372 (0.001)  
13 0.9299 0.0644 (0.0013) 0.0057 (0.0004) 0.233 0.764 (0.0028) 0.004 (0.0004) 0.1608 0.8006 (0.0021) 0.0386 (0.001) 
14 0.928 0.0662 (0.0013) 0.0058 (0.0004) 0.233 0.764 (0.0028) 0.004 (0.0004) 0.1426 0.8176 (0.002) 0.0398 (0.001) 
15 0.9262 0.068 (0.0014) 0.0058 (0.0004) 0.233 0.764 (0.0028) 0.004 (0.0004) 0.1266 0.8325 (0.002) 0.0409 (0.001) 
16 0.9244 0.0697 (0.0014) 0.0059 (0.0004) 0.233 0.764 (0.0028) 0.004 (0.0004) 0.1126 0.8456 (0.0019) 0.0418 (0.001) 
17 0.9227 0.0713 (0.0014) 0.006 (0.0004) 0.233 0.764 (0.0028) 0.004 (0.0004) 0.1001 0.8572 (0.0018) 0.0427 (0.001) 
18 0.921 0.0729 (0.0014) 0.0061 (0.0004) 0.233 0.764 (0.0028) 0.004 (0.0004) 0.0891 0.8674 (0.0018) 0.0435 (0.001) 
19 0.9194 0.0744 (0.0014) 0.0062 (0.0004) 0.233 0.764 (0.0028) 0.004 (0.0004) 0.0794 0.8764 (0.0017) 0.0442 (0.001) 
20 0.918 0.0758 (0.0014) 0.0062 (0.0004) 0.233 0.764 (0.0028) 0.004 (0.0004) 0.0709 0.8843 (0.0016) 0.0448 (0.001) 
21 0.9164 0.0773 (0.0014) 0.0063 (0.0004) 0.233 0.764 (0.0028) 0.004 (0.0004) 0.0633 0.8914 (0.0016) 0.0453 (0.001) 
22 0.915 0.0786 (0.0015) 0.0064 (0.0004) 0.233 0.764 (0.0028) 0.004 (0.0004) 0.0566 0.8976 (0.0015) 0.0458 (0.001) 
23 0.9136 0.08 (0.0015) 0.0064 (0.0005) 0.233 0.764 (0.0028) 0.004 (0.0004) 0.0505 0.9032 (0.0015) 0.0463 (0.001) 
24 0.9122 0.0813 (0.0015) 0.0065 (0.0005) 0.233 0.764 (0.0028) 0.004 (0.0004) 0.0452 0.9081 (0.0014) 0.0467 (0.001) 
25 0.9109 0.0825 (0.0015) 0.0066 (0.0005) 0.233 0.764 (0.0028) 0.004 (0.0004) 0.0405 0.9125 (0.0014) 0.047 (0.001) 
26 0.9096 0.0838 (0.0015) 0.0066 (0.0005) 0.233 0.764 (0.0028) 0.004 (0.0004) 0.0362 0.9164 (0.0014) 0.0474 (0.0011) 
27 0.9083 0.085 (0.0015) 0.0067 (0.0005) 0.233 0.764 (0.0028) 0.004 (0.0004) 0.0325 0.9199 (0.0013) 0.0476 (0.0011) 
28 0.9072 0.0861 (0.0015) 0.0067 (0.0005) 0.233 0.764 (0.0028) 0.004 (0.0004) 0.0291 0.923 (0.0013) 0.0479 (0.0011) 
29 0.9059 0.0873 (0.0015) 0.0068 (0.0005) 0.233 0.764 (0.0028) 0.004 (0.0004) 0.0262 0.9257 (0.0013) 0.0481 (0.0011)  
30 0.9048 0.0884 (0.0015) 0.0068 (0.0005) 0.233 0.764 (0.0028) 0.004 (0.0004) 0.0234 0.9282 (0.0013) 0.0484 (0.0011) 
Digestive: diseases of the digestive system 
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Table C26: Transition probabilities for the first 30 days used in the central hospital-Digestive 
Day Transition Probability (Standard Error) 
Community to A&E to Admission to 
Community  A&E (SE) Dead (SE) Community Admission(SE) Dead(SE) Admission  Community(SE) Dead (SE) 
1 0.9776 0.0206 (0.0015) 0.0018 (0.0005) 0.241 0.755 (0.0057) 0.004 (0.0008) 0.7761 0.219 (0.0044) 0.0049 (0.0006) 
2 0.9698 0.0279 (0.0018) 0.0023 (0.0006) 0.241 0.755 (0.0057) 0.004 (0.0008) 0.6309 0.3594 (0.0053) 0.0097 (0.0009) 
3 0.9641 0.0333 (0.002) 0.0026 (0.0006) 0.241 0.755 (0.0057) 0.004 (0.0008) 0.5201 0.466 (0.0056) 0.0139 (0.0011) 
4 0.9595 0.0377 (0.0022) 0.0028 (0.0006) 0.241 0.755 (0.0057) 0.004 (0.0008) 0.4323 0.55 (0.0056) 0.0177 (0.0013) 
5 0.9555 0.0415 (0.0023) 0.003 (0.0007) 0.241 0.755 (0.0057) 0.004 (0.0008) 0.3615 0.6176 (0.0054) 0.0209 (0.0014) 
6 0.9519 0.0449 (0.0024) 0.0032 (0.0007) 0.241 0.755 (0.0057) 0.004 (0.0008) 0.3036 0.6726 (0.0052) 0.0238 (0.0015) 
7 0.9486 0.048 (0.0025) 0.0034 (0.0007) 0.241 0.755 (0.0057) 0.004 (0.0008) 0.2560 0.7178 (0.005) 0.0262 (0.0016) 
8 0.9457 0.0508 (0.0025) 0.0035 (0.0007) 0.241 0.755 (0.0057) 0.004 (0.0008) 0.2165 0.7552 (0.0048) 0.0283 (0.0016) 
9 0.9429 0.0535 (0.0026) 0.0036 (0.0007) 0.241 0.755 (0.0057) 0.004 (0.0008) 0.1836 0.7863 (0.0045) 0.0301 (0.0017) 
10 0.9402 0.056 (0.0027) 0.0038 (0.0007) 0.241 0.755 (0.0057) 0.004 (0.0008) 0.1560 0.8123 (0.0043) 0.0317 (0.0017) 
11 0.9378 0.0583 (0.0027) 0.0039 (0.0007) 0.241 0.755 (0.0057) 0.004 (0.0008) 0.1328 0.8341 (0.0041) 0.0331 (0.0017) 
12 0.9355 0.0605 (0.0028) 0.004 (0.0008) 0.241 0.755 (0.0057) 0.004 (0.0008) 0.1132 0.8525 (0.0039) 0.0343 (0.0018) 
13 0.9333 0.0626 (0.0028) 0.0041 (0.0008) 0.241 0.755 (0.0057) 0.004 (0.0008) 0.0968 0.8679 (0.0036) 0.0353 (0.0018) 
14 0.9312 0.0646 (0.0029) 0.0042 (0.0008) 0.241 0.755 (0.0057) 0.004 (0.0008) 0.0828 0.881 (0.0034) 0.0362 (0.0018) 
15 0.9292 0.0665 (0.0029) 0.0043 (0.0008) 0.241 0.755 (0.0057) 0.004 (0.0008) 0.0710 0.8921 (0.0033) 0.0369 (0.0018) 
16 0.9272 0.0684 (0.0029) 0.0044 (0.0008) 0.241 0.755 (0.0057) 0.004 (0.0008) 0.0608 0.9016 (0.0031) 0.0376 (0.0018)  
17 0.9254 0.0702 (0.003) 0.0044 (0.0008) 0.241 0.755 (0.0057) 0.004 (0.0008) 0.0522 0.9096 (0.0029) 0.0382 (0.0018) 
18 0.9236 0.0719 (0.003) 0.0045 (0.0008) 0.241 0.755 (0.0057) 0.004 (0.0008) 0.0449 0.9164 (0.0028) 0.0387 (0.0018) 
19 0.9218 0.0736 (0.003) 0.0046 (0.0008) 0.241 0.755 (0.0057) 0.004 (0.0008) 0.0387 0.9222 (0.0027) 0.0391 (0.0018) 
20 0.9201 0.0752 (0.0031) 0.0047 (0.0008)  0.241 0.755 (0.0057) 0.004 (0.0008) 0.0333 0.9272 (0.0026) 0.0395 (0.0018) 
21 0.9185 0.0768 (0.0031) 0.0047 (0.0008) 0.241 0.755 (0.0057) 0.004 (0.0008) 0.0287 0.9315 (0.0025) 0.0398 (0.0019) 
22 0.9169 0.0783 (0.0031) 0.0048 (0.0008) 0.241 0.755 (0.0057) 0.004 (0.0008) 0.0248 0.9351 (0.0024) 0.0401 (0.0019) 
23 0.9153 0.0798 (0.0032) 0.0049 (0.0008) 0.241 0.755 (0.0057) 0.004 (0.0008) 0.0213 0.9383 (0.0023) 0.0404 (0.0019) 
24 0.9139 0.0812 (0.0032) 0.0049 (0.0008) 0.241 0.755 (0.0057) 0.004 (0.0008) 0.0185 0.9409 (0.0022) 0.0406 (0.0019) 
25 0.9123 0.0827 (0.0032) 0.005 (0.0009) 0.241 0.755 (0.0057) 0.004 (0.0008) 0.0159 0.9433 (0.0022) 0.0408 (0.0019) 
26 0.9109 0.084 (0.0032) 0.0051 (0.0009) 0.241 0.755 (0.0057) 0.004 (0.0008) 0.0139 0.9452 (0.0021) 0.0409 (0.0019) 
27 0.9095 0.0854 (0.0032) 0.0051 (0.0009) 0.241 0.755 (0.0057) 0.004 (0.0008) 0.0119 0.947 (0.0021) 0.0411 (0.0019) 
28 0.9081 0.0867 (0.0033) 0.0052 (0.0009) 0.241 0.755 (0.0057) 0.004 (0.0008) 0.0104 0.9484 (0.0021) 0.0412 (0.0019) 
29 0.9068 0.088 (0.0033) 0.0052 (0.0009) 0.241 0.755 (0.0057) 0.004 (0.0008) 0.0090 0.9497 (0.002) 0.0413 (0.0019) 
30 0.9054 0.0893 (0.0033) 0.0053 (0.0009) 0.241 0.755 (0.0057) 0.004 (0.0008) 0.0078 0.9508 (0.002) 0.0414 (0.0019) 
Digestive: diseases of the digestive system 
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Table C27: Transition probabilities for the first 30 days used in the local hospital- Abnormal 
Day Transition Probability (Standard Error) 
Community to A&E to Admission to 
Community  A&E (SE) Dead (SE) Community Admission (SE) Dead (SE) Admission  Community(SE) Dead(SE) 
1 0.9793 0.019 (0.0005) 0.0017 (0.0002) 0.5435 0.4560 (0.0025) 0.0005 (0.0001) 0.6926 0.306 (0.0024) 0.0014 (0.0001) 
2 0.9729 0.0251 (0.0006) 0.002 (0.0002) 0.5435 0.4560 (0.0025) 0.0005 (0.0001) 0.5488 0.4484 (0.0027) 0.0028 (0.0002) 
3 0.9682 0.0296 (0.0007) 0.0022 (0.0002) 0.5435 0.4560 (0.0025) 0.0005 (0.0001) 0.4490 0.5469 (0.0027) 0.0041 (0.0003) 
4 0.9644 0.0332 (0.0007) 0.0024 (0.0002) 0.5435 0.4560 (0.0025) 0.0005 (0.0001) 0.3740 0.6207 (0.0026) 0.0053 (0.0003) 
5 0.9612 0.0363 (0.0008) 0.0025 (0.0002) 0.5435 0.4560 (0.0025) 0.0005 (0.0001) 0.3155 0.6782 (0.0025) 0.0063 (0.0004) 
6 0.9583 0.039 (0.0008) 0.0027 (0.0002) 0.5435 0.4560 (0.0025) 0.0005 (0.0001) 0.2684 0.7243 (0.0024) 0.0073 (0.0004) 
7 0.9557 0.0415 (0.0008) 0.0028 (0.0002) 0.5435 0.4560 (0.0025) 0.0005 (0.0001) 0.2300 0.7619 (0.0023) 0.0081 (0.0004) 
8 0.9534 0.0438 (0.0009) 0.0028 (0.0002) 0.5435 0.4560 (0.0025) 0.0005 (0.0001) 0.1982 0.7929 (0.0022) 0.0089 (0.0004) 
9 0.9512 0.0459 (0.0009) 0.0029 (0.0002) 0.5435 0.4560 (0.0025) 0.0005 (0.0001) 0.1718 0.8187 (0.0021) 0.0095 (0.0004) 
10 0.9491 0.0479 (0.0009) 0.003 (0.0002) 0.5435 0.4560 (0.0025) 0.0005 (0.0001) 0.1494 0.8405 (0.0019) 0.0101 (0.0005) 
11 0.9472 0.0497 (0.0009) 0.0031 (0.0002) 0.5435 0.4560 (0.0025) 0.0005 (0.0001) 0.1303 0.859  (0.0018) 0.0107 (0.0005) 
12 0.9454 0.0515 (0.0009) 0.0031 (0.0002) 0.5435 0.4560 (0.0025) 0.0005 (0.0001) 0.1142 0.8747 (0.0017) 0.0111 (0.0005) 
13 0.9437 0.0531 (0.001) 0.0032 (0.0002) 0.5435 0.4560 (0.0025) 0.0005 (0.0001) 0.1002 0.8882 (0.0016) 0.0116 (0.0005) 
14 0.942 0.0547 (0.001) 0.0033 (0.0002) 0.5435 0.4560 (0.0025) 0.0005 (0.0001) 0.0882 0.8998 (0.0015) 0.012 (0.0005) 
15 0.9405 0.0562 (0.001) 0.0033 (0.0003) 0.5435 0.4560 (0.0025) 0.0005 (0.0001) 0.0779 0.9098 (0.0015) 0.0123 (0.0005) 
16 0.9389 0.0577 (0.001) 0.0034 (0.0003) 0.5435 0.4560 (0.0025) 0.0005 (0.0001) 0.0689 0.9185 (0.0014) 0.0126 (0.0005) 
17 0.9375 0.0591 (0.001) 0.0034 (0.0003) 0.5435 0.4560 (0.0025) 0.0005 (0.0001) 0.0610 0.9261 (0.0013) 0.0129 (0.0005) 
18 0.9361 0.0604 (0.001) 0.0035 (0.0003) 0.5435 0.4560 (0.0025) 0.0005 (0.0001) 0.0542 0.9327 (0.0012) 0.0131 (0.0005) 
19 0.9347 0.0618 (0.001) 0.0035 (0.0003) 0.5435 0.4560 (0.0025) 0.0005 (0.0001) 0.0481 0.9385 (0.0012) 0.0134 (0.0005) 
20 0.9335 0.063 (0.001) 0.0035 (0.0003) 0.5435 0.4560 (0.0025) 0.0005 (0.0001) 0.0429 0.9435 (0.0011) 0.0136 (0.0005) 
21 0.9321 0.0643 (0.0011) 0.0036 (0.0003) 0.5435 0.4560 (0.0025) 0.0005 (0.0001) 0.0382 0.948 (0.0011) 0.0138 (0.0005) 
22 0.931 0.0654 (0.0011) 0.0036 (0.0003) 0.5435 0.4560 (0.0025) 0.0005 (0.0001) 0.0342 0.9519 (0.001) 0.0139 (0.0005) 
23 0.9297 0.0666 (0.0011) 0.0037 (0.0003)  0.5435 0.4560 (0.0025) 0.0005 (0.0001) 0.0305 0.9554 (0.001) 0.0141 (0.0005) 
24 0.9286 0.0677 (0.0011) 0.0037 (0.0003) 0.5435 0.4560 (0.0025) 0.0005 (0.0001) 0.0274 0.9584 (0.0009) 0.0142 (0.0005) 
25 0.9275 0.0688 (0.0011) 0.0037 (0.0003) 0.5435 0.4560 (0.0025) 0.0005 (0.0001) 0.0245 0.9612 (0.0009) 0.0143 (0.0005)  
26 0.9263 0.0699 (0.0011) 0.0038 (0.0003) 0.5435 0.4560 (0.0025) 0.0005 (0.0001) 0.0219 0.9636 (0.0008) 0.0145 (0.0005) 
27 0.9253 0.0709 (0.0011) 0.0038 (0.0003) 0.5435 0.4560 (0.0025) 0.0005 (0.0001) 0.0197 0.9657 (0.0008) 0.0146 (0.0005) 
28 0.9242 0.072 (0.0011) 0.0038 (0.0003) 0.5435 0.4560 (0.0025) 0.0005 (0.0001) 0.0177 0.9676 (0.0008) 0.0147 (0.0005) 
29 0.9231 0.073 (0.0011) 0.0039 (0.0003) 0.5435 0.4560 (0.0025) 0.0005 (0.0001) 0.0160 0.9693 (0.0007) 0.0147 (0.0005) 
30 0.9221 0.074 (0.0011) 0.0039 (0.0003) 0.5435 0.4560 (0.0025) 0.0005 (0.0001) 0.0144 0.9708 (0.0007) 0.0148 (0.0005) 
Abnormal: abnormal clinical laboratory findings 
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Table C28: Transition probabilities for the first 30 days used in the central hospital-Abnormal 
Day Transition Probability (Standard Error) 
Community to A&E to Admission to 
Community  A&E (SE) Dead (SE) Community Admission(SE) Dead(SE) Admission  Community(SE) Dead (SE) 
1 0.9867 0.0119 (0.0009) 0.0014 (0.0004) 0.5739 0.4258 (0.0053) 0.0003 (0.0002) 0.6568 0.3422 (0.0056) 0.001 (0.0002) 
2 0.9815 0.0168 (0.0011) 0.0017 (0.0004) 0.5739 0.4258 (0.0053) 0.0003 (0.0002) 0.5055 0.4924 (0.006) 0.0021 (0.0004) 
3 0.9775 0.0206 (0.0012) 0.0019 (0.0005) 0.5739 0.4258 (0.0053) 0.0003 (0.0002) 0.4039 0.5931 (0.0059) 0.003 (0.0005) 
4 0.9741 0.0238 (0.0013) 0.0021 (0.0005) 0.5739 0.4258 (0.0053) 0.0003 (0.0002) 0.3294 0.6667 (0.0057) 0.0039 (0.0006) 
5 0.9711 0.0266 (0.0014) 0.0023 (0.0005) 0.5739 0.4258 (0.0053) 0.0003 (0.0002) 0.2724 0.7229 (0.0053) 0.0047 (0.0007) 
6 0.9685 0.0291 (0.0015) 0.0024 (0.0005) 0.5739 0.4258 (0.0053) 0.0003 (0.0002) 0.2276 0.7669 (0.005) 0.0055 (0.0007) 
7 0.9661 0.0314 (0.0016) 0.0025 (0.0005) 0.5739 0.4258 (0.0053) 0.0003 (0.0002) 0.1917 0.8022 (0.0047) 0.0061 (0.0008) 
8 0.9639 0.0335 (0.0016) 0.0026 (0.0005) 0.5739 0.4258 (0.0053) 0.0003 (0.0002) 0.1625 0.8308 (0.0044) 0.0067 (0.0008) 
9 0.9617 0.0356 (0.0017) 0.0027 (0.0005) 0.5739 0.4258 (0.0053) 0.0003 (0.0002) 0.1386 0.8542 (0.0041) 0.0072 (0.0008) 
10 0.9597 0.0375 (0.0017) 0.0028 (0.0006) 0.5739 0.4258 (0.0053) 0.0003 (0.0002) 0.1187 0.8737 (0.0038) 0.0076 (0.0008) 
11 0.9578 0.0393 (0.0018) 0.0029 (0.0006) 0.5739 0.4258 (0.0053) 0.0003 (0.0002) 0.1021 0.8899 (0.0035) 0.008 (0.0009) 
12 0.956 0.041 (0.0018) 0.003 (0.0006) 0.5739 0.4258 (0.0053) 0.0003 (0.0002) 0.0881 0.9035 (0.0033) 0.0084 (0.0009) 
13 0.9542 0.0427 (0.0019) 0.0031 (0.0006) 0.5739 0.4258 (0.0053) 0.0003 (0.0002) 0.0763 0.915 (0.0031) 0.0087 (0.0009) 
14 0.9527 0.0442 (0.0019) 0.0031 (0.0006) 0.5739 0.4258 (0.0053) 0.0003 (0.0002) 0.0662 0.9248 (0.0029) 0.009 (0.0009) 
15 0.951 0.0458 (0.0019) 0.0032 (0.0006) 0.5739 0.4258 (0.0053) 0.0003 (0.0002) 0.0577 0.9331 (0.0027) 0.0092 (0.0009) 
16 0.9495 0.0472 (0.002) 0.0033 (0.0006) 0.5739 0.4258 (0.0053) 0.0003 (0.0002) 0.0504 0.9402 (0.0025) 0.0094 (0.0009) 
17 0.948 0.0487 (0.002) 0.0033 (0.0006) 0.5739 0.4258 (0.0053) 0.0003 (0.0002) 0.0441 0.9463 (0.0023) 0.0096 (0.0009) 
18 0.9465 0.0501 (0.002) 0.0034 (0.0006) 0.5739 0.4258 (0.0053) 0.0003 (0.0002) 0.0386 0.9516 (0.0022) 0.0098 (0.0009) 
19 0.9451 0.0514 (0.002) 0.0035 (0.0006) 0.5739 0.4258 (0.0053) 0.0003 (0.0002) 0.0339 0.9561 (0.0021) 0.01 (0.0009) 
20 0.9438 0.0527 (0.0021) 0.0035 (0.0006) 0.5739 0.4258 (0.0053) 0.0003 (0.0002) 0.0298 0.9601 (0.0019) 0.0101 (0.001) 
21 0.9424 0.054 (0.0021) 0.0036 (0.0006) 0.5739 0.4258 (0.0053) 0.0003 (0.0002) 0.0263 0.9635 (0.0018) 0.0102 (0.001) 
22 0.9411 0.0553 (0.0021) 0.0036 (0.0006) 0.5739 0.4258 (0.0053) 0.0003 (0.0002) 0.0232 0.9664 (0.0017) 0.0104 (0.001) 
23 0.9398 0.0565 (0.0021) 0.0037 (0.0006) 0.5739 0.4258 (0.0053) 0.0003 (0.0002) 0.0205 0.969 (0.0016) 0.0105 (0.001) 
24 0.9386 0.0577 (0.0022) 0.0037 (0.0006) 0.5739 0.4258 (0.0053) 0.0003 (0.0002) 0.0182 0.9713 (0.0016) 0.0105 (0.001) 
25 0.9374 0.0588 (0.0022) 0.0038 (0.0006) 0.5739 0.4258 (0.0053) 0.0003 (0.0002) 0.0161 0.9733 (0.0015) 0.0106 (0.001) 
26 0.9362 0.06 (0.0022) 0.0038 (0.0006) 0.5739 0.4258 (0.0053) 0.0003 (0.0002) 0.0143 0.975 (0.0014) 0.0107 (0.001) 
27 0.935 0.0611 (0.0022) 0.0039 (0.0007) 0.5739 0.4258 (0.0053) 0.0003 (0.0002) 0.0126 0.9766 (0.0014) 0.0108 (0.001) 
28 0.9339 0.0622 (0.0022) 0.0039 (0.0007) 0.5739 0.4258 (0.0053) 0.0003 (0.0002) 0.0113 0.9779 (0.0013) 0.0108 (0.001) 
29 0.9329 0.0632 (0.0022) 0.0039 (0.0007) 0.5739 0.4258 (0.0053) 0.0003 (0.0002) 0.0100 0.9791 (0.0013) 0.0109 (0.001) 
30 0.9317 0.0643 (0.0023) 0.004 (0.0007) 0.5739 0.4258 (0.0053) 0.0003 (0.0002) 0.0090 0.9801 (0.0012) 0.0109 (0.001)  
Abnormal: abnormal clinical laboratory findings 
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Table C29: Transition probabilities for the first 30 days used in the local hospital- Injury 
Day Transition Probability (Standard Error) 
Community to A&E to Admission to 
Community  A&E (SE) Dead (SE) Community Admission (SE) Dead (SE) Admission  Community(SE) Dead(SE) 
1 0.9791 0.0184 (0.0005) 0.0025 (0.0002) 0.4192 0.5801 (0.0027) 0.0007 (0.0001) 0.7921 0.205 (0.0022) 0.0029 (0.0002) 
2 0.9729 0.0242 (0.0006) 0.0029 (0.0002) 0.4192 0.5801 (0.0027) 0.0007 (0.0001) 0.6926 0.3023 (0.0026) 0.0051 (0.0003) 
3 0.9684 0.0284 (0.0007) 0.0032 (0.0003) 0.4192 0.5801 (0.0027) 0.0007 (0.0001) 0.6189 0.374 (0.0027) 0.0071 (0.0004) 
4 0.9648 0.0318 (0.0008) 0.0034 (0.0003) 0.4192 0.5801 (0.0027) 0.0007 (0.0001) 0.5597 0.4315 (0.0028) 0.0088 (0.0005) 
5 0.9616 0.0348 (0.0008) 0.0036 (0.0003)  0.4192 0.5801 (0.0027) 0.0007 (0.0001) 0.5103 0.4793 (0.0028) 0.0104 (0.0005) 
6 0.959 0.0373 (0.0008) 0.0037 (0.0003) 0.4192 0.5801 (0.0027) 0.0007 (0.0001) 0.4679 0.5202 (0.0028) 0.0119 (0.0006) 
7 0.9564 0.0397 (0.0009) 0.0039 (0.0003) 0.4192 0.5801 (0.0027) 0.0007 (0.0001) 0.4310 0.5558 (0.0028) 0.0132 (0.0006) 
8 0.9542 0.0418 (0.0009) 0.004 (0.0003) 0.4192 0.5801 (0.0027) 0.0007 (0.0001) 0.3986 0.587 (0.0028) 0.0144 (0.0006) 
9 0.9521 0.0438 (0.0009) 0.0041 (0.0003) 0.4192 0.5801 (0.0027) 0.0007 (0.0001) 0.3696 0.6148 (0.0027) 0.0156 (0.0006) 
10 0.9502 0.0456 (0.0009) 0.0042 (0.0003) 0.4192 0.5801 (0.0027) 0.0007 (0.0001) 0.3438 0.6396 (0.0027) 0.0166 (0.0007) 
11 0.9483 0.0474 (0.001) 0.0043 (0.0003) 0.4192 0.5801 (0.0027) 0.0007 (0.0001) 0.3205 0.6619 (0.0026) 0.0176 (0.0007) 
12 0.9466 0.049 (0.001) 0.0044 (0.0003) 0.4192 0.5801 (0.0027) 0.0007 (0.0001) 0.2993 0.6822 (0.0026) 0.0185 (0.0007) 
13 0.9449 0.0506 (0.001) 0.0045 (0.0003) 0.4192 0.5801 (0.0027) 0.0007 (0.0001) 0.2801 0.7006 (0.0026) 0.0193 (0.0007) 
14 0.9435 0.052 (0.001) 0.0045 (0.0003) 0.4192 0.5801 (0.0027) 0.0007 (0.0001) 0.2625 0.7174 (0.0025) 0.0201 (0.0007) 
15 0.9419 0.0535 (0.001) 0.0046 (0.0003) 0.4192 0.5801 (0.0027) 0.0007 (0.0001) 0.2463 0.7328 (0.0025) 0.0209 (0.0007) 
16 0.9405 0.0548 (0.001) 0.0047 (0.0003) 0.4192 0.5801 (0.0027) 0.0007 (0.0001) 0.2315 0.7469 (0.0024) 0.0216 (0.0008) 
17 0.9392 0.0561 (0.0011) 0.0047 (0.0003) 0.4192 0.5801 (0.0027) 0.0007 (0.0001) 0.2179 0.7599 (0.0024) 0.0222 (0.0008) 
18 0.9378 0.0574 (0.0011) 0.0048 (0.0003) 0.4192 0.5801 (0.0027) 0.0007 (0.0001) 0.2052 0.7719 (0.0024) 0.0229 (0.0008) 
19 0.9365 0.0586 (0.0011) 0.0049 (0.0003)  0.4192 0.5801 (0.0027) 0.0007 (0.0001) 0.1936 0.783 (0.0023) 0.0234 (0.0008) 
20 0.9353 0.0598 (0.0011) 0.0049 (0.0003)  0.4192 0.5801 (0.0027) 0.0007 (0.0001) 0.1827 0.7933 (0.0023) 0.024 (0.0008) 
21 0.9341 0.0609 (0.0011) 0.005 (0.0003) 0.4192 0.5801 (0.0027) 0.0007 (0.0001) 0.1726 0.8029 (0.0022) 0.0245 (0.0008) 
22 0.933 0.062 (0.0011) 0.005 (0.0003)  0.4192 0.5801 (0.0027) 0.0007 (0.0001) 0.1632 0.8118 (0.0022) 0.025 (0.0008) 
23 0.9318 0.0631 (0.0011) 0.0051 (0.0003) 0.4192 0.5801 (0.0027) 0.0007 (0.0001) 0.1544 0.8201 (0.0022) 0.0255 (0.0008) 
24 0.9307 0.0642 (0.0011) 0.0051 (0.0003) 0.4192 0.5801 (0.0027) 0.0007 (0.0001) 0.1463 0.8278 (0.0021) 0.0259 (0.0008) 
25 0.9296 0.0652 (0.0011) 0.0052 (0.0003) 0.4192 0.5801 (0.0027) 0.0007 (0.0001) 0.1386 0.8351 (0.0021) 0.0263 (0.0008) 
26 0.9286 0.0662 (0.0012) 0.0052 (0.0003) 0.4192 0.5801 (0.0027) 0.0007 (0.0001) 0.1314 0.8419 (0.0021) 0.0267 (0.0008) 
27 0.9275 0.0672 (0.0012) 0.0053 (0.0003) 0.4192 0.5801 (0.0027) 0.0007 (0.0001) 0.1247 0.8482 (0.002) 0.0271 (0.0008) 
28 0.9266 0.0681 (0.0012) 0.0053 (0.0003) 0.4192 0.5801 (0.0027) 0.0007 (0.0001) 0.1185 0.8541 (0.002) 0.0274 (0.0009) 
29 0.9256 0.069 (0.0012) 0.0054 (0.0003) 0.4192 0.5801 (0.0027) 0.0007 (0.0001) 0.1125 0.8597 (0.0019) 0.0278 (0.0009) 
30 0.9246 0.07 (0.0012) 0.0054 (0.0003) 0.4192 0.5801 (0.0027) 0.0007 (0.0001) 0.1069 0.865 (0.0019) 0.0281 (0.0009) 
Injury: injury poisoning and certain consequences 
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Table C30: Transition probabilities for the first 30 days used in the central hospital-Injury 
Day Transition Probability (Standard Error) 
Community to A&E to Admission to 
Community  A&E (SE) Dead (SE) Community Admission(SE) Dead(SE) Admission  Community(SE) Dead (SE) 
1 0.9846 0.0136 (0.0011) 0.0018 (0.0005) 0.371 0.628 (0.0059) 0.001 (0.0004) 0.7839 0.2139 (0.0045) 0.0022 (0.0004) 
2 0.9787 0.019 (0.0013) 0.0023 (0.0005) 0.371 0.628 (0.0059) 0.001 (0.0004) 0.6791 0.3167 (0.0053) 0.0042 (0.0006) 
3 0.9743 0.0231 (0.0015) 0.0026 (0.0006) 0.371 0.628 (0.0059) 0.001 (0.0004) 0.6017 0.3923 (0.0056) 0.006 (0.0008) 
4 0.9706 0.0265 (0.0016) 0.0029 (0.0006) 0.371 0.628 (0.0059) 0.001 (0.0004) 0.5397 0.4526 (0.0057) 0.0077 (0.0009) 
5 0.9675 0.0294 (0.0018) 0.0031 (0.0006) 0.371 0.628 (0.0059) 0.001 (0.0004) 0.4881 0.5026 (0.0057) 0.0093 (0.001) 
6 0.9646 0.0321 (0.0018) 0.0033 (0.0006) 0.371 0.628 (0.0059) 0.001 (0.0004) 0.4441 0.5451 (0.0057) 0.0108 (0.0011) 
7 0.962 0.0345 (0.0019) 0.0035 (0.0006) 0.371 0.628 (0.0059) 0.001 (0.0004) 0.4061 0.5818 (0.0056) 0.0121 (0.0012) 
8 0.9596 0.0368 (0.002) 0.0036 (0.0007) 0.371 0.628 (0.0059) 0.001 (0.0004) 0.3728 0.6138 (0.0055) 0.0134 (0.0012) 
9 0.9573 0.0389 (0.002) 0.0038 (0.0007) 0.371 0.628 (0.0059) 0.001 (0.0004) 0.3432 0.6422 (0.0055) 0.0146 (0.0013) 
10 0.9552 0.0409 (0.0021) 0.0039 (0.0007) 0.371 0.628 (0.0059) 0.001 (0.0004) 0.3169 0.6674 (0.0054) 0.0157 (0.0013) 
11 0.9531 0.0428 (0.0021) 0.0041 (0.0007) 0.371 0.628 (0.0059) 0.001 (0.0004) 0.2934 0.6899 (0.0053) 0.0167 (0.0014) 
12 0.9513 0.0445 (0.0022) 0.0042 (0.0007) 0.371 0.628 (0.0059) 0.001 (0.0004) 0.2721 0.7102 (0.0052) 0.0177 (0.0014) 
13 0.9494 0.0463 (0.0022) 0.0043 (0.0007) 0.371 0.628 (0.0059) 0.001 (0.0004) 0.2528 0.7286 (0.0051) 0.0186 (0.0015) 
14 0.9477 0.0479 (0.0023) 0.0044 (0.0007) 0.371 0.628 (0.0059) 0.001 (0.0004) 0.2353 0.7452 (0.005) 0.0195 (0.0015) 
15 0.946 0.0495 (0.0023) 0.0045 (0.0007) 0.371 0.628 (0.0059) 0.001 (0.0004) 0.2193 0.7604 (0.0049) 0.0203 (0.0015) 
16 0.9444 0.051 (0.0023) 0.0046 (0.0007) 0.371 0.628 (0.0059) 0.001 (0.0004) 0.2048 0.7742 (0.0048) 0.021 (0.0015) 
17 0.9428 0.0525 (0.0024) 0.0047 (0.0008) 0.371 0.628 (0.0059) 0.001 (0.0004) 0.1914 0.7869 (0.0047) 0.0217 (0.0016) 
18 0.9413 0.0539 (0.0024) 0.0048 (0.0008) 0.371 0.628 (0.0059) 0.001 (0.0004) 0.1791 0.7985 (0.0046) 0.0224 (0.0016) 
19 0.9398 0.0553 (0.0024) 0.0049 (0.0008) 0.371 0.628 (0.0059) 0.001 (0.0004) 0.1678 0.8092 (0.0045) 0.023 (0.0016) 
20 0.9384 0.0567 (0.0025) 0.0049 (0.0008) 0.371 0.628 (0.0059) 0.001 (0.0004) 0.1573 0.8191 (0.0044) 0.0236 (0.0016) 
21 0.937 0.058 (0.0025) 0.005 (0.0008) 0.371 0.628 (0.0059) 0.001 (0.0004) 0.1477 0.8281 (0.0044) 0.0242 (0.0016) 
22 0.9357 0.0592 (0.0025) 0.0051 (0.0008) 0.371 0.628 (0.0059) 0.001 (0.0004) 0.1387 0.8366 (0.0043) 0.0247 (0.0017) 
23 0.9343 0.0605 (0.0025) 0.0052 (0.0008) 0.371 0.628 (0.0059) 0.001 (0.0004) 0.1304 0.8444 (0.0042) 0.0252 (0.0017) 
24 0.9331 0.0617 (0.0026) 0.0052 (0.0008) 0.371 0.628 (0.0059) 0.001 (0.0004) 0.1227 0.8516 (0.0041) 0.0257 (0.0017) 
25 0.9318 0.0629 (0.0026) 0.0053 (0.0008) 0.371 0.628 (0.0059) 0.001 (0.0004) 0.1155 0.8583 (0.004) 0.0262 (0.0017) 
26 0.9305 0.0641 (0.0026) 0.0054 (0.0008) 0.371 0.628 (0.0059) 0.001 (0.0004) 0.1089 0.8645 (0.0039) 0.0266 (0.0017) 
27 0.9294 0.0652 (0.0026) 0.0054 (0.0008) 0.371 0.628 (0.0059) 0.001 (0.0004) 0.1026 0.8704 (0.0039) 0.027 (0.0017) 
28 0.9282 0.0663 (0.0027) 0.0055 (0.0008) 0.371 0.628 (0.0059) 0.001 (0.0004) 0.0968 0.8758 (0.0038) 0.0274 (0.0017) 
29 0.927 0.0674 (0.0027) 0.0056 (0.0008) 0.371 0.628 (0.0059) 0.001 (0.0004) 0.0915 0.8808 (0.0037) 0.0277 (0.0017) 
30 0.9259 0.0685 (0.0027) 0.0056 (0.0008) 0.371 0.628 (0.0059) 0.001 (0.0004) 0.0863 0.8856 (0.0036) 0.0281 (0.0018) 
Injury: injury poisoning and certain consequences 
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Table C31: Cost and utility parameters used in models of sub-group- Male 
Resource  Unit (Standard Error) Reference 
 Local Model Central Model  
Cost    
Mean travel time to the 
A&E 
14.69 min (0.038) 19.7 min (0.088) Estimated from HES data 
Cost per minute of 
ambulance journey 
£8.18 £8.18 PSSRU 2008 
Cost of mean travel 
time to the A&E 
£120.16 (£0.31) £161.15 (£0.72) Product of mean travel time 
and cost per minute 
ambulance journey 
Cost per attendance of 
A&E 
£115.01 (£10.39) 
 
£115.01 (£10.39) 
 
PSSRU 2010 
Cost per day admitted 
in the hospital 
£155.32 (£16.64) 
 
£115.01 (£10.39) PSSRU 2010 
Cost per day in the 
community 
0 0 Assumed 
Cost per 20 minutes 
time of emergency 
medicine consultant 
0 £35.67 PSSRU 2016/17- assumed 
same as consultant-surgical 
and computed from £107 
per hour cost 
Utility Mean Standard Error  
A&E 0.48 0.0097 Goodacre et al 2012 
Admission 0.48 0.0097 Goodacre et al 2012 
Community 0.85 0.0017 Sullivan et al 2011 
Dead 0 0 Assumed 
 
Table C32: Cost and utility parameters used in models of sub-group- Female 
Resource  Unit (Standard Error) Reference 
 Local Model Central Model  
Cost    
Mean travel time to the 
A&E 
14.2 min (0.031) 19.42 min (0.08) Estimated from HES data 
Cost per minute of 
ambulance journey 
£8.18 £8.18 PSSRU 2008 
Cost of mean travel 
time to the A&E 
£116.16 (£0.25) £158.86 (£0.66) Product of mean travel time 
and cost per minute 
ambulance journey 
Cost per attendance of 
A&E 
£115.01 (£10.39) 
 
£115.01 (£10.39) 
 
PSSRU 2010 
Cost per day admitted 
in the hospital 
£155.32 (£16.64) 
 
£115.01 (£10.39) PSSRU 2010 
Cost per day in the 
community 
0 0 Assumed 
Cost per 20 minutes 
time of emergency 
medicine consultant 
0 £35.67 PSSRU 2016/17- assumed 
same as consultant-
surgical and computed 
from £107 per hour cost 
Utility Mean Standard Error  
A&E 0.43 0.0091 Goodacre et al 2012 
Admission 0.43 0.0091 Goodacre et al 2012 
Community 0.815 0.002 Sullivan et al 2011 
Dead 0 0 Assumed 
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Table C33: Cost and utility parameters used in models of sub-group- Age <=29 
Resource  Unit (Standard Error) Reference 
 Local Model Central Model  
Cost    
Mean travel time to the 
A&E 
13.61 min (0.065) 17.64 min (0.19) Estimated from HES data 
Cost per minute of 
ambulance journey 
£8.18 £8.18 PSSRU 2008 
Cost of mean travel 
time to the A&E 
£111.33 (£0.53) £144.30 (£1.54) Product of mean travel time 
and cost per minute 
ambulance journey 
Cost per attendance of 
A&E 
£115.01 (£10.39) 
 
£115.01 (£10.39) 
 
PSSRU 2010 
Cost per day admitted 
in the hospital 
£155.32 (£16.64) 
 
£115.01 (£10.39) PSSRU 2010 
Cost per day in the 
community 
0 0 Assumed 
Cost per 20 minutes 
time of emergency 
medicine consultant 
0 £35.67 PSSRU 2016/17- assumed 
same as consultant-surgical 
and computed from £107 
per hour cost 
Utility Mean Standard Error  
A&E 0.65 0.0362 Goodacre et al 2012 
Admission 0.65 0.0362 Goodacre et al 2012 
Community 0.905 0.0021 Sullivan et al 2011 
Dead 0 0 Assumed 
 
Table C34: Cost and utility parameters used in models of sub-group- Age-30-64 
Resource  Unit (Standard Error) Reference 
 Local Model Central Model  
Cost    
Mean travel time to 
the A&E 
14.21 min (0.04) 18.77 min (0.09) Estimated from HES data 
Cost per minute of 
ambulance journey 
£8.18 £8.18 PSSRU 2008 
Cost of mean travel 
time to the A&E 
£116.24 (£0.32) £153.54 (£0.76) Product of mean travel time 
and cost per minute 
ambulance journey 
Cost per attendance of 
A&E 
£115.01 (£10.39) 
 
£115.01 (£10.39) 
 
PSSRU 2010 
Cost per day admitted 
in the hospital 
£155.32 (£16.64) 
 
£115.01 (£10.39) PSSRU 2010 
Cost per day in the 
community 
0 0 Assumed 
Cost per 20 minutes 
time of emergency 
medicine consultant 
0 £35.67 PSSRU 2016/17- assumed 
same as consultant-
surgical and computed 
from £107 per hour cost 
Utility Mean Standard Error  
A&E 0.51 0.0488 Goodacre et al 2012 
Admission 0.51 0.0488 Goodacre et al 2012 
Community 0.828 0.0049 Sullivan et al 2011 
Dead 0 0 Assumed 
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Table C35: Cost and utility parameters used in models of sub-group- Age 65+ 
Resource  Unit (Standard Error) Reference 
 Local Model Central Model  
Cost    
Mean travel time to the 
A&E 
14.71 min (0.03) 20.32 min (0.08) Estimated from HES data 
Cost per minute of 
ambulance journey 
£8.18 £8.18 PSSRU 2008 
Cost of mean travel 
time to the A&E 
£120.33 (£0.28) £166.22 (£0.68) Product of mean travel time 
and cost per minute 
ambulance journey 
Cost per attendance of 
A&E 
£115.01 (£10.39) 
 
£115.01 (£10.39) 
 
PSSRU 2010 
Cost per day admitted 
in the hospital 
£155.32 (£16.64) 
 
£115.01 (£10.39) PSSRU 2010 
Cost per day in the 
community 
0 0 Assumed 
Cost per 20 minutes 
time of emergency 
medicine consultant 
0 £35.67 PSSRU 2016/17- assumed 
same as consultant-surgical 
and computed from £107 
per hour cost 
Utility Mean Standard Error  
A&E 0.45 0.0164 Goodacre et al 2012 
Admission 0.45 0.0164 Goodacre et al 2012 
Community 0.774 0.0039 Sullivan et al 2011 
Dead 0 0 Assumed 
 
Table C36: Cost and utility parameters used in models of sub-group- CCI0 
Resource  Unit (Standard Error) Reference 
 Local Model Central Model  
Cost    
Mean travel time to 
the A&E 
14.47 min (0.03) 19.46 min (0.09) Estimated from HES data 
Cost per minute of 
ambulance journey 
£8.18 £8.18 PSSRU 2008 
Cost of mean travel 
time to the A&E 
£118.36 (£0.27) £159.18 (£0.71) Product of mean travel 
time and cost per minute 
ambulance journey 
Cost per attendance 
of A&E 
£115.01 (£10.39) 
 
£115.01 (£10.39) 
 
PSSRU 2010 
Cost per day admitted 
in the hospital 
£155.32 (£16.64) 
 
£115.01 (£10.39) PSSRU 2010 
Cost per day in the 
community 
0 0 Assumed 
Cost per 20 minutes 
time of emergency 
medicine consultant 
0 £35.67 PSSRU 2016/17- 
assumed same as 
consultant-surgical and 
computed from £107 per 
hour cost 
Utility Mean Standard Error  
A&E 0.45 0.006 Goodacre et al 2012 
Admission 0.45 0.006 Goodacre et al 2012 
Community 0.828 0.0015 Sullivan et al 2011 
Dead 0 0 Assumed 
CCI0: Charlson’s co-morbidity index=0 
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Table C37: Cost and utility parameters used in models of sub-group- CCI4 
Resource  Unit (Standard Error) Reference 
 Local Model Central Model  
Cost    
Mean travel time to 
the A&E 
14.52 min (0.08) 20.49 min (0.18) Estimated from HES data 
Cost per minute of 
ambulance journey 
£8.18 £8.18 PSSRU 2008 
Cost of mean travel 
time to the A&E 
£118.77 (£0.64) £167.61 (£1.48) Product of mean travel time 
and cost per minute 
ambulance journey 
Cost per attendance of 
A&E 
£115.01 (£10.39) 
 
£115.01 (£10.39) 
 
PSSRU 2010 
Cost per day admitted 
in the hospital 
£155.32 (£16.64) 
 
£115.01 (£10.39) PSSRU 2010 
Cost per day in the 
community 
0 0 Assumed 
Cost per 20 minutes 
time of emergency 
medicine consultant 
0 £35.67 PSSRU 2016/17- assumed 
same as consultant-
surgical and computed 
from £107 per hour cost 
Utility Mean Standard Error  
A&E 0.45 0.006 Goodacre et al 2012 
Admission 0.45 0.006 Goodacre et al 2012 
Community 0.828 0.0015 Sullivan et al 2011 
Dead 0 0 Assumed 
CCI4: Charlson’s co-morbidity index>=4 
 
Table C38: Cost and utility parameters used in models of sub-group- IMD1 
Resource  Unit (Standard Error) Reference 
 Local Model Central Model  
Cost    
Mean travel time to 
the A&E 
12.57 min (0.05) 18.81 min (0.11) Estimated from HES data 
Cost per minute of 
ambulance journey 
£8.18 £8.18 PSSRU 2008 
Cost of mean travel 
time to the A&E 
£102.82 (£0.39) £153.87 (£0.88) Product of mean travel time 
and cost per minute 
ambulance journey 
Cost per attendance of 
A&E 
£115.01 (£10.39) 
 
£115.01 (£10.39) 
 
PSSRU 2010 
Cost per day admitted 
in the hospital 
£155.32 (£16.64) 
 
£115.01 (£10.39) PSSRU 2010 
Cost per day in the 
community 
0 0 Assumed 
Cost per 20 minutes 
time of emergency 
medicine consultant 
0 £35.67 PSSRU 2016/17- assumed 
same as consultant-
surgical and computed 
from £107 per hour cost 
Utility Mean Standard Error  
A&E 0.45 0.006 Goodacre et al 2012 
Admission 0.45 0.006 Goodacre et al 2012 
Community 0.828 0.0015 Sullivan et al 2011 
Dead 0 0 Assumed 
IMD1: Index of mean deprivation 1st quintile 
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Table C39: Cost and utility parameters used in models of sub-group- IMD5 
Resource  Unit (Standard Error) Reference 
 Local Model Central Model  
Cost    
Mean travel time to 
the A&E 
10.48 min (0.02) 14.11 min (0.03) Estimated from HES data 
Cost per minute of 
ambulance journey 
£8.18 £8.18 PSSRU 2008 
Cost of mean travel 
time to the A&E 
£85.73 (£0.14) £115.42 (£0.28) Product of mean travel time 
and cost per minute 
ambulance journey 
Cost per attendance of 
A&E 
£115.01 (£10.39) 
 
£115.01 (£10.39) 
 
PSSRU 2010 
Cost per day admitted 
in the hospital 
£155.32 (£16.64) 
 
£115.01 (£10.39) PSSRU 2010 
Cost per day in the 
community 
0 0 Assumed 
Cost per 20 minutes 
time of emergency 
medicine consultant 
0 £35.67 PSSRU 2016/17- assumed 
same as consultant-
surgical and computed 
from £107 per hour cost 
Utility Mean Standard Error  
A&E 0.45 0.006 Goodacre et al 2012 
Admission 0.45 0.006 Goodacre et al 2012 
Community 0.828 0.0015 Sullivan et al 2011 
Dead 0 0 Assumed 
IMD5: Index of mean deprivation 5th quintile 
 
Table C40: Cost and utility parameters used in models of sub-group- 
Circulatory 
Resource  Unit (Standard Error) Reference 
 Local Model Central Model  
Cost    
Mean travel time to 
the A&E 
15.17 min (0.08) 20.22 min (0.18) Estimated from HES data 
Cost per minute of 
ambulance journey 
£8.18 £8.18 PSSRU 2008 
Cost of mean travel 
time to the A&E 
£124.09 (£0.64) £165.40 (£1.51) Product of mean travel time 
and cost per minute 
ambulance journey 
Cost per attendance of 
A&E 
£115.01 (£10.39) 
 
£115.01 (£10.39) 
 
PSSRU 2010 
Cost per day admitted 
in the hospital 
£155.32 (£16.64) 
 
£115.01 (£10.39) PSSRU 2010 
Cost per day in the 
community 
0 0 Assumed 
Cost per 20 minutes 
time of emergency 
medicine consultant 
0 £35.67 PSSRU 2016/17- assumed 
same as consultant-
surgical and computed 
from £107 per hour cost 
Utility Mean Standard Error  
A&E 0.46 0.0141 Goodacre et al 2012 
Admission 0.46 0.0141 Goodacre et al 2012 
Community 0.828 0.0015 Sullivan et al 2011 
Dead 0 0 Assumed 
Circulatory: diseases of the circulatory system 
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Table C41: Cost and utility parameters used in models of sub-group- 
Respiratory 
Resource  Unit (Standard Error) Reference 
 Local Model Central Model  
Cost    
Mean travel time to 
the A&E 
13.88 min (0.06) 18.99 min (0.17) Estimated from HES data 
Cost per minute of 
ambulance journey 
£8.18 £8.18 PSSRU 2008 
Cost of mean travel 
time to the A&E 
£113.54 (£0.54) £155.34 (£1.38) Product of mean travel time 
and cost per minute 
ambulance journey 
Cost per attendance of 
A&E 
£115.01 (£10.39) 
 
£115.01 (£10.39) 
 
PSSRU 2010 
Cost per day admitted 
in the hospital 
£155.32 (£16.64) 
 
£115.01 (£10.39) PSSRU 2010 
Cost per day in the 
community 
0 0 Assumed 
Cost per 20 minutes 
time of emergency 
medicine consultant 
0 £35.67 PSSRU 2016/17- assumed 
same as consultant-
surgical and computed 
from £107 per hour cost 
Utility Mean Standard Error  
A&E 0.39 0.0148 Goodacre et al 2012 
Admission 0.39 0.0148 Goodacre et al 2012 
Community 0.828 0.0015 Sullivan et al 2011 
Dead 0 0 Assumed 
Respiratory: diseases of respiratory system 
 
Table C42: Cost and utility parameters used in models of sub-group- Digestive 
Resource  Unit (Standard Error) Reference 
 Local Model Central Model  
Cost    
Mean travel time to 
the A&E 
14.63 min (0.08) 19.5 min (0.18) Estimated from HES data 
Cost per minute of 
ambulance journey 
£8.18 £8.18 PSSRU 2008 
Cost of mean travel 
time to the A&E 
£119.67 (£0.64) £159.51 (£1.46) Product of mean travel time 
and cost per minute 
ambulance journey 
Cost per attendance of 
A&E 
£115.01 (£10.39) 
 
£115.01 (£10.39) 
 
PSSRU 2010 
Cost per day admitted 
in the hospital 
£155.32 (£16.64) 
 
£115.01 (£10.39) PSSRU 2010 
Cost per day in the 
community 
0 0 Assumed 
Cost per 20 minutes 
time of emergency 
medicine consultant 
0 £35.67 PSSRU 2016/17- assumed 
same as consultant-
surgical and computed 
from £107 per hour cost 
Utility Mean Standard Error   
A&E 0.53 0.0225 Goodacre et al 2012 
Admission 0.53 0.0225 Goodacre et al 2012 
Community 0.828 0.0015 Sullivan et al 2011 
Dead 0 0 Assumed 
Digestive: diseases of the digestive system 
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Table C43: Cost and utility parameters used in models of sub-group- Abnormal 
Resource  Unit (Standard Error) Reference 
 Local Model Central Model  
Cost    
Mean travel time to 
the A&E 
13.9 min (0.05) 19.34 min (0.14) Estimated from HES data 
Cost per minute of 
ambulance journey 
£8.18 £8.18 PSSRU 2008 
Cost of mean travel 
time to the A&E 
£113.70 (£0.44) £158.20 (£1.18) Product of mean travel time 
and cost per minute 
ambulance journey 
Cost per attendance of 
A&E 
£115.01 (£10.39) 
 
£115.01 (£10.39) 
 
PSSRU 2010 
Cost per day admitted 
in the hospital 
£155.32 (£16.64) 
 
£115.01 (£10.39) PSSRU 2010 
Cost per day in the 
community 
0 0 Assumed 
Cost per 20 minutes 
time of emergency 
medicine consultant 
0 £35.67 PSSRU 2016/17- assumed 
same as consultant-
surgical and computed 
from £107 per hour cost 
Utility Mean Standard Error  
A&E 0.5 0.0152 Goodacre et al 2012 
Admission 0.5 0.0152 Goodacre et al 2012 
Community 0.828 0.0015 Sullivan et al 2011 
Dead 0 0 Assumed 
Abnormal: abnormal clinical laboratory findings 
 
Table C44: Cost and utility parameters used in models of sub-group- Injury 
Resource  Unit (Standard Error) Reference 
 Local Model Central Model  
Cost    
Mean travel time to 
the A&E 
14.99 min (0.07) 20.06 min (0.17) Estimated from HES data 
Cost per minute of 
ambulance journey 
£8.18 £8.18 PSSRU 2008 
Cost of mean travel 
time to the A&E 
£122.62 (£0.57) £164.09 (£1.39) Product of mean travel time 
and cost per minute 
ambulance journey 
Cost per attendance of 
A&E 
£115.01 (£10.39) 
 
£115.01 (£10.39) 
 
PSSRU 2010 
Cost per day admitted 
in the hospital 
£155.32 (£16.64) 
 
£115.01 (£10.39) PSSRU 2010 
Cost per day in the 
community 
0 0 Assumed 
Cost per 20 minutes 
time of emergency 
medicine consultant 
0 £35.67 PSSRU 2016/17- assumed 
same as consultant-
surgical and computed 
from £107 per hour cost 
Utility Mean Standard Error  
A&E 0.43 0.0173 Goodacre et al 2012 
Admission 0.43 0.0173 Goodacre et al 2012 
Community 0.828 0.0015 Sullivan et al 2011 
Dead 0 0 Assumed 
Injury: injury poisoning and certain consequences 
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